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1.1 Ocular embryology
The development of the eye and its adnexa mark an important milestone in sensory organ em-
bryology occurring from the twenty-fi rst day of gestation and extending into early adolescence. 
The fi rst sign of human eye development occurs by 21 days of gestation when the optic pits 
are noticed. This occurs during the period of embryogenesis that lasts until the end of the third 
gestational week, marked by the formation of the optic grooves, the anlage of the eye on the 
inner surface of the anterior neural folds. The optic sulci are seen as invaginations of the neural 
ectoderm. At the junction of the neural and surface ectoderm are the neural crest cells, which 
migrate below the ectoderm and spread into the optic sulci. These cells later form the corneal 
stroma, iris stroma, choroid, sclera, ciliary muscle, orbital cartilage and bone. At this stage of 
gestation, the neural tube is partially fused and segmentation occurs resulting in the formation 
of the primitive prosencephalon, mesencephalon and rhombencephalon. Fibroblastic growth 
factors (FGF), vascular–like growth factors (VGF), and neurotrophic, angiogenic growth factors 
are involved in embryonic development at this stage (Tripathi et al 1991).
The period of organogenesis lasts until the eighth week of gestation when primary organ 
rudiments form. The optic vesicles form as invaginations of the optic sulci towards the surface 
ectoderm of the forebrain vesicle. Complete closure of the neural tube and the formation of the 
optic vesicle occur by 25 days of gestation when the embryo measures 3 mm. The neural crest 
cells around the optic vesicle form the connective tissue structures of the eye, while the expan-
sion of the vesicle continues under the mechanical infl uence of the growing cytoskeleton and 
extracellular matrix. The surface ectoderm in contact with the optic vesicle thickens to form the 
lens placode, which later invaginates with the neural ectoderm forming the optic cup (Figure 1). 
The inner and outer neuroblastic layers are established in the 12 mm stage at the posterior pole 
and development proceeds radially through the optic cup. Expression of the homeobox genes 
determines the development of specialised structures at this stage (Beebe 1994).
The period of differentiation starts at the beginning of the third month of gestation when the 
primitive organs develop into defi nitive structures. This period continues after birth too in the 
macular region. The invagination of the optic cup results in the formation of the optic fi ssure 
Figure 1: Early development of the eye
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as the mesenchymal tissue invades the area and the hyaloid artery develops. The optic stalk 
connecting the eye to the ventricle gives rise to the optic nerve. The retina develops from the 
optic vesicle. The double layer of folded neural ectoderm of the optic cup differentiates into 
the inner neurosensory retina and outer retinal pigment epithelial (RPE) layer with the subretinal 
space in between (Pei & Rhodin 1970). The RPE is attached to Bruchs membrane which is well 
developed by the sixth month when the embryo measures between 14 and 18 cm. Vasculariza-
tion of the retina begins in the sixteenth week of intrauterine life at the optic nerve head and 
reaches the ora by birth.
Several ocular genes regulate the specifi c areas of development. RX and PAX6 are important 
in the formation of the optic cup. Transcription factors like CRX bind to retinal gene promoters 
which are specifi c DNA sites that regulate transcription of genes involved in ocular structure 
and function.
Retinogenesis
Retinogenesis results in the formation of the three distinct cellular layers of the retina. These 
layers consist of the outer nuclear layer of photoreceptor cells consisting of rods and cones, 
the inner nuclear layer of Müller, amacrine, horizontal and bipolar cells and the neuronal layer of 
ganglion cells. Retinal progenitor cells differentiate to give rise to the various retinal cell types in 
a sequential pattern proceeding from the center to the periphery of the optic cup. The fi rst retinal 
cells to develop are the ganglion cells followed by the cones, horizontal and amacrine cells. The 
rod, bipolar and Müller cells develop last. The proliferation of cells is regulated by growth factors 
through intracellular signaling. Cells leaving the cell cycle migrate to their specifi ed locations 
to differentiate. Cellular differentiation occurs earlier in the central retina than in the peripheral 
retina, while proliferation of cells ceases in the central retina earlier than in the peripheral retina 
(Young 1985). Cell migration and differentiation play a pivotal role in the development of the 
retina.
The fovea develops by the eleventh embryonic week, while the foveal pit forms postnatally 
between the eleventh and fi fteenth months. The cone density in the fovea increases after birth, 
due to the centripetal migration of cone cells towards the center of the fovea. The retina con-
tinues to develop after birth, with peripheral rods, Müller cells and cone cells being formed until 
the third postnatal month. bHLH and the homeobox proteins are transcription factors involved 
in the differentiation of retinal cells while CHX10 and Mitf are associated with formation of the 
sensorineural retina and the RPE cells.
1.2 Genetics of retinal disease
Hereditary retinal disease accounts for approximately 5% of blindness worldwide and Leber 
congenital amaurosis accounts for 5% of all inherited retinal dystrophies (Kaplan et al 1990). 
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Patterns of genetic inheritance for retinal disease may be chromosomal, monogenic or complex. 
Single gene traits, often referred to as Mendelian (after Gregor Mendel 1822-1884) are listed 
categorically in the Online Mendelian Inheritance of Man database (http://ncbi.nlm.nih.gov/
Omim). This database is a catalog of human genes and genetic disorders authored and edited 
by Victor A. McKusick and his colleagues at Johns Hopkins University, and developed for the 
World Wide Web (www) by the National Center for Biotechnology Information (NCBI). Complex 
inheritance typically has an inheritance pattern which is non-Mendelian; polygenic when many 
genes at different loci contribute small additive effects, and multifactorial when alleles at more 
than one locus interact with environmental factors.
Retinal diseases are catalogued on-line at the RetNet site (http://www.sph.uth.tmc.edu/
RetNet) conceived by Stephen Daiger, which lists cloned and mapped genes with clinical as-
sociations, protein product (if known), primary references and links to other sites. Currently, 189 
retinal genes and loci causing disease have been identifi ed and 135 genes have been cloned 
(RetNet last update May 2007). The list of mapped and cloned genes causing retinal disease has 
steadily increased in the last two decades. Together with X-linked mental retardation (Ropers & 
Hamel 2005) and sensorineural deafness (http://webhost.ua.ac.be/hhh/), retinitis pigmentosa 
(RP) is among the most complex groups of Mendelian disorders affecting mankind.
Discovering the molecular basis of inherited retinal diseases is the fi rst step in understanding 
pathogenesis and hence, developing therapeutic strategies.
Family history provides information about consanguinity and the pattern of transmission, 
although it is essential to clinically examine all living relatives to defi ne their phenotypes. Marked 
intrafamilial clinical heterogeneity amongst members of the same family with the same mutation 
is prevalent and well documented. Consanguinity describes closely related relatives from the 
same population who are more likely to carry the same recessive gene defects.
Some retinal diseases appear to follow simple classical Mendelian inheritance and are 
termed single gene or monogenic disorders, which are determined by alleles at a single locus. A 
variant allele replaces the original wild type allele on either or both chromosomes. The presence 
of identical alleles (homozygous) or different alleles, one being normal (heterozygous) or both 
alleles being abnormal (compound heterozygous), defi ne the genotype.
1.2.1 Autosomal dominant inheritance
The phenotype is described as autosomal dominant (AD) when only one chromosome of the 
pair carries a mutant allele in a patient. Typically, a phenotype expressed in both homozygotes 
and heterozygotes is dominant, while a phenotype expressed only in homozygotes is recessive. 
The phenotype in AD disorders is usually observed in every generation. Occasionally a new 
dominant mutation is detected in the gamete of a phenotypically normal parent. Rarely, due to 
variable expressivity, an autosomal disorder may have mild clinical signs despite inheritance of 
the abnormal gene. This provides a practical diffi culty because these patients with mild phe-
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notypes and subtle clinical signs may not be detected, except on careful clinical examination, 
leading to problems in assigning the inheritance pattern.
In a dominant condition the child of an affected parent has a 50% risk of inheriting the disor-
der. Males and females are equally affected, new mutations may be the cause of isolated cases 
and phenotypically normal parents rarely transmit the phenotype to their offspring. Differences 
in expression occur in AD retinal disease due to variable expression and pleiotropy. Penetrance 
is the fraction of individuals with a genotype who exhibit signs of the disease. Heritable retinal 
disease, like many other genetic diseases, is often not expressed in all genetically predisposed 
persons (incomplete penetrance). Persons carrying the mutant gene but who do not express 
the phenotype are considered non-penetrant. Expressivity is the extent to which a genetic 
defect is manifest, the expression of the trait may be from mild to severe. For example, in Leber 
congenital amaurosis (LCA), CRX mutations in a mother and son are associated with diverse 
clinical features and ERG changes due to variable expressivity, despite having the same geno-
type (Koenekoop et al 2002). Individuals may have variable clinical expression or phenotype 
with regard to the severity (variable expressivity) or age of onset (age-related penetrance) or 
both. Intrafamilial variability in expression and incomplete penetrance has been documented in 
many diseases including cone-rod dystrophy (CORD) mapping to chromosome 17p12, with se-
quence changes in retinal guanyl cyclase 2D (GUCY2D). Pleiotropy refers to multiple phenotypic 
effects of a single gene or gene pair in several tissues.
Autosomal dominant disorders may arise from several pathogenic mechanisms. Haploinsuf-
fi ciency occurs when loss of half the normal activity of a protein causes disease. This is often 
seen in genes encoding transcriptions factors, structural proteins, and cell surface receptors 
(Kedzierski et al 2001). A dominant negative effect is observed when an abnormal protein 
interferes with the functional product of the normal allele. Gain of function occurs either when 
the mutant protein acquires an enhanced or a novel function. In dominantly inherited cancers 
(e.g. retinoblastoma) a random somatic mutation occurs as a “second hit” on a background 
of a germline mutation (“fi rst hit”). Therefore, although the predisposition to retinoblastoma is 
inherited as a dominant trait, the mutations that result in neoplasia are recessive at the cellular 
level because both copies of the gene are affected. Thus, the distinction between dominant 
and recessive mutant alleles depends on the concept of haploinsuffi ciency. If the mutant allele 
causes disease despite a normal allele, that is, the normally functioning allele is not suffi cient to 
carry out its designated function then the allele and the disorder is termed dominant. The mutant 
allele may also be capable of blocking the function of the normal allele. Phenotypic or clinical 
heterogeneity occurs when there are clinically different phenotypes arising from mutations in the 
same gene (Sullivan & Daiger 1996). Variability of clinical expression may be dependent on the 
genetic background and the environment and can even occur within the same pedigree (Ayuso 
et al 1996).
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1.2.2 Autosomal recessive inheritance
When the disease is expressed only when both chromosomes carry a mutant allele, auto-
somal recessive (AR) transmission is described, as seen in congenital stationary night-blindness 
(CSNB), RP, and LCA. In autosomal recessive inheritance the phenotype is usually observed 
in the same sibship, males and females are equally affected and the parents are usually as-
ymptomatic carriers of the mutant alleles. The recurrence risk for each affected sibling is 1 in 
4. Consanguinity in the pedigree may be likely if the gene responsible is rare in the population. 
In a European population 10% of patients with LCA had a history of parental consanguinity 
(Grieshaber et al 1998).
 Consanguinity in the parental generation is strong evidence for autosomal recessive in-
heritance, however if the gene frequency is high in the general population (e.g. cystic fi brosis 
in north-western Europe), then the incidence of AR disease in non-consanguineous matings 
in that population is increased. The coeffi cient of inbreeding is the probability that a homozy-
gote procured both alleles at a locus from the same ancestral source. It is also the fraction of 
chromosomal regions at which an individual is homozygous or identical by descent. In genetic 
isolates the frequency of rare recessive genes may be higher than in the general population due 
to inbreeding as observed in the achromats of Pingelap (Sundin et al 2000). A disorder is termed 
recessive if in heterozygotes (one normal and one mutant allele) 50% of the gene product is 
suffi cient to perform its normal function. Changes at the molecular, cellular and biochemical 
level have been observed in heterozygotes (Tucker et al 2004).
1.2.3 X-linked Inheritance
X-linked (XL) dominant and recessive inheritance have been described in retinal disease. Since 
males have only a single X chromosome, they are hemizygous, while in females due to random 
X inactivation, most genes are expressed only on one X chromosome. Several retinal dystro-
phies including ~10% of RP have an X-linked pattern of inheritance (Breuer et al 2002). X-linked 
inheritance however has not been reported in LCA.
1.2.4 Digenic Inheritance
Retinal disease may also be inherited due to disease-causing mutations in two different genes. 
Digenic RP due to mutations in two different genes, ROM1 and peripherin/rds, located on 
chromosomes 11 and 6 respectively, has been described. The encoded wildtype proteins are 
related in structure and interact. Heterozygous ROM1 mutations alone do not lead to RP, unlike 
some mutations in peripherin/rds that cause AD RP (Kajiwara et al 1994, Dryja et al 1997). 
Offspring of patients with this type of digenic disease have a 25% chance of inheriting both 
disease alleles and manifest disease. Reports of digenic disease have been documented in 
Bardet-Biedl syndrome, a complex pleitropic autosomal recessive disease that manifests with 
retinal degeneration, obesity and polydactyly, hypogonadism, renal malformations and learning 
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disabilities (Fauser 2003). Some patients with Bardet-Biedl syndrome may carry three mutant 
alleles; two in one gene and one in another. Therefore the chance of affected offspring is low.
1.2.5 Uniparental isodisomy (UPD)
Uniparental disomy occurs when two chromosomes are inherited from only one parent. In uni-
parental isodisomy an identical chromosome or chromosome segment is present in duplicate; 
in uniparental heterodisomy, both homologs from one parent are inherited. Paternal uniparental 
isodisomy (UPD) of chromosomes 1 and 2 respectively has been reported for RPE65 and 
MERTK-associated retinal dystrophy (Thompson et al 2002).
1.3 Tools and methods for gene identifi cation
1.3.1 Genetic markers
Molecular genetic techniques have accelerated the detection of genes, and the sequencing 
of the human genome has aided in the mapping and identifi cation of retinal genes. Restriction 
fragment length polymorphisms (RFLPs) were the fi rst generation of DNA markers. Restriction 
enzymes and their role in molecular genetics were discovered by Werner Arber, Daniel Nathans 
and Hamilton Smith who were awarded the Nobel Prize in 1978 (Nathans & Smith 1975). Detec-
tion of altered nucleotide sequences enables specifi c endonucleases to cleave DNA at that 
specifi c site. Changes in the restriction site alter the length of the fragments generated following 
enzymatic cleavage, which can be visualized on a polyacrylamide or agarose gel by electro-
phoresis. As RFLPs have only two alleles with a maximum heterozygosity of 0.5 they are not 
always informative when used in disease mapping and their recent utilization in high throughput 
techniques (single nucleotide polymphisms; see 1.3.2.2) has lead to their re-emergence as 
genetic markers.
Polymerase chain reaction (PCR) has revolutionised molecular biology since it amplifi es small 
amounts of specifi c DNA or RNA fragments and elevates the quantity to the detection level. 
This method was developed by Kary Mullis who was awarded the Nobel Prize in 1993 (Mullis 
K 1990a, 1990b). Molecular markers that are highly polymorphic show marked differences 
among individuals. Single nucleotide polymorphisms (SNPs) occur at the rate of 1 in 500 nucle-
otides (Antonarakis et al 1985). Variations in short sequence repeats (SSR) serve as common 
polymorphisms since they occur at an average of 1 in 50 kilo bases (kb) of DNA and may be 
used as genetic markers (Saiki et al 1988, Weber et al 1989). SSRs consist of 10-20 copies of 
di-, tri-, or tetranucleotide repeats and are amenable to analysis by PCR. DNA polymorphisms 
are used to construct extensive linkage maps in genetic mapping studies and they also play 
a central role in paternity and forensic studies, tracing genetic evolution, recombination of the 
genome and distinguishing normal from mutant chromosomes. Other genetic markers include 
variable number of tandem repeats (VNTRs or minisatellites) the repeat unit of which are 5-10 
Sharola BW.indd   24 29-May-07   10:45:25 AM
Introduction 25
bps long, and two-allele SNPs (Botstein et al 1980). VNTRs are used in forensic studies and 
SSRs enables the unequivocal fi ngerprinting of individuals (Jeffreys et al 1990). Minisatellites are 
potentially more than 10,000 in number, consist of many alleles, and tend to cluster near the 
ends of chromosomes. On the other hand SNPs are more than 4,000,000 in number, are less 
informative than microsatellite markers, but can be typed using automated equipment without 
gel or capillary electrophoresis. SNPs are exploited in ultra-high throughput genotyping and are 
available on the worldwide web (SNP database). Short tandem repeats (STR) were used most 
frequently in the studies described in this thesis. Primer software is available on the worldwide 
web to design custom oligonucleotides and conduct virtual (e-PCR) experiments. The e-PCR 
program has also been utilized in this study.
1.3.2 Cloning approaches
1.3.2.1 Functional cloning
Knowledge of the protein product leading to the identifi cation of the disease constitutes 
functional cloning and was used successfully in for example the mapping of phenylketonuria, 
hemophilia A, and gyrate atrophy (Valle et al 1977). This method involved the synthesis of short 
oligonucleotide probes based on the relevant (defi cient) protein, which were used to screen a 
cDNA library constructed from a cell line in which the relevant gene was known to be expressed. 
Alternatively, antibodies were used raised against the target protein to screen a cDNA expres-
sion library and the identifi ed cDNA clone was used to screen a genomic library to detect the 
disease causing gene.
1.3.2.2 Positional cloning
Positional cloning on the other hand involves the use of molecular methods to initially map 
and isolate the disease gene prior to the identifi cation of the protein product. The fi rst stage 
consists of defi ning the approximate gene location using linkage analysis, autozygosity map-
ping or physical mapping of chromosomal abnormalities, while the second stage consists of 
identifying candidate genes using the genome browser, identifi cation of expressed sequences 
and database mining from the human genome sequence databases.
Currently genetic mapping is based on high-resolution maps saturated with SNPs or STRs. 
This provides effective strategies for discovering candidate genes involved in determining retinal 
phenotypes. RP, the commonest retinal dystrophy, occurs in 1 in 3,000 live births worldwide. 
The fi rst locus for this large group of retinal dystrophies was mapped to the short arm of chro-
mosome X using molecular genetic techniques in 1984 (Bhattacharaya et al 1984). The RP2 
and RP3 genes, RP2 and retinitis pigmentosa GTPase regulator (RPGR) were later identifi ed 
using positional cloning (Meindl et al 1996, Roepman et al 1996). Identifi cation of genes for 
LCA and RP was achieved following the combined approach of linkage analysis and candidate 
gene sequencing (Dryja et al 1990, Humphries et al 1990, Dryja et al 1991, Rosenfeld et al 
Sharola BW.indd   25 29-May-07   10:45:25 AM
26
1992, Perrault et al 1996). Choroideremia, a progressive X-linked chorioretinal dystrophy was 
mapped by cloning a large part of the gene, now known as the Rab escort protein (REP) by 
deletion mapping (Cremers et al 1989, 1990). The gene for Norrie disease, which consists of 
progressive atrophy of the eye, associated with microcephaly, deafness, mental retardation 
and hypogonadism in one-third of the cases, was mapped to Xp11.3-p11.4 and subsequently 
identifi ed using the positional cloning approach taking advantage of microdeletions in the X 
chromosome (Zhu et al 1989, Berger et al 1992, Chen et al 1992, 1993).
1.3.2.2.1 Mapping of the candidate region
Linkage analysis
Haldane, Fisher and Pierce were instrumental in laying the foundations of human genetic analysis 
in the 1930s, using mathematical statistics and genetics. Haldane and Smith in 1947 devel-
oped the use of the likelihood ratio and the maximum likelihood estimation, which includes the 
computation of likelihoods on extended pedigrees. Morton in 1955 introduced the LOD scores 
of Barnard to linkage analysis. The advent of DNA markers based on the genetic sequence 
revolutionized mapping (Botstein et al 1980). Mapping disease genes starts with identifying 
and enrolling a suffi cient number of patients or families to establish linkage. The establishment 
of the chromosomal location of a gene is possible through gene mapping. Peripheral venous 
blood or cheek swabs are usually obtained following informed consent in accordance with 
the declaration of Helsinki and the DNA extracted from these samples is used to genotype a 
set of polymorphic markers across the whole genome. The localization of a disease gene to a 
chromosome is analysed using linkage analysis.
Linkage analysis is the process by which genes or alleles are assigned their relative genetic 
distances from other known genes or alleles. Using pedigrees for haplotype analysis the num-
ber of informative meiosis is analysed. Linkage analysis uses probability models and parametric 
inference as its basis to compute the statistical signifi cance of genetic distances and recom-
bination fractions (Kruglyak et al 1996). Successful genetic mapping is performed using highly 
polymorphic genetic markers at regular intervals and genotyping pedigrees for linkage analysis 
(Dib et al 1996). Genes and markers on the same chromosome are inherited together, unless 
separated by crossing over, resulting in recombination. Genetic crosses are used to establish 
the location of genetic markers and to determine the genetic distance between markers. The 
genetic distance is obtained by the frequency of crossing over between markers. The closer 
together the marker and the target genes are, the less likely it is for crossing over to take place 
between them during meiosis and vice versa. The genetic distance expressed in centi-Morgans 
(cM) can be thus computed using the recombination frequency. Alleles are inherited variations 
in DNA sequence at any given locus and they cosegregate at a rate related to the distance 
between them on a chromosome. This rate theta (θ) is the recombination fraction or probability 
of recombination occurring between two loci. The recombination fraction ranges from θ = 0 
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for loci close to each other to θ = 0.5 for loci far apart or on different chromosomes. A genetic 
distance between loci of 1 cM corresponds to a recombination fraction of 1% possible on the 
same chromosome. The number of recombinants divided by the total progeny and expressed 
as a percentage provides the recombination frequency.
Loci are genetically linked when θ = <0.5. Using linkage analysis it is possible to estimate θ, 
the recombinant frequency and test if it is less than 0.5 (Ott 1974). The statistical method known 
as the LOD (logarithm of odds) score method is used to test for possible linkage between both 
the specifi c marker and the disease gene. This method makes use of data obtained from a 
large number of pedigrees, calculates, and compares the probability of two markers being 
linked. It is possible to evaluate the likelihood of a pedigree under different assumptions of the 
recombination between two loci using linkage analysis programs like LINKAGE. A LOD that 
generates a score of 3 or higher (1 in 1,000 probability) is accepted as conclusive evidence of 
linkage, while scores of –2 or lower is suggestive of non-linkage (Morton 1955). Theoretically a 
LOD score of 3 in autosomal disease may be spurious in only 1 in 1000 times (Ott & Terwilliger 
1991). The formula used to compute the LOD score is Z (θ) =log 10 L (θ) divided by L (0.5). The 
log likelihood is calculated using linkage analysis programs. LINKAGE helps establish linkage 
between the target gene and the marker. MAKEPED, MLINK, SIMLINK etc are used to compute 
the LOD scores (Ploughman & Boehnke 1989). Standard LOD score determination is vulnerable 
to errors and there are computational limitations to analysis. Locus heterogeneity is a drawback 
and diffi culties with specifying the genetic model, the mode of inheritance, the affectation status, 
the penetrance and the gene frequencies further limit this method. Two-point mapping involves 
the use of two loci at a time for analysis and this method is less effi cient as it does not take into 
consideration informativeness of several markers simultaneously.
Linkage analysis aids in localising the target interval. The genetic size of the human genome 
is 3000 cM with 1 cM corresponding to 1 Mb. As the human genome contains 30,000 genes 
distributed over a physical distance of 3000 cM, narrowing the candidate region to 10 cM would 
include ~100 genes. Candidate genes located in the interval may be sequenced in order to de-
tect alterations. When linkage is established the proximity of the gene to the marker is measured 
by the recombination frequency. Mapping of the disorder to the resolution of several million base 
pairs, though still requiring a formidable effort in many cases, make it possible to identify and 
isolate the disease gene. Multipoint linkage analysis is often used in combination with two-point 
mapping to take into account the informativeness of markers and to establish the chromosomal 
order of a set of linked loci. The Centre d’Etude du Polymorphisme Humain (CEPH) marker 
framework map constructed from the data of the Cooperative Human Linkage Center (CHLC) 
families may be used to provide a reliable starting point for disease-marker mapping (http://gai.
nci.nih.gov/CHLC). Computer software programs like LINKMAP and GENEHUNTER are able 
to place the disease locus under investigation across the marker framework and calculate the 
likelihood of linkage at each point. The results can be plotted on a graph to generate a curve 
of LOD scores against a map location, with the highest peak of the LOD scores favoring the 
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location of the disease gene. Multipoint mapping has the advantage of linkage exclusion when 
the curve is below the LOD score of -2 in that specifi c region.
Autozygosity mapping
Markers or genes at a particular locus are considered autozygous when they are identical 
due to descent from a common ancestor. This allows a robust method of linkage mapping in 
autosomal recessive disease. Consanguinity and inbreeding further contribute to the power 
of analysis. Affected individuals are often autozygous by descent at the disease locus and 
at adjacent loci thus identifying an autozygous region not shared by the unaffected individu-
als making it likely the disease harboring region. The gene NPHP3, involved in Senior-Løken 
syndrome, was mapped using this method (Omran H et al 2000). The mathematical power of 
this technique enables the mapping of rare autosomal disease loci in inbred pedigrees with just 
three affected individuals (Dharmaraj et al 2000a). Identifying shared ancestral haplotypes allows 
high resolution mapping for rare autosomal recessive disease. Nijmegen breakage syndrome, 
which consists of microcephaly, growth retardation, immunodefi ciency and predisposition to 
cancer due to chromosomal instability, was mapped to the NBS gene, by identifying a common 
ancestral haplotype of Slav origin, and mutations in the gene confi rmed the presence of the 
same mutation in all the individuals (Cerosaletti et al 1998, Varon et al 1998).
Physical mapping of chromosomal abnormalities
Chromosomal abnormalities provide an alternative method to localise a disease gene. Ap-
parently balanced translocations that result in an abnormal phenotype can be cause by the 
disruption of a gene at one of the two breakpoints, or could be due to submicroscopic loss or 
gain of DNA. The breakpoint, which can be identifi ed by fl uorescent in situ hybridization (FISH), 
provides a valuable clue to the location of the disease causing gene. Cloning breakpoints often 
provide the quickest way to identify the disease gene. Breakpoints can also alter the function 
of genes located several kilobases away by affecting the structure of large scale chromatin 
domains leading to a position effect and haploinsuffi ciency. This was noted in aniridia with PAX6 
mutations (Lauderdale 2000).
1.3.2.2.2 Identifying candidate genes
The Human Genome Project
The Human Genome Project started in 1990 and was completed in 2003. DNA sequences 
were cloned into phages, cosmids, bacterial artifi cial chromosomes, and yeast artifi cial chromo-
somes that can harbour DNA fragments of between 35 and 1000 kb (Schlessinger et al 1990). 
In the early phase of this project, contigs were constructed of these cloned DNA fragments. 
Subsequently, a total of 3 billion base pairs were sequenced which led to the detection of 
~30,000 protein-coding genes (IHGHC 2004). This was a combined venture conducted in large 
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genome centers with high throughput sequencing capacity in several countries. The information 
generated through this venture was coordinated by the human genome organization (HUGO) 
and was made available electronically to smaller laboratories worldwide which were involved in 
specifi c genetic projects. Automated fl uorescence labeling- and capillary-based DNA sequenc-
ing contributed to the rapid output. The accelerated pace of gene mapping and the discovery 
of genes associated with disease is dependent on the advances in molecular biology and the 
expansion of electronic genetic and biologic databases. The publication of the working drafts 
of the sequence of the human genome was made possible by the International Human Gene 
Sequencing Consortium (Venter et al 2001).
Identifi cation of expressed sequences
Web based databases make the process of identifying expressed sequences less laborious. One 
of the laboratory methods that enhance database analysis for identifying expressed sequences 
within genomic clones is transcript mapping. Transcript mapping is possible through cDNA 
library screening using genomic clones from the candidate region as probes. Currently there are 
over 37 million ESTs available in databases (Genbank) which have been produced by one-shot 
sequencing of cloned mRNA. ESTs being about 500 to 800 nucleotides long represent portions 
of genes and can be physically mapped using radiation hybrid mapping or FISH. DNA sequence 
similairity searches between ESTs and localized regions of interest help identify genes and are 
useful in designing probes for DNA microarrays.
Identifi cation of a candidate gene
Identifying the disease gene is based on its structure, function and expression pattern while 
establishing its pathologic role is demonstrated by mutation detection. The genes identifi ed 
become good candidates for retinal disease when they are specifi cally expressed in the 
retina. Candidate genes could be human homologs of genes responsible for similar disease 
phenotypes in other organisms (comparative candidates; orthologous genes) or they could be 
members of a gene family of which other members have been implicated in related disorders 
(homologous genes).
There are various techniques to identify tissue-specifi cally expressed genes, for example, by 
serial analysis of gene expression (SAGE) based on the sequencing of short DNA fragments from 
a representative set of mRNA transcripts from cell or tissue samples (Velculescu et al 1995). This 
extensive method of gene expression profi ling is of use in identifying candidate genes for retinal 
disease and the SAGE database is available on the worldwide web (Blackshaw et al 2001). 
DNA micro-arrays based on either cDNA or oligonucleotides allow the study of simultaneous 
expression assays of represented genes. Expressed sequence tag (EST) databases provide 
large sources of information for gene discovery and expression (Strausberg et al 2003).
Screening of candidate genes in pedigrees may be performed initially using either single 
stranded conformational polymorphism analysis (SSCP) or heteroduplex analysis (dHPLC). 
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When aberrant migration patterns are noted, direct sequencing is undertaken in an effort to 
identify the specifi c mutation.
1.3.3 Mutation Analysis
1.3.3.1 Mutations
Mutations result from different mechanisms. The commonest disease-causing mutations are 
single nucleotide substitutions, termed transitions when a purine is substituted for a purine (A 
to G, G to A) or when a pyrimidine is substituted for another pyrimidine (T to C, C to T) and 
termed transversions when a purine is substituted for a pyrimidine or vice versa. Transitions 
(approximately 2/3 of substitutions) are more common than transversions (approximately 1/3 
of substitutions). CpG dinucleotides mutate to TpG, at a higher rate than mutations in other 
dinucleotides. This transition of C to T occurs more often in the male germline than the female, 
probably because of the greater number of cell divisions in spermatogenesis and the greater 
chance of copy errors in DNA replication (Cooper & Gerber-Huber 1985, Cooper & Krawczak 
1990).
Mutations of CpG nucleotides to TG or CA account for 90% of substitutions and methylation-
mediated deamination of 5-methylcytosine resulting in thymine is the mechanism (Cooper & 
Schmidtke 1992, Cooper 1992). Point mutations, such as missense, nonsense, and splice site 
mutations are the commonest gene alterations causing human pathology. Missense mutations 
(substitutions) that occur in amino acid residues of functional signifi cance could potentially 
eliminate or adversely alter the activity of the protein (non-conservative missense mutation). De-
letions and insertions, including duplications, can alter the reading frame, causing a frameshift 
resulting in a shortened (truncated) protein product. All types of mutation have been observed 
in LCA (Perrault et al 1999, Dharmaraj et al 2000, Lotery et al 2000).
1.3.3.2 Polymorphisms
There exist a large number of normal variations in the DNA sequence in the general population 
which do not necessarily alter gene expression. This wide variation in the human population can 
present a problem with testing for nucleotide changes, which may be mutations (pathogenic 
changes) or polymorphisms (non-pathogenetic changes). Strictly, a polymorphism is the occur-
rence in a population of two or more alternative genotypes, each at a frequency greater than 
that which could be maintained by recurrent mutation alone. A locus is arbitrarily considered 
to be polymorphic if the rare allele has a frequency of at least 0.01 so that the heterozygote 
frequency is at least 0.02. Any allele rarer than this is termed a rare variant. This is in contrast 
to the defi nition of a mutation, which is any permanent heritable change in the sequence of 
genomic DNA causing pathology.
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1.3.3.3 Mutation detection
Southern blotting
Southern blotting may be used to detect rearrangements in the gene (Southern 1974,1975). 
Genomic DNA is fragmented using restriction enzymes separated via gel electrophoresis, dena-
tured and blotted on to a nylon fi lter ultra-violet light. A single stranded radio-labeled DNA probe 
complementary to the target gene is added to the fi lter where it hybridizes to complementary 
sequences. These bands are identifi ed by autoradiography to detect insertions, deletions and 
rearrangements. Mutations in restriction sites result in hybridization of the probe to a different 
fragment making them amenable to detection. Southern blotting is time-consuming and since 
the development of the polymerase chain reaction is used less often.
PCR-based scanning methods
Since the polymerase chain reaction enables target DNA fragments to be generated from 
minute amounts of DNA obtained from peripheral venous leucocytes or cells from oral mucosa, 
alterations in sequence can be studied. Sequencing of amplifi ed PCR products enables iden-
tifi cation of alterations in mutant genes. PCRs do not involve the use of radiation and are easy 
to undertake as the process is automated, technically undemanding and require only a small 
amount of DNA. At least 90% of mutations are detected using this technique.
Single strand conformational polymorphism
Single strand conformational polymorphism (SSCP) involves the simultaneous labeling and 
amplifi cation of target DNA sequences by PCR. The PCR products are denatured and the frag-
ments of DNA are separated on a polyacrylamide gel by electrophoresis under non-denaturing 
conditions to preserve the inherent secondary structure. Mutations are detected by the altera-
tion in mobility of the separate strands (Orita et al 1989a, 1989b). The sensitivity of this test 
is approximately 80% and is relatively cheap, making it a good screening method prior to 
sequencing (Sheffi eld et al 1993).
Heteroduplex analysis
Hereoduplexes are formed on heating the heterozygous test PCR product to promote denatur-
ing and then subjecting it to slow cooling. A heteroduplex consists of a hybrid strand of double-
stranded DNA made up of two mismatched strands. Heteroduplexes have an abnormal mobility 
on nondenaturing polyacrlyamide gel. This feature is exploited when subjecting PCR products 
from suspected carriers to denaturing and reannealing, facilitating the normal and mutant single 
strands to form heteroduplexes, which can then be detected on a gel. The relevant target area 
may be sequenced to detect the mutation. This is a simple method when sequences less than 
200 bps are employed and is useful in detecting insertions, deletions and most base substitu-
tions (Keen et al 1991).
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Denaturing gradient gel electrophoresis (DGGE)
Heteroduplexes have abnormal denaturing profi les resulting in varying mobility of the fragments 
on gel. The PCR products are run on a special denaturing gel that contains increasing concen-
trations of denaturing material like urea. As the double stranded DNA denatures to form single 
strands, the mutant strands migrate differently in the gel. These are then sequenced to identify 
the underlying mutation. This method has a sensitivity of 90% once the method is optimized, as 
special primers and conditions are necessary for maximal results.
Denaturing high performance liquid chromatography (DHPLC)
This method also exploits the fact that heteroduplexes have abnormal denaturing profi les and 
that the fragment mobility changes with denaturing. This WAVEMAKER technology may be 
used for high throughput analysis as it is extremely sensitive and is useful in the detection of 
base substitutions, small deletions and insertions. Differential separation of mismatched het-
eroduplexes form normal and mutant DNA strands on reannealing. PCR products are placed 
in a column containing an increasing gradient of acetonitrite and the elution of homo- and 
heteroduplexes is dependent on the size and sequence of the fragments and the concentration 
of acetonitrite. This method also is reported to have a sensitivity of over 90%.
Sequencing
Sequencing involves the process of determining the order of nucleotide bases along DNA 
strands and this is possible using the chain determination or degradation methods. Since the 
late 1970s the more commonly used method of chain termination made use of the fact that 
single-stranded DNA molecules differed in length by just a single nucleotide and could be sepa-
rated from one another by polyacrylamide gel electrophoresis (Sanger et al 1977). Sequencing 
using chemical decomposition of Maxam & Gilbert is based on the occurrence of base-specifi c 
fi ssion (Maxam & Gilbert 1977).
Microarray
This new technology makes use of several hybridizations on a single slide. The gene chip 
consists of a small device in the form of a coated glass microscopic slide on which hundreds of 
different DNA sequences (oligonucleotides) are produced by in situ synthesis (e.g. resequencing 
chip Affymetrix) or spotted onto the microarray (e.g. APEX technology Asper Biotech). PCR 
products from target samples to be analysed are hybridized to the array. For APEX this in 
essence involves several simultaneous mini-sequencing reactions. The pattern of binding at 
each pair of spots gives a visual record of the genotype. This method may be also be used to 
study the expression pattern of genes.
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1.3.4 Bioinformatics
The two most important events in recent times have been the discovery of the structure of 
DNA and the completion of the Human Genome Project. Bioinformatics is defi ned as the use 
of computers for the acquisition, management and analysis of biological information (Brown 
et al 2000). It has now become easier to understand heredity at the chemical level, delve into 
the chemical structure, expression and function of genes. Most of this is possible because of 
free information sharing on the Internet and the existence of numerous well managed biological 
databases. It has become as important to navigate through the maze of bioinformatics, as 
it is to work at the bench. Computing, data gathering and analysis have become an integral 
part of genomics which is the application of high throughput automated technology to biology. 
Integrating data from diverse biological fi elds and using the Web browser to gain information 
have become an integral part of genetics.
Many of the web sites used in this study have been listed in the reference section of this 
chapter. The http://genome.ucsc.edu web tool, with rapid and reliable display of the genome 
with aligned annotation tracks, was used extensively. The browser displays assembly contigs 
and gaps, mRNA and expressed sequence tag alignments, multiple gene predictions, cross-
species homologies, SNPs, STSs, radiation hybrid data and transposon repeats. Text and 
sequence-based searches provide quick and precise access to any region of specifi c interest. 
Secondary links from the individual features lead to sequence details and supplementary off-site 
databases making the database a very valuable resource. Databases are used to obtain marker 
information, gene positions, functions and expression. The databases and the software for 
comparing and analysing data provide ample integration of genomic and cDNA sequences, 
physical and genetic maps, structure and function of genes.
Extensive catalogs of gene mutations, phenotypic descriptions and copious amounts of 
literature have made it possible to understand and study heritable retinal disease in an inte-
grated fashion. A major portion of gene identifi cation and characterization can now be done 
in silico which may give a fi rst indication of the tissue distribution of a gene. For example, 
the NCBI UniSTS website (http://www.ncbi.nlm.nih.gov/genome/sts/epcr.cgi) electronic-PCR 
feature allows the testing of a DNA sequence for the presence of sequence tagged sites: e-PCR 
looks for STSs in DNA sequences by searching for subsequences that closely match the PCR 
primers and have the correct order, orientation, and spacing that they could plausibly prime 
the amplifi cation of a PCR product of the correct molecular weight (Schuler et al 1997). Most 
databases are accessible through the National Center for Biotechnology of the National Library 
of Medicine (http://www.ncbi.nlm.nih.gov) and its numerous links. Information hyperlinked over 
proteins (iHOP) includes information on genes and proteins and aids in text and data mining 
interlinking medical and biological concepts in a few short steps (Hoffmann & Valencia 2004).
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1.4 Retinal anatomy
The retina is the innermost layer of the eye and is derived from the neuroectoderm. It is 42 mm 
in diameter and lines the back of the eye (Figures 2 & 3). The optic disc represents the axons 
of the ganglion cells with the central retinal artery and vein in the center, and is about 2 mm in 
diameter. From the center of the disc to the center of the retina (the anatomic fovea) is usually 5 
Figure 2: Cross section of the eye
Figure 3: Cross section of the retina
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mm, or 17° or 2.5 disc diameters. The macula surrounds the central fovea and has a diameter 
of 6 mm (Van Buren 1963, Kolb 1991). There are two main layers: the outer retinal pigment 
epithelium (RPE) and the inner sensorineural retina which varies in thickness from 0.4 mm 
near the optic nerve to approximately 0.15 mm anteriorly at the ora serata, i.e. the area where 
the RPE is continuous with the pigment epithelium of the ciliary body. The retina comprises of 
10 histological layers: the RPE, the photoreceptor cells (rods and cones), the external limiting 
membrane, the outer nuclear layer, the outer plexiform layer, the inner nuclear layer, the inner 
plexiform layer, the ganglion cell layer, the nerve fi ber layer and the inner limiting membrane 
(Figure 3).
The rods and cones transduce light signals into electric impulses, which are amplifi ed and 
integrated through circuitry involving bipolar, horizontal, amacrine and ganglion cells; the signal 
is transmitted to the optic nerve via the nerve fi ber layer.
1.4.1 Retinal structure
The sensory retina is a laminated structure and has three layers of nuclei. The retina is a highly 
specialized tissue composed of six main cell types, namely the cone and rod photorecep-
tors, bipolar, horizontal, amacrine, Müller and ganglion cells. The rods and cones are the two 
major classes of photoreceptor cells in the retina, and together they make up the outer nuclear 
layer. The photoreceptor cells synapse in the outer plexiform layer between the outer and inner 
nuclear layers (Bok et al 1985).
The inner nuclear layer is composed of the cell bodies of the horizontal, bipolar and amacrine 
cells that are interconnected, and also synapse with the ganglion cells in the inner plexiform 
layer. On and off bipolar cells act as second messengers in the retina. The amacrine cells 
form a rich synapsing network in the inner retina and are divided into several classes based 
on the neuropeptides and neurotransmitters involved in transmission. The innermost ganglion 
cell layer forms the inner nuclear layer of cell nuclei that is thin in the retinal periphery and thick 
in the macula. The axons of the ganglion cells pass through the optic disc, forming the optic 
nerve. The periphery of the retina is rod-dominated while the human macula contains a cone-
dominated, avascular fovea, surrounded by a rod-dominated parafovea. The macula is 3 mm 
in diameter and the fovea is 0.5 mm in diameter situated in the center of the macular region. 
The avascular foveola located in the center of the fovea measures 0.3 mm and is composed of 
~100,000 cones.
The retina is a highly metabolic layer and receives dual blood supply. The inner retina has its 
own capillary network situated at the level of the internal nuclear layer. The larger arterioles and 
venules of the retinal circulation travel in the nerve fi ber layer and ganglion cell layer. The capillar-
ies extend to the inner nuclear layer close to the foveal avascular zone where the capillaries form 
a single layer but elsewhere they form two or more distinct layers. The outer half of the retina has 
a high metabolic requirement and derives oxygen and nutrients from the choriocapillaris that is 
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supplied by the choroidal circulation through diffusion. The two circulations do not overlap and 
constitute the blood retinal barrier (Cunha-Vaz et al 1979).
Retinal cells communicate with one another via synaptic interactions and gap junctions. 
Neurotrophic factors, retinoids, growth factors and ions infl uence retinal cell interactions. The 
interphotoreceptor matrix that extends from the outer limiting membrane to the surface of the 
RPE cells provides a rich background of nutrients and proteins, among which is IRBP that aids 
in the transport of retinoids from the photoreceptor cells to the retinal pigment epithelium.
1.4.1.1 Photoreceptor cells and function
Rod and cone photoreceptor cells are specialised cells involved in phototransduction converting 
photons of light into nerve signals. The rods are responsible for vision in dim light and the cones 
provide high speed color vision in bright light. Ninety two million rod cells are responsible for 
scotopic vision under low illumination, while 5 million cone cells are used for vision in photopic 
conditions (Curcio et al 1990). Cones are 100-fold less sensitive to light than rods but the 
photoresponse of cones is several fold faster than rods (Baylor et al 1979, Kefalov et al 2005, 
Travis et al 2005,). These cells are arranged in hexagonal mosaics. The outer segments of the 
rods and cones differ in size, with the cone outer segments being shorter and the distal ends 
being broader than their rod counterparts (Figure 4).
Figure 4: Rod structure
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 Each photoreceptor has a cell body, an inner and an outer segment with an intermediary 
cilium that is in constant communication between the two segments. The outer segment of 
the photoreceptor cells consist of fl at lipid bilayer discs while the inner segment is fi lled with 
mitochondria and other cell organelles (Figure 4). The cilium which is a microtubular structure 
in these cells plays a prominent role in molecular transport and disk morphogenesis (Schmitt 
et al 2001). The inner segment, in which protein synthesis occurs, and the rod outer segment 
where disc turnover occurs, are dependent on the connecting cilium for transport. The cilium is 
composed of a membrane bound axoneme which has a 9+0 confi guration of microtubules that 
are connected by dynein arms. The cilium is non-motile and myosin VIIa that localizes here is 
mutated in patients with Usher syndrome type I which is characterized by retinal degeneration 
and sensorineural deafness (El-Amraoui et al 1996). The entry of active metabolites into the 
inner segment facilitates cellular renewal and newly formed proteins are transported through the 
connecting cilium to the outer segment (Young 1968, Young & Droz 1968).
The estimated 5 million cones in the retina each carry one of three visual pigments (Curcio 
1990). Humans have three cone pigments, unlike rodents that have two and chickens that have 
four. Using microspherophotometry the wavelength of maximum absorption of the blue, green 
and red photoreceptors were measured to be 420, 530 and 560 nm respectively (Dartnall et 
al 1983). The human retina has more red cones than green or blue cones. The red and green 
cones are concentrated in the fovea, which contains very few blue cones. The cone cell pigment 
is located within the membrane of the transverse discs of the outer segment of the cones. 
Each cone cell has 1000-2000 disks and 109 photopigment molecules. The cone cells make 
contact with the bipolar cells that in turn contact ganglion cells, forming only a 3-neuron chain 
in comparison to the 4-neuron chain of the rod cells. The cone cells elicit either hyperpolarizing 
or depolarizing effects on the bipolar cells. The outer segments of rods are made up of ~600 to 
1000 discs delicately arranged one on top of the other. The discs are sac-like structures made 
up of bilipid membranes and are separate from the plasma membrane of the inner segment 
in rods, unlike in cones where they are continuous. The discs are formed by evagination of 
the plasma membrane at the junction between the outer and inner segments of the plasma 
membrane near the connecting cilium. The lamellar regions in the rod discs are rich in rhodopsin 
while the rim region is abundant in RDS/peripherin. Rhodopsin, which is necessary for the 
conversion of light energy into an electrical impulse, is found in high concentration in the disc 
membrane and accounts for up to 95% of protein in the rod outer segments. Rhodopsin is 
synthesized in the rough endoplasmic reticulum of the inner segment. It is transported to the 
outer segment past the connecting cilium and inserted into the plasma membrane of the outer 
segment, with the carboxyterminal on the cytoplasmic surface of the disc bilayer (Hargrave & 
Fong 1977, Papermaster et al 1980, Hargrave et al 2001). Rhodopsin consists of a vitamin 
A derivative, 11-cis retinal, which is a chromophore, and opsin, a polypeptide of 349 amino 
acids. Mutations in rhodopsin affect phototransduction and cause autosomal dominant RP 
(Dryja et al 1990, Humphries et al 1990), ARRP (Rosenfeld et al 1992), and autosomal dominant 
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CSNB (Dryja et al 1993). Mutations in both rhodopsin and peripherin are known to cause retinal 
dystrophies (Sohocki et al 2001). The retinal proteins phosphodiesterase, transducin and cyclic 
GMP are also associated with the disc membrane.
Arrestin, transducin, rhodopsin kinase and phosphodiesterase are peripheral retinal proteins 
involved in phototransduction. Photoreceptor proteins include integral membrane proteins like 
ROM1, ABCA4, guanylate cyclase and retinal dehydrogenase among others. ROM1 and RDS/
peripherin are essential for outer segment morphogenesis. Prominin is another outer segment 
disc protein when mutated causes recessive retinal degeneration in mice (Maw et al 2000). 
The rod photoreceptor pathway is concerned with scotopic vision and ~75,000 rod cells drive 
5000 bipolar cells and then 250 amacrine cells converge to a ganglion cell (Gartner et al 1981, 
Sterling et al 1988, Kolb & Nelson 1993).
1.4.1.2 Function and structure of the retinal pigment epithelium
The retinal pigment epithelium (RPE) is a monolayer of 4-6 million cells with their apical microvilli 
in apposition to the photoreceptor cells and the basal infoldings towards the choroid. It forms 
the blood-retinal barrier and is involved in the bi-directional transport of metabolites between 
the retinal cells and the choriocapillaris. It is also involved in photoreceptor cell renewal, main-
tenance and survival. The RPE is responsible for uptake, storage and metabolism of vitamin A 
and retinoids. Vitamin A defi ciency resulting in dysfunctional retinoid metabolism is refl ected as 
night blindness (Somner et al 1980, Thompson et al 2003).
Recycling of 11-cis retinal occurs in the RPE making it vital for photorecovery. 11-cis retinal 
is converted to all-trans retinal during phototransduction and the regeneration of 11-cis retinal 
from all-trans retinal is possible only in the RPE where retinal isomerase is present. IRBP trans-
ports the retinoids between the photoreceptor cell and the RPE. The RPE is also involved in 
free radical scavenging, interphotoreceptor matrix production and the transport of metabolites. 
Phagocytosis of rod and cone cell discs occurs in the RPE.
The RPE is involved in retinal attachment as it pumps fl uid from the subretinal space creat-
ing a negative pressure to maintain photoreceptor cell apposition (Duvall et al 1987). Most 
genes expressed in the RPE are involved in protein degradation or retinoid metabolism and 
dysfunction of these processes leads to retinal dystrophies. Mutations in the gene encoding 
cellular retinaldehyde-binding protein (CRALBP1) cause autosomal recessive RP (Maw et al 
1997), retinitis punctata albescens (Morimura et al 1999), and fundus albipunctatus (Katsanis 
et al 2001). CRALBP binds 11-cis retinol and 11-cis retinaldehyde in the RPE, both essential 
components in the regeneration of rhodopsin. Müller cells too are involved in the recycling of 
chromophore and contain CRALBP (Saari & Bredberg 1987, Das et al 1992, Limb et al 2002).
The RPE is also responsible for the generation of the c-wave of the ERG. Light causes 
a decrease in the dark current and hence a decrease in the rate of pumping of the Na+/ K+ 
channels in the photoreceptor cells. This is followed by a decrease in the K+ concentration in the 
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extracellular subretinal space, leading to hyperpolarisation of the retinal membrane of the RPE, 
which is refl ected as a c-wave in the ERG (Oakely & Green 1976).
1.4.2 Retinal physiology
The scotopic sensitivity of the retina is mediated by the rods while the photopic sensitivity is 
mediated by cones. Colour discrimination is a function of the photopic retina. Photoreceptor 
outer segments damaged by light are renewed in a diurnal manner. The outer segments of the 
photoreceptor cell are subject to rapid metabolic turnover and hence are susceptible to damage 
either at the level of synthesis of new outer disc membranes or at the level of phagocytosis and 
removal of the spent outer segment discs. Complete removal of rod outer segments takes 9-10 
days. The tips of the rod outer segments are shed every morning, while new ones are generated 
by invaginations at the base of the outer segment and the cellular components are synthesized 
in the inner segment and transported via the cilium. The cone cell outer segment discs are 
renewed in the evening. Photoreceptor outer segment shedding and phagocytosis have impor-
tant implications for retinal degeneration. Defects in phagocytosis leading to retinal dystrophy 
have been noted due to mutations in Mertk in the Royal College of Surgeons (RCS) rat, the mer 
receptor tyrosine kinase knockout mouse and in humans with mutations in the MERTK gene 
(Gal et al 2000, Duncan et al 2003). The retina is also susceptible to light induced damage from 
free radicals and is actively involved in phototransduction and retinoid metabolism. More than 
80% of retinal glucose is utilized by the photoreceptor cells due to its high metabolic turnover.
Figure 5: Phototransduction cascade (© Bart P. Leroy)
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1.4.2.1 Phototransduction
The conversion of photic stimulation to an electrical signal constitutes phototransduction and 
forms the basis of normal vertebrate vision (Figure 5). The most important ocular function being 
that of phototransduction, more than 15 major interacting retinal proteins are involved to amplify 
the signal from photoactivated visual pigment. Rhodopsin is an integral cell membrane protein 
in the rod outer segments and in the dark resting state, the sodium channels are maintained in 
the open position by cGMP which is the second messenger and is synthesized by guanylate 
cyclase (Pepe et al 1989, Pepe 1999, 2001). The absorption of a single photon of light by the 
visual pigment rhodopsin isomerizes the retinal chromophore from the 11-cis to the all-trans 
form of retinal (Fung et al 1981, Stryer 1991) the activated intermediate that triggers phototrans-
duction. 11-cis retinal is re-synthesised from all-trans retinol (vitamin A) in the RPE.
The fi rst step in the phototransduction cascade is the confi gurational change in rhodopsin 
to a catalytically active form that activates several molecules of transducin via a (GDP) guanine 
diphosphate to (GTP) exchange. The beta and gamma subunits dissociate from the alpha subunit 
of GTP-alpha transducin which activates the crucial retinal enzyme cGMP phosphodiesterase 
(PDE) which in turn hydrolyses cGMP that is bound to the rod photoreceptor cGMP-gated 
channel protein. This results in lowering of the cytoplasmic cGMP concentration. The decrease 
in cGMP levels causes the closure of the cGMP-dependent cation gated channels in the plasma 
membrane of the rod outer segments. Closure of these channels prevents the infl ux of calcium 
and sodium leading to the hyperpolarisation of the rod cell plasma membrane and the initiation 
of the visual transduction signal. This causes the release of glutamate at the synaptic terminal 
of the rods generating a nerve signal.
Photorecovery is slower than photoactivation by a few hundred milliseconds and is initiated 
by decreased intracellular calcium, leading to the opening of the channels in the rod outer 
segment and the inactivation of transducin (Jindrova et al 1998). A decrease in calcium levels 
stimulates recoverin which activates retinal guanylate cyclase (RETGC). A rise in the cGMP level 
occurs, reopening the cGMP gated channels.
Rhodopsin is inactivated by phosphorylation induced by rhodopsin kinase and the phospho-
rylated rhodopsin is then bound to arrestin, which causes the release of all-trans retinal from 
rhodopsin, and the replacement of 11-cis retinal occurs (Hofman et al 1992). Increased levels 
of calcium prevent the phosphorylation of rhodopsin by promoting the interaction of S-modulin 
to rhodopsin kinase. The phosphorylation of activated rhodopsin increases its arrestin affi nity, 
preventing further transducin activation and thus speeding rhodopsin recovery and restoring the 
rod cells to the ground state (Palczewski & Rispoli 1992).
Arrestin is involved in the dissociation of all-trans retinal from opsin. In the rods all-trans retinal 
is reduced enzymatically to all-trans retinol and is transported to the RPE where it is isomerized 
to 11-cis retinol and oxidised to 11-cis retinal (McBee et al 2001). This prevents the continuing 
activation of transducin, thus terminating the stimulation of cGMP phosphodiesterase (Polans 
et al 1996, Yang & Garbers 1997). The level of intracellular GMP is restored by the increased 
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synthesis of cGMP from GTP by retinal guanylate cyclase (RETGC) 1 & 2. The decrease in 
intracellular calcium is mediated by guanylate cyclase activating protein (GCAP 1, 2 & 3) and 
recoverin (Klenchin et al 1995).
Activation of RETGC by recoverin increases intracellular cGMP that leads to the opening of 
cGMP-gated channels (Yau et al 1994). Increase in intracellular calcium activates GCAP and 
stimulates cGMP synthesis by RETGC. The increase in cytosolic cGMP causes an increase in 
the number of open GMP-gated channels. Calcium-dependent modulation of RETGC activ-
ity restores the rod outer segment cAMP level (Rispoli et al 1998). Calcium-bound recoverin 
inhibits rhodopsin kinase. In photoactivation the decrease in calcium inhibits calcium binding 
to recoverin and releases the inhibition of rhodopsin kinase. 11-cis retinal is returned to the rod 
outer segment (ROS) where it binds to opsin to regenerate rhodopsin (Saari 2000).
Sustained vision in daylight is subserved by cones and an alternate visual cycle in cones 
that augments pigment regeneration is essential to maintain this 200-fold higher regeneration 
in comparision to rods (Arshvarsky et al 2002, Mata et al 2002). Cones regenerate their opsins 
through an alternate retinoid cycle based on the interaction between cones and Müller cells. In 
cone-dominated retinas of ground squirrels and chickens three novel catalytic enzymes present 
in cones and Müller cells provide an alternate pathway for cone regeneration. All-trans retinol 
leaving the outer segment of the photoreceptor cells is absorbed by Müller cells where conver-
sion to 11-cis retinol occurs by a novel enzyme, all-trans retinol isomerase. The 11-cis retinol 
is released by the Müller cells to be oxidized to 11-cis retinal by another novel cone specifi c 
dehydogenase in the cones (Mata et al 2000). This allows faster regeneration of cone pigment 
in conditions of bright light and precludes utilization of 11-cis retinal by the rods (Mata et al 
2000).
1.4.2.2 Retinoid metabolism
The RPE is involved in retinoid metabolism (Figure 6). Activation and regeneration of visual 
pigment takes approximately 400 seconds for rhodopsin and about 100 seconds for cone 
visual pigments. Retinol gains entry into the retinal pigment epithelium via the choroidal and 
retinal circulations as it is bound to retinal binding protein (RPB) in plasma.
In the RPE, the all-trans form of retinol from the choroidal circulation is bound to cellular 
retinal binding protein (CRBP). All-trans retinol is converted to all-trans retinylester by lecithin/
retinol acyltransferase (LRAT), and isomerized to 11-cis retinol by isomerohydrolase. 11-cis 
retinol is bound to cellular retinaldehyde-binding protein (CRALBP) and may be either re-
esterifi ed by LRAT and stored in the RPE as 11-cis retinyl ester or oxidized to 11-cis retinal by 
11-cis retinoldehydrogenase. All-trans retinol generated in the rod outer segment by conversion 
from all-trans retinal is bound to IRBP in the subretinal space to enter the RPE from the apical 
surface.
Mutations in RPE65 disrupt the synthesis of the opsin chromophore ligand 11-cis retinal and 
this results in elevated levels of all-trans retinyl esters. The constitutive activation of sensory 
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transduction by unliganded opsin causes a constant turnon of the phototransduction cascade, 
which results in the lowering of cGMP and the abnormal closure of the cGMP gated channels, 
a situation similar to constant light expore. This is hypothesized to represent light-independent 
retinal degeneration in LCA (Woodruff et al 2003). Palmitoylated membrane-associated RPE65 
(mRPE65) acts as a chaperone for all-trans retinyl esters and facilitates conversion to 11-cis 
retinol. 11-cis retinol in the RPE is further converted to 11-cis retinal. The soluble RPE65 is not 
palmitoylated and is a chaperone for all-trans retinol. Lecithin acyl transferase acts a palmi-
toylated transferase and converts mRPE65 to sRPE65, effectively blocking the synthesis of 
11-cis retinal (Xue et al 2004). In the light 11-cis retinol is generated in the RPE and in the dark 
isomerisation is switched off (Winston and Rando 1998). Mutations in RPE65 cause early-onset 
RP or LCA in humans (Gu et al 1997, Morimura et al 1998, Simovich et al 2001). Autosomal 
recessive retinal dystrophy is noted in Briard dogs (Veske et al 1999).
Proteins involved in retinoid metabolism are necessary for photoreceptor cell survival. De-
fects in the gene RLBP1 that encodes CRALBP lead to autosomal recessive retinitis punctata 
albescens (Morimura et al 1999), while mutations in IRBP cause ARRP in humans (Valverde et 
Figure 6: Retinoid metabolism
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al 1998). 11-cis retinol in the photoreceptor cell is converted to 11-cis retinal by RDH12. 11-cis 
retinal is converted to all-trans retinal in the presence of light. LRAT plays a role in the conversion 
of all-trans retinal to all-trans retinyl ester which accumulates in the absence of RPE65. In the 
absence of RPE65 there is no formation of 11-cis retinal necessary for the regeneration of 
rhodopsin.
1.5 Retinal disease
The diagnosis of heritable retinal disease is currently based on the clinical features. With the 
advent of molecular techniques confi rmation of diseases and the effect of the mutant genes 
is being established. Correlation of the retinal morphology with the electrophysiology is key 
to the diagnosis if molecular diagnosis is unavailable. In the presence of molecular informa-
tion however, a more accurate diagnosis is possible. Molecular genetics has brought better 
understanding to the inheritance of retinal dystrophies.
The classifi cation of hereditary retinal disorders into various subtypes is based on phenotypic 
differences. Disorders that affect the central retina fi rst include macular dystrophies, like age-
related macular degeneration (ARMD) and cone-rod degeneration (CORD) leading to loss of 
central vision, while those affecting the peripheral retina early include RP and congenital station-
ary nightblindness (CSNB) wherein loss of peripheral vision occurs earlier (Musarella 2001). LCA 
includes both peripheral and central retinal disease leading to profound loss of vision.
Most hereditary retinal disorders are bilateral and the mode of inheritance can either be auto-
somal dominant, recessive, X-linked or mitochondrial in nature. The retina is made up of several 
cell types and has the highest metabolic rate of any histological layer, hence it is possible for 
mutations in any of the proteins involved in the numerous functions to lead to retinal degenera-
tion. Outer (RPE, rods & cones) retinal disorders are characterized by slow retinal degeneration 
and include not only RP, and rod and cone dystrophies, but also macular dystrophy. In several 
inherited retinal disorders photoreceptor cell death occurs as a result of apoptosis (Chang et al 
1993, Rattner et al 1999). RP, the commonest retinal dystrophy, is characterized by progres-
sive cell death of rods and cones. Mutations involving rod cell structure and function lead to 
apoptosis, which have an indirect effect on the cones, causing further cone dysfunction and 
loss. Cone cell loss occurs when rod outer segment degenerate to more than 75% as observed 
by electroretinography (Cideciyan et al 1998). Cone loss correlates spatially and temporally with 
rod loss (Milam et al 1998, Mohand-Said et al 2001, Sahel et al 2001).
Loss of rod photoreceptors causes loss of peripheral vision, motion detection, and decreased 
vision in scotopic conditions (nyctalopia). Night blindness and loss of peripheral visual fi elds are 
noted. Loss of cone photoreceptor cells results in loss of central vision (acuity loss), trichromatic 
colour discrimination (dyschromatopsia), vision loss in photopic conditions (hemerelopia) and 
ocular discomfort under photopic conditions (photoaversion or photophobia). In many retinal de-
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generations apoptosis of the photoreceptor cells leads to decreased oxygen need. This altered 
oxygen tension stimulates auto regulation in the retinal vasculature causing attenuation of the 
blood vessels as a secondary effect noted ophthalmoscopically along with optic disc pallor.
LCA like RP, is also observed in conjunction with other systemic and syndromic disorders, 
like cerebellar disease (Joubert syndrome), epiphyseal disease (Saldino-Mainzer syndrome) and 
renal disease (Senior–Løken syndrome). Currently more than 135 retinal disease genes have 
been mapped and identifi ed and for another 54 retinal diseases, the chromosomal locus but not 
the underlying gene has been identifi ed (OMIM URL, RetNet URL May 2007).
1.5.1 Clinical diagnosis of retinal disorders
Decreased visual acuity as a result of heritable retinal disease occurs in 1 in 3000 humans 
(Inglehearn et al 1998). Retinal dystrophies could present in early infancy, whereby the arrested 
development of the photoreceptors is followed by degeneration. When dystrophies present in 
later life, the degeneration occurs after the photoreceptors have developed but their survival is 
not sustained.
The diagnosis of heritable retinal disease is possible following the elucidation of a detailed 
family history and thorough clinical investigations. Examination includes not only the affected 
individuals, but also potential carriers and other family members who may have subtle clini-
cal fi ndings. Family history and examination will elucidate the inheritance pattern. The clinical 
examination consists of assessing best-corrected visual acuity, optical assessment (under 
cycloplegia in children) slit-lamp bio-microscopy and dilated fundoscopy. Other relevant investi-
gations include electrophysiological (ERG, dark adaptation curves and EOG) and psychophysi-
cal testing (static or kinetic visual fi eld tests), imaging and molecular studies.Imaging includes 
fundus photography, optical coherence tomography, scanning laser ophthalmoscopy fundus 
fl uorescein angiography and retinal autofl uorescence (if available). It is also important to perform 
a thorough medical and genetic examination in an effort to identify other clinical features sug-
gestive of a syndromic form of retinal degeneration.
1.5.1.1 Imaging
High resolution photography provides good documentation of both the anterior segment and 
the fundus. Serial photography in patients with heritable retinal disease gives greater insight into 
the progression of these disorders.
Fluorescein angiography is useful in understanding the pathophysiologic process that occurs, 
clearly showing transit time of dye in ocular vasculature, defi ning areas of hyper-, hypo- and 
blocked fl uorescence. In patients with retinal degeneration due to RP, the retinal arteries are 
narrowed and irregular fi lling may be observed. During the venous phase of the fl uorescein 
angiography, abnormal dilation of the perifoveal capillaries may be observed. Early transit of the 
dye shows increase in choroidal background hyperfl uorescence due to depigmentation of the 
RPE. Mottling of fl uorescence due to diffuse RPE degeneration is noted as patchy hyper- and 
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hypofl uorescence, seen in the mid-transit phase. Mottled fl uorescence of the posterior pole 
suggests extensive degeneration of the RPE. Leakage of fl uorescein suggestive of impaired 
vascular permeability may be observed in the macular, peripapillary and optic disc areas in the 
late transit phase. Hypofl uorescent patches represent areas of RPE and choroidal atrophy.
Increased hyperfl uorescence from the choroid along the vascular arcades may be seen. Late 
angiographic features include diffuse hyperfl uorescence extending from the superior and inferior 
poles of the optic nerve and along the temporal arcades. This is secondary to RPE atrophy giv-
ing the appearance of a window defect. Typical cystoid macular edema with leakage in the late 
phases may be seen. Mid-peripheral diffuse areas of hyperfl uorescence deep into the sensory 
retina, secondary to RPE atrophy, are observed in the late phase while blockage of background 
fl uorescence is due to pigment migration and clumping.
The confocal scanning laser ophthalmoscope is used to image autofl uorescence in the RPE 
and this is noted as a homogenous pattern on the retina (von Ruckmann et al 1995, Bellman 
et al 2003, Trieschmann et al 2003). Areas of increased autofl uorescence result in the ac-
cumulation of metabolic products from the photoreceptor cells. Later atrophy of the RPE and 
the photoreceptor cells follow (von Ruckmann et al 1997, 1999). Autofl uorescence results from 
lipofuscin breakdown obtained from the phagocytosis of the photoreceptor cell outer segment 
and is not visualised during normal ophthalmoscopy, but is seen using a confocal scanning 
laser ophthalmoscope (Kennedy et al 1995). Fundus autofl uorescence is preserved in several 
patients with LCA despite poor visual function (Scholl et al 2004).
Using optical coherence tomography (OCT) the thickness of the retina can be measured. 
Evaluation of the structural and the pathological changes leading to altered retinal thickness 
may be assessed by laser interferometry (Hamada et al 2000). Retinal morphology using mi-
croscopy and OCT correlate well as studied in animal retinas (Toth et al 1997). Visualisation of 
the photoreceptor layer is possible using a modifi ed high resolution confocal scanning laser 
ophthalmoscope (Fitzke 2000).
1.5.1.2 Electrophysiology
The electro-retinogram (ERG) is the recording of the diffuse electrical response generated by 
retinal cells, following photic stimulation in both light and dark adapted states. The ERGs are 
recorded using Burien-Allen electrodes. The pupils are dilated for this procedure. The photopic 
ERGs can be obtained using either a single fl ash or 30 Hz fl icker stimulus, while the scotopic 
recordings can be obtained using either a single fl ash or fl icker at 10 Hz in a dark adapted retina. 
The ERG represents the activity of the outer retinal layers namely the photoreceptors and the 
bipolar cells (Figure 7). The full-fi eld ERG measures the retinal response to a fl ash of light. A 
contact lens electrode is placed on the patient’s eye and the recordings of electrical responses 
from various parts of the retina to external stimulation by light of varying intensity are made.
As per the ISCEV (International Society for Clinical Electrophysiology of Vision) guidelines the 
standard responses include recordings using a bright light fl ash that measures the mixed rod-
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cone activity. The scotopic rod responses are recorded following dark adaptation. Light adapted 
photopic responses to transient and 30 Hz fl icker inform the operator about the patient’s cone 
function. The ERG is evaluated in both light and dark adapted conditions and this includes the 
measurement of the latency and amplitude. The amplitudes of the responses are measured in 
microvolts while the implicit times in microseconds. Obtaining an ERG involves adequate light 
stimulation of varying intensity of the retina to cause signal phototransduction and then record 
the ensuing electrical potentials according to the ICSEV guidelines.
Decreased ERG recordings are due to retinal disease alone but patients with relatively rea-
sonable visual acuity may present with unrecordable ERGs due to retinal dystrophies (Denier van 
der Gon et al 1956, Armington et al 1961). The diminution of ERG potential in the presence of 
normal latent implies a decrease in the population of normal photoreceptors, while a prolonged 
implicit time implies widespread photoreceptor dysfunction (Berson et al 1969).
The ERG is a combined recording of the electrical potentials of the retinal cells generated 
when a photon of light strikes the retina, converting light energy to electrochemical energy. The 
response occurs due to the transretinal movement of sodium and potassium in the extracellular 
space following light-induced stimulation. The initial defl ection is a negative a wave generated 
by the photoreceptors. The positive b wave is generated by the bipolar and Müller cells. The 
positive c wave is generated by the RPE. The absorption of light by the pigment in the outer 
segment of the photoreceptors, initiates the photo-transduction cascade.
The early receptor potential generated from the photochemical reaction induced by photons 
striking the outer segment has a short latent period and is dependent on the concentration of 
visual pigment, rhodopsin in the rod cells (Brown & Murukami 1964, Cone 1964, Cone 1967). 
The early receptor potential is reduced in early XLRP and in ADRP, due to the reduction of 
visual pigment in the photoreceptors (Goldstein & Berson 1969, Berson & Goldstein 1970). 
The resultant decrease in the cGMP levels leads to the closure of the sodium channels pres-
Figure 7: Normal ERG
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ent in the outer segment membrane of the photoreceptors, which are normally permeable to 
sodium in the dark. The ensuing hyperpolarisation due to the decrease in sodium conductance 
is measured as a corneal negative a wave.
This hyperpolarisation causes a decrease in the release of glutamate at the synaptic termi-
nals and depolarisation of the bipolar cells results, leading to an increase in the extracellular 
potassium and further depolarisation of the Müller cells, generating the corneal positive b wave. 
Disorders of the retina causing a decrease in the a wave also cause a decrease in the b wave. 
Disorders affecting the inner retinal layer cause a decrease in the b wave amplitude alone. De-
layed cone b wave implicit time is observed with progressive retinal degenerations (Berson et al 
1969). Recovery following bleach is slow in patients with RP (Alexander et al 1984, Moore et al 
1992). As a result of photoreceptor cell loss the ERG is abnormal in both light and dark-adapted 
states (Bunt-Milam et al 1983). Dark adaptation is prolonged although cone adaptation and 
the initial recovery of rod sensitivity are normal in these patients. Since the diagnosis of LCA is 
largely dependent on electroretinography, it is important to understand retinal responses in the 
developing retina. The ERG is recordable in both normal preterm and term infants as early as 7 
hours after birth (Mactier et al 1988). The implicit times are prolonged in comparison to adults. 
The b wave develops through infancy to adult levels by the age of 12 months, while sensitivity 
reaches adult values by 5-6 months of age (Fulton 1985).
The pattern ERG (PERG) measures macular function and is abnormal in macular, cone and 
cone-rod dystrophies. The decrease of the full fi eld ERG in combination with the decreased 
PERG is suggestive of rod–cone dystrophies. In macular dystrophies the full fi eld ERG is unaf-
fected, while in cone dystrophies the 30 Hz fl icker ERG is abnormal and in cone-rod dystrophies 
the scotopic response is reduced too. As the distribution, density and spatial orientation of 
cone cells across the retina is not homogenous, it is useful to perform focal and multifocal 
ERGs (MERG) to test cone function. The focal ERG primarily tests macular function, where the 
cone cells account for 9% of the total cone density (Curcio et al 1990). The MERG is a sensitive 
diagnostic indicator of outer retinal disease and is a cross correlational study of several points in 
a given area of the retina. Dark adaptometry quantitatively determines the kinetics of cone and 
rod recovery following a high intensity fl ash that bleaches the retina (Steinmetz et al 1993).
Electrooculography (EOG) records the light induced rise in resting potential across the RPE 
following a period of dark adaptation (Behrens et al 1998). It measures the Arden ratio which is 
the light peak to dark trough amplitude. The EOG is recordable in infancy and compares well 
with adult values (Trimble et al 1977). An abnormal EOG is obtained in cone, cone-rod and 
rod-cone dystrophies (Gouras & Carr 1964, Krill 1966, Krill et al 1973).
1.5.2 Phenotype of retinal disorders
Retinal dystrophies display genetic heterogeneity, i.e. the occurrence of mutations in different 
genes leading to the same clinical entity, as well as variable expression, i.e. the presence of 
mutations in one gene leading to several ophthalmologic disorders. Mutations in RDS/peripherin 
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cause ADRP, AD macular degeneration, butterfl y shaped pigmented foveal dystrophy, patterned 
macular degeneration, digenic RP with additional mutations in ROM1 and AD adult vitelliform 
macular degeneration (Connell et al 1990, Travis et al 1991, Jordan et al 1992, Nichols et al 
1993a,1993b, Wells et al 1993, Dryja et al 1997, Felbor et al 1997). The phenotypes of all these 
disorders show remarkable variation and some overlap too. Interestingly this phenomenon is 
not only noted in patients with different mutations, but also in members within a family. This 
large phenotypic spectrum associated with allelic mutations may be due to different molecular 
mechanisms (Kohl et al 1997). The mutant rds/peripherin gene in mice causes abnormal devel-
opment of photoreceptor outer segments followed by slow degeneration of rods and cones and 
varying phenotypes were not detected (Travis et al 1989).
The phenotype is the result of a developmental process whose dynamics is controlled 
by genes and possibly environmental factors. In many developmental processes, there is a 
non-linear relationship between genetic variation and phenotypic variation. Retinal disease is 
inherited by diverse mechanisms and expression is variable. Several factors modulate gene 
expression and hence the phenotype. The phenotype in turn is infl uenced by the variability in the 
genetic background on which a gene is expressed and modulated by different environmental 
factors.
Cell development, survival, maintenance, structure or function when awry, cause retinal 
degeneration. Survival of photoreceptor cells is dependent on surrounding tissue like the retinal 
pigment epithelium and interphotoreceptor matrix. Rod-specifi c gene mutations lead to the 
loss of normal cones and the loss of postnatal cone circuitry has been noted in transgenic 
swine harboring P347H mutation in rhodopsin, implying that the need for rod cell connectivity 
to neighboring healthy cones is essential for cone survival (Banin et al 1999). Secondary cone 
cell death in primary rod photoreceptor disease may be due to several factors. Inadequate 
cell-cell interaction and an altered microenvironment play a signifi cant role in cone loss. The 
presence of toxic factors generated by degenerating rods and depleted rod derived trophic 
factors is sub-optimal for cone survival (Mohand-Said et al 1998). Normal inner retinal circuitry 
is disturbed following variable rod and cone neurite sprouting in RP (Milam et al 1998). All of 
these mechanisms may play a role in LCA.
The wide range of phenotypic variation associated with CRB1 mutations is likely to be 
partially due to the dosage effect of the gene (den Hollander et al 2001). The variations in the 
phenotype may be due to allelic or locus heterogeneity. Modifi er genes could also infl uence the 
clinical phenotype in individuals affected by CRB1 mutations. In LCA a few instances of modifi er 
mutations have been identifi ed, which perhaps alter the progress of the disease (Dharmaraj et 
al 2000b, Silva et al 2004, Zernant et al 2005). Both allelic and genetic heterogeneity occur in 
LCA (Perrault et al 1999, Cremers et al 2002). The site of a mutation in a particular gene may 
lead to a different phenotype. Mutations in the dimerization domain of GUCY2D are responsible 
for AD CORD, while mutations elsewhere in the gene cause LCA or ARRP (Kelsell et al 1998, 
Perrault et al 2000).
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 Variable expressivity leading to either ADRP or macular dystrophy based on the location 
of mutations is observed in the RDS/peripherin gene (Kajiwara et al 1993, Wells et al 1993, 
Nichols et al 1993a,1993b). The relationship between the genotype and the phenotype in 
monogenic disorders may be complex. Both LCA and CORD are caused by mutations in the 
aryl hydrocarbon interacting protein-like gene, AIPL1 (Sohocki et al 2000). Retinal function is 
altered based on rod and cone survival. Decreased rod function is noted in cone dystrophy 
(Holopigian 2004).
1.5.3 Pathology of retinal degeneration
Advances in the study of the micrometabolism of retinal cells have made it possible to under-
stand the pathogenesis of retinal dystrophies. The development, maintenance and survival of 
photoreceptor cells when affected adversely, result in retinal degeneration. This could be due 
to mutations that affect rod and cone cells or neighboring supporting tissue function. The retina 
however is capable of responding to stress only in a fi nite number of ways and the symptoms 
and signs that develop due to retinal disease may have overlapping features.
Primary pigmentary degeneration of the retina is characterized by pigment migration, at-
tenuation of the retinal vasculature, and pallor of the optic disc. Pigmentary migration into the 
sensory retina appears as bone-spicule like pigment. It may occasionally be the only retinal 
change (Bastek & Siegel 1982), which depends on the relative preservation of the ganglion and 
nerve fi ber layers. Histologically, in RP, the earliest pigmentary changes occur in the equato-
rial zone, which then extends peripherally and centrally. The nuclei of the photoreceptor cells 
migrate outward and the retinal pigment migrates into the retina around blood vessels in small 
clusters, leading to subsequent degeneration. Cystoid macular edema, epiretinal membrane 
formation and macular holes may develop in RP (Li et al 1995). Initially the rods undergo de-
generation with the outer segments showing changes earlier than the inner segments. There 
is gradual depigmention of the RPE. Phagocytosis of liberated pigment by the macrophages 
and migration of pigment into the retina occur resulting in gradual depigmentation of the RPE. 
Outer retinal degeneration precedes inner retinal changes (Stone et al 1992). When the latter 
occurs degeneration of the axons of the ganglion cells is noted and waxy pallor of the optic disc 
develops (Cogan et al 1950, Landolt et al 1972, Gartner & Henkind 1982). Arterial thinning oc-
curs earlier than venous obliteration by hyalinization of the vessel walls. The choriocapillaris and 
the choroid do not show any ultrastructural changes initially (Kolb et al 1974). Photoreceptor cell 
loss and disorientation of the rods and cones are observed in ADRP (Szamie et al 1979). Gliosis 
derived from the retinal glial cells, and degeneration of pericytes and endothelial cells have been 
observed. A decrease in the number of photoreceptor cells with atrophy and thickening of the 
basement membrane of the RPE is noted in RP. Ultrastructurally, mitochondrial swelling and loss 
of organelles are observed in XLRP and ADRP while a large percentage of inner retinal neurons 
are preserved (Santos et al 1997). Bone spicule-like pigmentary retinal changes have been 
observed on ophthalmoscopy and these accumulations of retinal pigment are derived from the 
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RPE through phagocytosis and migration. In cone-rod dystrophy equatorial preservation of rods 
and cones have been observed with RPE loss in the macular area and lipofuscin-like granular 
accumulation in the RPE (Rabb et al 1986).
Since most eye specimens of RP have been obtained late in the course of the disease, 
greater insight into the natural course of the disease, pathogenesis and genetics of RP have 
been studied in animal models. Retinal changes in aborted fetuses with retinal dystrophy have 
also provided some understanding of pathology in LCA (Wong 1994, Porto et al 2002, Milam et 
al 2003). Several mechanisms cause disruption of photoreceptor cell function leading to apop-
tosis. Photoreceptor cell loss in retinal dystrophies occurs as a result of programmed cell death 
also called apoptosis (Reme et al 1998). Apoptosis, unlike necrosis, is programmed cell death 
that is a genetically encoded function of cells and plays a pivotal role in embryonic development 
and cell turnover (Raff et al 1994). In both animal models and humans with RP, apoptosis has 
been implicated as the cause of cell death (Chang et al 1993, Portera-Calliau et al 1994).
Apoptosis increases if dying cells release factors that decrease cell survival of neighboring 
cells (Siegel et al 1997). Photoreceptor cell degeneration results from mutations in more than 
60 genes (Chowers et al 2004). Defects in the activation of the phototransduction cascade, 
cellular accumulation of mutant proteins and oxygen toxicity cause degeneration (Travis 1998). 
Apoptosis occurs in the photoreceptor cells in retinal dystrophies and genes that modulate this 
process could be manipulated to arrest degeneration.
1.5.4 Animal models and retinal degeneration
Rats, mice, dogs, pigs and cats have provided good models of retinal degeneration. Muta-
tions in the cyclic GMP phosphodiesterase (βPDE) gene in the rd mouse leads to rapid retinal 
degeneration by the eighth post-natal week due to accumulation of toxic levels of cyclic GMP, 
causing autosomal recessive RP (Lolley et al 1997). The rds (retinal degeneration slow) mouse 
exhibits a mutation in the RDS/peripherin gene resulting in the arrest of the rod outer segment 
function and leads to progressive retinal degeneration over a year (Chader et al 1985). Rhodop-
sin knock-out mice (rho) with homozygous mutations in rhodopsin cause autosomal recessive 
RP (Humphries et al 1997). The RCS (Royal College of Surgeons) rat, due to mutations in the 
receptor tyrosine kinase gene (Mertk) has retinal degeneration (D’Cruz et al 2000). The RPE 
is unable to phagocytose the photoreceptor cell outer segment metabolites resulting in the 
accumulation of toxic debris in the sub-retinal space. In-frame deletions in Cep290 could lead 
to faulty interaction with Rpgr causing retinal degeneration in rd16 mice (Chang et al 2006)
Larger animal models showing retinal degeneration include the rdy cats, the rcd1, Rpe65 
dogs and transgenic pigs. In the rdy cats autosomal rod-cone dysplasia is observed (Leon et 
al 1990, 1991, 1995). In rcd1 dogs early retinal degeneration is seen (Clements et al 1993). 
Mutations in Rpe65 cause early onset retinal degeneration in Briard dogs (Aguirre et al 1998). In 
both human and animal models of RP caused by rod specifi c gene defects, the loss of rod cells 
eventually leads to the loss of cone cells too suggesting that the degenerating rod cells induce 
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apoptosis in the cone cells (Huang et al 1993). Retinal degeneration in mice and rats activate 
the apoptotic pathway of cell death (Papermaster & Windle 1995). Manipulation of the genes in-
volved in apoptosis in these animal models could essentially arrest photoreceptor degeneration. 
Factors modifying apoptosis like the increased expression of bcl-2 and its homologues reduce 
apoptosis and have been shown to cause photoreceptor rescue in mouse models (Tsang et al 
1997). Upregulating anti-apoptotic factors in retinal cells would alter retinal degeneration and 
it has been shown that expression of anti-apoptotic genes in Drosophila photoreceptor cells 
expressing mutant rhodopsin, leads to cell survival (Davidson et al 1998).
1.6 Aim and outline of this thesis
The term Leber congenital amaurosis (LCA) is often used in clinical practice to describe severe 
retinal disease causing congenital visual loss although it is now known that LCA consists of a 
group or spectrum of retinal diseases, found to be genetically heterogenous. LCA is a disorder 
that causes blindness due to photoreceptor function in early life and little was known about the 
molecular genetics in the mid-1990s.
The aim of this work was to identify new loci and genes, detect mutations in the known LCA 
associated genes, study the genotype/phenotype relationship in LCA and gain an understand-
ing of retinal disease.
Chapter 2 focusses specifi cally on LCA. Chapter 3 describes the effort to fi nd a new locus 
for LCA in a large recessive pedigree. The combined approach of linkage analysis to assign a 
new specifi c chromosomal region followed by candidate gene sequencing to identify the target 
gene is described. Chapter 4 analyses the genotype-phenotype correlation in patients with 
mutations in three LCA genes, namely CRX, GUCY2D and RPE65, in an effort to elucidate com-
mon disease mechanisms found in retinal dystrophies. This may help in the understanding of 
the natural history and prognosis of disease. Chapter 5 compares and contrasts the phenotype 
of AIPL1-associated LCA with those associated to the other LCA genes. Chapter 6 provides 
a commentary on the presence and infl uence of modifi er genes in Leber congenital amaurosis. 
Chapter 7 deals with the use of arrayed primer extension (APEX) technology for systematic 
detection and analysis of genetic variation in LCA. Chapter 8 is a short discussion of the entire 
thesis.
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2.1 Clinical evaluation
Introduction
Leber congenital amaurosis (LCA) has been described as a severe form of RP presenting in 
infancy or early childhood with the absence of photoreceptor function (Leber 1869). LCA is a 
genetically and clinically heterogenous disorder causing profound visual loss, nystagmus, poorly 
reactive pupils and a markedly diminished or non-detectable electro-retinogram (ERG) (Leber 
1869, Franceschetti et al 1954). Theodore Leber in 1869 fi rst described the condition, but 
confi rmation of the diagnosis was made easier by Adolphe Franceschetti, a Swiss ophthalmolo-
gist who noted the attenuated electro-retinographic responses in patients with LCA in 1954. 
The heterogeneity of LCA had been well documented prior to the era of molecular diagnosis 
and reinforced currently (Waardenburg et al 1961, Camuzat et al 1996).
LCA accounts for 0.005% of blindness world-wide, although it appears to be more common 
in regions with a high degree of consanguineous unions, for example, Saudi Arabia, and South 
India (Kumaramanickavel et al 2002). The clinical history has been well documented over the 
last century and accounts for a large number of blind school admissions each year. It accounts 
for 5% of all inherited retinal dystrophies and 1-3 in 100,000 live births per year (Kaplan et al 
1990). The incidence of RP, the more common retinal dystrophy is 1 in 3500 (Bunker 1984). 
Most cases of LCA are transmitted in an autosomal recessive fashion, but dominant forms of 
LCA have been described (Sorsby et al 1961, Sohocki et al 1998, Rivolta et al 2001, Perrault 
et al 2003). Several pedigrees causing syndromic LCA (Table 2) have been identifi ed (Dekaban 
1969, Popovic-Rolovic et al 1976, Robins et al 1976).
Clinical fi ndings
Patients with LCA present in early infancy with wandering or roving eyes, photophobia and an 
inability to focus. Often there is a history of photophobia or photo attraction. Eye poking (digito-
ocular phenomena of Franceschetti) is often noted in a large number of patients, often resulting 
in enophthalmos due to atrophy of orbital fat. The entoptic phenomena induced by eye poking 
may be habitual behavior observed in some patients. Oculo-digital signs include recurrent eye 
rubbing, eye pressing and eye-poking and are not pathognomic of LCA (Fazzi et al 1999, 2005). 
Sequelae of this habitual visual behavior may include enophthalmos, keratoconus and ocular 
infections (Fazzi 2003).
Decreased pupillary responses to light are observed in most patients, due to an afferent pu-
pillary defect. The retinae on ophthalmoscopy are either essentially normal in their appearance 
or show varying degrees of pigmentary changes (François 1968, Heher et al 1992). Additional 
ocular features may include cataracts, and keratoconus and keratoglobus (Karel 1968, Leighton 
et al 1973, Schroeder et al 1987, Flanders et al 1984, Heher et al 1992, Elder et al 1994, Stoiber 
et al 2000). Keratoconus, observed in some patients may be explained by genetic susceptibility 
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or the secondary effect of the digito-ocular phenomena (Schroeder 1987, Heher et al 1992, 
Elder 1994, Stoiber et al 2000, Dharmaraj 2004).
 The overall phenotype in LCA is infl uenced by pathological changes in non-retinal tissues. 
The presence of cataracts, keratoconus, and high grades of refractive errors further increase the 
severity of the phenotype. High hypermetropia and myopia have also been reported (Wagner 
et al 1985). Hyperopia was noted in most patient groups; myopia was reported in several other 
cases (Heher et al 1992, Dharmaraj et al 2000b, Lorenz et al 2000). Patients presenting with 
high refractive errors have benefi ted from using corrective spectacle lenses. The progressive 
retinal degeneration with age has been associated with increasing keratoconus and cataract 
(Alström et al 1957, Schroeder et al 1987, Heher et al 1992). It has been noted that 29% of 
Table 2: LCA: Associations
Serial 
No
Associations References
1 High hypermetropia Wagner  1985
2 Keratoglobus, Keratoconus Heher 1992, Kennedy  
1986
3 Strabismus Heher 1992
4 Cataract Heher  1992
5 Psychomotor delay Fazzi  1999
6 Neurodevelopmental anomalies Fazzi  2005
7 Nephronophthisis
(Senior-Løken syndrome) AR
Senior 1961, Loken 1961
8 Nephronophthisis, cone-shaped epiphyses of the hand and 
cerebellar ataxia 
(Saldino-Mainzer syndrome) AR
Mainzer 1970
9 Vermis hypoplasia, oculomotor anomalies and neonatal 
respiratory apnea
(Joubert syndrome) AR
Joubert 1969, Saraiva 
1992
10 Multicystic kidneys, Joubert syndrome (AR) Ivarsson 1993
11 Joubert syndrome and chorio-retinal coloboma
(Dekaban-Arima syndrome ) AR
Cerebello-oculo-hepato-renal involvement
(Arima syndrome) AR
Dekaban 1969, 
Arima1971, Lindhout 
1980
Matsuzaka 1986
12 Osteopetrosis Keith  1968
13 Cardiomyopathy, short stature, deafness and diabetes mellitus
(Alstrom syndrome) AR
Alstrom 1957, 
Russell-Eggitt 1998
14 Short stature, growth hormone defi ciency, mental retardation, 
hepatic dysfunction and metabolic acidosis
Ehara 1997 
15 Hyperthrenoninemia, hepatomegaly, psychomotor retardation Hayasaka 1986
16 Saccade palsy Moore 1984
17 Ehler-Danlos like syndrome Rahn 1968
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patients with LCA develop keratoconus (Kennedy et al 1986). The presence of keratoconus has 
been noted in patients with AIPL1, GUCY2D and CRX mutations. This could be coincidental, 
related to habitual rubbing and pressing of the eyes or due to increased genetic susceptibility. 
Keratoconus is characterised by progressive corneal thinning and the cornea assumes an ir-
regular conical shape with the apex directed outwards. Irregular corneal astigmatism ensues as 
the inferior portion of the cornea steepens, and the apex of the cone thins further. The sequelae 
of keratoconus include breaks in Descemet membrane, leading to hydrops and increased 
corneal scarring. Treatment for the milder cases of corneal astigmatism includes spectacle 
correction and the condition is progressive usually for about 5-7 years. Rigid gas permeable 
lenses are used when it is possible to overcome the diffi culties of lens manipulation in the setting 
of nystagmus and markedly decreased vision. In patients with already greatly compromised 
vision due to the retinal pathology of LCA and the added presence of pendular nystagmus the 
diffi culty of contact lens insertion is enormous. Nevertheless, in an effort to maintain any residual 
visual function in these patients, corneal transplants have been undertaken when the degree 
of keratoconus has warranted surgery (Stoiber et al 2000). Cataract removal in patients with 
LCA has not always led to improvement in visual function as the retinal degeneration causes a 
profound loss of vision.
Strabismus too has been a common fi nding and is often related to nystagmus and poor oc-
ulomotor control. To be able to minimize altered head position and nystagmus in some patients, 
surgical correction is undertaken. The oculodigital sign was noted in 25% of patients and is not 
pathognomic of LCA (Grieshaber et al 1998). The presence of enophthalmos or eye poking did 
not show an adequate correlation with the molecular diagnosis.
Visual acuity in this disease ranges from light perception (LP) to vision 20/400, although 
rarely better visual acuity of 20/80 has been observed (Heher et al 1992). Relatively better vision 
has been noted in patients with CRB1 and RPE65 mutations (Lotery et al 2000).
LCA progression vs stability
Progression of the disorder is characterized by worsening visual function, increased retinal 
pigmentary and atrophic changes, attenuation of retinal vasculature and optic nerve atrophy. 
This was observed in one third of LCA patients for which the underlying gene defects were not 
identifi ed (Grieshaber et al 1998). Worsening is also noted in patients with other ocular fi ndings 
like keratoconus and cataract, which add to the decreased clarity of the media (Heher et al 
1992, Dharmaraj et al 2004).
Diagnosis
The electroretinogram (ERG) is non-detectable, extinguished, or markedly reduced as a result 
of both rod and cone photoreceptor dysfunction. Since an LCA-like phenotype may co-exist 
with a signifi cant systemic disease, a measure of suspicion must accompany each workup of 
an infant with LCA. Investigations that are relevant to include while making a diagnosis of LCA 
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are an ERG, serum very long chain fatty acids (VLCFA) assays, abdominal ultrasonography, 
MRI (magnetic resonance imaging) and developmental assessment. VLCFA are raised in per-
oxisomal disease, which may mimic the retinal phenotype of LCA along with liver, spleen and 
central nervous system involvement. The presence of cystic changes in the kidneys or liver 
on ultrasonography is indicative of Senior-Løken or Arima syndrome respectively. When renal 
disease is identifi ed in Senior–Løken syndrome, morbidity increases, hence it is important to 
screen patients ultrasonographically and biochemically. Early renal transplants in these patients 
prolong survival and reduce mortality and morbidity. Constant monitoring of renal function is 
mandatory throughout childhood in these patients. Hand radiography showing cone-shaped 
epiphysis may be useful in making the diagnosis of the Saldino-Mainzer disease (Table 3).
MRI study of the brain is essential to detect abnormalities of the cerebellar vermis associated 
with Joubert syndrome and also to screen for other associated structural anomalies. A consul-
tation by a neurogenetics team and a metabolic work-up are important. The history of devel-
opmental milestones, visual behavior, psychomotor delay and social behavior are important in 
understanding development, as LCA has been associated with both autism and psychomotor 
delay. Psychomotor development may be delayed in the setting of blindness due to the lack of 
adequate visual input, which is essential for early development (Jan et al 1975, Fazzi et al 1999). 
Mental retardation has been associated with LCA (~ 20%) and accounts for variable expression 
even within a family (Nickel 1982, Schuil et al 1998). This has important implications for genetic 
counseling (Nickel et al 1982). Neuro and psychomotor developmental delay was noted in 8.1% 
of patients with LCA (Galvin et al 2005). The relationship between LCA, seizures, autism and 
pscychomotor delay is not well understood.
Table 3: LCA: Differential diagnosis
Differential diagnosis Features
Ocular albinism Hypopigmented fundi, iris transillumination; supranormal 
ERGs, misrouting of optic nerve fi bers detected by pattern-
appearance VEP.
Achromatopsia Normal rod specifi c ERG with undetectable single fl ash 
photopic and 30Hz fl icker ERG
X-linked Retinitis pigmentosa Characteristic bone-spicule-like retinal pigmentation; minimal 
or non-detectable a and b waves using high luminance stimuli 
noted at an early age
Complete congenital stationary 
night blindness
Profoundly electronegative  ERG with no detectable rod 
specifi c ERG
Blue cone monochromacy Normal rod specifi c ERG with small delayed responses to 
single fl ash
Peroxisomal disease Leopard-skin-like retinal mottling; increased very long chain 
fatty acids, decreased decosohexanoic acid
Delayed visual maturation Gradual Improvement in vision, when not associated with other 
ocular abnormalities.
Cerebral visual impairment Normal pupillary refl exes and no ocular abnormalities; near 
normal VEPs, neuro-imaging of the posterior visual pathways 
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It is also important to elicit a detailed family history, draw a complete pedigree, chart ethnicity 
and genealogical origins. In the light of understanding the phenotype of LCA better, it is relevant 
to elicit the history of photophobia, photo attraction and night blindness.
Differential diagnosis of LCA
The differential diagnosis of LCA includes: peroxisomal disorders (such as Zelweger disease, 
adrenoleukodystrophy and infantile Refsum disease), neuronal ceroid lipofuscinosis and various 
forms of chorioretinal dystrophy. Cortical blindness, delay in visual maturation and optic nerve 
hypoplasia may also be mistakenly diagnosed as LCA (Table 3).
LCA should be differentiated from other forms of chorioretinal dystrophy like congenital sta-
tionary night-blindness, achromatopsia, juvenile RP, albinism and high myopia. Albinism is the 
most common misdiagnosis (Kriss et al 1992). Much effort must be invested in differentiating 
these overlapping conditions, because of signifi cant differences in familial recurrence, progno-
sis, associated conditions and future treatment. The correct diagnosis in congenital blindness 
often involves several consultations (Weiss et al 1989). The reasons for this situation involve 
overlapping signs and symptoms with other conditions and the inability to subjectively assess 
visual acuity accurately in early infancy. ERGs obtained in early infancy quite often need to be 
recorded again in one year for reliability.
Infants presenting with decreased vision need careful investigation to arrive at the correct 
diagnosis. Misdiagnosis has been encountered in LCA, and establishing a defi nitive genetic 
diagnosis becomes imperative (Lambert et al 1989). In the absence of systemic abnormalities, 
an extinguished ERG combined with nystagmus and poorly reactive pupils would make LCA a 
very likely diagnosis.
2.2 Clinical associations
The presence of LCA with nephronophthisis in Senior-Løken syndrome; nephronophthisis, 
cone-shaped epiphyses of the hand and cerebellar ataxia in Saldino-Mainzer syndrome; vermis 
hypoplasia, oculomotor anomalies and neonatal respiratory apnea in Joubert syndrome have 
been documented (Løken 1961, Senior 1961, Mainzer et al 1970, Joubert et al 1969, Ellis 1984). 
The clinical heterogeneity of Senior-Løken is indicated by the variable age of onset of the retinal 
and renal abnormalities. Variability in the retinal involvement from retinitis pigmentosa to LCA 
has been reported (Godel et al 1979). The conorenal syndrome includes renal histopathologic 
changes consistent with a primarily glomerular disorder and short distal phalanges with cone 
shaped epiphysis (Mendley et al 1995). ERG changes have been noted in heterozygotes of 
renal–retinal dysplasia (Hogewind et al 1977).
LCA has also been reported with mental retardation (Tipton & Hussels 1971). LCA has been 
associated with demyelination, autism, psychomotor delay and other neurodevelopmental 
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anomalies (Dekaban 1969, Mainzer et al 1970, Curless 1991, Vaizey et al 1977). LCA has also 
been observed in association with osteopetrosis (Keith 1968). Joubert syndrome has been 
associated with LCA and multicystic kidneys (Ivarsson et al 1993). Alström syndrome presents 
with LCA, cardiomyopathy, short stature, deafness and diabetes mellitus. Cardiomyopathy is 
noted at infancy, although diabetes mellitus occurs in the second or third decade (Russell-Eggitt 
et al 1998). The Arima syndrome, cerebello-oculo-hepato-renal syndrome, is a rare though 
well defi ned entity that includes hepatic involvement (Matsuzka et al 1986). Dekaban-Arima 
syndrome includes Joubert syndrome and chorio-retinal coloboma (Table 2).
Renal-retinal syndromes
The triad of nephronophthisis, retinal degeneration or hypoplasia, and congenital hepatic fi brosis 
has been described (Boichis et al 1973, Proesmans et al 1975, Delaney et al 1978 & Robins et 
al 1976). Nephronophthisis is the most frequent cause of end-stage renal disease in children 
and young adults and pigmentary retinal dystrophy is the most common association (Scolari et 
al 2003).
Senior and Løken described the association of nephronophthisis and LCA in 1961. Several 
genes have also been identifi ed for Senior-Løken syndrome. Senior-Løken syndrome has been 
associated with homozygous mutations in NPHP1 on chromosome 2q13, encoding nephro-
cystin and nephrocystin 4 NPHP4 (KIAA0673, nephroretinin) on chromosome 1p36 (Mollet et 
al 2002, Otto et al 2002). In addition, Senior-Løken syndrome (SLNS3) has been mapped to 
a locus on 3q22 overlapping NPHP3 (Olbirch H et al 2003). Nephrocystin (NPH1, NPHP1, 
nephronophthisis 1) maps to 2q13 (Saunier et al 1997, Hildebrandt et al 1993, 1997) and the 
clinical features of this form of autosomal recessive familial juvenile nephronophthisis include 
anemia, polyuria, polydipsia with the absence of hypertension and proteinuria. Homozygous 
deletions in exon 20 of this gene cause nephronophthisis with retinitis pigmentosa (Caridi et al 
1998). The gene (NPHP1) responsible for NPHP1 consists of 20 exons and the gene product, 
nephrocystin, is a novel protein of unknown function that contains a src-homology 3 domain 
(SH3) which suggests focal adhesion signaling properties (Hildebrandt et al 1997).
Identifi cation of a gene locus for SLS in the region of the nephronophthisis 3 gene on chro-
mosome 3q21-q22 (NPHP3), further illustrates the heterogeneity of this disorder (Omran et al 
2002). Mutations in NPHP3 cause nephronophthisis in association with hepatic fi brosis or LCA. 
NPHP3 encodes a novel protein, nephroretinin, expressed in the neural tissues, retina, kidney 
tubules, liver and biliary tract. It interacts with nephrocystin (Olbirch et al 2003). The interaction 
of nephrocystin to nephroretinin and the β tubulin of cilia forms a complex in the primary cilia and 
colocalises in the renal epithelial cells. Cilial dysfunction due to improper focal adhesion signaling 
complexes via interactions with nephrocystinin lead to nephronophthisis. The connecting cilium 
in photoreceptor cells, plays a key role in the transport of molecules from the inner to the outer 
segment. Another gene (NPHP4, SLSN4) mutated in patients with Senior-Løken syndrome is 
located on 1p36 and consists of 30 exons (Otto et al 2002, Mollet et al 2002, Schuermann et 
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al 2002). The interaction of NPHP4 with NPHP1 was demonstrated, suggesting a common 
signaling pathway (Mollet et al 2002). Mutations in nephrocystinin 4 causing nephronophthisis, 
RP and LCA have been reported in several families (Fillastre et al 1976, Mollet et al 2002, Otto 
et al 2002, Schuermann et al 2002). Ophthalmic fi ndings were observed either in infancy or 
adolescence and the development of end stage renal disease ranged from 6-35 years (Polak et 
al 1983, Mollet et al 2002, Otto et al 2002). Asymptomatic heterozygous carriers of a NPHP4 
gene-defect show electroretinographic abnormalities (Polak et al 1983).
Cerebello-ocular-renal syndromes
The cerebello-oculo-renal (CORS) syndromes include Joubert and other syndromes that exhibit 
a “molar tooth sign” on magnetic resonance imaging which consists of cerebellar aplasia or 
hypoplasia, thickened superior cerebellar peduncles and a large interpeduncular fossa (Maria 
et al 1997, 1999, Gleeson et al 2004). Pathologically this represents signifi cant brainstem 
malformation.
The reported incidence of autosomal recessive Joubert syndrome is 1:100,000-1:150,000 
and has been diagnosed by prenatal ultrasound examination of the posterior fossa and mo-
lecular genetic testing (Campbell et al 1984). The major clinical features of Joubert syndrome 
(autosomal recessive JBTS1) are LCA with cerebellar vermian hypoplasia, episodic hyperpnea 
and oculomotor apraxia. Other neurological fi ndings are hypotonia, developmental delay, trun-
cal ataxia and cognitive impairment. Joubert syndrome has also been associated with extra-
central nervous system features such as congenital hepatic fi brosis, congenital medullary cystic 
disease and multicystic kidneys (Ivarsson et al 1993, Lewis et al 1994). Other eye fi ndings 
include chorioretinal coloboma and retinal dysplasia (Dekaban et al 1969, Lindhout et al 1980, 
King et al 1984, King & Stephenson 1984). Retinal dystrophy ran true in families and was 
never absent when renal cysts were reported (Saraiva & Baraitser 1992). Characteristic features 
include a large head, prominent forehead, high rounded eyebrows, epicanthal folds, occasional 
ptosis, upturned nose with prominent nostrils, occasionally low-set and tilted ears, open mouth, 
tongue protrusion and rhythmic tongue motions (Maria et al 1999).
The LCA observed in patients with Joubert syndrome is stable, although symptoms associ-
ated with renal or hepatic involvement present in childhood or early adolescence, necessitating 
careful observation of blood pressure, blood urea nitrogen, urinalysis, liver function tests and ab-
dominal ultrasonography to detect early renal and hepatic pathology. Visual impairment presents 
in early infancy. The presence of tachypnea admixed with periods of central apnea, seizures and 
brain stem abnormalities help make the diagnosis of Joubert syndrome. High quality magnetic 
imaging, polysomnograms and ophthalmic evaluation to assess visual function are indicated.
JBTS1 maps to 9q34.3 and evidence of both clinical and genetic heterogeneity has been 
reported in consanguineous Arabian/ Persian families (Saar et al 1999). JBTS2 or CORS2 (sans 
retinal involvement) maps to the pericentromeric region of chromosome 11, identifying a second 
locus (Keeler et al 2003, Valente et al 2003).
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Homozygous deletion of the NPHP1 (nephrocystin) gene on 2q13 in two siblings with Jou-
bert syndrome has been described (Parisi et al 2004). Interestingly NPHP4 (1p36) interacts with 
nephrocystin (2q13), suggesting that these two proteins are involved in a common signaling 
pathway mediating adhesion. Similarly RPGRIP1 interacts with NPHP4 furthering our under-
standing of Joubert syndrome (Roepman et al 2005).
Mutations in the Abelson helper integration site 1 gene AHI1 on chromosome 6q23 have 
been described in families with Joubert syndrome, identifying JBTS3 as a third locus for Joubert 
syndrome (Dixon-Salazar et al 2004, Ferland et al 2004, Lagier-Tourenne et al 2004). AIH1 is 
highly expressed in embryonic hind- and forebrain, and contains seven Trp-Asp repeats, an 
SH3 domain and SH3-binding sites. Mutations in the gene encoding the ciliary/centrosomal 
protein CEP290 (NPHP6) or nephrocystin-6 lead to Joubert syndrome, and due to interactions 
with ATF4, a transcription factor involved in cAMP dependent cyst formation, it is now possible 
to understand the phenotype of retinal degeneration and renal failure. CEP290 is located in 
renal epithelial centrosomes and in the connecting cilia of photoreceptors (Sayer et al 2006). 
Considerable phenotypic overlap exists between Joubert and Senior-Løken syndromes and 
mutations in CEP290 have been detected in both disorders (Sayer et al 2006, Valente et al 
2006). Mutations in CEP290 were found to be the most frequent cause of LCA (den Hollander 
et al 2006).
Peroxisomal disease
In peroxisomal disease, retinal dysfunction is characterised by markedly attenuated photopic 
and scotopic ERGs. Peroxisomes are ubiquitous cell organelles involved in lipid metabolism 
(Wanders & Tager 1998). Peroxins encoded by the PEX family of genes are responsible for 
various aspects of assembly and biogenesis of peroxisomes. Peroxisomes contain vitamin A 
storing lipid droplets that are distributed along the basal and lateral surfaces of the retinal 
pigment epithelium where receptors for retinal binding protein (RBP) are located. Müller cells 
also contain a high number of peroxisomes.The exact mechanism of loss of photoreceptor 
function is not completely understood and the phenotypic appearance of the retina along with 
the retinographic abnormalities is similar to LCA. The presence of photoreceptor dysfunction 
has been attributed to mutations in the PEX genes. The PEX group of genes are involved in 
peroxisomal biogenesis and assembly. Zellweger syndrome, neonatal adrenoleukodystrophy, 
infantile Refsums disease and rhizomelic chondrodysplasia are among the commoner peroxi-
somal disorders.
2.3 Genes and loci
The molecular genetics of LCA has been studied rather intensely over the last decade thus 
opening wider avenues of research. The thirteen genes identifi ed so far are all involved in dif-
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ferent functions of the retina (Table 4). Three loci have also been identifi ed on chromosomes 
6q11-16 (LCA5), 14q24 (LCA3), and 1p36 (LCA 9), all in consanguineous families (Stockton et 
al 1998, Dharmaraj et al 2000a, Keen et al 2003) (Table 5). The gene at the LCA5 locus has 
recently been identifi ed (den Hollander et al 2007)
Genes implicated in LCA
Retinal Guanylate cyclase (GUCY2D)
The fi rst gene linked to LCA, the photoreceptor retinal guanylate cyclase (GUCY2D) on 
chromosome 17p13.1, encodes a retinal protein that is involved in phototransduction. This 
gene encodes retinal guanylate cyclase, which consists of a ligand–binding N-terminal, a 
transmembrane domain, a protein kinase homology region and a catalytic domain. It is 16 kb 
long and has 20 exons sharing 87% homology to murine retgc (Oliveira et al 1994, Perrault et 
al 1996). RETGC1 is a protein involved in photo recovery in the phototransduction cascade and 
mutations in the gene hinder the restoration of cGMP in the rods and cones to the basal state, 
resulting in permanent closure of the cGMP gated channels (Perrault et al 1996).
Mutations in GUCY2D have now been associated with several distinct phenotypes, namely 
AD CORD, juvenile ARRP, early onset severe RP and ARLCA (Perrault et al 1996, 1998, 2000, 
2005, Kelsell et al 1998, Dharmaraj et al 2000b, Gregory-Evans et al 2000, Hanein et al 2004).
Retinal Pigment Epithelium 65 gene
The Retinal Pigment Epithelium 65 (RPE65) gene on chromosome 1p31 encodes a protein 
which plays a pivotal role in retinoid metabolism. RPE65 is a non-glycosylated 65 kD microsomal 
protein expressed in retinal pigment epithelium and is conserved in mammals, reptiles and birds 
(Hamel et al 1993). It is necessary for the production of 11-cis retinol (Redmond et al 1998). It 
is now known to be the long sought isomerohydrolase which stimulates the enzymatic conver-
sion of all-trans retinyl palmitate to 11-cis retinol in the microsomes of RPE cells. It presents 
retinylesters as substrate to the isomerase for synthesis of rhodopsin (Mata et al 2004).
Mutations in RPE65 disrupt the synthesis of the opsin chromophore ligand 11-cis retinal 
and partial to total loss of isomerzation (Redmond et al 2005). The deactivation of sensory 
transduction by opsins causes light independent retinal degeneration in LCA (Wooduff et al 
2003). RPE65 defects result in progressive photoreceptor cell death. Both LCA and severe 
ARRP have been reported with mutations in RPE65 (Gu et al 1997, Marlhens et al 1997, 1998, 
Table 5: LCA: Loci 
Locus Chromosomal 
location
Origin of pedigrees References
LCA3 14q24 Saudi Arabia Stockton 1998
LCA5 6q11-16 United States of America Dharmaraj 2000
LCA9 1p36 Pakistan Keen  2003
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Morimura et al 1998, Perrault et al 2000, Dharmaraj et al 2000b, Thompson et al 2000, Joseph 
et al 2002, Sitorus et al 2003, Yzer et al 2003).
Cone-rod homeobox gene
The cone-rod homeobox gene (CRX) on chromosome 19q13 encodes a transcription factor 
important in embryonic photoreceptor development. The gene consists of a homeodomain, 
WSP motif and an OTX tail (Freund et al 1997, Furukawa et al 1997). Recently, enhancer and 
promoter regions of CRX have been identifi ed (Hodges et al 2002). CRX belongs to the otx/
otd homeobox family of genes and is similar to the human OTX1 and OTX2 homeodomain 
protein (Simeone et al 1992). It is expressed in the pineal gland and in developing and mature 
retinal photoreceptor cells. CRX is also expressed in the inner nuclear layer (Bibb et al 2001). It 
is necessary for the maintenance of normal cone and rod function (Furukawa et al 1997). This 
cone-rod otx-like photoreceptor homeobox transcription factor is capable of transactivating 
several photoreceptor cell-specifi c genes and plays a crucial role in differentiation (Furukawa et 
al 1997, Freund et al 1998). The CRX protein contains 299 amino acids and is highly conserved 
across species. CRX activates the promoters of several photoreceptor specifi c genes e.g. rho-
dopsin, arrestin, β-phosphodiesterase and interphotoreceptor matrix protein (Chen et al 1997). 
CRX in synergy with NRL plays a role in the differentiation of rod photoreceptor cells (O’Brien et 
al 2003). CRX interacts with NRL to regulate photoreceptor gene expression and transactivates 
the rhodopsin promoter in a synergistic fashion (Swaroop et al 1992, Rehemtulla et al 1996, 
Chen et al 1997).
Mutations in CRX are known to cause LCA, autosomal dominant cone rod dystrophy and 
autosomal dominant retinitis pigmentosa (Swain et al 1997, Sohocki et al 1998, Tzekov et al 
2000, Tzekov et al 2001, Rivolta et al 2001). Some AD mutations in CRX are associated with 
LCA (Sorsby 1960, Sohocki et al 2000, Rivolta et al 2001, Perrault et al 2003). Interestingly CRX 
interacts with NRL, and missense mutations in NRL cause ADRP and not LCA, while recessive 
mutations cause thickening of the retina and an unusual pigmentary retinopathy (DeAngelis et 
al 2002, Nishiguchi et al 2004).
Aryl hydrocarbon receptor-interacting protein-like gene
The aryl hydrocarbon-interacting protein-like (AIPL1) gene located on chromosome 17p13.1 
has 6 exons and is expressed in the inner segment, nucleus, perinuclear region, synaptic 
terminals and cytoplasm of the photoreceptor cells. It is expressed in the developing retina and 
is essential for the normal development of the rods and cones (Sohocki et al 2000, Van der 
Spuy et al 2002, Ramamurthy et al 2003). AIPL1 contains 384 amino acids and has a molecular 
weight of 44 kD. It contains one peptidyl-propyl isomerase (PPI) domain and 3 tetratricopeptide 
(TPR) repeat domains like the aryl hydocarbon receptor-interacting protein (AIP) and has a role 
in protein-protein interaction based on this structure. Mutations in AIPL1 cause AD CORD, 
juvenile RP and LCA (Sohocki et al 2000).
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 AIPL1 is involved in cytoplasmic stability, nuclear transport and traffi cking and is an im-
portant component of cell cycle progression during photoreceptor development (Akey et al 
2002). It is involved in the fi nal stages of photoreceptor differentiation and synapse formation. 
As photoreceptor differentiation proceeds, AIPL1 is upregulated (Dyer et al 2004). AIPL1 is 
necessary for the protein translocation of NEDD8 ultimate buster (NUB1), which is a cell cycle 
regulator. AIPL1 also affects the expression, stability and biosynthesis of rod-specifi c cGMP 
phosphodiesterase by its chaperone function (Dyer et al 2004, Liu X et al 2004). AIPL1 aids in 
the processing of farsenylated proteins as protein farsenylation is essential for the maintenance 
of retinal photoreceptor cell structure (Pittler et al 1995, Ramamurthy et al 2003).
 As AIPL1 is known to interact with multiple proteins, like NUB1, mutations in this gene 
may lead to defective interaction and defective farnesylation of multiple proteins (Akey et al 
2002, Ramamurthy et al 2003). W278X, the commonest mutation in AIPL1, alters the structure, 
stability, and transport of the protein (Gallon et al 2004). AIPL1 interacts with NUB1; however 
mutations in NUB1 have not been clearly well studied as yet. Only a subset of mutations in AIPL1 
namely, I206N, G262S, R302L and P376S were found to have an effect on the interaction with 
NUB1, while others like W278X, A197P and C23R do not. Both sets of AIPL1 mutations lead 
to LCA, further substantiating that more than disrupted interaction with NUB1 cannot be the 
only trigger for retinal degeneration (Ramamurthy et al 2003, Kanaya et al 2004). The interacting 
domains for NUB1 and AIPL1 are codons 181-330 and 569-584, respectively (Kanaya et al 
2004). AIPL1 interacts with farnesylated proteins and plays an essential role in processing of 
farnesylated proteins in retina. It also affects the stability of active PDE leading to a decrease in 
cGMP causing apoptosis of rods (Ramamurthy et al 2003, 2004).
In keeping with greater loss of rod function both in heterozygote carriers of AIPL1-associated 
LCA and in patients with LCA with mutations in both AIPL1 copies, the survival of adult rods is 
more dependent on AIPL1 function than cones. The absence of AIPL1 in early retinal develop-
ment leads to both rod and cone dysfunction as AIPL1 is required for the normal development 
of both rod and cone photoreceptors (Dharmaraj et al 2004, Vander Spuy et al 2005).
Crumbs homolog 1gene
The Crumbs homolog 1 gene (CRB1) was isolated by subtractive hybridisation as it is expressed 
in the apical membranes of retinal photoreceptors (den Hollander et al 1999a, 1999b). CRB1 
maps to 1q31-32.1 and encodes an extracellular protein with 19 EGF-like domains, 3 laminin-A 
G-like domains, a transmembrane domain and a cytoplasmic tail of 37 amino acids. It is a 1,376 
amino-acid protein with 35% similarity to crb of Drosophila melanogaster. The gene consists of 
12 exons. It is expressed in the adult and fetal brain. CRB1 is expressed in the inner segment 
of rods and cones in the vicinity of the zonula adherens (Pellika et al 2002). CRB1 is involved 
in cell-cell interaction and may be responsible for the maintenance of retinal cell polarity. CRB1 
is essential for the integrity of the external limiting membrane and photoreceptor cell morpho-
genesis (Mehalow et al 2003). Crb1 plays a pivotal role in maintaining the scaffolding complex. 
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It is needed to maintain an organized layer of photoreceptor cells during light exposure and in 
its absence adhesion between the photoreceptor cells and the Müller cells are lost resulting in 
both structural and functional changes. Light exposure results in an increase in the focal retinal 
lesions (van de Pavert et al 2004).
Drosophila stardust is a partner of crumbs and is involved in the control of epithelial cell 
polarity (Bachmann et al 2001, Izaddoost et al 2002). In Drosophila crumbs localizes to the stalk 
of the fl y photoreceptor and may be a component of the molecular scaffold that controls proper 
development of polarity in the eye. The intracellular domain of CRB1 composed of 37 amino 
acids behaves similarly to its Drosophila counterpart when overexpressed in the fl y eye (Izad-
doost et al 2002). Defects in the integrity of the zonula adherens leads to retinal dystrophy. The 
extracellular domain of CRB1 containing Ig EGF-like domains and 3 laminin-A G-like domains 
might mediate protein-protein interactions (Woodarz et al 1993, Pellika et al 2002).
Mutations in this gene are associated with a severe form of RP, RP12, and with LCA (den 
Hollander et al 1999, 2001, Lotery et al 2001, Gerber et al 2002, Khaliq et al 2003). Mutations 
in CRB1 were detected in patients with RP and Coats-like vasculopathy and in patients with RP 
and preserved para arteriolar retinal pigment epithelium (den Hollander et al 2001). The retinal 
phenotype is variable and nummular pigment clumping and white dots have been observed in 
LCA and slow progression of the disease has been noted (den Hollander et al 1999b, Lotery et 
al 2001, Gerber et al 2002) Mutations also result in RP without para-artiolar RPE preservation 
(Lotery et al 2001).
Retinitis Pigmentosa Guanosine Triphosphatase (GTPase) regulator interacting protein 1 gene
The Retinitis Pigmentosa Guanosine Triphosphatase (GTPase) regulator interacting protein 1 
gene (RPGRIP1) on chromosome 14q11 encodes a protein that is involved in disc morphogen-
esis. RPGRIP1 was identifi ed as an interactor of RPGR (Retinitis Pigmentosa GTPase Regulator); 
both localise to the connecting cilium. Mutations in RPGR cause X-Linked RP (RP3) (Meindl et al 
1996). The RPGRIP1 protein interacts with RPGR through a well conserved RPGR-interacting 
domain (RID) in murine, bovine and human retinas (Roepman et al 2000, Boylan et al 2000, 
Hong et al 2001, 2004). RPGRIP1 consists of 24 exons and the predicted protein consists of 
1259 amino acids
RPGRIP1 consists of two coiled-coil domains that are similar to those found in proteins 
involved in vesicular traffi cking (Roepman et al 2000, Boylan et al 2000, Hong et al 2001). 
RPGRIP1 anchors RPGR to the connecting cilium. RPGRIP1 is involved in disc morphogen-
esis through regulating actin cytoskeleton dynamics (Zhao et al 2003). RPGRIP1 isoforms are 
also expressed in the amacrine cells of the inner nuclear cells of the retina and mutations in 
RPGRIP1 compromise more than photoreceptor function alone (Castagnet et al 2003). Muta-
tions in RPGRIP1 lead to LCA and AR CORD (Gerber et al 2001, Dryja et al 2001, Hameed et 
al 2003).
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Retinol dehydogenase 12 (RDH12)
The retinol dehydrogenase 12 (RDH12) gene on chromosome 14q23.3-q24.1 has been impli-
cated in early onset severe retinal dystrophy and LCA (Janecke et al 2004, Perrault et al 2004). 
It encodes a photoreceptor protein that is important in retinoid metabolism. The gene consists 
of 7 exons and encodes a protein of 316 amino acids. RDH12 belongs to the super-family of 
short-chain alcohol dehydrogenases and reductases. RDH12 may be involved in the conversion 
of 11-cis retinol to 11-cis retinal during the regeneration of cone visual pigments. RDH12 is 
expressed predominantly in the neuroretina in photoreceptors (Haeseleer et al 2002).
Inosine monophosphate dehydrogenase 1 (IMPDH1)
Inosine monophosphate dehydrogenase 1 on chromosome 7q31.3-q32 is involved in cyclic 
nucleoside metabolism within photoreceptors (Bowne et al 2002). It belongs to the IMPDH/
GMPR family and consists of 2 CBS domains. Inhibition of cellular IMP dehydrogenase activity 
leads to the cessation of DNA synthesis and a block in the cell cycle at the G1-S interface (Gu 
et al 1994).
Mutations in IMPDH1 cause ADRP (RP10) (Kennan et al 2002, Bowne et al 2002, Daiger et 
al 2003, Kozma et al 2005, Mortimer & Hedstrom 2005, Schatz et al 2005, Wada et al 2005). 
More recently, mutations in IMPDH1 have been shown to cause LCA (Bowne et al 2006).
Tubby-like protein (TULP1)
This gene is analogous to the tub gene in mice that is responsible for maturity-onset obesity, 
insulin resistance, retinal degeneration and neurosensory hearing loss. Tub is known to cause 
early progressive retinal degeneration in mice (Hagstrom et al 1999). Human TULP1 maps to 
chromosome 6p21.3, consists of 15 exons and is expressed exclusively in the retina. Mutations 
in this gene are known to cause early retinal dystrophy (Banerjee et al 1998, Lewis et al 1999, 
Paloma et al 2000). The human tubby TU and tubby-like proteins TULP1, TULP2 and TULP3 
belong to a highly evolutionarily conserved gene family and play an important role in obesity, 
sensorineuronal degeneration and development (North et al 1997, 2002). The TULPs are ex-
pressed in the brain, retina and cochlea and have a highly conserved domain of ~260 amino 
acids in the carboxyl terminus (Carroll et al 2004). They are implicated in neuronal synapse 
formation and rhodopsin transport in the retinal photoreceptors (Ikeda et al 2002).
TULP1 localises to the perinucleolar cap region in photoreceptor cells and is involved in 
protein traffi cking. Tulp1 labelling is noted in the inner segments of rods and cones in fetal 
retinas at ~8 weeks (Milam et al 2000). TULP1 is a transcription factor involved in the control of 
downstream genes in photoreceptors (Boggon et al 1999).
Lecithin retinol acyltransferase (LRAT)
LRAT maps to 4q31 and encodes a polypeptide of 230 amino acids LRAT is synthesized in the 
RPE (Ruiz et al 1999, 2001). LRAT catalyses the initial series of reactions in the conversion of 
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all trans retinol to all trans retinyl ester in the RPE and plays a vital role in the regeneration of 
the visual chromophore (Rando et al 1991). Mutations in LRAT lead to early onset severe retinal 
dystrophy (Thompson et al 2001).
CEP290
CEP290, also known as nephrocystin 6 is a 93 kb gene composed of 53 exons and maps to 
12q21.32. CEP290 is a 290 kDa centrosomal protein composed of 2479 amino acids, localised 
to the centrosome of dividing cells and to the connecting cilium of retinal photoreceptors. It has 
13 putative coiled-coil domains, 3 tropmyosin homology domains, an ATP/GTP binding site and 
a myosin head-like domain. CEP290 plays a crucial role in estabilishing polarity and regulating 
intracellular transport in post-mitotic cells, besides being involved in ciliary transport. Mutations 
are known to cause Joubert syndrome, Senior-Løken and AR LCA (den Hollander et al 2006, 
Sayer et al 2006, Valente et al 2006).
RD3
RD3 also known as C1orf36 (chromosome 1 open reading frame 36) maps to chromosome 
1q32.3. The gene has 3 exons and spans 15.45 kb. The encoded 22.7kD protein is composed 
of 194 aminoacids. It is composed of an N-terminal mitochondrial targeting signal, a coiled-coil 
domain, and 2 potential phosphorylation sites (Lavorgna et al 2003). It is expressed in the retina 
in a subnuclear location and is involved in transcription and splicing (Friedman et al 2006).
Mutations in RD3 lead to Leber congenital amaurosis (Friedman et al 2006).
LCA5
Recently the LCA5 gene, also known as C6ORF152 (chromosome 6 open reading frame 152) 
was identifi ed on chromosome 6q14 (den Hollander et al 2007) The 9 exon gene encodes a 
novel ciliary protein, lebercilin which localises to the connecting cilia of photoreceptors and to 
the microtubules and centrioles. It is a 697 amino acid protein predicted to form coiled-coils and 
is expressed widely in cilial axonemes. Mutations have been identifi ed in several families besides 
the original family described in this thesis (Dharmaraj et al 2000a, Mohammed et al 2003, den 
Hollander et al 2007). Homozygous nonsense and frameshift mutations were detected in fi ve 
families.
2.4 Pathogenesis
Few studies on the histopathologic appearance of the retina in patients with LCA have been 
undertaken. Normal retinal architecture has been reported in early heredo-familial chorioreti-
nal degeneration (Horsten & Winkleman 1960, Babel 1963). A study in 2 patients with LCA 
showed absent rods and cones in one while in the other patient disorganized rods and cones 
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were noted (Francios et al 1969). Pyknosis of the photoreceptor cells was observed and the 
RPE was normal. Loss of the cone outer segments and shortening of the inner segments with 
fewer mitochondria and large partially pigmented inclusions in the RPE were observed in the 
posterior region. Total photoreceptor loss was noted in the equatorial area (Kroll & Kuwabara 
1964, Francios & Hanssens 1969). Light and electron microscopic studies have demonstrated 
selective destruction of the outer segments of photoreceptors with some macrophages in the 
vicinity (Mizuno et al 1977). Shortening of the outer segments of the photoreceptor cells and 
a decrease in the ganglion cell layer have been observed (Noble et al 1978). The primary cell 
layers affected in LCA in a post-mortem study of a three-year-old included the outer nuclear 
layer and photoreceptors indicating the degenerative nature of the disorder (Sullivan TJ 1994).
Very few pathological studies on retinal degenerative disease have been reported in which 
the genetic defect was known. Studies of LCA gene expression and regulation in the fetus will 
provide greater depth in understanding the cellular basis of this disorder. There are very few 
such reports in literature. For example, CRX expression in the fetus occurs at 10 -12 weeks in 
the foveal region when the rods are generated in the retina and this is followed by further CRX 
expression that proceeds towards the peripheral retina (Bibb et al 2001).
A 26-week-old aborted fetus with LCA harboring W21R mutations in GUCY2D showed de-
creased photoreceptor cells, stunted and disorganised outer segments and ill-formed synaptic 
extensions (Porto et al 2001). Eyes obtained from a 11-year-old child with GUCY2D-associated 
LCA with the R660Q variation however showed relative preservation of rods and cones in the 
macula and far periphery with a normal inner nuclear and a reduced ganglion cell layer (Milam 
et al 2003).
An important comparative pathological study examined retinal tissue from a human fetus 
with RPE65 mutations and compared the histopathology and immunohistochemistry with an 
age-matched normal fetal retina (Porto et al 2002). Compared to normal fetal retina, the affected 
retina displayed cell loss and thinning of the outer nuclear (photoreceptor) layer, decreased 
immunoreactivity for key phototransduction proteins, and aberrant synaptic and inner retinal 
organisation. The homozygous RPE65 mutation C330Y abolished detectable expression of 
RPE65 within the RPE of affected eyes, and ultrastructural examination revealed the presence 
of lipid and vesicular inclusions not seen in normal RPE. The mutant eye demonstrated thicken-
ing, detachment and collagen fi bril disorganisation in the underlying Bruch’s membrane, and the 
choroid was distended and abnormally vascularised, in comparison with the control eye (Porto 
et al 2002). These human fetal fi ndings contrast with the late-onset ocular changes observed in 
animal models, indicating the problems of inferring human retinal pathophysiology from animal 
models (Aguirre et al 1998). This work also underlined the early prenatal pathogenic insult and 
congenital nature of human LCA in contrast to human RP, which is a disease of later onset.
In retinal tissue obtained from a 22-year-old patient with LCA harboring a novel heterozygous 
H82Y mutation in AIPL1, histopathological examination showed almost total absence of pho-
toreceptor cells, decreased ganglion cells, increased vacuolisation of the nerve fi ber layer with 
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retinal gliosis and a characteristic alteration of arterioles with venular dilation. Increased areas 
of retinal atrophy, sclerosis and attenuation of the blood vessels and pigment accumulation 
were also observed. Both the RPE and the Bruch’s membrane were intact with a normal optic 
nerve (Heegaard et al 2003). This appearance correlates well with the phenotypic appearance 
observed in AIPL1-associated LCA (Dharmaraj et al 2004).
Human retinal degeneration in both GUCY2D and RPE65-associated LCA appear to oc-
cur prenatally, leading to profound photoreceptor dysfunction (Porto et al 2003). Interestingly, 
although the retinal appearance on ophthalmoscopy may appear normal, histopathological 
studies may show different changes as observed in the fetal appearance of both GUCY2D 
and RPE65-associated LCA retinas with decreased photoreceptor cells and disorganised outer 
segments. This may have important implications in the considerations for clinical trials in the 
prenatal and postnatal stages and the extent of photoreceptor cell rescue possible. As more 
human fetal retinal tissue is studied, greater understanding of gene function in early develop-
ment is possible.
2.5 Animal models of LCA
Animal models provide a basis to study disease pathology in LCA and understand the function 
of various genes involved in LCA, and at the same time allow for experimental treatment strate-
gies, that may be translated to humans in the near future. Not only do they provide background 
information, but also aid in grading patterns of visual outcome with the use of different modali-
ties of therapy.
As there is allelic variation and interspecies variation in LCA and RP, it is incorrect to extrapo-
late the fi ndings in animal models to humans (Acland et al 1998). RPE65 mutations in dogs, 
mice and humans vary as with the phenotype of GUCY2D mutations in mice, chickens and 
humans (Marlhens et al 1997,1998, Aguirre et al 1998, Semple-Rowland et al 1998, Perrault et 
al 2000, Acland et al 2001, 2003, Porto et al 2002).
In animal models of LCA, Rpe65 -/- mice and Briard dogs, near-normal retinal histology at 
birth was noted, even though no recordable photoreceptor function was detected. Structural 
degeneration then occurs with delayed onset, cone death generally preceding that of rods 
(Veske et al 1999).
Gucy2d
The rd chicken has a null mutation in guanylate cyclase (GC1), which results in decreased 
cGMP in the rods and cones leading to a decrease in phototransduction and causing retinal 
degeneration (Semple-Rowland et al 1998). Chickens have a cone-dominated retina and in the 
rd chicken both rods and cones are normal at birth, but are absent at 6 weeks and the ERG of 
rods and cones is markedly decreased. Despite the presence of normal rod and cone morphol-
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ogy at birth, neither scotopic nor photopic ERGs are reliable. Retinal degeneration begins at 
1 week post gestationally, proceeds from the center to the periphery and is complete by 6-8 
months (Ulshafer et al 1984). The RPE and the inner retina degenerate (Ulshafer et al 1985). The 
absence of GC1 abolishes phototransduction due to decreased levels of cGMP.
In Gucy2e -/- mice, both rods and cones are normal at birth and although the rods are 
normal at 1 year, the cone loss occurs between 5 and 6 weeks. The mutant allele eliminates the 
expression of GC-E, but the rod outer segments remain intact with normal expression of other 
photoreceptor proteins like rhodopsin and rds/peripherin. Photoreceptor function in knockout 
mice is not detected due to severe degeneration at 1 year. Gucy2e knockout mice show cone 
degeneration primarily with abnormal rod responses (Yang et al 1999). A decrease in the cone 
ERG is seen before morphological changes are observed in cones, and there is absence of an 
ERG at 2 months. Heterozygous mutant Gucy2e mice exhibit normal morphology and photore-
ceptor function as evidenced by the presence of normal rod and cone ERGs at all ages (Yang 
et al 1999). Interestingly, cone loss as seen in human GUCY2D-associated CORD is also seen 
in Gucy2e -/- mice (Payne et al 2001). GC-1 knockout mice show a decrease in the number 
of cones in the retina by 6 months although they are normal in size and morphology at birth 
as also seen in knockout GC-E chickens and GUCY2D -associated LCA (Coleman et al 2004). 
Rod-dominated mouse retinas do not mirror human retinal changes of LCA.
Rpe65
Rpe65 knockout mice lack rhodopsin, but all-trans retinyl esters accumulate in the RPE, with the 
absence of 11-cis retinyl esters (Redmond et al 1998). Initially intact rod and cone photorecep-
tor cells are present at birth, although thinning of the outer nuclear layer occurs from 15 weeks 
and the ERG is not recordable. In Rpe65 -/- mice, the rods behave like dark adapted rods and 
may die due to RPE dysfunction resulting from the accumulating retinyl esters (Rohrer et al 
2003). Isorhodopsin mediates rod function in Rpe65 knockout mice. Interestingly residual visual 
preservation in Rpe65 -/- mice is due to rod function (Seeliger et al 2001). RPE65 is essential for 
the biosynthesis of 11-cis retinal (Xue et al 2004). Impairment of the pupillary response occurs 
in Rpe65 -/- mice and this may be used in determining the response to treatment when 9-cis 
retinal is administered therapeutically. An improvement with the decrease in threshold to the 
thermal pupillary light response is observed in knockout mice, following therapy (Aleman et al 
2004).
Swedish Briard dogs with a spontaneous 4-nucleotide deletion in exon 5 of the RPE65 gene 
that causes a frameshift and a premature stop codon, show rod and cone dysfunction (Aguirre 
et al 1998). Distortion and disorientation of the rod outer segments is noticed in Rpe65 -/- dogs 
at 5 weeks. Slow progression of retinal morphological changes occurs with time (Veske A et 
al 1999). Accumulation of lipid vacuoles in the retinal pigment epithelium is observed. In older 
animals short cone outer segments and absence of rod outer segments was noted (Wrigstad 
et al 1992, 1994). Dark-adapted ERGs showed no recordable response (Narfström et al 1995). 
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The positive c wave was replaced by a large negative wave indicative of RPE damage (Nilsson 
et al 1992). As RPE65 is necessary for the regeneration of rhodopsin, following photo bleaching 
of the retina, an absence of normal rhodopsin was detected (Saari 2001).
Crx
Targeted disruption of the Crx gene in mice leads to attenuated circadian entrainment and 
retinopathy. The photoreceptor cells are not elongated and there is a decrease in the expres-
sion of photoreceptor cell associated genes (Furukawa et al 1999) Absence of outer segment 
structures were observed in Crx -/- mice as early as postnatal day 14 and at postnatal day 21, 
a thin outer nuclear layer and dislocated photoreceptor cells beneath the RPE were observed. 
The rod ERG at one month showed less than 1% of activity, while the cone ERG was not detect-
able (Furukawa et al 1999). Although the heterozygous Crx +/- mice developed shorter outer 
segments than wild type mice at P14, no differences were observed at P21. The rod ERGs were 
reduced and cone ERGs were not detected.
By 2 months both rod and cone ERGs of these Crx +/- mice were not different compared 
to wild-type mice and at 2 months the photoreceptor nuclei in the Crx -/- mice dwindled re-
sulting in to 2-3 rows by 6 months of age (Furukawa et al 1999). Abnormal development of 
axonal arborization of rod and cone bipolar cells, along with sprouting of the axonal complex 
of horizontal cells is also observed in the retina of Crx -/- mice. The ganglion cells appear to be 
normal, although cone and rod bipolar cells undergo remodeling by 5 and 7 months respectively 
(Pignatelli et al 2004).
Aipl1
Both knockout and hypomorphic Aipl1 mice have been generated to study the structure and 
function of photoreceptor cells in the absence and decrease of AIPL1. Mice with decreased 
Aipl1 down to 25% due to a hypomorphic mutation show decrease in the synthesis of retinal 
rod phosphodiesterase (PDE) (Liu et al 2004). Initially at 3 months no decrease in the number 
of photoreceptor cells was noticed, but by 8 months half the photoreceptor cells were lost 
and the inner and outer segments were shortened. Upregulation of glial fi brillary acidic protein 
indicative of retinal degeneration is noticed in the early weeks of post-natal life (Liu et al 2004, 
Ramamurthy et al 2004). Aipl1 -/- mice on the other hand, despite the development of a normal 
outer nuclear layer photoreceptor cells degenerate quickly starting at the second week of life 
and leading to complete rod and cone degeneration in the fourth week of life. Disorganised, 
short, fragmented photoreceptor cell outer segments with vacuolar inclusions in the inner seg-
ments of the photoreceptor cell layer, lacking both photopic and scotopic ERGs is observed. 
Heterozygous Aipl1 +/- mice show no abnormal retinal morphology or ERG changes at 8 
months. Adult Aipl1 +/- mice like human AIPL1-associated LCA heterozygotes have a delayed 
rod response, indicated by the prolonged implicit time (Dyer et al 2004).
Sharola BW.indd   77 29-May-07   10:45:40 AM
78
 Retinal degeneration in Aipl1 -/- mice is independent of light. Rod cGMP PDE, a farnesylated 
protein, is absent and this leads to the abolition of cGMP hydrolysis and the accumulation of 
increased levels of cGMP precedes retinal degeneration (Ramamurthy et al 2004). The pheno-
type in AIPL1-associated LCA is in keeping with the early severe rod and cone dysfunction also 
seen in Aipl1 -/- mice, leading to blindness (Ramamurthy et al 2004, Dharmaraj et al 2004). 
This makes it a preclinical model to test the therapeutic rescue of photoreceptor function in 
AIPL1-associated LCA (Dyer et al 2004). The presence of night blindness observed in more than 
half the patients with mutations in AIPL1, may be due to gross rod dysfunction as the absence 
of AIPL1 leads to instability of the rod PDE, altering cGMP balance, and thus affecting photo 
transduction.
Crb1
Retinal folds and pseudo rosettes are seen along with normal retinal architecture in mice with 
Crb1 mutations (Mehalow et al 2003). The integrity of the external limiting membrane in mice 
is lost and the photoreceptor cell bodies protrude into the inner segment. The external limiting 
membrane and the zonula adherens is fragmented in mice and Drosophila with Crb1 mutations. 
Crumbs is required to inhibit light induced photoreceptor degeneration as seen in Drosophila 
(Johnson et al 2002). In humans with CRB1 mutations, the retina was thickened and abnormal 
laminations and pseudo rosettes were seen on ocular coherence tomography (Jacobson et al 
2003).
Developmental defects were observed in Crb1 -/- mice 2 weeks after birth. Shortened and 
disorderly inner and outer segments of the photoreceptors are observed. By 10 weeks frag-
mentation of the outer segment and the discs occur leading to the formation of granular debris. 
Heterozygous crb1 +/- mice show no histological abnormalities (Mehalow et al 2003).
Crb1 -/- mice develop localized lesions where the integrity of the outer limiting membrane is 
lost and giant rosettes form which increase following light exposure as the protective infl uence 
of Crb1 is lost (van de Pavert et al 2004). Photoreceptor degeneration in Crb1 mutants varies 
with the genetic background thus suggesting the role of genetic modifi ers in altering phenotype 
(Mehalow et al 2003).
Rpgrip1
Rpgrip1 -/- mice initially have a normal nuclear layer of photoreceptors. As early as postnatal 
day 15 they show pyknotic nuclei suggestive of ongoing cell death, and near total cell loss was 
apparent by 3 months. The disk diameter membranes were larger and the disks were arranged 
parallel to the long axis of the outer segment. Both rod and cone opsins were mislocalised in the 
cell bodies. Disruption of the outer segment discs occur due to the mislocalisation of rhodopsin. 
Both the photopic and scotopic ERGs showed a marked reduction in amplitude. Rpgrip 1 
+/- mice on the other hand showed no histological abnormalities (Zhao et al 2003). Interestingly 
Sharola BW.indd   78 29-May-07   10:45:40 AM
Leber congenital amaurosis 79
Rpgrip1 -/- mice showing progressive photoreceptor loss may be successfully rescued both 
structurally and functionally following gene replacement (Pawlyk et al 2005).
Rdh12
Rdh12 -/- mice showed small white dots beneath the retinal vessels by 5 months of age and a 
mildly pigmented mottled appearance in the retina by 15 months with a mild progressive delay 
and loss of amplitude on dark adapted electroretinography. Shortening of the outer nuclear layer 
was noted initially at 7 months with a decrease to 3-4 layers by 27 months with outer segment 
degeneration. RPE cells showed atrophy and hypopigmentation with the accumulation of lipid-
like material noted initially at 3 weeks of age (Pang et al 2005). Lack of rhodopsin, 11-cis retinal 
and rpe65 expression were noted in double-mutant mice with an added deletion in Rpe65.
Impdh1
Mice lacking impdh1 although initially normal show progressive decrease in rod and cone func-
tions as evidenced by the ERG amplitudes (Aherne et al 2004). Depletion in GTP leads to a 
decrease in phototransduction. A mild RP-like retinopathy is noted in older animals, while the 
structure of the retina is well preserved in young mice.
Tulp1
Ectopic accumulation of rhodopsin occurs in Tulp1-/- mice at an early age with no evidence 
of obesity as noted in Tub -/- mice (Hagstrom et al 1999, 2001, Ikeda et al 2000). Extracellular 
vesicles accumulate near the inner segments of photoreceptor cells in Tulp1 -/-mice. Heterozy-
gote mice are phenotypically normal (Hagstrom et al 1999).
Lrat
Lrat -/- mice show ~35% shorter rods with severely attenuated ERG responses and abnormal 
pupillometry at 6-8 weeks with impaired absorption and storage of retinoids (O’Byrne et al 
2005). Lrat +/- mice showed no changes. The RPE was devoid of all trans retinyl esters (Batten 
et al 2004). A marked improvement however of both electroretinographic and pupillary func-
tion was noted on intraocular replacement recombinant AAV gene therapy. Pharmacological 
intervention with 9 cis retinyl succinate too resulted in long lasting restoration of retinal function 
(Batten et al 2005).
Cep290
An in-frame deletion in Cep290 leads to early-onset retinal degeneration in the rd16 mouse. 
Cep290 localises to the centrosomes of dividing cells and to the connecting cilium of photo-
receptor cells. It associates with several microtubule based transport proteins in the mouse 
retina. Altered interaction of RPGR and mutant CEP290 with a redistribution of RPGR and 
phototransduction proteins is noted in these mice (Chang et al 2006). Within two months 
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patchy pigmentary retinopathy is observed. Cep290-/- mice show both reduced rod and cone 
electroretinograms and early progressive photoreceptor outer segment degeneration with thin-
ning of the outer nuclear layer on histology (Chang et al 2006).
Rd3
Rd3 mice show photoreceptor degeneration in the fi rst 2 weeks of life often followed by com-
plete loss of cells with an absent ERG response in 16 weeks. At birth however both rods and 
cones are morphologically normal, followed postnatally by rod and later cone degeneration 
(Chang et al 1993).
2.6 Genotype-Phenotype correlation
LCA constitutes the most severe form of retinal dystrophy since retinal function is profoundly 
decreased, as evidenced by extinguished ERGs in infancy. The clinical heterogeneity of this 
disorder however spares some individuals from extreme severity, allowing for some residual 
Figure 8: LCA protein localisation
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retinal function (Perrault et al 1999, Dharmaraj et al 2000b, Thompson et al 2000, Felius et al 
2002, Paunescu et al 2004).
The diagnosis and distinction between early onset retinitis pigmentosa and LCA comes with 
the extinguished or markedly attenuated ERG obtained in patients with LCA during early infancy 
(Leber 1869). Leber in his early description of the disease included the early onset severe retinal 
dystrophy. The phenotype in LCA is not only determined by the primary defect but is also 
infl uenced by the genetic background and the environment. The dysfunctional biochemical, 
structural and physiological pathways involved in vision in LCA have an impact on the pheno-
type (Table 6). The timing of the insult too, infl uences the phenotypic appearance. The natural 
passage of time further alters the retinal appearance in LCA. Mutations in the known genes can 
be detected only in about 35-60% of patients with LCA (Hanein et al 2004, Allikmets et al 2004, 
Yzer et al 2006, den Hollander et al 2006). All the gene products are diverse in their sub-cellular 
locations and functions (Figure 8).
The natural course of LCA has been reported to be stable, show slow deterioration, or in a 
very few cases exhibit some improvement (Heher et al 1992, Fulton et al 1996, Perrault et al 
1999, Dharmaraj et al 2000b, Lorenz et al 2000, Koenekoop et al 2002). Summarising several 
longitudinal studies, the stability of clinical course and visual function was observed in 75% 
of patients with LCA, deterioration in 15% and an improvement in visual function in 10% of 
patients (Heher et al 1992, Fulton et al 1996, Brecelj et al 1999, Koenekoop et al 2004). Com-
paring the phenotypes in patients with a molecular diagnosis, patients with GUCY2D mutations 
have a stable clinical course, while those with RPE65 mutations show progressive deterioration 
(Perrault et al 1999, Dharmaraj et al 2000b, Lorenz et al 2000, Yzer et al 2003).
GUCY2D
Functional analyses shows that the missense mutations in the catalytic domain of GUCY2D 
result in the inability to hydrolyse GTP to GMP, while mutations in the extracellular domain do 
not affect catalytic activity when the initiation codon is intact. The mutations perhaps cause 
misfolding of the mutant protein with degradation in the endoplasmic reticulum (Duda et al 
1999, Rozet et al 2001). Mutations in the dimerisation domain of GUCY2D affect the coiled-coil 
formation and lead to CORD. Patients with mutations in GUCY2D give a history of photophobia 
and do not complain of night blindness (Perrault et al 1999, Dharmaraj et al 2000b). Gross retinal 
changes are not usually observed at presentation in infancy, but mild pigmentary retinopathy 
is documented in later life (Dharmaraj et al 2000b). GUCY2D mutations account for 6-20% of 
LCA (Dharmaraj et al 2000b, Hanein et al 2004). Interestingly a founder mutation (2493delG) has 
been traced in Finnish families (Hanein et al 2002).
RPE65
Fundus autofl uorescence is due to the accumulation of lipofuscin derivatives in the RPE resulting 
from the incomplete digestion of N-retinylidene-phosphatidyl-ethanolamine from shed photo-
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receptor cell outer segments. A2E derived from N-retinylidene-phosphatidyl-ethanolamine ac-
counts for the fl uorescence. Lack of autofl uorescence up to 488 nm is observed in patients with 
early onset severe retinal dystrophy harboring either compound heterozygous or homozygous 
mutations in RPE65. Reduced levels of RPE lipofuscin fl uorophores A2E and iso-A2E have been 
observed in some patients with RPE65 mutations (Kim et al 2004). Patients with mutations in 
RPE65 have absent or very low fundus autofl uorescence within the fi rst decade of life (Lorenz 
et al 2004). Absence of autofl uorescence as noted in humans correlates well with the Rpe65 
-/-mouse model (Katz et al 2001). With both 11-cis retinal and all-trans retinal being absent 
from the RPE the formation of lipofuscin fl uorophores is inhibited (Lorenz et al 2004). Follow-
ing the stage of absent or markedly decreased autofl uorescence in these patients atrophy of 
the photoreceptor cell and retinal pigment epithelium is observed. The absence or profound 
decrease of fundus autofl uorescence may be used as a clinical marker of RPE65 mutations to 
monitor the effect of therapy both in animal models and in humans in clinical trials.
Patients with mutations in RPE65 complain of night-blindness further explaining dysfunctional 
retinoid metabolism (Perrault et al 1999, Dharmaraj et al 2000b, Lorenz et al 2000, Thompson 
et al 2000). Mutations in RPE65 causing LCA account for 3-16% of LCA (Morimura et al 1998, 
Dharmaraj et al 2000b, Hanein et al 2004).
CRX
Patients with mutations in CRX are known to have autosomal dominant LCA or harbor de novo 
mutations (Sohocki et al 1998, Rivolta et al 2001a,b). Most CRX mutations are completely 
penetrant and cause disease in heterozygotes, although exceptions have been reported (Rivolta 
et al 2001, Silva et al 2000). Interestingly, in some CRX-associated LCA a few systemic changes 
have been observed. Decreased bone density and deafness with primary ovarian dysfunction 
have been reported (Silva et al 2000, Tzekov et al 2001). CRX is expressed in the fetal retina 
early in life and the early macular coloboma-like appearance in CRX-associated LCA could be 
attributed to the dysfunctional CRX protein in the fovea in utero (Silva et al 2000, Bibb et al 
2001, Nakamura et al 2002).
Autosomal recessive LCA caused by R90W in the homeodomain results in a protein with 
decreased DNA binding and transcriptional activity. Decreased interaction with NRL, another 
transcription factor, impairs nuclear transport (Swaroop et al 1999, Fei & Hughes 2000, Mitton 
et al 2000). Mutations in the WSP domain lead to decreased CRX mediated transactivation 
since the OTX tail is eliminated (Freund et al 1998, Chau et al 2000, Lotery et al 2000, Silva et 
al 2000).
Although homeodomain mutations have been shown to cause decreased transactivation, 
a defi nite relationship between the magnitude of the biochemical abnormality and the disease 
severity was not observed, further suggesting that other modifying factors contribute to the 
phenotype (Chen et al 2002). Mutations in CRX cause only 2-3% of LCA (Dharmaraj et al 2000b, 
Lotery et al 2000).
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AIPL1
A severe retinal phenotype is noted in AIPL1-associated LCA. The rods are primarily affected 
and this is consistent with the high rod expression of AIPL1. Maculopathy in these patients may 
be in keeping with the presence of increased rod density in the paramacular region. Retinal 
degeneration in humans proceeds from the centre to the periphery as also noted in mouse 
models, due perhaps to the defects in rod PDE biosynthesis (Ramamurthy et al 2004). Selective 
rod dysfunction has been observed in carriers of AIPL1-mutations, which may be related to the 
role of AIPL1 in rod function (Dharmaraj et al 2004, Ramamurthy et al 2004). Patients with muta-
tions in AIPL1 have a higher incidence of associated keratoconus and maculopathy (Dharmaraj 
et al 2004). AIPL1 mutations account for ~ 6% of all LCA mutations (Sohocki et al 2000).
CRB1
Sequence changes in both alleles of CRB1 were noted in 3-11% of patients with LCA, while 
changes in only one allele were detected in 11-13% of patients (Lotery et al 2001, den Hollander 
et al 2001, 2004). C948Y was the most commonly occurring mutation in the cohort in patients 
with LCA and RP (den Hollander et al 2001, Lotery et al 2001). Patients with LCA carry null alleles 
more frequently than patients with RP, consistent with the model of gene dosage. C948Y was 
the most commonly occurring mutation in the cohort causing LCA in the homozygous state (den 
Hollander et al 2004). This mutation alters the proper folding of the EGF-like domain. Patients 
with mutations in CRB1 appear to have a variable retinal phenotype ranging from 20/60 vision to 
profound loss of vision presenting at an early age (den Hollander et al 2001, Lotery et al 2001).
RPGRIP1
Mutations in RPGRIP1 are known to cause LCA and AR CORD (Gerber et al 2001, Dryja et 
al 2001, Hameed et al 2003). Six percent of patients with LCA harbor mutations in RPGRIP1 
(Gerber et al 2001, Dryja et al 2001, Hanein et al 2004). The phenotype of LCA with RPGRIP1 
mutations is very severe (Galvin et al 2005).
RDH12
Mutations in RDH12 were initially detected in 3 consanguineous Austrian kindreds, presenting 
with early onset severe retinal dystrophy (Janecke et al 2004). Mutations in RDH12 account for 
4% of patients with LCA. The A269fsX270 in exon 6 has been the most commonly occurring 
change in a cohort of patients with LCA. Thirty-three per cent of RDH12-associated patients 
with LCA harboured this change (Perrault et al 2004). Progressive rod and cone degeneration 
has been reported with mutations in RDH12.
IMPDH1
Mutations in Inosine monophosphate dedydrogenase1 (IMPDH1) cause ADRP (RP10) (Kennan 
A 2002, Bowne SJ 2002, Mortimer & Hedstrom 2005). More recently mutations in IMPDH1 
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have been found to cause LCA with early retinal dystrophy and attenuated ERGs (Bowne et al 
2006).
TULP1
Mutations in TULP1 have been known to cause early onset progressive retinal degeneration 
in an autosomal recessive fashion (Banerjee et al 1998, Gu et al 1998, Hagstrom et al 1998, 
Lewis et al 1999, Paloma et al 2000). The ERG obtained in early childhood was extinguished. 
Nystagmus and loss of vision were noted a few months after birth (Paloma et al 2000).
LRAT
Mutations in LRAT have resulted in early onset retinal dystrophy detected in patients between 
the ages of 2-7 years. The presence of nyatagmus associated with peripheral retinal atrophy, 
maculopathy and attenuation of retinal vasculature has been noted with severe attenuation of 
ERG responses (Thompson et al 2001).
CEP290
A common intronic mutation (c.2991+1655A>G) that creates a strong splice-donor site leading 
to the insertion of a cryptic exon in the CEP290 mRNA has been detected in several patients 
with LCA. Both homozygous and heterozygous mutations in CEP290 have been identifi ed in 
21% of patients with LCA. The phenotype ranges from a normal retina to moderate retinal 
pigment mottling associated with attenuated retinal vasculature, hyperopia and keratoconus 
in some patients (den Hollander et al 2006). CEP290 mutations have also been detected in 
patients with mental retardation, autism, Senior-Løken syndrome and Joubert syndromes (Per-
rault et al 2007, Valente et al 2006, Sayer et al 2006).
RD3
Homozygous mutations in the donor splice site of exon 2 (c.296+1G>A) have caused LCA in 
2 Indian siblings. The mutation leads to truncation of the protein. The retina showed atrophic 
maculas with attenuated vasculature and pigment migration (Friedman et al 2006).
LCA5
The affected individuals of a family (Old Order River Brethren) of German-Swiss descent map-
ping to chromosome 6q11-q16, presented with visual acuities in the order of 20/100-20/400, 
high hyperopia and normal fundi in early infancy and childhood. LCA5 is located in a region 
rich with retinal genes. In the Old Order River Brethren family a homozygous 1598 bp deletion 
(g.-19612-18015d) encompassing 1077 bps of the promoter and exon 1 was detected in the 
patients and the LCA5 transcript was absent (den Hollander et al 2007). Interestingly though, one 
of the patients shows a heterozygous change in GUCY2D (P701S) which may exert a modifying 
infl uence on the phenotype causing a more severe retinal phenotype (Dharmaraj et al 2000a,b).
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The phenotype however of another family from Pakistan mapping to the same locus was 
quite different. Progressive, severe maculopathy consisting of pigmentary disturbance and 
retinal pigmentary atrophy was noted (Mohamed et al 2003). Atrophic retinal maculopathy was 
a distinct feature in the Pakistani kindred, however despite a similair ophthalmoscopic appear-
ance the LCA5 locus was excluded in a Turkish pedigree (Ozgul et al 2006).
LCA3
Patients presenting with this subset of LCA had enophthalmos, nystagmus in early life, moder-
ate hyperopia, variable strabismus, profound visual loss, retinal pigment mottling and clumping. 
Older individuals of the Saudi Arabian kindreds had perception of light, nuclear or cortical 
cataracts, optic atrophy, clumping of retinal pigment, atrophic maculas and vascular attenuation 
(Stockton et al 1998). LCA3 maps to chromosome 14q24 and the gene is yet to be identifi ed.
LCA9
This new locus on chromosome 1p36 was identifi ed in a Pakistani pedigree (Keen et al 2003). 
Visual acuity was the perception of light in all affected individuals. Posterior sub-capsular lens 
opacities, macular staphylomas, varying degrees of retinal white spots and pigmentary retin-
opathy with optic atrophy were noted (Keen et al 2003).
Carriers of LCA mutations
It has been noticed that several phenotypically normal carrier parents harboring heterozygous 
mutations in the LCA-associated genes have abnormalities in rod or/and cone ERGs, sugges-
tive of mild rod or and cone dysfunction (Koenekoop et al 2002, Dharmaraj 2004, Dharmaraj et 
al 2004, Galvin et al 2005).
Drusen-like deposits were noted in carriers of mutations in RPE65, AIPL1, CRB1 and 
RPGRIP1, while mild peripheral chorio-retinal atrophy was detected in carriers of AIPL1 and 
RPE65 mutations (Galvin et al 2005). Retinal changes in the form of inferior retinal atrophy 
have been detected in carriers of CRB1 mutations. These fi ndings indicate that carriers of 
LCA-associated mutations can now be identifi ed in several families with LCA based on ERGs 
showing mild rod or cone dysfunction (Al–Zuhaibi et al 2005).
2.7 Molecular genetic diagnosis
With the identifi cation of genes involved in LCA, screening for mutations has become an impor-
tant part of the diagnosis. To be able to maximise diagnostic yield for moleculair screening, on 
examining ocular phenotypes some caveats may be helpful (Table 7). As the number of patients 
with each phenotype is small, it is diffi cult to compute statistically signifi cant data. The presence 
of sequence changes in genomic DNA may be detected using mutation-scanning techniques. 
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Single strand conformational polymorphism (SSCP) analysis and direct sequencing, both of 
which are PCR based methods, have been used intensively in this study. PCR amplifi cation 
products obtained from each reaction of primer and genomic DNA is screened for aberrations 
using denaturing high-pressure liquid chromatography (DHPLC) or SSCP (Table 1). DHPLC 
analysis using the Wave DNA fragment analysis system was also undertaken. PCR fragments 
with aberrant patterns on either DHPLC or SSCP assays were subject to further sequencing 
using automated or manual sequencing techniques.
The gold standard for mutation detection currently is sequencing but heterozygous deletions 
and duplications are missed. To overcome this problem techniques such as adapter-ligation 
mediated allele-specifi c amplifi cation may be used (Wang et al 2006).
LCA disease chip
A genotyping microarray that includes the disease causing mutations and sequence variants in 
the known LCA genes allows for mutation detection in a single reaction. An LCA ‘disease’ chip 
has been constructed using (APEX) Arrayed Primer Extension Technology (Asperbiotech). This 
technology is rapid, effective, simple and accurate and involves amplifi cation of the exons or 
LCA: Caveats helpful in molecular screening. 
Caveat Gene
Age of onset At birth GUCY2D, CRX, AIPL1, RPGRIP1, 
CRB1, IMPDH1, CEP290
Later than 1 year TULP1, RPE65,  RDH12 
Presence or history of photophobia GUCY2D
Presence or history of night-blindness RPE65,  RDH12
Presence of moderate to high hyperopia CRB1, GUCY2D
Presence of keratoconus AIPL1, RPGRIP1, CEP290
Severe pigmentary retinopathy between 0-2 years AIPL1, RPGRIP1
Low fundus autofl uoresence especially in the second decade RPE65
Normal appearance of retina at birth GUCY2D
Presence of macular refl ex IMPDH1, LCA5
Coloboma-like macular appearance/ maculopathy at birth CRX, AIPL1, CRB1
Pigmented nummular retinopathy CRB1, CEP290
White dot retinal leisons CRB1,CEP290
Preserved para-arteriolar RPE (PPRPE) CRB1
Early peripheral pigmentary retinopathy  RPE65, TULP1
Stable visual function GUCY2D, CRX, CRB1, RPGRIP1
Deterioration of visual function RPE65, TULP1
Autosomal dominant mode of inheritance CRX, IMPDH1
Severe early loss of vision GUCY2D, AIPL1, RPGRIP1
Early severe onset retinal dystrophy RPE65, TULP1, LRAT
LCA associated with autism, psychomotor retardation CEP290
LCA associated with Joubert or Senior-Løken syndrome CEP290
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amplicons containing known LCA gene mutations with specifi c oligonucleotide primers, which 
are hybridised to allele-specifi c oligonucleotide probes on a chip. Using this technique multiple 
simultaneous mutation analysis is possible, thus identifying known mutations, insertions and 
deletions in every new sample tested.
Prenatal diagnosis
If the disease-causing gene in LCA is known for a particular family then specifi c PCR prim-
ers can be used on fetal-derived tissue samples, e.g. early embryonic cells, chorionic villus 
samples, amniotic fl uid, fetal blood to detect these LCA mutations. Currently, prenatal diagnosis 
using chorionic villus sampling (10-12 weeks gestation), amniocentesis (15-18 weeks gestation) 
and fetal blood sampling (17 weeks gestation) are established methods for clinical testing for 
aneuploidies and single gene disorders. The knowledge of a prenatal positive test result gives 
much needed information about the genetic status.
Preimplantation genetic diagnosis is an earlier, but not widely available, alternate testing 
option to prenatal diagnosis and allows selection of unaffected fertilized embryos for establish-
ing pregnancy in couples at risk for transmitting LCA (Kanavakis et al 2002). Preimplantation 
genetic diagnosis involves the genotyping of single cells from early embryos produced in vitro 
before implantation in the patient’s uterus, which includes polar bodies from the oocyte-zygote 
stage, blastomeres from cleavage stage embryos and trophoectoderm cells from blastocysts. 
The advantage of preimplantation genetic diagnosis is that it allows diagnosis of affected fe-
tuses and selection and implantation of unaffected fetuses. Preimplantation genetic diagnosis 
methods have been commonly employed in the diagnosis of other severe autosomal recessive 
and X-linked disease like cystic fi brosis and Tay-Sachs disease respectively.
2.8 Treatment strategies
The diagnosis for most patients has spelt a lifetime of coping with debilitating visual loss as 
there have been no treatment options. In the last few decades, greater molecular understanding 
of the disease has been possible, paving the way for a new look at treatment options.
2.8.1 Ethical considerations
Genetic testing and prenatal diagnosis carry ethical and moral considerations which should be 
debated by society at large before being used as part of a clinical service. As blindness is not life 
threatening issues of genetic testing need to be evaluated very carefully. Genetic counseling un-
dertaken for AR LCA implies a 1 in 4 risk for offspring being affected when parents are carriers. 
Recurrence risk for the progeny of affected patients is low in the absence of consanguinity, as 
noted in a recent study (Hanein et al 2004). When genetic counseling is undertaken, considering 
AD LCA, the recurrence risk for children of affected patients is 50%, but the risk of parents of 
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CRX-associated LCA patients with de novo mutations having a second child with LCA is less 
than 25%.
Therapeutic strategies are too fraught with ethical considerations. Although a good outcome 
was reported in the treatment of sub-acute combined immune defi cency using gene therapy, 
instances of induced cancer were brought to light and clinical trials were suspended (Aiuti et 
al 2002, Cavazzana-Calvo et al 2000, Hacien–Bey- Abina et al 2003). Shortly, gene therapy 
trials for LCA using RPE65 will be underway following the stringent guidelines of the ethical and 
clinical committees.
2.8.2 Current management
Supportive medical management
Refractive errors which have included the correction of astigmatism, hyperopia and myopia with 
spectacles have helped a few patients to some degree. Low visual aids assisting in magnifi cation 
and the closed circuit television have been used with some success. Patients have used Braille 
and talking books. Guide dogs and mobility aids have added a dimension of independence 
in navigation. Support groups have provided help and encouragement for patients and their 
families.
Supportive surgical treatment
Although no treatment in LCA is currently curative, several treatment measures have been un-
dertaken in LCA to preserve gross structure and existing visual function. Corrective strabismus 
surgery to ensure ocular alignment has been performed for esotropia and exotropia. Laser 
correction of hyperopia has not been strongly advocated. In the setting of decreased vision with 
altered head posture and face turn the null point in nystagmus, may be surgically corrected. 
The Kastenbaum procedure is undertaken to centralize the null zone and it involves rotation 
of both eyes, by surgically recessing and resecting the ocular muscles to an equal amount to 
maintain the parallelism of the visual axis, thus obliterating the altered head and face posture 
and enabling better vision with the nystagmus. This procedure is undertaken in older children 
and adults and does not always provide satisfactory results.
When LCA is associated with keratoconus the markedly decreased vision is reduced still 
further in the presence hydrops which is basically a hazy cornea resulting from corneal edema 
due to breaks in the Descemets membrane with failure of the endothelial pump mechanism. 
Medical management in the form of topical hyperosmolar agents is helpful in some instances, 
but a corneal transplant may be indicated in recalcitrant or severe corneal haze. Keratoconus 
has been treated surgically by donor cadaveric corneal grafts. Cataract removal with intra ocular 
implantation has been undertaken in patients to maintain all the best vision possible. Naviga-
tional vision and an ability to appreciate contrast are vital for the patients. Cataract surgery has 
been benefi cial despite severe retinopathy (Sarangapani et al 2002).
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In a continuing effort to understand the evolution of the disease, it is important to examine 
the patients at periodic intervals. Serial fundus photography, optical coherence tomography and 
electroretinography document the structural and functional changes.
2.8.3 Novel treatment
Treatment for LCA perhaps is becoming a real option now, although considerable preparation 
is in order prior to this endeavor. A rational balance between feasibility, effi cacy and safety 
is necessary to devise adequate guidelines and regulations for all clinical trials (Cavazzana 
–Calvo et al 2004). Rods being necessary for cone survival, it becomes essential to replace 
degenerating rods to salvage the cones and thus preserve vision. On the other hand it may 
also be benefi cial to protect the cones from rod mediated cell loss. Either trophic factors or 
pharmacologically derived nano molecules mimicking the same function could be used to 
prevent the degeneration of cones which are so vital for vision (Mohand-Said et al 1998, 2001, 
Sahel et al 2001, Leveillard et al 2004a,b). Gene therapy to correct the underlying molecular 
defect, pharmacotherapy, retinal cell transplantation and the use of visual prosthesis are all 
being studied extensively.
2.8.3.1 Gene therapy
Great progress has been made in gene therapy studies and the use of animal models in retinal 
disease (Friedmann et al 1989, Dejneka et al 2003). The retina is considered to be a region of 
immune privilege, thus making it a viable area for gene therapy (Streilein et al 2002). Genetically 
based therapy could involve either replacement or suppression of dominant-negative muta-
tions. Gene-replacement therapy has been shown to rescue photoreceptors in a mouse model 
of ADRP induced by a rhodopsin mutation (McNally et al 1999).
Adenovirus vectors are non-enveloped, double stranded DNA viruses capable of gene 
transfer in retinal cells. Adenoma-associated and recombinant adenoma virus vectors have 
been used successfully for gene transfer in the retina (Ali et al 1996, Grant et al 1997, Bennett 
et al 1999). Adenoma-associated virus (AAV) and lentivirus have been used to transfect RPE 
cells with therapeutic genes to delay photoreceptor death in rodents (Dejneka et al 2001). 
AAV-mediated intravitreal therapy has also been shown to reduce lysosomal storage in the 
retinal pigment epithelium of adult MPS VII mice. Both histological preservation and function of 
the outer nuclear layer in the retina were maintained following therapy (Hennig et al 2004). AAV 
vectors have been used for gene transfer in the mouse retina to rescue photoreceptor function 
(Ali et al 2000). The heterogeneity of retinal disorders however makes gene based therapeutics 
a more diffi cult option.
Photoreceptor cell rescue noted in rd mice with retinal degeneration has been promising 
(Bennett 1996). AAV-Mediated mertk gene transfer slows photoreceptor loss in the RCS rat 
model of retinitis pigmentosa and prolonged photoreceptor cell survival and function has been 
observed. Similarly the effect of simian lentivirus (SIV)-mediated subretinal gene transfer of pig-
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ment epithelium-derived factor (PEDF), which is a potent neurotrophic factor, Royal College of 
Surgeons (RCS) rats protects against progressive photoreceptor cell dysfunction (Miyazaki et al 
2003). Thus the success of gene transfer has been demonstrated in several animal models of 
retinal degeneration paving the way for a viable therapeutic option in LCA. Despite the eye being 
easily accessible for viral vector delivery and gene therapy it is necessary to develop the means 
to regulate gene expression. Tet-on, a bacterial gene, has been used to control the expres-
sion of genes transferred to the retina (McGuire et al 2004). Delivery of a replacement gene via 
inoculation permits integration into the host genome thus facilitating expression and regulation of 
cellular function. Replacement gene therapy, wherein one copy of the mutant gene is replaced by 
a wild-type has shown effective results of retinal rescue in animal models (Travis et al 1992).
Physicochemical gene transfer using lipofection, and plasmids have been used for transgene 
expression and regulation (Chaum et al 1999). Individual mutations have been targeted using 
hammerhead ribozymes and siRNA molecules (La Vail et al 2000, Hauswirth et al 2000, a,b). 
Lentiviral delivery of phosphoglycerate kinase and elongation factor 1 is able to control the 
expression of supporting secreting factors in the RPE and retinal cells respectively, thus slowing 
or restoring retinal cells from degeneration. The PGK promoter is useful in targeting specifi c 
expression in the RPE to either restore function or express a specifi c photoreceptor survival 
factor. The EF promoter on the other hand may be used to express transgene throughout the 
retina and effect cell rescue and survival (Kostic et al 2003). Using human HIV vector mediated 
gene transfer photoreceptor cell rescue from retinal degeneration in rd mice has been possible 
(Takaheshi et al 1999).
Restoration of visual function in Briard dogs with RPE65-associated LCA; long term survival 
of the retina in transgenic autosomal dominant rat models expressing dominant rhodopsin 
mutations and preservation of the retina in the RCS rat have contributed encouraging results 
(Acland et al 2001). Intraocular gene transfer via subretinal injections, albeit uveitis has shown 
remarkable recovery of photoreceptor function in Rpe65-associated LCA dogs. Swedish Briard 
dogs with a naturally occurring 4 bp deletion in RPE65 showed improvement of electroretino-
graphic function following injections with recombinant AAV-RPE65 (Narfström et al 2003). An 
added milestone in the treatment of congenital blindness as observed in LCA is the use of 
successful in utero gene therapy. The in utero delivery of human RPE65 cDNA to the RPE cells 
using AAV2/1 capsid in RPE65 knockout mice results in effi cient transduction with measurable 
levels of rhodopsin and restoration of visual function (Dejneka et al 2004).
As apoptosis may be the fi nal common pathway of cell death in retinal degeneration, modify-
ing the process could delay degeneration (Tso et al 1994). Gene therapy using trophic growth 
factors enhances the survival both ultra-structurally and functionally of photoreceptors in retinal 
degeneration (Ali et al 2000). The use of basic fi broblast growth factor gene into the retina 
delayed retinal degeneration in the RCS rat (Akimoto et al 1999, Uteza et al 1999). Similarly 
using the anti-apoptotic gene bcl-2 delayed retinal degeneration in mice (Chen et al 1996, 
Joseph et al 1996, Bennett et al 1998, Nir et al 2000).
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The protective effect of neurotrophic factors like ciliary neurotrophic factor has been exploited 
in gene transfer and a delay in retinal degeneration has been noted (Unoki et al 1994, Cayoutte 
et al 1997, 1998). LCA in most instances results in the profound loss of photoreceptor function 
and gene therapy directed at this disease involves long-term stable expression of trangenes 
for several decades. Despite the pace of translational research in retinal degenerative diseases 
being fairly fast, several diffi culties still need to be overcome. The duration of gene expression 
over a life time to confer therapeutic effi cacy, inducibility of translational control of transgene 
expression and the improved safety of therapy continue to be important issues.
Gene replacement therapy for RPE-based retinal dystrophies rescue photoreceptor function 
as noted in the RCS rats with wild type mertk therapy and in Briard dogs with RPE65 gene 
therapy (Acland et al 2001, Vollrath et al 2001). Cone loss correlates spatially and temporally 
with rod loss (Cidecyian et al 1998, Milam et al 1998, Mohand-Said et al 2001, Sahel et al 
2001). Clinical trials using RPE65 gene therapy in adults initially are underway and have strict 
guidelines involving both safety and effi cacy.
2.8.3.2 Pharmacotherapy
As most mutations affect rods and apoptosis occurs due to a decrease in growth factors and 
a disorganized cell cycle modifying this process pharmacologically would be benefi cial (Chang 
et al 1993). Novel pharmacological molecules slow down the progression of photoreceptor 
degeneration in different models rescuing the cones from further death.
Pharmacological modifi cation of the retinoid cycle in instances when this pathway is involved 
in retinal disease has offered some promising results. Vitamin A supplementation slows down 
photoreceptor degeneration in RP (Berson et al 1993, Berson et al 1993). 11-cis retinal therapy 
in Rpe65 knockout mice has shown that early administration of a single oral dose of 9- cis 
retinal results in the generation of isorhodopsin and restoration of light sensitivity occurs (Van 
Hooser et al 2000). Accumulation of retinal esters is decreased and evidence of restored rod 
retinal function is noted on electroretinography. Maintenance of rod photopigment for more than 
6 months in the dark is observed, demonstrating that pharmacological intervention produces 
long lasting preservation of visual function in dark-reared Rpe65 -/- mice (Van Hooser et al 
2002).
Neuroprotective molecules introduced into the eye by injections or using viral vectors have 
been studied (Cayouette et al 1997). Trophic factors like glial derived neurotrophic factor are 
known to slow down photoreceptor degeneration and preserve retinal function (Frasson et al 
1999). However ciliary neurotrophic factor induces morphological rescue but causes a para-
doxical decrease in photopic and scotopic responses (Cayouette et al 1997, Liang et al 2001, 
Bok et al 2002). Although the neuroprotective effect of fi broblastic growth factor 2 is seen both 
histologically and functionally, pathogenic neovascularisation is also triggered (Faktorovich et al 
1990, Uteza et al 1999, Lau et al 2000). Since both rod and cone dysfunction occurs in LCA 
the use of trophic factors in this disorder could be explored.
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Another drug, D-cis-diltiazem, acts on the cGMP gated channels to block the rise in calcium 
which occurs in RP. The increase in calcium triggers apoptosis in RP. Calcium channel blockers 
thus decrease photoreceptor degeneration in RP (Lee & Tsien 1983, Koch et al 1985). Both 
retinal function and morphology were preserved in the rcs rat following therapy with nilvadipine, 
also a calcium antagonist (Yamazaki et al 2002). Preserved visual function due to photorecep-
tor rescue following the use of diltiazem in rd mice has been observed (Frasson et al 1999). 
Nevertheless this effect was not demonstrated either histologically or electrophysiologically in 
rcd1 dogs with retinal degeneration and mutations in the Pdeb gene (Pearce-Kelling et al 2001). 
However, these results depend on the model of retinal degeneration and the type of calcium 
blocker used (Yanmazaki et al 2002).
The use of endogenous viability factors which prevent indirect cone degeneration following 
rod loss will be useful in retinal degeneration. Rod dependent cone viability factors may be 
suitable for pharmacological replacement (Leveillard et al 2004). Treatment with isotretinoin 
(Accutane) inhibits lipofuscin accumulation, delaying visual loss in retinal degeneration caused 
by mutations in the Abca4 gene (Radu et al 2003).
A combination of taurine, diltiazem and Vitamin E intake has been shown to retard the 
progressive visual fi eld defects observed in human RP (Pasantes–Morales et al 2002). Decoso-
hexanoic acid supplementation has also improved the visual and electroretinographic status in 
juvenile Stargardt disease as noted in a case study (Macdonald et al 2004).
2.8.3.3 Cell transplantation
Since LCA is a heterogeneous disease implicating genes involved in several different pathways 
the use of cell transplantation circumvents individual gene-related mechanisms of overcoming 
retinal degeneration. Transplantation serves to replace damaged cells or provide growth and 
survival factors to cells to prevent further cell death.
RPE transplants provide benefi cial effects to the adjacent photoreceptor cells. The RPE 
cells have been introduced into the subretinal space either transvitreally or transsclerally. Both 
cadaveric and fetal RPE cells have been used in humans with not entirely successful results. The 
main disadvantages have included poor synapse formation, immune reactions and decreased 
cell survival all resulting in no restoration of visual function. The RCS rat, which has a normal 
retina at birth, shows degeneration of the photoreceptors due to defective phagocytosis, thus 
making it a good model for RPE transplantation. Following transplantation of RPE, a delay in 
the loss of photoreceptors, restoration of normal metabolism and an improvement in visual 
function have been observed (Gouras et al 1989, Sheedlo et al 1989, LaVail et al 1992, Jiang 
& Hamasaki 1994, Whiteley et al 1996). Cortical function is preserved in these rats following 
RPE transplantation (Lund et al 2003). Immortalised RPE, porcine or autologous RPE have 
been used. Fetal RPE cells have shown poor survival due to unavailability of extracellular matrix 
receptors required for attachment and spreading for repopulation (Girman et al 2003). Allogenic 
fetal retinal pigment epithelial cell transplants in patients with geographic atrophy resulting from 
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age–related macular degeneration (ARMD) have led to an immunogenic reaction (Weisz et al 
1999).
Photoreceptor cell transplants replace degenerating tissue. However, photoreceptor cell 
transplants are a more diffi cult proposition as they pose numerous problems to culture (Lund et 
al 2001). The role of stem or precursor cell transplants in retinal degenerative disease provides 
a potential route to photoreceptor cell renewal. New neurons are generated continuously from 
stem cells in the different parts of the mammalian retina (McKay 1997, Gage 2000, Momma 
et al 2000, Zhao et al 2003). This property has been exploited in neuro-degenerative disease. 
Persistent neurogenesis has been observed in the mature retinas of telost fi sh (Otteson et al 
2003). Retinal progenitors are located in the peripheral ciliary margin which gives rise to new 
neurons, however this is not demonstrable in mammalian retinas making neurogenesis more 
challenging (Kubota et al 2002). Photoreceptor survival following stem cell transplants occurs 
due to the release of trophic factors both close to the transplant and away from it (Mohand-Said 
et al 1997, 2001, Sahel et al 2001). Following transplantation of embryonic cells in the subretinal 
space, the transplants survive, differentiate and the neuronal fi bers synapse to be able to medi-
ate light and dark preferences (Aramant et al 1995). Rod dependent cone viability factors play 
a role in the rescue process (Fintz et al 2003).
2.8.3.4 Retinal prosthesis
Another experimental treatment option is the use of a visual prosthesis which uses electrical 
stimulation to bypass damaged nerve endings. This approach has been successful in cochlear 
implants in the treatment of deafness. In the treatment of retinal degenerative disorders, retinal 
prosthesis have been used on an experimental basis (Margalit et al 2002). Both the crude 
appreciation of the sensation of light and the ability to detect motion has been possible using 
these prosthesis (Weiland et al 2005). It is hoped that the development of silicon chip eye 
implants will bypass damaged rods and cones, pass on signals to ganglion cells restoring vision 
lost from retinal degeneration (Rizzo et al 2001). It has been shown that implantable electronic 
devices are capable of transferring visual signals to the brain (Yagi et al 1999). The occipital cor-
tex is not totally dysfunctional in the absence of light sensitive input but activation of the visual 
cortex is observed by positron emission tomography scanning and during functional magnetic 
resonance imaging while Braille reading and the period of cross-modal plasticity extends into 
the second decade of life in the blind (Cohen et al 1999, Sadato et al 2004). This involves tactile 
somatosensory pathways, paving the way for understanding visual–neural pathways in visual 
loss since infancy (Sadato et al 1998). Understanding the connections and fi ring mechanisms 
between ganglion cells and the visual cortex via the lateral geniculate body is an initial step in 
deciphering visual and neural coding (Kara et al 2003).
In the last decade, implants of a basic prototype have resulted in the ability of markedly 
visually impaired subjects to appreciate shades of light and outlines of objects (Humayun et al 
2003, Rizzo et al 2003). Permanent implants are still being perfected and understanding visual 
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neural coding thoroughly may be the key to success in this endeavor. Electrical stimulation of 
the eye evokes phosphenes with gross two-point discrimination and spatial orientation (Dobelle 
et al 1974, Dobelle & Mladejovsky 1974). Retinal implants placed subretinally or epiretinally rely 
on the normal connectivity and function of the second order neurons (Humayun et al 1998).
 Micro-photodiodes convert light into electricity which is delivered to the adjacent tissue 
using microelectrodes (Chow et al 2002, Zrenner et al 2002). Retinal visual improvement oc-
curs possibly due to neurotrophic-type rescue and the subretinal electrical stimulation of the 
retina also leads to visual cortical responses (Chow et al 2004). Epiretinal stimulation of retinal 
ganglion cells causes crude pattern recognition. Light entering the eye is converted into a 
pattern of electrical pulses which is decoded by an electrode array resting on the retinal surface 
and 820-nm laser is transmitted to a micro fabricated polyamide array receiver which is in 
contact with the retinal ganglion cell layer and the induced perception of retinal stimulation are 
ascertainable (Rizzo et al 2003,a,b). The artifi cial silicone retina developed by Optobionics is 
a micro photodiode array that converts light energy to electrical impulses and stimulates the 
remaining functional retinal cells (Chow et al 2002). Human trials are underway using this chip 
with great attention being paid to patient selection (Yanai et al 2003, Chow et al 2004).
A hybrid retinal implant placed subretinally uses a microelectromechanical system with trans-
planted neural cells serving as live wires, and the new axons are guided to the central nervous 
system using axon-guided substrates, thus establishing connectivity even in the absence of 
ganglion cells and a functional optic nerve. This system makes use of a photo sensor in the 
anterior chamber and a signal decoder in the subretinal space. Transretinal electrical stimulation 
using multichannel arrays have shown effi cient results (Nakauchi et al 2004). Electronic pho-
toreceptor prosthesis are limited by their biocompatibility, longevity, stability and image quality 
(Zrenner et al 2002).
2.8.3.5 Cortical devices
Implantation of a cortical stimulation unit attached to a camera and a laptop computer has 
been able to increase the visual potential (Dobelle 2000). Intracortical microelectrode visual 
prosthesis array implantation into area IV of the cortex with connections to an electronic module 
driven by responses sent to transcutaneous link have also been developed and artifi cial vision 
for the blind by electrical stimulation of the visual cortex may be realized (Dobelle et al 1979).
Neurotransmission using chemicals instead of electrodes for stimulation of the brain have 
been developed. Spatio-temporally controlled neurotransmitter release has a higher specifi city 
of stimulation and spatial resolution. A rapid temporal response is noted with this microfl udic 
prodrug delivery channel system that uses caged glutamate release by an ultraviolet light delivery 
to the brain (Lezzi et al 2003). Finally as both tactile and auditory pathways are well developed 
in subjects with profound loss of vision, voice and tactile technology is being made use of to 
simulate vision as clearer understanding of cross-modal links in spatial attention is established 
(Macaluso 2000, Hillis et al 2002).
Sharola BW.indd   97 29-May-07   10:45:46 AM
98
References
Acland GM, Aguirre GD, Ray J, Zhang Q, Aleman TS, Cideciyan AV, Pearce-Kelling SE, Anand V, Zeng Y, Maguire 
AM, Jacobson SG, Hauswirth WW, Bennett J. Gene therapy restores vision in a canine model of childhood 
blindness. Nat Genet. 2001; 28(1): 92-95.
Acland GM, Ray K, Mellersh CS, Gu W, Langston AA, Rine J, Ostrander EA, Aguirre GD. Linkage analysis and 
comparative mapping of canine progressive rod-cone degeneration (prcd) establishes potential locus homology 
with retinitis pigmentosa (RP17) in humans. Proc Natl Acad Sci U S A. 1998; 95(6):3048-3053.
Aguirre GD, Baldwin V, Pearce-Kelling S, Narfstrom K, Ray K, Acland GM. Congenital stationary night blindness in 
the dog: common mutation in the RPE65 gene indicates founder effect. Mol Vis. 1998; 4:23.
Aiuti A, Slavin S, Aker M, Ficara F, Deola S, Mortellaro A, Morecki S, Andolfi  G, Tabucchi A, Carlucci F, Marinello E, 
Cattaneo F, Vai S, Servida P, Miniero R, Roncarolo MG, Bordignon C. Correction of ADA-SCID by stem cell gene 
therapy combined with nonmyeloablative conditioning.
Science. 2002; 296(5577):2410-2413.
Aherne A, Kennan A, Kenna PF, McNally N, Lloyd DG, Alberts IL, Kiang AS, Humphries MM, Ayuso C, Engel PC, Gu 
JJ, Mitchell BS, Farrar GJ, Humphries P. On the molecular pathology of neurodegeneration in IMPDH1-based 
retinitis pigmentosa.Hum Mol Genet. 2004; 13(6):641-650.
Akeo K, Saga M, Hiida Y, Oguchi Y, Okisaka S. Progression of visual fi eld loss in patients with retinitis pigmentosa of 
sporadic and autosomal recessive types. Ophthalmic Res. 1998; 30(1):11-22.
Akey DT, Zhu X, Dyer M, Li A, Sorensen A, Blackshaw S, Fukuda-Kamitani T, Daiger SP, Craft CM, Kamitani T, 
Sohocki MM. The inherited blindness associated protein AIPL1 interacts with the cell cycle regulator protein 
NUB1. Hum Mol Genet. 2002; 11(22):2723-2733. Erratum in: Hum Mol Genet. 2003;12(4):451.
Akimoto M, Miyatake S, Kogishi J, Hangai M, Okazaki K, Takahashi JC, Saiki M, Iwaki M, Honda Y. Adenovirally 
expressed basic fi broblast growth factor rescues photoreceptor cells in RCS rats.
Invest Ophthalmol Vis Sci. 1999; 40(2):273-279.
Aleman TS, Jacobson SG, Chico JD, Scott ML, Cheung AY, Windsor EA, Furushima M, Redmond TM, Bennett J, 
Palczewski K, Cideciyan AV. Impairment of the transient pupillary light refl ex in Rpe65(-/-) mice and humans with 
leber congenital amaurosis. Invest Ophthalmol Vis Sci. 2004; 45(4):1259-1271.
Alexander KR, Fishman GA. Prolonged rod dark adaptation in retinitis pigmentosa. Br J Ophthalmol. 1984; 
68(8):561-569.
Ali RR, Reichel MB, Thrasher AJ, Levinsky RJ, Kinnon C, Kanuga N, Hunt DM, Bhattacharya SS. Gene transfer into 
the mouse retina mediated by an adeno-associated viral vector. Hum Mol Genet. 1996; 5(5):591-594.
Ali RR, Sarra GM, Stephens C, Alwis MD, Bainbridge JW, Munro PM, Fauser S, Reichel MB, Kinnon C, Hunt DM, 
Bhattacharya SS, Thrasher AJ. Restoration of photoreceptor ultrastructure and function in retinal degeneration 
slow mice by gene therapy. Nat Genet. 2000; 25(3):306-310.
Allikmets R. Leber congenital amaurosis: a genetic paradigm. Ophthalmic Genet. 2004; 25(2):67-79.
Alström CH, and Olson O. Heredo-retinopathia congenitalis monohybrida recessiva autosomalis. Hereditas 1957; 
43:178-185.
Antignac C, Arduy CH, Beckmann JS, Benessy F, Gros F, Medhioub M, Hildebrandt F, Dufi er JL, Kleinknecht C, 
Broyer M, et al. A gene for familial juvenile nephronophthisis (recessive medullary cystic kidney disease) maps to 
chromosome 2p. Nat Genet. 1993; 3(4):342-345.
Aramant RB, Seiler MJ. Fiber and synaptic connections between embryonic retinal transplants and host retina. Exp 
Neurol. 1995; 133(2):244-255.
Arima M, Ono K, Hisada K, Handa T. A familial syndrome of maldevelopment of the brain, polycystic kidneys, 
congenital tapeto-retinal dysplasia with coloboma and unilateral pstosis. No To Hattatsu1971; 3 :330-331
Armington JC, Gouras P, Tepas DI, Gunkel R. Detection of the electroretinogram in retinitis pigmentosa. Exp Eye 
Res. 1961; 1:74-80.
Arshavsky V. Like night and day: rods and cones have different pigment regeneration pathways.
Neuron. 2002; 36(1):1-3.
Ayuso C, Trujillo MJ, Robledo M, Ramos C, Benitez J, Martin-Oses F, del Rio T, Garcia-Sandoval B. Novel rhodopsin 
mutation in an autosomal dominant retinitis pigmentosa family: phenotypic variation in both heterozygote and 
homozygote Val137Met mutant patients. Hum Genet. 1996; 98(1):51-54.
Babel J. Histological fi ndings in Leber’s infantile amaurosis and in different forms of hemeralopia Ophthalmologica. 
1963; 145:399-402.
Sharola BW.indd   98 29-May-07   10:45:46 AM
Leber congenital amaurosis 99
Bachmann A, Schneider M, Theilenberg E, Grawe F, Knust E. Drosophila Stardust is a partner of Crumbs in the 
control of epithelial cell polarity. Nature. 2001; 414(6864):638-643.
Banerjee P, Kleyn PW, Knowles JA, Lewis CA, Ross BM, Parano E, Kovats SG, Lee JJ, Penchaszadeh GK, Ott 
J, Jacobson SG, Gilliam TC. TULP1 mutation in two extended Dominican kindreds with autosomal recessive 
retinitis pigmentosa. Nat Genet. 1998; 18(2):177-179.
Bascom RA, Liu L, Heckenlively JR, Stone EM, McInnes RR. Mutation analysis of the ROM1 gene in retinitis pigmen-
tosa. Hum Mol Genet. 1995; 4(10):1895-1902.
Bastek JV, Siegel EB, Straatsma BR, Foos RY. Chorioretinal juncture. Pigmentary patterns of the peripheral fundus. 
Ophthalmology. 1982; 89(12):1455-1463.
Batten ML, Imanishi Y, Maeda T, Tu DC, Moise AR, Bronson D, Possin D, Van Gelder RN, Baehr W, Palczewski K. 
Lecithin-retinol acyltransferase is essential for accumulation of all-trans-retinyl esters in the eye and in the liver. J 
Biol Chem. 2004; 279(11):10422-10432.
Batten ML, Imanishi Y, Tu DC, Doan T, Zhu L, Pang J, Glushakova L, Moise AR, Baehr W, Van Gelder RN, Hauswirth 
WW, Rieke F, Palczewski K. Pharmacological and rAAV gene therapy rescue of visual functions in a blind mouse 
model of Leber congenital amaurosis. PLoS Med. 2005; 2(11):e333
Baylor DA, Lamb TD, Yau KW. Responses of retinal rods to single photons.J Physiol. 1979; 288:613-634.
Beebe DC. Homeobox genes and vertebrate eye development. Invest Ophthalmol Vis Sci. 1994; 35(7):2897-2900.
Behrens F, Weiss LR. An automated and modifi ed technique for testing the retinal function (Arden test) by use of the 
electro-oculogram (EOG) for clinical and research use. Doc Ophthalmol. 1998-99; 96(4):283-292.
Bellmann C, Rubin GS, Kabanarou SA, Bird AC, Fitzke FW. Fundus autofl uorescence imaging compared with 
different confocal scanning laser ophthalmoscopes. Br J Ophthalmol. 2003; 87(11):1381-1386.
Bennett J, Maguire AM, Cideciyan AV, Schnell M, Glover E, Anand V, Aleman TS, Chirmule N, Gupta AR, Huang 
Y, Gao GP, Nyberg WC, Tazelaar J, Hughes J, Wilson JM, Jacobson SG. Stable transgene expression in rod 
photoreceptors after recombinant adeno-associated virus-mediated gene transfer to monkey retina. Proc Natl 
Acad Sci U S A. 1999; 96(17):9920-9925.
Bennett J, Tanabe T, Sun D, Zeng Y, Kjeldbye H, Gouras P, Maguire AM. Photoreceptor cell rescue in retinal 
degeneration (rd) mice by in vivo gene therapy. Nat Med.; 2(6):649-654.
Bennett J, Zeng Y, Bajwa R, Klatt L, Li Y, Maguire AM. Adenovirus-mediated delivery of rhodopsin-promoted bcl-2 
results in a delay in photoreceptor cell death in the rd/rd mouse. Gene Ther. 1998; 5(9):1156-1164.
Berger W, Meindl A, van de Pol TJ, Cremers FPM, Ropers HH, Doerner C, Monaco
A, Bergen AA, Lebo R, Warburg M, et al. Isolation of a candidate gene for Norrie disease by positional cloning. Nat 
Genet. 1992; 1(3):199-203. Erratum in: Nat Genet. 1992; 2(1):84.
Bernal S, Calaf M, Garcia-Hoyos M, Garcia-Sandoval B, Rosell J, Adan A, Ayuso C, Baiget M. Study of the involve-
ment of the RGR, CRPB1, and CRB1 genes in the pathogenesis of autosomal recessive retinitis pigmentosa.J 
Med Genet. 2003; 40(7):e89.
Berson EL, Goldstein EB. Early receptor potential in dominantly inherited retinitis pigmentosa. Arch Ophthalmol. 
1970a; 83(4):412-420
Berson EL, Goldstein EB. The early receptor potential in sex-linked retinitis pigmentosa. Invest Ophthalmol. 1970b; 
9(1):58-63
Berson EL, Gouras P, Hoff M. Temporal aspects of the electroretinogram. Arch Ophthalmol. 1969; 81(2):207-214.
Berson EL, Rosner B, Sandberg MA, Hayes KC, Nicholson BW, Weigel-DiFranco C, Willett W.
A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa. Arch Ophthalmol. 1993a; 
111(6):761-772.
Berson EL, Rosner B, Sandberg MA, Hayes KC, Nicholson BW, Weigel-DiFrano C, Willett W. Vitamin A supplemen-
tation for retinitis pigmentosa. Arch Ophthalmol. 1993b; 111(11):1456-1459.
Besch D, Jagle H, Scholl HP, Seeliger MW, Zrenner E. Inherited multifocal RPE-diseases: mechanisms for local 
dysfunction in global retinoid cycle gene defects. Vision Res. 2003; 43(28):3095-3108.
Bessant DA, Ali RR, Bhattacharya SS. Molecular genetics and prospects for therapy of the inherited retinal dystro-
phies. Curr Opin Genet Dev. 2001; 11(3):307-316.
Bhattacharya SS, Wright AF, Clayton JF, Price WH, Phillips CI, McKeown CM, Jay M, Bird AC, Pearson PL, Southern 
EM, et al. Close genetic linkage between X-linked retinitis pigmentosa and a restriction fragment length polymor-
phism identifi ed by recombinant DNA probe L1.28.
Nature. 1984; 309(5965):253-255.
Sharola BW.indd   99 29-May-07   10:45:46 AM
100
Bibb LC, Holt JK, Tarttelin EE, Hodges MD, Gregory-Evans K, Rutherford A, Lucas RJ, Sowden JC, Gregory-Evans 
CY. Temporal and spatial expression patterns of the CRX transcription factor and its downstream targets. Critical 
differences during human and mouse eye development. Hum Mol Genet. 2001; 10(15):1571-1579.
Blackshaw S, Fraioli RE, Furukawa T, Cepko CL. Comprehensive analysis of photoreceptor gene expression and the 
identifi cation of candidate retinal disease genes.
Cell. 2001; 107(5):579-589.
Blair IP, Gibson RR, Bennett CL, Chance PF. Search for genes involved in Joubert syndrome: evidence that one or 
more major loci are yet to be identifi ed and exclusion of candidate genes EN1, EN2, FGF8, and BARHL1. Am J 
Med Genet. 2002; 107(3):190-196.
Boggon TJ, Shan WS, Santagata S, Myers SC, Shapiro L. Implication of tubby proteins as transcription factors by 
structure-based functional analysis. Science. 1999; 286(5447):2119-2125
Booij JC, Florijn RJ, ten Brink JB, Loves W, Meire F, van Schooneveld MJ, de Jong PT, Bergen AA. Identifi ca-
tion of mutations in the AIPL1, CRB1, GUCY2D, RPE65, and RPGRIP1 genes in patients with juvenile retinitis 
pigmentosa. J Med Genet. 2005; 42(11):e67.
Boichis H, Passwell J, David R, Miller H. Congenital hepatic fi brosis and nephronophthisis. A family study. Q J Med. 
1973; 42(165):221-233.
Bok D. Retinal photoreceptor-pigment epithelium interactions. Friedenwald lecture.
Invest Ophthalmol Vis Sci. 1985; 26(12):1659-1694.
Bok D, Yasumura D, Matthes MT, Ruiz A, Duncan JL, Chappelow AV, Zolutukhin
S, Hauswirth W, LaVail MM. Effects of adeno-associated virus-vectored ciliary neurotrophic factor on retinal structure 
and function in mice with a P216L rds/peripherin mutation.
Exp Eye Res. 2002; 74(6):719-735.
Botstein D, White RL, Skolnick M, Davis RW. Construction of a genetic linkage map in man using restriction fragment 
length polymorphisms. Am J Hum Genet. 1980; 32(3):314-331.
Bowne SJ, Sullivan LS, Blanton SH, Cepko CL, Blackshaw S, Birch DG, Hughbanks-Wheaton D, Heckenlively JR, 
Daiger SP. Mutations in the inosine monophosphate dehydrogenase 1 gene (IMPDH1) cause the RP10 form of 
autosomal dominant retinitis pigmentosa. Hum Mol Genet. 2002; 11(5):559-568.
Bowne SJ, Sullivan LS, Mortimer SE, Hedstrom L, Zhu J, Spellicy CJ, Gire AI, Hughbanks-Wheaton D, Birch 
DG, Lewis RA, Heckenlively JR, Daiger SP. Spectrum and frequency of mutations in IMPDH1 associated with 
autosomal dominant retinitis pigmentosa and Leber congenital amaurosis. Invest Ophthalmol Vis Sci. 2006; 
47(1):34-42.
Boylan JP, Wright AF. Identifi cation of a novel protein interacting with RPGR. Hum Mol Genet. 2000; 9(14):2085-
2093.
Brecelj J, Stirn-Kranjc B. ERG and VEP follow-up study in children with Leber’s congenital amaurosis. Eye. 1999; 
13 (Pt 1):47-54.
Breuer DK, Yashar BM, Filippova E, Hiriyanna S, Lyons RH, Mears AJ, Asaye B, Acar C, Vervoort R, Wright AF, 
Musarella MA, Wheeler P, MacDonald I, Iannaccone A, Birch D, Hoffman DR, Fishman GA, Heckenlively JR, Ja-
cobson SG, Sieving PA, Swaroop A. A comprehensive mutation analysis of RP2 and RPGR in a North American 
cohort of families with X-linked retinitis pigmentosa. Am J Hum Genet. 2002; 70(6):1545-1554.
Brown KT, Murakami M. A new receptor potential of the monkey retina with no detectable latency. Nature. 1964; 
201:626-628.
Brown S. Bioinformatics: a biologist’s guide to biocomputing and the internet. Eaton Publishing, 2000.
Bunker CH, Berson EL, Bromley WC, Hayes RP, Roderick TH. Prevalence of retinitis pigmentosa in Maine. Am J 
Ophthalmol. 1984; 97(3):357-365.
Bunt-Milam AH, Kalina RE, Pagon RA. Clinical-ultrastructural study of a retinal dystrophy.
Invest Ophthalmol Vis Sci. 1983; 24(4):458-469.
Burstedt MS, Sandgren O, Holmgren G, Forsman-Semb K. Bothnia dystrophy caused by mutations in the cel-
lular retinaldehyde-binding protein gene (RLBP1) on chromosome 15q26. Invest Ophthalmol Vis Sci. 1999; 
40(5):995-1000.
Camuzat A, Rozet JM, Dollfus H, Gerber S, Perrault I, Weissenbach J, Munnich A, Kaplan J. Evidence of genetic 
heterogeneity of Leber’s congenital amaurosis (LCA) and mapping of LCA1 to chromosome 17p13. Hum Genet. 
1996; 97(6):798-801.
Caridi G, Murer L, Bellantuono R, Sorino P, Caringella DA, Gusmano R, Ghiggeri GM. Renal-retinal syndromes: 
association of retinal anomalies and recessive nephronophthisis in patients with homozygous deletion of the 
NPH1 locus. Am J Kidney Dis. 1998; 32(6):1059-1062.
Sharola BW.indd   100 29-May-07   10:45:46 AM
Leber congenital amaurosis 101
Carroll K, Gomez C, Shapiro L. Tubby proteins: the plot thickens. Nat Rev Mol Cell Biol. 2004 ; 5(1):55-63.
Castagnet P, Mavlyutov T, Cai Y, Zhong F, Ferreira P. RPGRIP1s with distinct neuronal localization and biochemical 
properties associate selectively with RanBP2 in amacrine neurons.
Hum Mol Genet. 2003; 12(15):1847-1863.
Casteels I, Spileers W, Demaerel P, Casaer P, De Cock P, Dralands L, Missotten L. Leber congenital amaurosis-
-differential diagnosis, ophthalmological and neuroradiological report of 18 patients. Neuropediatrics. 1996; 
27(4):189-193.
Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G, Gross F, Yvon E, Nusbaum P, Selz F, Hue C, Certain S, 
Casanova JL, Bousso P, Deist FL, Fischer A. Gene therapy of human severe combined immunodefi ciency 
(SCID)-X1 disease. Science. 2000; 288(5466):669-672.
Cayouette M, Gravel C. Adenovirus-mediated gene transfer of ciliary neurotrophic factor can prevent photoreceptor 
degeneration in the retinal degeneration (rd) mouse. Hum Gene Ther. 1997; 8(4):423-430.
Cayouette M, Behn D, Sendtner M, Lachapelle P, Gravel C. Intraocular gene transfer of ciliary neurotrophic factor 
prevents death and increases responsiveness of rod photoreceptors in the retinal degeneration slow mouse. J 
Neurosci. 1998; 18(22):9282-9293.
Cerosaletti KM, Lange E, Stringham HM, Weemaes CM, Smeets D, Solder B, Belohradsky BH, Taylor AM, Karnes P, 
Elliott A, Komatsu K, Gatti RA, Boehnke M, Concannon P. Fine localization of the Nijmegen breakage syndrome 
gene to 8q21: evidence for a common founder haplotype. Am J Hum Genet. 1998; 63(1):125-134.
Chader GJ, Fletcher RT, Sanyal S, Aguirre GD. A review of the role of cyclic GMP in neurological mutants with 
photoreceptor dysplasia. Curr Eye Res. 1985; 4(7):811-819.
Chang B, Hawes NL, Hurd RE, Davisson MT, Nusinowitz S, Heckenlively JR. Retinal degeneration mutants in the 
mouse. Vision Res. 2002;42(4):517-525.
Chang GQ, Hao Y, Wong F. Apoptosis: fi nal common pathway of photoreceptor death in rd, rds, and rhodopsin 
mutant mice. Neuron. 1993; 11(4):595-605.
Chang B, Khanna H, Hawes N, Jimeno D, He S, Lillo C, Parapuram SK, Cheng H,Scott A, Hurd RE, Sayer JA, Otto 
EA, Attanasio M, O’toole JF, Jin G, Shou C,Hildebrandt F, Williams DS, Heckenlively JR, Swaroop A. In-frame 
deletion in a novel centrosomal/ciliary protein CEP290/NPHP6 perturbs its interaction with RPGR and results in 
early-onset retinal degeneration in the rd16 mouse. Hum Mol Genet. 2006; 15(11):1847-1857.
Chau KY, Chen S, Zack DJ, Ono SJ. Functional domains of the cone-rod homeobox (CRX) transcription factor. J 
Biol Chem. 2000; 275(47):37264-37270.
Chaum E, Hatton MP, Stein G. Polyplex-mediated gene transfer into human retinal pigment epithelial cells in vitro. J 
Cell Biochem. 1999; 76(1):153-160.
Chen J, Flannery JG, LaVail MM, Steinberg RH, Xu J, Simon MI. bcl-2 overexpression reduces apoptotic photore-
ceptor cell death in three different retinal degenerations. Proc Natl Acad Sci U S A. 1996; 93(14):7042-7047.
Chen S, Wang QL, Xu S, Liu I, Li LY, Wang Y, Zack DJ. Functional analysis of cone-rod homeobox (CRX) mutations 
associated with retinal dystrophy. Hum Mol Genet. 2002; 11(8):873-884.
Chen S, Wang QL, Nie Z, Sun H, Lennon G, Copeland NG, Gilbert DJ, Jenkins NA, Zack DJ. Crx, a novel Otx-like 
paired-homeodomain protein, binds to and transactivates photoreceptor cell-specifi c genes. Neuron. 1997; 
19(5):1017-1030.
Chen ZY, Hendriks RW, Jobling MA, Powell JF, Breakefi eld XO, Sims KB, Craig IW.
Isolation and characterization of a candidate gene for Norrie disease. Nat Genet. 1992; 1(3):204-208.
Chen ZY, Battinelli EM, Hendriks RW, Powell JF, Middleton-Price H, Sims KB, Breakefi eld XO, Craig IW. Norrie 
disease gene: characterization of deletions and possible function.
Genomics. 1993; 16(2):533-535.
Chow AY, Chow VY, Packo KH, Pollack JS, Peyman GA, Schuchard R. The artifi cial silicon retina microchip for the 
treatment of vision loss from retinitis pigmentosa. Arch Ophthalmol. 2004; 122(4):460-469.
Chow AY, Pardue MT, Perlman JI, Ball SL, Chow VY, Hetling JR, Peyman GA, Liang C, Stubbs EB Jr, Peachey NS. 
Subretinal implantation of semiconductor-based photodiodes: durability of novel implant designs. J Rehabil Res 
Dev. 2002; 39(3):313-321.
Chowers I, Esumi N, Campochiaro P, Zack DJ. Studies on retinal and retinal pigment epithelial gene expression. 
Novartis Found Symp. 2004; 255:131-45; discussion 145-6, 177-178.
Cideciyan AV, Hood DC, Huang Y, Banin E, Li ZY, Stone EM, Milam AH, Jacobson SG. Disease sequence from 
mutant rhodopsin allele to rod and cone photoreceptor degeneration in man. Proc Natl Acad Sci U S A. 1998; 
95(12):7103-7108.
Sharola BW.indd   101 29-May-07   10:45:46 AM
102
Clements PJ, Gregory CY, Peterson-Jones SM, Sargan DR, Bhattacharya SS. Confi rmation of the rod cGMP 
phosphodiesterase beta subunit (PDE beta) nonsense mutation in affected rcd-1 Irish setters in the UK and 
development of a diagnostic test. Curr Eye Res. 1993; 12(9):861-866.
Cogan DG. Primary chorioretinal aberrations with night blindness; pathology.
Trans Am Acad Ophthalmol Otolaryngol. 1950; 629-661.
Cohen LG, Weeks RA, Sadato N, Celnik P, Ishii K, Hallett M. Period of susceptibility for cross-modal plasticity in the 
blind. Ann Neurol. 1999; 45(4):451-460.
Coleman JE, Zhang Y, Brown GA, Semple-Rowland SL. Cone cell survival and downregulation of GCAP1 protein in 
the retinas of GC1 knockout mice. Invest Ophthalmol Vis Sci. 2004; 45(10):3397-3403.
Cone RA. Early receptor potential of the vertebrate retina. Nature. 1964; 204:736-739.
Cone RA. Early receptor potential: photoreversible charge displacement in rhodopsin. Science. 1967; 155(766):1128-
1131.
Cooper DN, Gerber-Huber S. DNA methylation and CpG suppression. Cell Differ. 1985; 17(3):199-205.
Cooper DN, Krawczak M. The mutational spectrum of single base-pair substitutions causing human genetic disease: 
patterns and predictions. Hum Genet. 1990; 85(1):55-74.
Cooper DN, Schmidtke J. Molecular genetic approaches to the analysis and diagnosis of human inherited disease: 
an overview. Ann Med. 1992; 24(1):29-42.
Cooper DN. Regulatory mutations and human genetic disease. Ann Med. 1992; 24(6):427-437.
Connell GJ, Molday RS. Molecular cloning, primary structure, and orientation of the vertebrate photoreceptor cell 
protein peripherin in the rod outer segment disk membrane.
Biochemistry. 1990; 29(19):4691-4698.
Cotton RG. Mutation detection by chemical cleavage. Genet Anal. 1999; 14(5-6):165-168.
Cremers FPM, van de Pol DJ, Diergaarde PJ, Wieringa B, Nussbaum RL, Schwartz M, Ropers HH. Physical fi ne 
mapping of the choroideremia locus using Xq21 deletions associated with complex syndromes. Genomics. 
1989; 4(1):41-46.
Cremers FPM, van de Pol DJ, van Kerkhoff LP, Wieringa B, Ropers HH. Cloning of a gene that is rearranged in 
patients with choroideraemia. Nature. 1990;347(6294):674-677.
Cremers FPM, van den Hurk JA, den Hollander AI. Molecular genetics of Leber congenital amaurosis. Hum Mol 
Genet. 2002;11(10):1169-1176.
Cunha-Vaz J. The blood-ocular barriers. Surv Ophthalmol. 1979; 23(5):279-296.
Curcio CA, Sloan KR, Kalina RE, Hendrickson AE. Human photoreceptor topography.J Comp Neurol. 1990; 
292(4):497-523.
Curless RG, Flynn JT, Olsen KR, Post MJ. Leber congenital amaurosis in siblings with diffuse dysmyelination. Pediatr 
Neurol. 1991; 7(3):223-225.
Daiger SP, Sullivan LS, Bowne SJ, Kennan A, Humphries P, Birch DG, Heckenlively JR; RP1 Consortium. Identifi cation 
of the RP1 and RP10 (IMPDH1) genes causing autosomal dominant RP.Adv Exp Med Biol. 2003; 533:1-11.
Dartnall HJ, Bowmaker JK, Mollon JD. Human visual pigments: microspectrophotometric results from the eyes of 
seven persons. Proc R Soc Lond B Biol Sci. 1983; 220(1218):115-130.
Das SR, Bhardwaj N, Kjeldbye H, Gouras P. Muller cells of chicken retina synthesize 11-cis-retinol. Biochem J. 1992; 
285 (Pt 3):907-913.
Davidson FF, Steller H. Blocking apoptosis prevents blindness in Drosophila retinal degeneration mutants. Nature. 
1998; 391(6667):587-591.
Dejneka NS, Bennett J. Gene therapy and retinitis pigmentosa: advances and future challenges. Bioessays. 2001; 
23(7):662-668.
Dejneka NS, Rex TS, Bennett J. Gene therapy and animal models for retinal disease. Dev Ophthalmol. 2003; 
37:188-198.
Dejneka NS, Surace EM, Aleman TS, Cideciyan AV, Lyubarsky A, Savchenko A, Redmond TM, Tang W, Wei Z, 
Rex TS, Glover E, Maguire AM, Pugh EN Jr, Jacobson SG, Bennett J. In utero gene therapy rescues vision in a 
murine model of congenital blindness. Mol Ther. 2004; 9(2):182-188.
Dekaban AS. Familial occurrence of congenital retinal blindness and developmental renal lesions. J Genet Hum. 
1969; 17(3):289-296.
Dekaban AS. Hereditary syndrome of congenital retinal blindness (Leber), polycystic kidneys and maldevelopment 
of the brain. Am J Ophthalmol. 1969; 68(6):1029-1037.
Delaney V, Mullaney J, Bourke E. Juvenile nephronophthisis, congenital hepatic fi brosis and retinal hypoplasia in 
twins. Q J Med. 1978; 47(187):281-290.
Sharola BW.indd   102 29-May-07   10:45:46 AM
Leber congenital amaurosis 103
den Hollander AI, van Driel MA, de Kok YJ, van de Pol DJ, Hoyng CB, Brunner HG, Deutman AF, Cremers FPM. 
Isolation and mapping of novel candidate genes for retinal disorders using suppression subtractive hybridization. 
Genomics. 1999a; 15;58(3):240-249.
den Hollander AI, ten Brink JB, de Kok YJ, van Soest S, van den Born LI, van Driel MA, van de Pol DJ, Payne AM, 
Bhattacharya SS, Kellner U, Hoyng CB, Westerveld A, Brunner HG, Bleeker-Wagemakers EM, Deutman AF, 
Heckenlively JR, Cremers FPM, Bergen AA. Mutations in a human homologue of Drosophila crumbs cause 
retinitis pigmentosa (RP12). Nat Genet. 1999b; 23(2):217-221.
den Hollander AI, Heckenlively JR, van den Born LI, de Kok YJ, van der Velde-Visser SD, Kellner U, Jurklies B, 
van Schooneveld MJ, Blankenagel A, Rohrschneider K, Wissinger B, Cruysberg JR, Deutman AF, Brunner 
HG, Apfelstedt-Sylla E, Hoyng CB, Cremers FPM. Leber congenital amaurosis and retinitis pigmentosa with 
Coats-like exudative vasculopathy are associated with mutations in the crumbs homologue 1 (CRB1) gene. Am 
J Hum Genet. 2001 Jul; 69(1):198-203. Erratum in: Am J Hum Genet 2001; 69(5):1160.
den Hollander AI, Davis J, van der Velde-Visser SD, Zonneveld MN, Pierrottet CO, Koenekoop RK, Kellner U, van 
den Born LI, Heckenlively JR, Hoyng CB, Handford PA, Roepman R, Cremers FPM. CRB1 mutation spectrum 
in inherited retinal dystrophies. Hum Mutat. 2004; 24(5):355-369.
den Hollander AI, Koenekoop RK, Yzer S, Lopez I, Arends ML, Voesenek KE, Zonneveld MN, Strom TM, Meitinger T, 
Brunner HG, Hoyng CB, van den Born LI, Rohrschneider K, Cremers FP. Mutations in the CEP290 (NPHP6) gene 
are a frequent cause of Leber congenital amaurosis. Am J Hum Genet. 2006 Sep;79(3):556-561.
den Hollander AI, Koenekoop RK, Mohamed MD, Arts H, Boldt K, Towns KV, McKibbin M, Dharmaraj S, Lopez I, 
Beer M, Strom T, Ivings L, Williams GA, Springell K, Woods GC, Jafri H, Rashid Y, van der Zwaag B, Gosens 
I, Kersten F, van Wijk E, Veltman J, Zonneveld M, van Beersum S, Cheetham ME, Maumenee IH, Ueffi ng M, 
Cremers FPM, Inglehearn CF, Roepman R. Mutations in LCA5, encoding the novel ciliary protein lebercilin, cause 
Leber congenital amaurosis. (Accepted Nat.Genet 2007)
Denier Van Der Gon JJ, Henkes HE, Van der Tweel LH. Selective amplifi cation of the electroretinogram. Ophthalmo-
logica. 1956; 132(3):140-150.
Dharmaraj S, Li Y, Robitaille JM, Silva E, Zhu D, Mitchell TN, Maltby LP, Baffoe-Bonnie AB, Maumenee IH. A novel 
locus for Leber congenital amaurosis maps to chromosome 6q. Am J Hum Genet. 2000a; 66(1):319-326.
Dharmaraj SR, Silva ER, Pina AL, Li YY, Yang JM, Carter CR, Loyer MK, El-Hilali HK, Traboulsi EK, Sundin OK, Zhu 
DK, Koenekoop RK, Maumenee IH. Mutational analysis and clinical correlation in Leber congenital amaurosis. 
Ophthalmic Genet. 2000b; 21(3):135-150.
Dharmaraj S, Lopez I, Fishman G, Racine J, Dorfman A, P Lachapelle, Maumenee I, Cremers F, Allikmets R, Koenek-
oop RK. Recessive RPGRIP1 mutations can cause rod and cone dysfunction in the heterozygous parents.Invest. 
Ophthalmol. Vis. Sci. 2004; 45: 2004a E-Abstract 4728
Dharmaraj S, Leroy BP, Sohock MM, Koenekoop RK, Perrault I, Anwar K, Khaliq S, Devi RS, Birch DG, De Pool E, 
Izquierdo N, Van Maldergem L, Ismail M, Payne AM, Holder GE, Bhattacharya SS, Bird AC, Kaplan J, Maumenee 
IH. The phenotype of Leber congenital amaurosis in patients with AIPL1 mutations. Arch Ophthalmol. 2004b; 
122(7):1029-1037.
Dib C, Faure S, Fizames C, Samson D, Drouot N, Vignal A, Millasseau P, Marc S, Hazan J, Seboun E, Lathrop M, 
Gyapay G, Morissette J, Weissenbach J. A comprehensive genetic map of the human genome based on 5,264 
microsatellites. Nature. 1996 ; 380(6570):152-154.
Dixon-Salazar T, Silhavy JL, Marsh SE et al. Mutations in the AHI1 gene, encoding Jouberin, cause Joubert syn-
drome with cortical polymicrogyria. Am J Hum Genet. 2004; 75(6): 979-987.
Dobelle WH, Mladejovsky MG, Girvin JP. Artifi cal vision for the blind: electrical stimulation of visual cortex offers hope 
for a functional prosthesis. Science. 1974; 183(123):440-444.
Dobelle WH, Mladejovsky MG. Phosphenes produced by electrical stimulation of human occipital cortex, and their 
application to the development of a prosthesis for the blind. J Physiol. 1974; 243(2):553-576.
Dobelle WH, Quest DO, Antunes JL, Roberts TS, Girvin JP. Artifi cial vision for the blind by electrical stimulation of 
the visual cortex. Neurosurgery. 1979; 5(4):521-527.
Dobelle WH. Artifi cial vision for the blind by connecting a television camera to the visual cortex.
ASAIO J. 2000; 46(1):3-9.
Dryja TP, McGee TL, Reichel E, Hahn LB, Cowley GS, Yandell DW, Sandberg MA, Berson EL. A point mutation of 
the rhodopsin gene in one form of retinitis pigmentosa. Nature. 1990; 343(6256):364-366.
Dryja TP, Hahn LB, Cowley GS, McGee TL, Berson EL. Mutation spectrum of the rhodopsin gene among patients 
with autosomal dominant retinitis pigmentosa. Proc Natl Acad Sci U S A. 1991; 88(20):9370-9374.
Sharola BW.indd   103 29-May-07   10:45:46 AM
104
Dryja TP, Berson EL, Rao VR, Oprian DD. Heterozygous missense mutation in the rhodopsin gene as a cause of 
congenital stationary night blindness. Nat Genet. 1993; 4(3):280-283.
Dryja TP, Hahn LB, Kajiwara K, Berson EL. Dominant and digenic mutations in the peripherin/RDS and ROM1 genes 
in retinitis pigmentosa. Invest Ophthalmol Vis Sci. 1997; 38(10):1972-1982.
Dryja TP, Adams SM, Grimsby JL, McGee TL, Hong DH, Li T, Andreasson S, Berson EL. Null RPGRIP1 alleles in 
patients with Leber congenital amaurosis. Am J Hum Genet. 2001; 68(5):1295-1298.
D’Cruz PM, Yasumura D, Weir J, Matthes MT, Abderrahim H, LaVail MM, Vollrath D. Mutation of the receptor tyrosine 
kinase gene Mertk in the retinal dystrophic RCS rat. Hum Mol Genet. 2000; 9(4):645-651.
Duncan JL, LaVail MM, Yasumura D, Matthes MT, Yang H, Trautmann N, Chappelow AV, Feng W, Earp HS, Mat-
sushima GK, Vollrath D. An RCS-like retinal dystrophy phenotype in mer knockout mice.Invest Ophthalmol Vis 
Sci. 2003; 44(2):826-838.
Duda T, Krishnan A, Venkataraman V, Lange C, Koch KW, Sharma RK. Mutations in the rod outer segment 
membrane guanylate cyclase in a cone-rod dystrophy cause defects in calcium signaling. Biochemistry. 1999; 
38(42):13912-13919.
Dyer MA, Donovan SL, Zhang J, Gray J, Ortiz A, Tenney R, Kong J, Allikmets R, Sohocki MM.
Retinal degeneration in Aipl1-defi cient mice: a new genetic model of Leber congenital amaurosis.
Brain Res Mol Brain Res. 2004 ; 132(2):208-220
Ehara H, Nakano C, Ohno K, Goto YI, Takeshita K. New autosomal-recessive syndrome of Leber congenital 
amaurosis, short stature,growth hormone insuffi ciency, mental retardation, hepatic dysfunction, and metabolic 
acidosis. Am J Med Genet. 1997; 71(3):258-266.
El-Amraoui A, Sahly I, Picaud S, Sahel J, Abitbol M, Petit C. Human Usher 1B/mouse shaker-1: the retinal pheno-
type discrepancy explained by the presence/absence of myosin VIIA in the photoreceptor cells. Hum Mol Genet. 
1996; 5(8):1171-1178.
Elder MJ. Leber congenital amaurosis and its association with keratoconus and keratoglobus. J Pediatr Ophthalmol 
Strabismus. 1994; 31(1):38-40.
Ellis DS, Heckenlively JR, Martin CL, Lachman RS, Sakati NA, Rimoin DL. Leber’s congenital amaurosis associated 
with familial juvenile nephronophthisis and cone-shaped epiphyses of the hands (the Saldino-Mainzer syndrome). 
Am J Ophthalmol. 1984; 97(2):233-239. Erratum in: Arch Ophthalmol 1998; 116(1):77.
Faktorovich EG, Steinberg RH, Yasumura D, Matthes MT, LaVail MM. Photoreceptor degeneration in inherited retinal 
dystrophy delayed by basic fi broblast growth factor. Nature. 1990; 347(6288):83-86.
Fauser S, Munz M, Besch D. Further support for digenic inheritance in Bardet-Biedl syndrome.
J Med Genet. 2003; 40(8):e104.
Fazzi E, Lanners J, Danova S, Ferrarri-Ginevra O, Gheza C, Luparia A, Balottin U, Lanzi G. Stereotyped behaviours 
in blind children. Brain Dev. 1999; 21(8):522-528.
Fazzi E, Signorini SG, Scelsa B, Bova SM, Lanzi G. Leber’s congenital amaurosis: an update. Eur J Paediatr Neurol. 
2003; 7(1):13-22
Fazzi E, Signorini SG, Uggetti C, Bianchi PE, Lanners J, Lanzi G. Towards improved clinical characterization of Leber 
congenital amaurosis: neurological and systemic fi ndings.
Am J Med Genet 2005; 132(1):13-19.
Fei Y, Hughes TE. Nuclear traffi cking of photoreceptor protein crx: the targeting sequence and pathologic implica-
tions. Invest Ophthalmol Vis Sci. 2000; 41(10):2849-2856.
Felbor U, Schilling H, Weber BH. Adult vitelliform macular dystrophy is frequently associated with mutations in the 
peripherin/RDS gene. Hum Mutat. 1997; 10(4):301-309.
Felius J, Thompson DA, Khan NW, Bingham EL, Jamison JA, Kemp JA, Sieving PA.Clinical course and visual 
function in a family with mutations in the RPE65
gene. Arch Ophthalmol. 2002; 120(1):55-61
Ferland RJ, Eyaid W, Collura RV, Tully LD, Hill RS, Al-Nouri D, Al-Rumayyan A, Topcu M, Gascon G, Bodell A, 
Shugart YY, Ruvolo M, Walsh CA. Abnormal cerebellar development and axonal decussation due to mutations in 
AHI1 in Joubert syndrome. Nat Genet. 2004; 36(9):1008-1013. Erratum in: Nat Genet. 2004, 36(10):1126.
Fillastre JP, Guenel J, Riberi P, Marx P, Whitworth JA, Kunh JM. Senior-Loken syndrome (nephronophthisis and 
tapeto-retinal degeneration): a study of 8 cases from 5 families. Clin Nephrol. 1976; 5(1):14-9.
Fintz AC, Audo I, Hicks D, Mohand-Said S, Leveillard T, Sahel J. Partial characterization of retina-derived cone 
neuroprotection in two culture models of photoreceptor degeneration. Invest Ophthalmol Vis Sci. 2003; 
44(2):818-825.
Fitzke FW. Imaging the optic nerve and ganglion cell layer. Eye. 2000; 14 (Pt 3B):450-453.
Sharola BW.indd   104 29-May-07   10:45:47 AM
Leber congenital amaurosis 105
Flanders M, Lapointe ML, Brownstein S, Little JM. Keratoconus and Leber’s congenital amaurosis: a clinicopatho-
logical correlation. Can J Ophthalmol. 1984; 19(7):310-314.
Fodde R, Losekoot M. Mutation detection by denaturing gradient gel electrophoresis (DGGE).
Hum Mutat. 1994; 3(2):83-94.
Francois J. Leber’s congenital tapetoretinal degeneration.
Int Ophthalmol Clin. 1968; 8(4):929-947.
Francois J, Hanssens M. [Histopathological study of 2 cases of Leber’s congenital tapeto-retinal degeneration] Ann 
Ocul (Paris). 1969; 202(2):127-155.
Franceschetti A, Dieterle P. Diagnostic and prognostic importance of the electroretinogram in tapetoretinal degen-
eration with reduction of the visual fi eld and hemeralopia.Confi n Neurol. 1954; 14(2-3):184-186.
Frasson M, Sahel JA, Fabre M, Simonutti M, Dreyfus H, Picaud S. Retinitis pigmentosa: rod photoreceptor rescue 
by a calcium-channel blocker in the rd mouse. Nat Med. 1999; 5(10):1183-1187.
Freund CL, Wang QL, Chen S, Muskat BL, Wiles CD, Sheffi eld VC, Jacobson SG, McInnes RR, Zack DJ, Stone 
EM. De novo mutations in the CRX homeobox gene associated with Leber congenital amaurosis. Nat Genet. 
1998; 18(4):311-312.
Freund CL, Gregory-Evans CY, Furukawa T, Papaioannou M, Looser J, Ploder L, Bellingham J, Ng D, Herbrick JA, 
Duncan A, Scherer SW, Tsui LC, Loutradis-Anagnostou A, Jacobson SG, Cepko CL, Bhattacharya SS, McInnes 
RR. Cone-rod dystrophy due to mutations in a novel photoreceptor-specifi c homeobox gene (CRX) essential for 
maintenance of the photoreceptor.Cell. 1997; 91(4):543-553.
Friedmann T. Progress toward human gene therapy. Science. 1989; 244(4910):1275-1281.
Friedman JS, Chang B, Kannabiran C, Chakarova C, Singh HP, Jalali S, Hawes NL, Branham K, Othman M, Filip-
pova E, Thompson DA, Webster AR, Andreasson S, Jacobson SG, Bhattacharya SS, Heckenlively JR, Swaroop 
A. Premature truncation of a novel protein, RD3, exhibiting subnuclear localization is associated with retinal 
degeneration. Am J Hum Genet. 2006 ;79(6):1059-1070. Erratum in: Am J Hum Genet. 2007;80(2):388.
Fulton AB, Hansen RM. Electroretinography: application to clinical studies of infants.
J Pediatr Ophthalmol Strabismus. 1985; 22(6):251-255.
Fulton AB, Hansen RM, Mayer DL. Vision in Leber congenital amaurosis.
Arch Ophthalmol. 1996; 114(6):698-703
Furukawa T, Morrow EM, Cepko CL. Crx, a novel otx-like homeobox gene, shows photoreceptor-specifi c expression 
and regulates photoreceptor differentiation. Cell. 1997; 91(4):531-541.
Furukawa T, Morrow EM, Li T, Davis FC, Cepko CL. Retinopathy and attenuated circadian entrainment in Crx-
defi cient mice. Nat Genet. 1999; 23(4):466-470.
Fung BK, Hurley JB, Stryer L. Flow of information in the light-triggered cyclic nucleotide cascade of vision. Proc Natl 
Acad Sci U S A. 1981; 78(1):152-156.
Gage FH. Mammalian neural stem cells. Science. 2000 Feb 25;287(5457):1433-1438.
Gal A, Li Y, Thompson DA, Weir J, Orth U, Jacobson SG, Apfelstedt-Sylla E, Vollrath D. Mutations in MERTK, 
the human orthologue of the RCS rat retinal dystrophy gene, cause retinitis pigmentosa. Nat Genet. 2000; 
26(3):270-271.
Galvin JA, Fishman GA, Stone EM, Koenekoop RK. Clinical phenotypes in carriers of Leber congenital amaurosis 
mutations. Ophthalmology. 2005; 112(2):349-356.
Galvin JA, Fishman GA, Stone EM, Koenekoop RK. Evaluation of genotype-phenotype associations in leber con-
genital amaurosis. Retina. 2005; 25(7):919-929.
Gartner S, Henkind P. Aging and degeneration of the human macula. 1. Outer nuclear layer and photoreceptors. Br 
J Ophthalmol. 1981; 65(1):23-28.
Gartner S, Henkind P. Pathology of retinitis pigmentosa. Ophthalmology. 1982; 89(12):1425-1432.
Gerber S, Perrault I, Hanein S, Barbet F, Ducroq D, Ghazi I, Martin-Coignard D, Leowski C, Homfray T, Dufi er JL, 
Munnich A, Kaplan J, Rozet JM. Complete exon-intron structure of the RPGR-interacting protein (RPGRIP1) 
gene allows the identifi cation of mutations underlying Leber congenital amaurosis. Eur J Hum Genet. 2001; 
9(8):561-571.
Gerber S, Perrault I, Hanein S, Shalev S, Zlotogora J, Barbet F, Ducroq D, Dufi er J, Munnich A, Rozet J, Kaplan J. A 
novel mutation disrupting the cytoplasmic domain of CRB1 in a large consanguineous family of Palestinian origin 
affected with Leber congenital amaurosis. Ophthalmic Genet. 2002; 23(4):225-235.
Girman SV, Wang S, Lund RD. Cortical visual functions can be preserved by subretinal RPE cell grafting in RCS rats. 
Vision Res. 2003; 43(17):1817-1827.
Sharola BW.indd   105 29-May-07   10:45:47 AM
106
Glavac D, Dean M. Applications of heteroduplex analysis for mutation detection in disease genes. Hum Mutat. 1995; 
6(4):281-287.
Gleeson JG, Keeler LC, Parisi MA, Marsh SE, Chance PF, Glass IA, Graham Jr JM, Maria BL, Barkovich AJ, Dobyns 
WB. Molar tooth sign of the midbrain-hindbrain junction: occurrence in multiple distinct syndromes. Am J Med 
Genet. 2004; 125A(2):125-134; discussion 117.
Godel V, Iaina A, Nemet P, Lazar M. Retinal manifestations in familial juvenile nephronophthisis. Clin Genet. 1979; 
16(4):277-281.
Goldstein EB, Berson EL. Cone dominance of the human early receptor potential. Nature. 1969; 222(200):1272-
1273.
Gouras P, Carr RE. Electrophysiological studies in early retinitis pigmentosa. Arch Ophthalmol. 1964; 72:104-110.
Gouras P, Lopez R. Transplantation of retinal epithelial cells. Invest Ophthalmol Vis Sci. 1989 ; 30(8):1681-1683.
Grant CA, Ponnazhagan S, Wang XS, Srivastava A, Li T. Evaluation of recombinant adeno-associated virus as a 
gene transfer vector for the retina. Curr Eye Res. 1997; 16(9):949-956.
Grieshaber MC, Niemeyer G. Leber congenital amaurosis: diagnosis, follow-up and differential diagnosis. Klin 
Monatsbl Augenheilkd. 1998; 212(5):309-310.
Gregory-Evans K, Kelsell RE, Gregory-Evans CY, Downes SM, Fitzke FW, Holder GE, Simunovic M, Mollon JD, Taylor 
R, Hunt DM, Bird AC, Moore AT. Autosomal dominant cone-rod retinal dystrophy (CORD6) from heterozygous 
mutation of GUCY2D, which encodes retinal guanylate cyclase. Ophthalmology. 2000; 107(1):55-61.
Gu JJ, Kaiser-Rogers K, Rao K, Mitchell BS. Assignment of the human type I IMP dehydrogenase gene (IMPDH1) 
to chromosome 7q31.3-q32). Genomics. 1994; 24(1):179-181.
Gu S, Lennon A, Li Y, Lorenz B, Fossarello M, North M, Gal A, Wright A. Tubby-like protein-1 mutations in autosomal 
recessive retinitis pigmentosa. Lancet. 1998; 351(9109):1103-1104.
Gu SM, Thompson DA, Srikumari CR, Lorenz B, Finckh U, Nicoletti A, Murthy KR, Rathmann M, Kumaramanickavel 
G, Denton MJ, Gal A. Mutations in RPE65 cause autosomal recessive childhood-onset severe retinal dystrophy. 
Nat Genet. 1997; 17(2):194-197.
Hacein-Bey-Abina S, Von Kalle C, Schmidt M, McCormack MP, Wulffraat N, Leboulch P, Lim A, Osborne CS, 
Pawliuk R, Morillon E, Sorensen R, Forster A, Fraser P, Cohen JI, de Saint Basile G, Alexander I, Wintergerst U, 
Frebourg T, Aurias A, Stoppa-Lyonnet D, Romana S, Radford-Weiss I, Gross F, Valensi F, Delabesse E, Macintyre 
E, Sigaux F, Soulier J, Leiva LE, Wissler M, Prinz C, Rabbitts TH, Le Deist F, Fischer A, Cavazzana-Calvo M. 
LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science. 2003; 
302(5644):415-419. Erratum in: Science. 2003, 302(5645):568.
Haeseleer F, Jang GF, Imanishi Y, Driessen CA, Matsumura M, Nelson PS, Palczewski K. Dual-substrate specifi city 
short chain retinol dehydrogenases from the vertebrate retina. J Biol Chem. 2002; 277(47):45537-45546.
Hagstrom SA, North MA, Nishina PL, Berson EL, Dryja TP. Recessive mutations in the gene encoding the tubby-like 
protein TULP1 in patients with retinitis pigmentosa. Nat Genet. 1998; 18(2):174-176.
Hagstrom SA, Adamian M, Scimeca M, Pawlyk BS, Yue G, Li T. A role for the Tubby-like protein 1 in rhodopsin 
transport. Invest Ophthalmol Vis Sci. 2001; 42(9):1955-1962.
Hagstrom SA, Duyao M, North MA, Li T. Retinal degeneration in tulp1-/- mice: vesicular accumulation in the inter-
photoreceptor matrix. Invest Ophthalmol Vis Sci. 1999; 40(12):2795-2802.
Hardy CA. The protein truncation test. Methods Mol Biol. 2002; 187:87-108.
Ikeda S, He W, Ikeda A, Naggert JK, North MA, Nishina PM. Cell-specifi c expression of tubby gene family members 
(tub, Tulp1,2, and 3) in the retina. Invest Ophthalmol Vis Sci. 1999; 40(11):2706-2712.
Hamada S, Yoshida K, Chihara E. Optical coherence tomography images of retinitis pigmentosa. Ophthalmic Surg 
Lasers. 2000; 31(3):253-256.
Hamel CP, Tsilou E, Pfeffer BA, Hooks JJ, Detrick B, Redmond TM. Molecular cloning and expression of RPE65, a 
novel retinal pigment epithelium-specifi c microsomal protein that is post-transcriptionally regulated in vitro. J Biol 
Chem. 1993; 268(21):15751-15757.
Hameed A, Abid A, Aziz A, Ismail M, Mehdi SQ, Khaliq S. Evidence of RPGRIP1 gene mutations associated with 
recessive cone-rod dystrophy.J Med Genet. 2003; 40(8):616-619.
Hanein S, Perrault I, Olsen P, Lopponen T, Hietala M, Gerber S, Jeanpierre M, Barbet F, Ducroq D, Hakiki S, Munnich 
A, Rozet JM, Kaplan J. Evidence of a founder effect for the RETGC1 (GUCY2D) 2943DelG mutation in Leber 
congenital amaurosis pedigrees of Finnish origin. Hum Mutat. 2002; 20(4):322-323.
Hanein S, Perrault I, Gerber S, Tanguy G, Barbet F, Ducroq D, Calvas P, Dollfus H, Hamel C, Lopponen T, Munier 
F, Santos L, Shalev S, Zafeiriou D, Dufi er JL, Munnich A, Rozet JM, Kaplan J. Leber congenital amaurosis: 
Sharola BW.indd   106 29-May-07   10:45:47 AM
Leber congenital amaurosis 107
comprehensive survey of the genetic heterogeneity, refi nement of the clinical defi nition, and genotype-phenotype 
correlations as a strategy for molecular diagnosis. Hum Mutat. 2004; 23(4):306-317.
Hargrave PA, Fong SL. The amino- and carboxyl-terminal sequence of bovine rhodopsin. J Supramol Struct. 1977; 
6(4):559-570.
Hargrave PA. Rhodopsin structure, function, and topography the Friedenwald lecture. Invest Ophthalmol Vis Sci. 
2001; 42(1):3-9.
Hauswirth WW, Lewin AS. Ribozyme uses in retinal gene therapy. Prog Retin Eye Res. 2000; 19(6):689-710.
Hauswirth WW, LaVail MM, Flannery JG, Lewin AS. Ribozyme gene therapy for autosomal dominant retinal disease. 
Clin Chem Lab Med. 2000; 38(2):147-153.
Hayasaka S, Hara S, Mizuno K, Narisawa K, Tada K. Leber’s congenital amaurosis associated with hyperthreonine-
mia. Am J Ophthalmol. 1986; A101(4):475-479.
Heegaard S, Rosenberg T, Preising M, Prause JU, Bek T. An unusual retinal vascular morphology in connection with 
a novel AIPL1 mutation in Leber’s congenital amaurosis. Br J Ophthalmol. 2003; 87(8):980-983.
Heher KL, Traboulsi EI, Maumenee IH. The natural history of Leber’s congenital amaurosis. Age-related fi ndings in 
35 patients. Ophthalmology. 1992; 99(2):241-245.
Hennig AK, Ogilvie JM, Ohlemiller KK, Timmers AM, Hauswirth WW, Sands MS. AAV-mediated intravitreal gene 
therapy reduces lysosomal storage in the retinal pigmented epithelium and improves retinal function in adult MPS 
VII mice. Mol Ther. 2004; 10(1):106-116.
Hillis JM, Ernst MO, Banks MS, Landy MS. Combining sensory information: mandatory fusion within, but not 
between, senses. Science. 2002; 298(5598):1627-1630.
Hildebrandt F, Singh-Sawhney I, Schnieders B, Centofante L, Omran H, Pohlmann A, Schmaltz C, Wedekind H, 
Schubotz C, Antignac C, et al. Mapping of a gene for familial juvenile nephronophthisis: refi ning the map and 
defi ning fl anking markers on chromosome 2. APN Study Group. Am J Hum Genet. 1993; 53(6):1256-1261.
Hildebrandt F, Otto E, Rensing C, Nothwang HG, Vollmer M, Adolphs J, Hanusch H, Brandis M. A novel gene 
encoding an SH3 domain protein is mutated in nephronophthisis type 1. Nat Genet. 1997; 17(2):149-153.
Hodges MD, Vieira H, Gregory-Evans K, Gregory-Evans CY. Characterization of the genomic and transcriptional 
structure of the CRX gene: substantial differences between human and mouse. Genomics. 2002; 80(5):531-
542.
Hoffmann R, Valencia A. Implementing the iHOP concept for navigation of biomedical literature.
Bioinformatics. 2005; 21 Suppl 2:ii252-ii258.
Hofmann KP, Pulvermuller A, Buczylko J, Van Hooser P, Palczewski K. The role of arrestin and retinoids in the 
regeneration pathway of rhodopsin. J Biol Chem. 1992; 267(22):15701-15706.
Hogewind BL, Veltkamp JJ, Polak BC, van Es LA. Electro-retinal abnormalities in heterozygotes of renal-retinal 
dysplasia. Acta Med Scand. 1977; 202(4):323-326.
Holopigian K, Greenstein VC, Seiple W, Hood DC, Carr RE. Rod and cone photoreceptor function in patients with 
cone dystrophy. Invest Ophthalmol Vis Sci. 2004; 45(1):275-281.
Hong DH, Pawlyk BS, Adamian M, Li T. Dominant, gain-of-function mutant produced by truncation of RPGR. Invest 
Ophthalmol Vis Sci. 2004; 45(1):36-41.
Hong DH, Yue G, Adamian M, Li T. Retinitis pigmentosa GTPase regulator (RPGRr)-interacting protein is stably 
associated with the photoreceptor ciliary axoneme and anchors RPGR to the connecting cilium. J Biol Chem. 
2001; 276(15):12091-12099.
HorstenGP, WinklemanJE. Development of the ERG in relation to histological differentiation of the retina in man and 
animals. Arch Ophthalmol. 1960 Feb;63:232-242.
Huang PC, Gaitan AE, Hao Y, Petters RM, Wong F. Cellular interactions implicated in the mechanism of photorecep-
tor degeneration in transgenic mice expressing a mutant rhodopsin gene. Proc Natl Acad Sci U S A. 1993; 
90(18):8484-8488.
Humphries P, Farrar GJ, Kenna P, McWilliam P. Retinitis pigmentosa: genetic mapping in X-linked and autosomal 
forms of the disease. Clin Genet. 1990; 38(1):1-13.
Humphries MM, Rancourt D, Farrar GJ, Kenna P, Hazel M, Bush RA, Sieving PA, Sheils DM, McNally N, Creighton 
P, Erven A, Boros A, Gulya K, Capecchi MR, Humphries P. Retinopathy induced in mice by targeted disruption 
of the rhodopsin gene. Nat Genet. 1997; 15(2):216-219.
Humayun MS, de Juan E Jr. Artifi cial vision. Eye. 1998;12 (Pt 3b):605-607.
Humayun MS, Weiland JD, Fujii GY, Greenberg R, Williamson R, Little J, Mech B, Cimmarusti V, Van Boemel G, 
Dagnelie G, de Juan E. Visual perception in a blind subject with a chronic microelectronic retinal prosthesis. 
Vision Res. 2003; 43(24):2573-25781.
Sharola BW.indd   107 29-May-07   10:45:47 AM
108
Ikeda S, Shiva N, Ikeda A, Smith RS, Nusinowitz S, Yan G, Lin TR, Chu S, Heckenlively JR, North MA, Naggert JK, 
Nishina PM, Duyao MP. Retinal degeneration but not obesity is observed in null mutants of the tubby-like protein 
1 gene. Hum Mol Genet. 2000; 9(2):155-163.
Ikeda A, Nishina PM, Naggert JK. The tubby-like proteins, a family with roles in neuronal development and function. 
J Cell Sci. 2002; 115(Pt 1):9-14
Inglehearn CF. Molecular genetics of human retinal dystrophies. Eye. 1998; 12 (Pt 3b):571-579.
International Human Genome Sequencing Consortium. (IHGHC) Finishing the euchromatic sequence of the human 
genome. Nature. 2004; 431(7011):931-945.
Ivarsson SA, Bjerre I, Brun A, Ljungberg O, Maly E, Taylor I. Joubert syndrome associated with Leber amaurosis and 
multicystic kidneys. Am J Med Genet. 1993; 45(5):542-547.
Izaddoost S, Nam SC, Bhat MA, Bellen HJ, Choi KW. Drosophila Crumbs is a positional cue in photoreceptor 
adherens junctions and rhabdomeres. Nature. 2002; 416(6877):178-183.
Jacobson SG, Cideciyan AV, Aleman TS, Pianta MJ, Sumaroka A, Schwartz SB, Smilko EE, Milam AH, Sheffi eld VC, 
Stone EM. Crumbs homolog 1 (CRB1) mutations result in a thick human retina with abnormal lamination. Hum 
Mol Genet. 2003; 12(9):1073-1078.
Jan JE, Robinson GC, Scott E, Kinnis C. Hypotonia in the blind child.
Dev Med Child Neurol. 1975; 17(1):35-40.
Janecke AR, Thompson DA, Utermann G, Becker C, Hubner CA, Schmid E, McHenry CL, Nair AR, Ruschendorf 
F, Heckenlively J, Wissinger B, Nurnberg P, Gal A. Mutations in RDH12 encoding a photoreceptor cell retinol 
dehydrogenase cause childhood-onset severe retinal dystrophy. Nat Genet. 2004; 36(8):850-854.
Jeffreys AJ, Neumann R, Wilson V. Repeat unit sequence variation in minisatellites: a novel source of DNA polymor-
phism for studying variation and mutation by single molecule analysis. Cell. 1990; 60(3):473-485.
Jiang LQ, Hamasaki D. Corneal electroretinographic function rescued by normal retinal pigment epithelial grafts in 
retinal degenerative Royal College of Surgeons rats. Invest Ophthalmol Vis Sci. 1994; 35(13):4300-4309.
Jindrova H. Vertebrate phototransduction: activation, recovery, and adaptation. Physiol Res. 1998; 47(3):155-168.
Johnson K, Grawe F, Grzeschik N, Knust E. Drosophila crumbs is required to inhibit light-induced photoreceptor 
degeneration.Curr Biol. 2002;12(19):1675-1680.
Jones BW, Watt CB, Frederick JM, Baehr W, Chen CK, Levine EM, Milam AH, Lavail MM, Marc RE. Retinal remodel-
ing triggered by photoreceptor degenerations. J Comp Neurol. 2003; 464(1):1-16.
Jordan SA, Farrar GJ, Kumar-Singh R, Kenna P, Humphries MM, Allamand V, Sharp EM, Humphries P. Autosomal 
dominant retinitis pigmentosa (adRP; RP6): cosegregation of RP6 and the peripherin-RDS locus in a late-onset 
family of Irish origin. Am J Hum Genet. 1992; 50(3):634-639.
Joseph B, Srinivasan A, Soumittra N, Vidhya A, Shetty NS, Uthra S, Kumaramanickavel G. RPE65 gene: multiplex 
PCR and mutation screening in patients from India with retinal degenerative diseases. J Genet. 2002; 81(1):19-
23.
Joseph RM, Li T. Overexpression of Bcl-2 or Bcl-XL transgenes and photoreceptor degeneration.
Invest Ophthalmol Vis Sci. 1996; 37(12):2434-2446.
Joubert M, Eisenring JJ, Robb JP, Andermann F. Familial agenesis of the cerebellar vermis. A syndrome of episodic 
hyperpnea, abnormal eye movements, ataxia, and retardation. Neurology. 1969;19(9):813-825.
Kajiwara K, Sandberg MA, Berson EL, Dryja TP. A null mutation in the human peripherin/RDS gene in a family with 
autosomal dominant retinitis punctata albescens. Nat Genet. 1993; 3(3):208-212.
Kajiwara K, Berson EL, Dryja TP. Digenic retinitis pigmentosa due to mutations at the unlinked peripherin/RDS and 
ROM1 loci. Science. 1994; 264(5165):1604-1608.
Kanavakis E, Traeger-Synodinos J. Preimplantation genetic diagnosis in clinical practice. J Med Genet. 2002; 
39(1):6-11.
Kaplan J, Bonneau D, Frezal J, Munnich A, Dufi er JL. Clinical and genetic heterogeneity in retinitis pigmentosa. Hum 
Genet. 1990; 85(6):635-642.
Kara P, Reid RC. Effi cacy of retinal spikes in driving cortical responses. J Neurosci. 2003; 23(24):8547-8557.
Karel I. Keratoconus in congenital diffuse tapetoretinal degeneration. Ophthalmologica. 1968; 155(1):8-15.
Katsanis N, Shroyer NF, Lewis RA, Cavender JC, Al-Rajhi AA, Jabak M, Lupski JR. Fundus albipunctatus and 
retinitis punctata albescens in a pedigree with an R150Q mutation in RLBP1. Clin Genet. 2001; 59(6):424-429.
Katz ML, Redmond TM. Effect of Rpe65 knockout on accumulation of lipofuscin fl uorophores in the retinal pigment 
epithelium. Invest Ophthalmol Vis Sci. 2001; 42(12):3023-3030.
Sharola BW.indd   108 29-May-07   10:45:47 AM
Leber congenital amaurosis 109
Kedzierski W, Nusinowitz S, Birch D, Clarke G, McInnes RR, Bok D, Travis GH. Defi ciency of rds/peripherin causes 
photoreceptor death in mouse models of digenic and dominant retinitis pigmentosa. Proc Natl Acad Sci U S A. 
2001; 98(14):7718-7723.
Keeler LC, Marsh SE, Leefl ang EP, Woods CG, Sztriha L, Al-Gazali L, Gururaj A, Gleeson JG. Linkage analysis 
in families with Joubert syndrome plus oculo-renal involvement identifi es the CORS2 locus on chromosome 
11p12-q13.3. Am J Hum Genet. 2003; 73(3):656-662.
Keen TJ, Mohamed MD, McKibbin M, Rashid Y, Jafri H, Maumenee IH, Inglehearn CF. Identifi cation of a locus 
(LCA9) for Leber’s congenital amaurosis on chromosome 1p36. Eur J Hum Genet. 2003;11(5):420-423.
Keen J, Lester D, Inglehearn C, Curtis A, Bhattacharya S. Rapid detection of single base mismatches as heterodu-
plexes on Hydrolink gels. Trends Genet. 1991; 7(1):5.
Kefalov VJ, Estevez ME, Kono M, Goletz PW, Crouch RK, Cornwall MC, Yau KW.
Breaking the covalent bond--a pigment property that contributes to desensitization in cones.
Neuron. 2005; 46(6):879-890.
Keith CG. Retinal atrophy in osteopetrosis. Arch Ophthalmol. 1968; 79(3):234-241.
Kelsell RE, Gregory-Evans K, Payne AM, Perrault I, Kaplan J, Yang RB, Garbers DL, Bird AC, Moore AT, Hunt DM. 
Mutations in the retinal guanylate cyclase (RETGC-1) gene in dominant cone-rod dystrophy. Hum Mol Genet. 
1998;7(7):1179-84.
Kennedy RH, Bourne WM, Dyer JA. A 48-year clinical and epidemiologic study of keratoconus. Am J Ophthalmol. 
1986; 101(3):267-273.
Kennedy CJ, Rakoczy PE, Constable IJ. Lipofuscin of the retinal pigment epithelium: a review.
Eye. 1995; 9 (Pt 6):763-771.
Khaliq S, Abid A, Hameed A, Anwar K, Mohyuddin A, Azmat Z, Shami SA, Ismail M, Mehdi SQ. Mutation screening 
of Pakistani families with congenital eye disorders. Exp Eye Res. 2003; 76(3):343-348.
Kim SR, Fishkin N, Kong J, Nakanishi K, Allikmets R, Sparrow JR. Rpe65 Leu450Met variant is associated with 
reduced levels of the retinal pigment epithelium lipofuscin fl uorophores A2E and iso-A2E. Proc Natl Acad Sci U 
S A. 2004; 101(32):11668-11672.
King MD, Dudgeon J, Stephenson JB. Joubert’s syndrome with retinal dysplasia: neonatal tachypnoea as the clue 
to a genetic brain-eye malformation. Arch Dis Child. 1984; 59(8):709-718.
King MD, Stephenson JB. Association of Joubert’s syndrome with Leber’s congenital amaurosis.
Arch Neurol. 1984; 41(12):1235.
Klenchin VA, Calvert PD, Bownds MD. Inhibition of rhodopsin kinase by recoverin. Further evidence for a negative 
feedback system in phototransduction. J Biol Chem. 1995; 270(27):16147-16152.
Koch KW, Kaupp UB. Cyclic GMP directly regulates a cation conductance in membranes of bovine rods by a 
cooperative mechanism. J Biol Chem. 1985; 260(11):6788-6800.
Koenekoop RK, Loyer M, Dembinska O, Beneish R. Visual improvement in Leber congenital amaurosis and the CRX 
genotype. Ophthalmic Genet. 2002; 23(1):49-59.
Koenekoop RK, Fishman GA, Iannaccone A, Ezzeldin H, Ciccarelli ML, Baldi A, Sunness JS, Lotery AJ, Jablonski 
MM, Pittler SJ, Maumenee I. Electroretinographic abnormalities in parents of patients with Leber congenital 
amaurosis who have heterozygous GUCY2D mutations. Arch Ophthalmol. 2002; 20(10):1325-1330.
Koenekoop RK. An overview of Leber congenital amaurosis: a model to understand human retinal development. 
Surv Ophthalmol. 2004; 49(4):379-398.
Kolb H, Gouras P. Electron microscopic observations of human retinitis pigmentosa, dominantly inherited. Invest 
Ophthalmol. 1974; 13(7):487-498.
Kolb, H. (1991) The neural organization of the human retina. In “Principles and Practices of Clinical Electrophysiology 
of Vision” (Eds. Heckenlively, J.R. and Arden, G.B.) Mosby Year Book Inc, St. Louis, pp. 25-52.
Kolb H, Nelson R. OFF-alpha and OFF-beta ganglion cells in cat retina: II. Neural circuitry as revealed by electron 
microscopy of HRP stains. J Comp Neurol. 1993; 329(1):85-110.
Kolb H, Nelson R, Ahnelt P, Cuenca N. Cellular organization of the vertebrate retina. Prog Brain Res. 2001; 131:3-
26.
Kohl S, Christ-Adler M, Apfelstedt-Sylla E, Kellner U, Eckstein A, Zrenner E, Wissinger B. RDS/peripherin gene 
mutations are frequent causes of central retinal dystrophies. J Med Genet. 1997; 34(8):620-626.
Kosaki K, Udaka T, Okuyama T. DHPLC in clinical molecular diagnostic services. Mol Genet Metab. 2005; 86(1-2): 
117-123.
Sharola BW.indd   109 29-May-07   10:45:47 AM
110
Kostic C, Chiodini F, Salmon P, Wiznerowicz M, Deglon N, Hornfeld D, Trono D, Aebischer P, Schorderet DF, Munier 
FL, Arsenijevic Y. Activity analysis of housekeeping promoters using self-inactivating lentiviral vector delivery into 
the mouse retina. Gene Ther. 2003; 10(9):818-821.
Kozlowski P, Olejniczak M, Krzyzosiak WJ. Rapid heteroduplex analysis by capillary electrophoresis. Clin Chim Acta. 
2005; 353(1-2):209-214.
Kozma P, Hughbanks-Wheaton DK, Locke KG, Fish GE, Gire AI, Spellicy CJ, Sullivan LS, Bowne SJ, Daiger SP, 
Birch DG. Phenotypic Characterization of a Large Family With RP10 Autosomal-Dominant Retinitis Pigmentosa: 
An Asp226Asn Mutation in the IMPDH1 Gene. Am J Ophthalmol. 2005;140(5):858-867.
Krill AE, Deutman AF, Fishman M. The cone degenerations. Doc Ophthalmol. 1973; 35(1):1-80.
Krill AE. The electroretinographic and electrooculographic fi ndings in patients with macular lesions. Trans Am Acad 
Ophthalmol Otolaryngol. 1966; 70(6):1063-1083.
Kriss A, Russell-Eggitt I. Electrophysiological assessment of visual pathway function in infants.
Eye. 1992; 6 (Pt 2):145-153.
Kroll AJ, Kuwabara T. Electron Microscopy of a retinal abiotrophy. Arch Ophthalmol. 1964 ; 71:683-690.
Kruglyak L, Daly MJ, Reeve-Daly MP, Lander ES. Parametric and nonparametric linkage analysis: a unifi ed multipoint 
approach. Am J Hum Genet. 1996; 58(6):1347-1363.
Kubota R, Hokoc JN, Moshiri A, McGuire C, Reh TA. A comparative study of neurogenesis in the retinal ciliary 
marginal zone of homeothermic vertebrates. Brain Res Dev Brain Res. 2002; 134(1-2):31-41.
Kumaramanickavel G, Joseph B, Vidhya A, Arokiasamy T, Shridhara Shetty N. Consanguinity and ocular genetic 
diseases in South India: analysis of a fi ve-year study.Community Genet. 2002; 5(3):182-185.
Lagier-Tourenne C, Boltshauser E, Breivik N, Gribaa M, Betard C, Barbot C, Koenig M.
Homozygosity mapping of a third Joubert syndrome locus to 6q23. J Med Genet. 2004; 41(4):273-277.
Lambert SR, Kriss A, Taylor D, Coffey R, Pembrey M. Follow-up and diagnostic reappraisal of 75 patients with 
Leber’s congenital amaurosis. Am J Ophthalmol. 1989; 107(6):624-631
Lau D, McGee LH, Zhou S, Rendahl KG, Manning WC, Escobedo JA, Flannery JG. Retinal degeneration is slowed in 
transgenic rats by AAV-mediated delivery of FGF-2. Invest Ophthalmol Vis Sci. 2000; 41(11):3622-3633.
Lauderdale JD, Wilensky JS, Oliver ER, Walton DS, Glaser T. 3’ deletions cause aniridia by preventing PAX6 gene 
expression. Proc Natl Acad Sci U S A. 2000; 97(25):13755-13759.
Lavail MM, Li L, Turner JE, Yasumura D. Retinal pigment epithelial cell transplantation in RCS rats: normal metabo-
lism in rescued photoreceptors. Exp Eye Res. 1992; 55(4):555-562.
LaVail MM, Yasumura D, Matthes MT, Drenser KA, Flannery JG, Lewin AS, Hauswirth WW. Ribozyme rescue of 
photoreceptor cells in P23H transgenic rats: long-term survival and late-stage therapy. Proc Natl Acad Sci U S 
A. 2000; 97(21):11488-11493.
Lavorgna G, Lestingi M, Ziviello C, Testa F, Simonelli F, Manitto MP,Brancato R, Ferrari M, Rinaldi E, Ciccodicola A, 
Banfi  S. Identifi cation and characterization of C1orf36, a transcript highly expressed in photoreceptor cells, and 
mutation analysis in retinitis pigmentosa.Biochem Biophys Res Commun. 2003 Aug 29;308(3):414-421
Leber T. Uber retinitis pigmentosa und angebore amaurose. Graefes Arch Klin Ophthalmol. 1869. 15:1-25.
Lee KS, Tsien RW. Mechanism of calcium channel blockade by verapamil, D600, diltiazem and nitrendipine in single 
dialysed heart cells. Nature. 1983; 302(5911):790-794.
Lem J, Flannery JG, Li T, Applebury ML, Farber DB, Simon MI. Retinal degeneration is rescued in transgenic rd mice 
by expression of the cGMP phosphodiesterase beta subunit. Proc Natl Acad Sci U S A. 1992; 89(10):4422-
4426.
Leon A, Curtis R. Autosomal dominant rod-cone dysplasia in the Rdy cat. 1. Light and electron microscopic fi ndings. 
Exp Eye Res. 1990; 51(4):361-381.
Leon A, Hussain AA, Curtis R. Autosomal dominant rod-cone dysplasia in the Rdy cat. 2. Electrophysiological 
fi ndings. Exp Eye Res. 1991; 53(4):489-502.
Leon A, Levick WR, Sarossy MG. Lesion topography and new histological features in feline taurine defi ciency 
retinopathy. Exp Eye Res. 1995; 61(6):731-741.
Leveillard T, Mohand-Said S, Fintz AC, Lambrou G, Sahel JA. The search for rod-dependent cone viability factors, 
secreted factors promoting cone viability. Novartis Found Symp. 2004; 255:117-27; discussion 127-30, 177-
178.
Leveillard T, Mohand-Said S, Lorentz O, Hicks D, Fintz AC, Clerin E, Simonutti M, Forster V, Cavusoglu N, Chalmel 
F, Dolle P, Poch O, Lambrou G, Sahel JA. Identifi cation and characterization of rod-derived cone viability factor. 
Nat Genet. 2004; 36(7):755-759.
Sharola BW.indd   110 29-May-07   10:45:47 AM
Leber congenital amaurosis 111
Lewis CA, Batlle IR, Batlle KG, Banerjee P, Cideciyan AV, Huang J, Aleman TS, Huang Y, Ott J, Gilliam TC, Knowles 
JA, Jacobson SG. Tubby-like protein 1 homozygous splice-site mutation causes early-onset severe retinal 
degeneration. Invest Ophthalmol Vis Sci. 1999; 40(9):2106-2114.
Lewis SM, Roberts EA, Marcon MA, Harvey E, Phillips MJ, Chuang SA, Buncic JR, Clarke JT. Joubert syndrome 
with congenital hepatic fi brosis: an entity in the spectrum of oculo-encephalo-hepato-renal disorders. Am J Med 
Genet. 1994; 52(4):419-426.
Lezzi R, Cottaris NP, Elfar SD, Walraven TL, Raza TM, Moncrieff R, McAllister JP, Auner GW, Johnson RR, Abrams 
GW. Neurotransmitter-Based Retinal Prosthesis Modulation of Retinal Ganglion Cell Responses In-Vivo Invest. 
Ophthalmol. Vis. Sci. 2003 44: E-Abstract 5083.
Li LX, Turner JE. Inherited retinal dystrophy in the RCS rat: prevention of photoreceptor degeneration by pigment 
epithelial cell transplantation. Exp Eye Res. 1988; 47(6):911-917.
Li ZY, Possin DE, Milam AH. Histopathology of bone spicule pigmentation in retinitis pigmentosa. Ophthalmology. 
1995; 102(5):805-816.
Liu X, Bulgakov OV, Wen XH, Woodruff ML, Pawlyk B, Yang J, Fain GL, Sandberg
MA, Makino CL, Li T. AIPL1, the protein that is defective in Leber congenital amaurosis, is essential for the biosyn-
thesis of retinal rod cGMP phosphodiesterase. Proc Natl Acad Sci U S A. 2004; 101(38):13903-13908.Erratum 
in: Proc Natl Acad Sci U S A. 2005; 102(2):515.
Liang, F.Q., Dejneka, N.S., Cohen, D.R., Krasnoperova, N.V., Lem, J., Maguire, A.M., Dudus, L., Fisher, K.J., 
Bennett, J., 2001. AAV-mediated delivery of ciliary neurotrophic factor prolongs photoreceptor survival in the 
rhodopsin knockout mouse. Mol Ther 3, 241–248.
Limb GA, Salt TE, Munro PM, Moss SE, Khaw PT. In vitro characterization of a spontaneously immortalized human 
Muller cell line (MIO-M1). Invest Ophthalmol Vis Sci. 2002; 43(3):864-869.
Lindhout D, Barth PG, Valk J, Boen-Tan TN. The Joubert syndrome associated with bilateral chorioretinal coloboma. 
Eur J Pediatr. 1980; 134(2):173-176.
Loken AC, Hanssen O, Halvorsen S, Jolster NJ.Hereditary renal dysplasia and blindness. Acta Paediat. 1961; 50: 
177-184.
Lolley RN, Farber DB, Rayborn ME, Hollyfi eld JG. Cyclic GMP accumulation causes degeneration of photoreceptor 
cells: simulation of an inherited disease. Science. 1997; 196(4290):664-666.
Lorenz B, Gyurus P, Preising M, Bremser D, Gu S, Andrassi M, Gerth C, Gal A. Early-onset severe rod-cone 
dystrophy in young children with RPE65 mutations. Invest Ophthalmol Vis Sci. 2000; 41(9):2735-2742.
Lorenz B, Wabbels B, Wegscheider E, Hamel CP, Drexler W, Preising MN. Lack of fundus autofl uorescence to 488 
nanometers from childhood on in patients with early-onset severe retinal dystrophy associated with mutations in 
RPE65. Ophthalmology. 2004; 111(8):1585-1594.
Lotery AJ, Namperumalsamy P, Jacobson SG, Weleber RG, Fishman GA, Musarella MA, Hoyt CS, Heon E, Levin A, 
Jan J, Lam B, Carr RE, Franklin A, Radha S, Andorf JL, Sheffi eld VC, Stone EM. Mutation analysis of 3 genes in 
patients with Leber congenital amaurosis. Arch Ophthalmol. 2000; 118(4):538-543.
Lotery AJ, Jacobson SG, Fishman GA, Weleber RG, Fulton AB, Namperumalsamy P, Heon E, Levin AV, Grover S, 
Rosenow JR, Kopp KK, Sheffi eld VC, Stone EM. Mutations in the CRB1 gene cause Leber congenital amaurosis. 
Arch Ophthalmol. 2001; 119(3):415-420.
Lund RD, Kwan AS, Keegan DJ, Sauve Y, Coffey PJ, Lawrence JM. Cell transplantation as a treatment for retinal 
disease. Prog Retin Eye Res. 2001; 20(4):415-449.
Lund RD, Ono SJ, Keegan DJ, Lawrence JM. Retinal transplantation: progress and problems in clinical application. 
J Leukoc Biol. 2003; 74(2):151-160.
Macaluso E, Frith CD, Driver J. Modulation of human visual cortex by crossmodal spatial attention. Science. 2000; 
289(5482):1206-1208.
MacDonald IM, Hebert M, Yau RJ, Flynn S, Jumpsen J, Suh M, Clandinin MT. Effect of docosahexaenoic acid 
supplementation on retinal function in a patient with autosomal dominant Stargardt-like retinal dystrophy. Br J 
Ophthalmol. 2004; 88(2):305-306.
Mactier H, Dexter JD, Hewett JE, Latham CB, Woodruff CW. The electroretinogram in preterm infants. J Pediatr. 
1988; 113(3):607-612.
Mainzer F, Saldino RM, Ozonoff MB, Minagi H. Familial nephropathy associatdd with retinitis pigmentosa, cerebellar 
ataxia and skeletal abnormalities. Am J Med. 1970; 49(4):556-562.
Maria BL, Boltshauser E, Palmer SC, Tran TX. Clinical features and revised diagnostic criteria in Joubert syndrome. 
J Child Neurol. 1999; 14(9):583-90; discussion 590-591.
Sharola BW.indd   111 29-May-07   10:45:47 AM
112
Maria BL, Hoang KB, Tusa RJ, Mancuso AA, Hamed LM, Quisling RG, Hove MT, Fennell EB, Booth-Jones M, Ring-
dahl DM, Yachnis AT, Creel G, Frerking B. “Joubert syndrome” revisited: key ocular motor signs with magnetic 
resonance imaging correlation. J Child Neurol. 1997; 12(7):423-430.
Margalit E, Maia M, Weiland JD, Greenberg RJ, Fujii GY, Torres G, Piyathaisere DV, O’Hearn TM, Liu W, Lazzi G, 
Dagnelie G, Scribner DA, de Juan E Jr, Humayun MS. Retinal prosthesis for the blind. Surv Ophthalmol. 2002; 
47(4):335-356.
Marlhens F, Bareil C, Griffoin JM, Zrenner E, Amalric P, Eliaou C, Liu SY, Harris E, Redmond TM, Arnaud B, Claustres 
M, Hamel CP. Mutations in RPE65 cause Leber’s congenital amaurosis. Nat Genet. 1997; 17(2):139-141.
Marlhens F, Griffoin JM, Bareil C, Arnaud B, Claustres M, Hamel CP. Autosomal recessive retinal dystrophy associ-
ated with two novel mutations in the RPE65 gene. Eur J Hum Genet. 1998; 6(5):527-531.
Mata NL, Radu RA, Clemmons RC, Travis GH. Isomerization and oxidation of vitamin a in cone-dominant retinas: a 
novel pathway for visual-pigment regeneration in daylight.
Neuron. 2002; 36(1):69-80
Mata NL, Moghrabi WN, Lee JS, Bui TV, Radu RA, Horwitz J, Travis GH. Rpe65 is a retinyl ester binding protein that 
presents insoluble substrate to the isomerase in retinal pigment epithelial cells. J Biol Chem. 2004; 279(1):635-
643.
Matsuzaka T, Sakuragawa N, Nakayama H, Sugai K, Kohno Y, Arima M. Cerebro-oculo-hepato-renal syndrome 
(Arima’ syndrome): a distinct clinicopathological entity. J Child Neurol. 1986; 1(4):338-346.
Maw MA, Corbeil D, Koch J, Hellwig A, Wilson-Wheeler JC, Bridges RJ, Kumaramanickavel G, John S, Nancarrow 
D, Roper K, Weigmann A, Huttner WB, Denton MJ. A frameshift mutation in prominin (mouse)-like 1 causes 
human retinal degeneration. Hum Mol Genet. 2000; 9(1):27-34.
Maw MA, Kennedy B, Knight A, Bridges R, Roth KE, Mani EJ, Mukkadan JK, Nancarrow D, Crabb JW, Denton MJ. 
Mutation of the gene encoding cellular retinaldehyde-binding protein in autosomal recessive retinitis pigmentosa. 
Nat Genet. 1997; 17(2):198-200.
Maxam AM, Gilbert W. A new method for sequencing DNA. Proc Natl Acad Sci U S A. 1977; 74(2):560-564.
McBee JK, Palczewski K, Baehr W, Pepperberg DR. Confronting complexity: the interlink of phototransduction and 
retinoid metabolism in the vertebrate retina. Prog Retin Eye Res. 2001; 20(4):469-529.
McKay R. Stem cells in the central nervous system. Science. 1997; 276(5309):66-71.
McNally N, Kenna P, Humphries MM, Hobson AH, Khan NW, Bush RA, Sieving PA, Humphries P, Farrar GJ. Struc-
tural and functional rescue of murine rod photoreceptors by human rhodopsin transgene. Hum Mol Genet. 1999; 
8(7):1309-1312.
Mehalow AK, Kameya S, Smith RS, Hawes NL, Denegre JM, Young JA, Bechtold L, Haider NB, Tepass U, Heck-
enlively JR, Chang B, Naggert JK, Nishina PM. CRB1 is essential for external limiting membrane integrity and 
photoreceptor morphogenesis in the mammalian retina. Hum Mol Genet. 2003; 12(17):2179-2189.
Meindl A, Dry K, Herrmann K, Manson F, Ciccodicola A, Edgar A, Carvalho MR, Achatz H, Hellebrand H, Lennon 
A, Migliaccio C, Porter K, Zrenner E, Bird A, Jay M, Lorenz B, Wittwer B, D’Urso M, Meitinger T, Wright A. A 
gene (RPGR) with homology to the RCC1 guanine nucleotide exchange factor is mutated in X-linked retinitis 
pigmentosa (RP3). Nat Genet. 1996; 13(1):35-42.
Mendley SR, Poznanski AK, Spargo BH, Langman CB. Hereditary sclerosing glomerulopathy in the conorenal 
syndrome. Am J Kidney Dis. 1995; 25(5):792-797.
Milam AH, Li ZY, Fariss RN. Histopathology of the human retina in retinitis pigmentosa.
Prog Retin Eye Res. 1998; 17(2):175-205.
Milam AH, Hendrickson AE, Xiao M, Smith JE, Possin DE, John SK, Nishina PM. Localization of tubby-like protein 1 
in developing and adult human retinas. Invest Ophthalmol Vis Sci. 2000; 41(8):2352-2356.
Milam AH, Barakat MR, Gupta N, Rose L, Aleman TS, Pianta MJ, Cideciyan AV, Sheffi eld VC, Stone EM, Jacob-
son SG. Clinicopathologic effects of mutant GUCY2D in Leber congenital amaurosis. Ophthalmology. 2003; 
110(3):549-558.
Mitton KP, Swain PK, Chen S, Xu S, Zack DJ, Swaroop A. The leucine zipper of NRL interacts with the CRX 
homeodomain. A possible mechanism of transcriptional synergy in rhodopsin regulation. J Biol Chem. 2000; 
275(38):29794-29799.
Mizuno K, Takei Y, Sears ML, Peterson WS, Carr RE, Jampol LM. Leber’s congenital amaurosis. Am J Ophthalmol. 
1977; 83(1):32-42.
Mohamed MD, Topping NC, Jafri H, Raashed Y, McKibbin MA, Inglehearn CF. Progression of phenotype in Leber’s 
congenital amaurosis with a mutation at the LCA5 locus. Br J Ophthalmol. 2003; 87(4):473-475.
Sharola BW.indd   112 29-May-07   10:45:47 AM
Leber congenital amaurosis 113
Mohand-Said S, Hicks D, Simonutti M, Tran-Minh D, Deudon-Combe A, Dreyfus H, Silverman MS, Ogilvie JM, 
Tenkova T, Sahel J. Photoreceptor transplants increase host cone survival in the retinal degeneration (rd) mouse. 
Ophthalmic Res. 1997; 29(5):290-297.
Mohand-Said S, Deudon-Combe A, Hicks D, Simonutti M, Forster V, Fintz AC, Leveillard T, Dreyfus H, Sahel JA. 
Normal retina releases a diffusible factor stimulating cone survival in the retinal degeneration mouse. Proc Natl 
Acad Sci U S A. 1998; 95(14):8357-8362.
Mohand-Said S, Hicks D, Dreyfus H, Sahel JA. Selective transplantation of rods delays cone loss in a retinitis 
pigmentosa model. Arch Ophthalmol. 2000; 118(6):807-811.
Mohand-Said S, Hicks D, Leveillard T, Picaud S, Porto F, Sahel JA. Rod-cone interactions: developmental and 
clinical signifi cance. Prog Retin Eye Res. 2001; 20(4):451-467.
Mollet G, Salomon R, Gribouval O, Silbermann F, Bacq D, Landthaler G, Milford D, Nayir A, Rizzoni G, Antignac C, 
Saunier S. The gene mutated in juvenile nephronophthisis type 4 encodes a novel protein that interacts with 
nephrocystin. Nat Genet. 2002; 32(2):300-305. Erratum in: Nat Genet 2002; 32(3):459.
Momma S, Johansson CB, Frisen J. Get to know your stem cells. Curr Opin Neurobiol. 2000; 10(1):45-49.
Moore AT, Fitzke FW, Kemp CM, Arden GB, Keen TJ, Inglehearn CF, Bhattacharya SS, Bird AC. Abnormal dark ad-
aptation kinetics in autosomal dominant sector retinitis pigmentosa due to rod opsin mutation. Br J Ophthalmol. 
1992; 76(8):465-469.
Moore AT, Taylor DS. A syndrome of congenital retinal dystrophy and saccade palsy--a subset of
Leber’s amaurosis. Br J Ophthalmol. 1984; 68(6):421-431
Morimura H, Fishman GA, Grover SA, Fulton AB, Berson EL, Dryja TP. Mutations in the RPE65 gene in patients 
with autosomal recessive retinitis pigmentosa or leber congenital amaurosis. Proc Natl Acad Sci U S A. 1998; 
95(6):3088-3093.
Morimura H, Berson EL, Dryja TP. Recessive mutations in the RLBP1 gene encoding cellular retinaldehyde-binding 
protein in a form of retinitis punctata albescens. Invest Ophthalmol Vis Sci. 1999; 40(5):1000-1004.
Morton NE. Sequential tests for the detection of linkage. Am J Hum Genet. 1955; 7(3):277-318.
Mortimer SE, Hedstrom L. Autosomal dominant retinitis pigmentosa mutations in inosine monophosphate dehydro-
genase type I disrupt nucleic acid binding.
Biochem J. 2005; 390(Pt 1):41-47.
Mullis KB. The unusual origin of the polymerase chain reaction. Sci Am. 1990a; 262(4):56-61, 64-65.
Mullis KB. Target amplifi cation for DNA analysis by the polymerase chain reaction.
Ann Biol Clin (Paris). 1990b;48(8):579-582.
Musarella MA. Molecular genetics of macular degeneration. Doc Ophthalmol. 2001; 102(3):165-177.
Nakamura M, Ito S, Miyake Y. Novel de novo mutation in CRX gene in a Japanese patient with leber congenital 
amaurosis. Am J Ophthalmol. 2002; 134(3):465-467.
Nakauchi K, Fujikado T, Kanda H, Morimoto T, Choi JS, Ikuno Y, Sakaguchi H,Kamei M, Ohji M, Yagi T, Nishimura 
S, Sawai H, Fukuda Y, Tano Y. Transretinal electrical stimulation by an intrascleral multichannel electrode array in 
rabbit eyes. Graefes Arch Clin Exp Ophthalmol. 2005; 243(2):169-174.
Narfstrom K, Katz ML, Bragadottir R, Seeliger M, Boulanger A, Redmond TM, Caro L, Lai CM, Rakoczy PE. Func-
tional and structural recovery of the retina after gene therapy in the RPE65 null mutation dog. Invest Ophthalmol 
Vis Sci. 2003; 44(4):1663-1672.
Narfstrom K, Katz ML, Ford M, Redmond TM, Rakoczy E, Bragadottir R. In vivo gene therapy in young and adult 
RPE65-/- dogs produces long-term visual improvement. J Hered. 2003; 94(1):31-37.
Narfstrom K, Andersson BE, Andreasson S, Gouras P. Clinical electroretinography in the dog with ganzfeld stimula-
tion: a practical method of examining rod and cone function. Doc Ophthalmol. 1995; 90(3):279-290.
Nathans D, Smith HO. Restriction endonucleases in the analysis and restructuring of DNA molecules. Annu Rev 
Biochem. 1975; 44:273-293.
Nichols BE, Sheffi eld VC, Vandenburgh K, Drack AV, Kimura AE, Stone EM. Butterfl y-shaped pigment dystrophy of 
the fovea caused by a point mutation in codon 167 of the RDS gene. Nat Genet. 1993a; 3(3):202-207.
Nichols BE, Drack AV, Vandenburgh K, Kimura AE, Sheffi eld VC, Stone EM. A 2 base pair deletion in the RDS gene 
associated with butterfl y-shaped pigment dystrophy of the fovea. Hum Mol Genet. 1993 May 2(5) 601-603. 
Erratum in Hum Mol Genet. 1993b; 2(8):1347.
Nickel B, Hoyt CS. Leber‘s congenital amaurosis. Is mental retardation a frequent associated defect? Arch Ophthal-
mol. 1982; 100(7):1089-1092.
Nilsson SE, Wrigstad A, Narfstrom K. Changes in the DC electroretinogram in Briard dogs with hereditary congenital 
night blindness and partial day blindness. Exp Eye Res. 1992; 54(2):291-296.
Sharola BW.indd   113 29-May-07   10:45:48 AM
114
Nir I, Kedzierski W, Chen J, Travis GH. Expression of Bcl-2 protects against photoreceptor degeneration in retinal 
degeneration slow (rds) mice. J Neurosci. 2000; 20(6):2150-2154.
Noble KG, Carr RE. Leber’s congenital amaurosis. A retrospective study of 33 cases and a histopathological study 
of one case. Arch Ophthalmol. 1978; 96(5):818-821.
North MA, Naggert JK, Yan Y, Noben-Trauth K, Nishina PM. Molecular characterization of TUB, TULP1, and TULP2, 
members of the novel tubby gene family and their possible relation to ocular diseases. Proc Natl Acad Sci U S 
A. 1997; 94(7):3128-3133.
North MA, Naggert JK, Yan Y, Noben-Trauth K, Nishina PM. Molecular characterization of TUB, TULP1, and TULP2, 
members of the novel tubby Nucleic Acids Res. 2002; 30(1):235-238.
Oakley B 2nd, Green DG. Correlation of light-induced changes in retinal extracellular potassium concentration with 
c-wave of the electroretinogram. J Neurophysiol. 1976; 39(5):1117-11133.
O’Brien KM, Schulte D, Hendrickson AE. Expression of photoreceptor-associated molecules during human fetal eye 
development. Mol Vis. 2003; 9:401-409.
O’Byrne SM, Wongsiriroj N, Libien J, Vogel S, Goldberg IJ, Baehr W, Palczewski K, Blaner WS. Retinoid absorption 
and storage is impaired in mice lacking lecithin:retinol acyltransferase (LRAT). J Biol Chem. 2005; 280(42):35647-
35657.
Olbrich H, Fliegauf M, Hoefele J, Kispert A, Otto E, Volz A, Wolf MT, Sasmaz G, Trauer U, Reinhardt R, Sudbrak 
R, Antignac C, Gretz N, Walz G, Schermer B, Benzing T, Hildebrandt F, Omran H. Mutations in a novel gene, 
NPHP3, cause adolescent nephronophthisis, tapeto-retinal degeneration and hepatic fi brosis. Nat Genet. 2003; 
34(4):455-459.
Oliveira L, Miniou P, Viegas-Pequignot E, Rozet JM, Dollfus H, Pittler SJ. Human retinal guanylate cyclase (GUC2D) 
maps to chromosome 17p13.1. Genomics. 1994; 22(2):478-481.
Omran H, Fernandez C, Jung M, Haffner K, Fargier B, Villaquiran A, Waldherr R, Gretz N, Brandis M, Ruschendorf F, 
Reis A, Hildebrandt F. Identifi cation of a new gene locus for adolescent nephronophthisis, on chromosome 3q22 
in a large Venezuelan pedigree. Am J Hum Genet. 2000; 66(1):118-127.
Omran H, Sasmaz G, Haffner K, Volz A, Olbrich H, Melkaoui R, Otto E, Wienker TF, Korinthenberg R, Brandis 
M, Antignac C, Hildebrandt F. Identifi cation of a gene locus for Senior-Loken syndrome in the region of the 
nephronophthisis type 3 gene. J Am Soc Nephrol. 2002; 13(1):75-79.
Orita M, Suzuki Y, Sekiya T, Hayashi K. Rapid and sensitive detection of point mutations and DNA polymorphisms 
using the polymerase chain reaction. Genomics. 1989a; 5(4):874-879.
Orita M, Iwahana H, Kanazawa H, Hayashi K, Sekiya T. Detection of polymorphisms of human DNA by gel electro-
phoresis as single-strand conformation polymorphisms.
Proc Natl Acad Sci U S A. 1989b; 86(8):2766-2770.
Ott J, JD Terwilliger, Handbook of human genetic linkage, 1991 JHU Press.
Ott J. Estimation of the recombination fraction in human pedigrees: effi cient computation of the likelihood for human 
linkage studies. Am J Hum Genet. 1974; 26(5):588-597.
Otteson DC, Hitchcock PF. Stem cells in the teleost retina: persistent neurogenesis and injury-induced regeneration. 
Vision Res. 2003; 43(8):927-936.
Otto E, Hoefele J, Ruf R, Mueller AM, Hiller KS, Wolf MT, Schuermann MJ, Becker A, Birkenhager R, Sudbrak R, 
Hennies HC, Nurnberg P, Hildebrandt F. A gene mutated in nephronophthisis and retinitis pigmentosa encodes 
a novel protein, nephroretinin, conserved in evolution. Am J Hum Genet. 2002; 71(5):1161-1167.
Ozgul RK, Bozkurt B, Kiratli H, Ogus A. Exclusion of LCA5 locus in a consanguineous Turkish family with macular 
coloboma-type LCA. Eye. 2006; 20(7):817-819.
Palczewski K, Rispoli G, Detwiler PB. The infl uence of arrestin (48K protein) and rhodopsin kinase on visual trans-
duction. Neuron. 1992; 8(1):117-126.
Pang JJ, Chang B, Hawes NL, Hurd RE, Davisson MT, Li J, Noorwez SM, Malhotra R, McDowell JH, Kaushal S, 
Hauswirth WW, Nusinowitz S, Thompson DA, Heckenlively JR. Retinal degeneration 12 (rd12): a new, spontane-
ously arising mouse model for human Leber congenital amaurosis (LCA). Mol Vis. 2005; 11:152-162.
Paloma E, Hjelmqvist L, Bayes M, Garcia-Sandoval B, Ayuso C, Balcells S, Gonzalez-Duarte R. Novel mutations in 
the TULP1 gene causing autosomal recessive retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2000; 41(3):656-
659.
Papermaster DS, Burstein Y, Schechter I. Opsin mRNA isolation from bovine retina and partial sequence of the in 
vitro translation product. Ann N Y Acad Sci. 1980; 343:347-355.
Papermaster DS, Windle J. Death at an early age. Apoptosis in inherited retinal degenerations. Invest Ophthalmol 
Vis Sci. 1995; 36(6):977-983.
Sharola BW.indd   114 29-May-07   10:45:48 AM
Leber congenital amaurosis 115
Parisi MA, Bennett CL, Eckert ML, Dobyns WB, Gleeson JG, Shaw DW, McDonald R, Eddy A, Chance PF, Glass 
IA. The NPHP1 gene deletion associated with juvenile nephronophthisis is present in a subset of individuals with 
Joubert syndrome. Am J Hum Genet. 2004; 75(1):82-91.
Pasantes-Morales H, Quiroz H, Quesada O. Treatment with taurine, diltiazem, and vitamin E retards the progressive 
visual fi eld reduction in retinitis pigmentosa: a 3-year follow-up study. Metab Brain Dis. 2002; 17(3):183-197.
Paunescu K, Wabbels B, Preising MN, Lorenz B. Longitudinal and cross-sectional study of patients with early-onset 
severe retinal dystrophy associated with RPE65 mutations.
Graefes Arch Clin Exp Ophthalmol. 2005; 243(5):417-426.
Pawlyk BS, Smith AJ, Buch PK, Adamian M, Hong DH, Sandberg MA, Ali RR, Li T.
Gene replacement therapy rescues photoreceptor degeneration in a murine model of Leber congenital amaurosis 
lacking RPGRIP. Invest Ophthalmol Vis Sci. 2005; 46(9):3039-3045.
Payne AM, Morris AG, Downes SM, Johnson S, Bird AC, Moore AT, Bhattacharya SS, Hunt DM. Clustering and 
frequency of mutations in the retinal guanylate cyclase (GUCY2D) gene in patients with dominant cone-rod 
dystrophies. J Med Genet. 2001; 38(9):611-614.
Pearce-Kelling SE, Aleman TS, Nickle A, Laties AM, Aguirre GD, Jacobson SG, Acland GM. Calcium channel 
blocker D-cis-diltiazem does not slow retinal degeneration in the PDE6B mutant rcd1 canine model of retinitis 
pigmentosa. Mol Vis. 2001; 7:42-47.
Pei YF, Rhodin JA. The prenatal development of the mouse eye. Anat Rec. 1970; 168(1):105-125.
Pellikka M, Tanentzapf G, Pinto M, Smith C, McGlade CJ, Ready DF, Tepass U. Crumbs, the Drosophila homologue 
of human CRB1/RP12, is essential for photoreceptor morphogenesis. Nature. 2002; 416(6877):143-149.
Pepe IM, Panfoli I, Hamm HE. Visual transduction in vertebrate photoreceptors. Light activation of guanylate cyclase. 
Cell Biophys. 1989; 14(2):129-137.
Pepe IM. Rhodopsin and phototransduction. J Photochem Photobiol B. 1999; 48(1):1-10.
Pepe IM. Recent advances in our understanding of rhodopsin and phototransduction. Prog Retin Eye Res. 2001; 
20(6):733-759.
Perier RC, Praz V, Junier T, Bonnard C, Bucher P. The eukaryotic promoter database (EPD). Nucleic Acids Res. 
2000; 28(1):302-303.
Perrault I, Rozet JM, Calvas P, Gerber S, Camuzat A, Dollfus H, Chatelin S, Souied E, Ghazi I, Leowski C, Bon-
nemaison M, Le Paslier D, Frezal J, Dufi er JL, Pittler S, Munnich A, Kaplan J. Retinal-specifi c guanylate cyclase 
gene mutations in Leber‘s congenital amaurosis. Nat Genet. 1996; 4(4):461-464.
Perrault I, Rozet JM, Gerber S, Kelsell RE, Souied E, Cabot A, Hunt DM, Munnich A, Kaplan J. A retGC-1 mutation 
in autosomal dominant cone-rod dystrophy. Am J Hum Genet. 1998; 63(2):651-654.
Perrault I, Rozet JM, Ghazi I, Leowski C, Bonnemaison M, Gerber S, Ducroq D, Cabot A, Souied E, Dufi er JL, 
Munnich A, Kaplan J. Different functional outcome of RetGC1 and RPE65 gene mutations in Leber congenital 
amaurosis. Am J Hum Genet. 1999; 64(4):1225-1228.
Perrault I, Rozet JM, Gerber S, Ghazi I, Leowski C, Ducroq D, Souied E, Dufi er JL, Munnich A, Kaplan J. Leber 
congenital amaurosis. Mol Genet Metab. 1999 Oct; 68(2):200-208.
Perrault I, Rozet JM, Gerber S, Ghazi I, Ducroq D, Souied E, Leowski C, Bonnemaison M, Dufi er JL, Munnich A, Ka-
plan J. Spectrum of retGC1 mutations in Leber’s congenital amaurosis. Eur J Hum Genet. 2000; 8(8):578-582.
Perrault I, Hanein S, Gerber S, Barbet F, Dufi er JL, Munnich A, Rozet JM, Kaplan J. Evidence of autosomal dominant 
Leber congenital amaurosis (LCA) underlain by a CRX heterozygous null allele. J Med Genet. 2003; 40(7):e90
Perrault I, Hanein S, Gerber S, Barbet F, Ducroq D, Dollfus H, Hamel C, Dufi er JL, Munnich A, Kaplan J, Rozet 
JM. Retinal dehydrogenase 12 (RDH12) mutations in leber congenital amaurosis. Am J Hum Genet. 2004; 
75(4):639-646.
Perrault I, Hanein S, Gerber S, Lebail B, Vlajnik P, Barbet F, Ducroq D, Dufi er JL, Munnich A, Kaplan J, Rozet JM. A 
novel mutation in the GUCY2D gene responsible for an early onset severe RP different from the usual GUCY2D-
LCA phenotype. Hum Mutat. 2005; 25(2):222.
Perrault I, Delphin N, Hanein S, Gerber S, Dufi er JL, Roche O, Defoort-Dhellemmes S, Dollfus H, Fazzi E, Munnich 
A, Kaplan J, Rozet JM. Spectrum of NPHP6/CEP290 Mutations in Leber congenital amaurosis and delineation 
of the associated phenotype. Hum Mutation; 956 online 2007
Pignatelli V, Cepko CL, Strettoi E. Inner retinal abnormalities in a mouse model of Leber’s congenital amaurosis. J 
Comp Neurol. 2004; 469(3):351-359.
Pittler SJ, Fliesler SJ, Fisher PL, Keller PK, Rapp LM. In vivo requirement of protein prenylation for maintenance of 
retinal cytoarchitecture and photoreceptor structure. J Cell Biol. 1995; 130(2):431-439.
Sharola BW.indd   115 29-May-07   10:45:48 AM
116
Ploughman LM, Boehnke M. Estimating the power of a proposed linkage study for a complex genetic trait. Am J 
Hum Genet. 1989; 44(4):543-551.
Polak BC, van Lith FH, Delleman JW, van Balen AT. Carrier detection in tapetoretinal degeneration in association with 
medullary cystic disease. Am J Ophthalmol. 1983; 95(4):487-494.
Polans A, Baehr W, Palczewski K. Turned on by Ca2+! The physiology and pathology of Ca(2+)-binding proteins in 
the retina. Trends Neurosci. 1996; 19(12):547-554.
Popovic-Rolovic M, Calic-Perisic N, Bunjevacki G, Negovanovic D. Juvenile nephronophthisis associated with retinal 
pigmentary dystrophy, cerebellar ataxia, and skeletal abnormalities. Arch Dis Child. 1976; 51(10):801-803.
Portera-Cailliau C, Sung CH, Nathans J, Adler R. Apoptotic photoreceptor cell death in mouse models of retinitis 
pigmentosa. Proc Natl Acad Sci USA. 1994; 91(3):974-978.
Porto FB, Perrault I, Hicks D, Rozet JM, Hanoteau N, Hanein S, Kaplan J, Sahel JA. Prenatal human ocular degen-
eration occurs in Leber’s congenital amaurosis (LCA2). J Gene Med. 2002; 4(4):390-396.
Porto FB, Perrault I, Hicks D, Rozet JM, Hanoteau N, Hanein S, Kaplan J, Sahel JA. Prenatal human ocular degen-
eration occurs in Leber’s Congenital Amaurosis (LCA1 and 2). Adv Exp Med Biol. 2003; 533: 59-68.
Proesmans W, Van Damme B, Macken J. Nephronophthisis and tapetoretinal degeneration associated with liver 
fi brosis. Clin Nephrol. 1975; 3(4):160-164.
Rabb MF, Tso MO, Fishman GA. Cone-rod dystrophy. A clinical and histopathologic report. Ophthalmology. 1986; 
93(11):1443-1451.
Radu RA, Mata NL, Nusinowitz S, Liu X, Sieving PA, Travis GH. Treatment with isotretinoin inhibits lipofuscin ac-
cumulation in a mouse model of recessive Stargardt’s macular degeneration.
Proc Natl Acad Sci U S A. 2003; 100(8):4742-4747.
Raff MC, Barres BA, Burne JF, Coles HS, Ishizaki Y, Jacobson MD. Programmed cell death and the control of cell 
survival. Philos Trans R Soc Lond B Biol Sci. 1994; 345(1313):265-268.
Rahn EK, Meadow E, Falls HF, Knaggs JG, Proux DJ. Leber’s congenital amaurosis with an Ehlers-Danlos-like 
syndrome. Study of an American family. Arch Ophthalmol. 1968; 79(2):135-141.
Ramamurthy V, Niemi GA, Reh TA, Hurley JB. Leber congenital amaurosis linked to AIPL1: a mouse model reveals 
destabilization of cGMP phosphodiesterase.
Proc Natl Acad Sci U S A. 2004; 101(38):13897-13902.
Ramamurthy V, Roberts M, van den Akker F, Niemi G, Reh TA, Hurley JB. AIPL1, a protein implicated in Leber’s 
congenital amaurosis, interacts with and aids in processing of farnesylated proteins. Proc Natl Acad Sci U S A. 
2003; 100(22):12630-12635.
Rando RR. Membrane phospholipids as an energy source in the operation of the visual cycle. Biochemistry. 1991; 
30(3):595-602.
Rattner A, Sun H, Nathans J. Molecular genetics of human retinal disease. Annu Rev Genet. 1999; 33:89-131.
Redmond TM, Yu S, Lee E, Bok D, Hamasaki D, Chen N, Goletz P, Ma JX, Crouch RK, Pfeifer K. Rpe65 is necessary 
for production of 11-cis-vitamin A in the retinal visual cycle. Nat Genet. 1998; 20(4):344-351.
Redmond TM, Poliakov E, Yu S, Tsai JY, Lu Z, Gentleman S. Mutation of key residues of RPE65 abolishes its enzy-
matic role as isomerohydrolase in the visual cycle. Proc Natl Acad Sci U S A. 2005; 102(38):13658-13663.
Rehemtulla A, Warwar R, Kumar R, Ji X, Zack DJ, Swaroop A. The basic motif-leucine zipper transcription factor Nrl 
can positively regulate rhodopsin gene expression. Proc Natl Acad Sci U S A. 1996; 93(1):191-195.
Reme CE, Grimm C, Hafezi F, Marti A, Wenzel A. Apoptotic cell death in retinal degenerations. Prog Retin Eye Res. 
1998; 17(4):443-464.
Riggs LA. Electroretinography in cases of night blindness. Am J Ophthalmol. 1954; 38(1:2):70-78.
Rispoli G. Calcium regulation of phototransduction in vertebrate rod outer segments. J Photochem Photobiol B. 
1998; 44(1):1-20.
Rivolta C, Berson EL, Dryja TP. Dominant Leber congenital amaurosis, cone-rod degeneration, and retinitis pigmen-
tosa caused by mutant versions of the transcription factor CRX. Hum Mutat. 2001a; 18(6):488-498.
Rivolta C, Peck NE, Fulton AB, Fishman GA, Berson EL, Dryja TP. Novel frameshift mutations in CRX associated with 
Leber congenital amaurosis. Hum Mutat. 2001b; 18(6):550-551.
Rizzo JF 3rd, Wyatt J, Humayun M, de Juan E, Liu W, Chow A, Eckmiller R, Zrenner E, Yagi T, Abrams G. Retinal 
prosthesis: an encouraging fi rst decade with major challenges ahead. Ophthalmology. 2001; 108(1):13-14.
Rizzo JF 3rd, Wyatt J, Loewenstein J, Kelly S, Shire D. Perceptual effi cacy of electrical stimulation of human retina 
with a microelectrode array during short-term surgical trials.
Invest Ophthalmol Vis Sci. 2003; 44(12):5362-5369.
Sharola BW.indd   116 29-May-07   10:45:48 AM
Leber congenital amaurosis 117
Rizzo JF 3rd, Wyatt J, Loewenstein J, Kelly S, Shire D. Methods and perceptual thresholds for short-term electrical 
stimulation of human retina with microelectrode arrays. Invest Ophthalmol Vis Sci. 2003; 44(12):5355-5361.
Robins DG, French TA, Chakera TM. Juvenile nephronophthisis associated with skeletal abnormalities and hepatic 
fi brosis. Arch Dis Child. 1976; 51(10):799-801.
Roepman R, van Duijnhoven G, Rosenberg T, Pinckers AJ, Bleeker-Wagemakers LM, Bergen AA, Post J, Beck A, 
Reinhardt R, Ropers HH, Cremers FP, Berger W. Positional cloning of the gene for X-linked retinitis pigmentosa 
3: homology with the guanine-nucleotide-exchange factor RCC1. Hum Mol Genet. 1996; 5(7):1035-1041.
Roepman R, Bernoud-Hubac N, Schick DE, Maugeri A, Berger W, Ropers HH, Cremers FP, Ferreira PA. The retinitis 
pigmentosa GTPase regulator (RPGR) interacts with novel transport-like proteins in the outer segments of rod 
photoreceptors. Hum Mol Genet. 2000; 9(14):2095-2105.
Roepman R, Letteboer SJ, Arts HH, van Beersum SE, Lu X, Krieger E, Ferreira PA, Cremers FP. Interaction of 
nephrocystin-4 and RPGRIP1 is disrupted by nephronophthisis or Leber congenital amaurosis-associated muta-
tions. Proc Natl Acad Sci U S A. 2005; 102(51):18520-18525.
Rohrer B, Ablonczy Z, Znoiko S, Redmond M, Ma JX, Crouch R. Does constitutive phosphorylation protect against 
photoreceptor degeneration in Rpe65-/- mice? Adv Exp Med Biol. 2003; 533:221-227.
Ropers HH, Hamel BC. X-linked mental retardation. Nat Rev Genet. 2005; 6(1):46-57.
Rosenfeld PJ, Cowley GS, McGee TL, Sandberg MA, Berson EL, Dryja TP. A null mutation in the rhodopsin gene 
causes rod photoreceptor dysfunction and autosomal recessive retinitis pigmentosa. Nat Genet. 1992; 1(3):209-
213.
Rozet JM, Perrault I, Gerber S, Hanein S, Barbet F, Ducroq D, Souied E, Munnich A, Kaplan J. Complete abolition 
of the retinal-specifi c guanylyl cyclase (retGC-1) catalytic ability consistently leads to leber congenital amaurosis 
(LCA). Invest Ophthalmol Vis Sci. 2001; 42(6):1190-1192.
Ruiz A, Winston A, Lim YH, Gilbert BA, Rando RR, Bok D. Molecular and biochemical characterization of lecithin 
retinol acyltransferase.J Biol Chem. 1999; 274(6):3834-3841.
Ruiz A, Kuehn MH, Andorf JL, Stone E, Hageman GS, Bok D. Genomic organization and mutation analysis of the 
gene encoding lecithin retinol acyltransferase in human retinal pigment epithelium. Invest Ophthalmol Vis Sci. 
2001; 42(1):31-37.
Russell-Eggitt IM, Clayton PT, Coffey R, Kriss A, Taylor DS, Taylor JF: Alström syndrome. Report of 22 cases and 
literature review. Ophthalmology. 1998; 105(7):1274-1280.
Saar K, Al-Gazali L, Sztriha L, Rueschendorf F, Nur-E-Kamal M, Reis A, Bayoumi R. Homozygosity mapping in 
families with Joubert syndrome identifi es a locus on chromosome 9q34.3 and evidence for genetic heterogene-
ity. Am J Hum Genet. 1999; 65(6):1666-1671.
Saari JC, Bredberg DL. Photochemistry and stereoselectivity of cellular retinaldehyde-binding protein from bovine 
retina. J Biol Chem. 1987; 262(16):7618-7622.
Saari JC. Biochemistry of visual pigment regeneration: the Friedenwald lecture. Invest Ophthalmol Vis Sci. 2000; 
41(2):337-348.
Saari JC. The sights along route 65. Nat Genet. 2001; 29(1):8-9.
Sadato N, Okada T, Kubota K, Yonekura Y. Tactile discrimination activates the visual cortex of the recently blind naïve 
to Braille: a functional magnetic resonance imaging study in humans. Neurosci Lett. 2004; 359(1-2):49-52.
Sadato N, Pascual-Leone A, Grafman J, Deiber MP, Ibanez V, Hallett M. Neural networks for Braille reading by the 
blind. Brain. 1998; 121 (Pt 7):1213-1229.
Sahel JA, Mohand-Said S, Leveillard T, Hicks D, Picaud S, Dreyfus H. Rod-cone interdependence: implications for 
therapy of photoreceptor cell diseases. Prog Brain Res. 2001;131:649-661.
Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, Mullis KB, Erlich HA. Primer-directed enzymatic 
amplifi cation of DNA with a thermostable DNA polymerase. Science. 1988; 239(4839):487-491
Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 
1977; 74(12):5463-5467.
Santos A, Humayun MS, de Juan E Jr, Greenburg RJ, Marsh MJ, Klock IB, Milam AH. Preservation of the inner retina 
in retinitis pigmentosa. A morphometric analysis. Arch Ophthalmol. 1997; 115(4):511-515.
Saraiva JM, Baraitser M. Joubert syndrome: A review. Am J Med Genet. 1992; 43(4):726-731.
Sarangapani S, Chang L, Gregory-Evans K. Cataract surgery in Senior-Loken syndrome is benefi cial despite severe 
retinopathy. Eye 2002; 16(6):782-785.
Sarkar G, Yoon HS, Sommer SS. Dideoxy fi ngerprinting (ddE): a rapid and effi cient screen for the presence of 
mutations. Genomics. 1992; 13(2):441-443.
Sharola BW.indd   117 29-May-07   10:45:48 AM
118
Saunier S, Calado J, Heilig R, Silbermann F, Benessy F, Morin G, Konrad M, Broyer M, Gubler MC, Weissenbach J, 
Antignac C. A novel gene that encodes a protein with a putative src homology 3 domain is a candidate gene for 
familial juvenile nephronophthisis. Hum Mol Genet. 1997; 6(13):2317-2323.
Sayer JA, Otto EA, O’toole JF, Nurnberg G, Kennedy MA, Becker C, Hennies HC, Helou J, Attanasio M, Fausett 
BV, Utsch B, Khanna H, Liu Y, Drummond I, Kawakami I, Kusakabe T, Tsuda M, Ma L, Lee H, Larson RG, Allen 
SJ, Wilkinson CJ, Nigg EA, Shou C, Lillo C, Williams DS, Hoppe B, Kemper MJ, Neuhaus T, Parisi MA, Glass 
IA, Petry M, Kispert A, Gloy J, Ganner A, Walz G, Zhu X, Goldman D, Nurnberg P, Swaroop A, Leroux MR, 
Hildebrandt F. The centrosomal protein nephrocystin-6 is mutated in Joubert syndrome and activates transcrip-
tion factor ATF4. Nat Genet. 2006; 38(6):674-681
Schatz P, Ponjavic V, Andreasson S, McGee TL, Dryja TP, Abrahamson M. Clinical phenotype in a Swedish family 
with a mutation in the IMPDH1 gene. Ophthalmic Genet. 2005; 26(3):119-124.
Schmitt A, Wolfrum U. Identifi cation of novel molecular components of the photoreceptor connecting cilium by 
immunoscreens. Exp Eye Res. 2001; 73(6):837-849.
Schlessinger D. Yeast artifi cial chromosomes: tools for mapping and analysis of complex genomes. Trends Genet. 
1990; 6(8):248, 255-258.
Scholl HP, Chong NH, Robson AG, Holder GE, Moore AT, Bird AC. Fundus autofl uorescence in patients with leber 
congenital amaurosis. Invest Ophthalmol Vis Sci. 2004; 45(8):2747-2752.
Schroeder R, Mets MB, Maumenee IH. Leber’s congenital amaurosis. Retrospective review of
43 cases and a new fundus fi nding in two cases. Arch Ophthalmol. 1987;105(3):356-359.
Schuermann MJ, Otto E, Becker A, Saar K, Ruschendorf F, Polak BC, Ala-Mello S, Hoefele J, Wiedensohler A, Haller 
M, Omran H, Nurnberg P, Hildebrandt F. Mapping of gene loci for nephronophthisis type 4 and Senior-Loken 
syndrome, to chromosome 1p36. Am J Hum Genet. 2002; 70(5):1240-1246.
Schuil J, Meire FM, Delleman JW. Mental retardation in amaurosis congenita of Leber. Neuropediatrics. 1998; 
29(6):294-297.
Schuler GD. Sequence mapping by electronic PCR. Genome Res. 1997; 7(5):541-550.
Scolari F, Viola BF, Ghiggeri GM, Caridi G, Amoroso A, Rampoldi L, Casari G. Towards the identifi cation of (a) gene(s) 
for autosomal dominant medullary cystic kidney disease. J Nephrol. 2003; 16(3):32132-8.
Seeliger MW, Grimm C, Stahlberg F, Friedburg C, Jaissle G, Zrenner E, Guo H, Reme CE, Humphries P, Hofmann 
F, Biel M, Fariss RN, Redmond TM, Wenzel A. New views on RPE65 defi ciency: the rod system is the source of 
vision in a mouse model of Leber congenital amaurosis. Nat Genet. 2001; 29(1):70-74.
Semple-Rowland SL, Lee NR, Van Hooser JP, Palczewski K, Baehr W. A null mutation in the photoreceptor gua-
nylate cyclase gene causes the retinal degeneration chicken phenotype. Proc Natl Acad Sci U S A. 1998; 
95(3):1271-1276.
Senior B, Friedmann A, Braudo J. Juvenile familial nephropathy with tapetoretinal degeneration: A new oculorenal 
dystrophy. Am J Ophthalmol 1961; 52: 625-633.
Sheedlo HJ, Li LX, Turner JE. Functional and structural characteristics of photoreceptor cells rescued in RPE-cell 
grafted retinas of RCS dystrophic rats. Exp Eye Res. 1989; 48(6):841-854.
Sheffi eld VC, Beck JS, Kwitek AE, Sandstrom DW, Stone EM. The sensitivity of single-strand conformation polymor-
phism analysis for the detection of single base substitutions.
Genomics. 1993;16(2):325-332.
Shiraishi M. Denaturing gradient gel electrophoresis to detect methylation changes in DNA.
Methods Mol Biol. 2004; 287:219-231.
Silva E, Yang JM, Li Y, Dharmaraj S, Sundin OH, Maumenee IH. A CRX null mutation is associated with both Leber 
congenital amaurosis and a normal ocular phenotype. Invest Ophthalmol Vis Sci. 2000; 41(8):2076-2079.
Silva E, Dharmaraj S, Li YY, Pina AL, Carter RC, Loyer M, Traboulsi E, Theodossiadis G, Koenekoop R, Sundin O, 
Maumenee I. A missense mutation in GUCY2D acts as a genetic modifi er in RPE65-related Leber Congenital 
Amaurosis. Ophthalmic Genet. 2004;25(3):205-217
Simeone A, Acampora D, Gulisano M, Stornaiuolo A, Boncinelli E. Nested expression domains of four homeobox 
genes in developing rostral brain. Nature. 1992; 358(6388):687-690.
Simovich MJ, Miller B, Ezzeldin H, Kirkland BT, McLeod G, Fulmer C, Nathans J, Jacobson SG, Pittler SJ. Four novel 
mutations in the RPE65 gene in patients with Leber congenital amaurosis. Hum Mutat. 2001; 18(2):164.
Sitorus RS, Lorenz B, Preising MN. Analysis of three genes in Leber congenital amaurosis in Indonesian patients. 
Vision Res. 2003; 43(28):3087-3093.
Smith MJ, Humphrey KE, Cappai R, Beyreuther K, Masters CL, Cotton RG. Correct heteroduplex formation for 
mutation detection analysis. Mol Diagn. 2000; 5(1):67-73.
Sharola BW.indd   118 29-May-07   10:45:48 AM
Leber congenital amaurosis 119
Sohocki MM, Perrault I, Leroy BP, Payne AM, Dharmaraj S, Bhattacharya SS, Kaplan J, Maumenee IH, Koenekoop 
R, Meire FM, Birch DG, Heckenlively JR, Daiger SP. Prevalence of AIPL1 mutations in inherited retinal degenera-
tive disease. Mol Genet Metab. 2000; 70(2):142-150.
Sohocki MM, Bowne SJ, Sullivan LS, Blackshaw S, Cepko CL, Payne AM, Bhattacharya SS, Khaliq S, Qasim Mehdi 
S, Birch DG, Harrison WR, Elder FF, Heckenlively JR, Daiger SP. Mutations in a new photoreceptor-pineal gene 
on 17p cause Leber congenital amaurosis. Nat Genet. 2000; 24(1):79-83.
Sohocki MM, Daiger SP, Bowne SJ, Rodriquez JA, Northrup H, Heckenlively JR, Birch DG, Mintz-Hittner H, Ruiz RS, 
Lewis RA, Saperstein DA, Sullivan LS. Prevalence of mutations causing retinitis pigmentosa and other inherited 
retinopathies. Hum Mutat. 2001; 17(1):42-51.
Sohocki MM, Sullivan LS, Mintz-Hittner HA, Birch D, Heckenlively JR, Freund CL, McInnes RR, Daiger SP. A range 
of clinical phenotypes associated with mutations in CRX, a photoreceptor transcription-factor gene. Am J Hum 
Genet. 1998; 63(5):1307-1315.
Sommer A, Hussaini G, Muhilal, Tarwotjo I, Susanto D, Saroso JS. History of nightblindness: a simple tool for 
xerophthalmia screening. Am J Clin Nutr. 1980; 33(4):887-891.
Sorsby A, Williams CE. Retinal aplasia as a clinical entity. Br Med J 1:293–297
Southern EM. An improved method for transferring nucleotides from electrophoresis strips to thin layers of ion-
exchange cellulose. Anal Biochem. 1974; 62(1):317-318.
Southern EM. Detection of specifi c sequences among DNA fragments separated by gel electrophoresis. J Mol Biol. 
1975; 98(3):503-517.
Steinmetz RL, Haimovici R, Jubb C, Fitzke FW, Bird AC. Symptomatic abnormalities of dark adaptation in patients 
with age-related Bruch’s membrane change. Br J Ophthalmol. 1993; 77(9):549-554.
Strausberg RL, Simpson AJ, Wooster R. Sequence-based cancer genomics: progress, lessons and opportunities. 
Nat Rev Genet. 2003; 4(6):409-418.
Sterling P, Freed MA, Smith RG. Architecture of rod and cone circuits to the on-beta ganglion cell. J Neurosci. 1988; 
8(2):623-642.
Stoiber J, Muss WH, Ruckhofer J, Thaller-Antlanger H, Alzner E, Grabner G. Recurrent keratoconus in a patient with 
Leber congenital amaurosis.Cornea. 2000; 19(3):395-398.
Stockton DW, Lewis RA, Abboud EB, Al-Rajhi A, Jabak M, Anderson KL, Lupski JR. A novel locus for Leber 
congenital amaurosis on chromosome 14q24. Hum Genet. 1998; 103(3):328-333.
Stone JL, Barlow WE, Humayun MS, de Juan E Jr, Milam AH. Morphometric analysis of macular photoreceptors and 
ganglion cells in retinas with retinitis pigmentosa. Arch Ophthalmol. 1992; 110(11):1634-1639.
Streilein JW, Ma N, Wenkel H, Ng TF, Zamiri P. Immunobiology and privilege of neuronal retina and pigment epithe-
lium transplants. Vision Res. 2002; 42(4):487-495.
Stryer L. Visual excitation and recovery. J Biol Chem. 1991; 266(17):10711-10714.
Sullivan TJ, Heathcote JG, Brazel SM, Musarella MA. The ocular pathology in Leber’s congenital amaurosis. Aust N 
Z J Ophthalmol. 1994 Feb;22(1):25-31.
Sullivan LS, Daiger SP. Inherited retinal degeneration: exceptional genetic and clinical heterogeneity. Mol Med Today. 
1996; 2(9):380-386.
Sundin OH, Yang JM, Li Y, Zhu D, Hurd JN, Mitchell TN, Silva ED, Maumenee IH. Genetic basis of total colourblind-
ness among the Pingelapese islanders. Nat Genet. 2000; 25(3):289-293.
Swain PK, Chen S, Wang QL, Affatigato LM, Coats CL, Brady KD, Fishman GA, Jacobson SG, Swaroop A, Stone 
E, Sieving PA, Zack DJ. Mutations in the cone-rod homeobox gene are associated with the cone-rod dystrophy 
photoreceptor degeneration. Neuron. 1997; 19(6):1329-1336.
Swaroop A, Wang QL, Wu W, Cook J, Coats C, Xu S, Chen S, Zack DJ, Sieving PA. Leber congenital amaurosis 
caused by a homozygous mutation (R90W) in the homeodomain of the retinal transcription factor CRX: direct 
evidence for the involvement of CRX in the development of photoreceptor function. Hum Mol Genet. 1999; 
8(2):299-305.
Swaroop A, Xu JZ, Pawar H, Jackson A, Skolnick C, Agarwal N. A conserved retina-specifi c gene encodes a basic 
motif/leucine zipper domain. Proc Natl Acad Sci U S A. 1992; 89(1):266-270.
Szamier RB, Berson EL, Klein R, Meyers S. Sex-linked retinitis pigmentosa: ultrastructure of photoreceptors and 
pigment epithelium. Invest Ophthalmol Vis Sci. 1979; 18(2):145-160.
Takahashi M, Miyoshi H, Verma IM, Gage FH. Rescue from photoreceptor degeneration in the rd mouse by human 
immunodefi ciency virus vector-mediated gene transfer. J Virol. 1999; 73(9):7812-7816.
Sharola BW.indd   119 29-May-07   10:45:48 AM
120
Thompson DA, Gyurus P, Fleischer LL, Bingham EL, McHenry CL, Apfelstedt-Sylla E, Zrenner E, Lorenz B, Richards 
JE, Jacobson SG, Sieving PA, Gal A. Genetics and phenotypes of RPE65 mutations in inherited retinal degen-
eration. Invest Ophthalmol Vis Sci. 2000; 41(13):4293-4299.
Thompson DA, Li Y, McHenry CL, Carlson TJ, Ding X, Sieving PA, Apfelstedt-Sylla E, Gal A.
Mutations in the gene encoding lecithin retinol acyltransferase are associated with early-onset severe retinal dystro-
phy. Nat Genet. 2001; 28(2):123-124.
Thompson DA, McHenry CL, Li Y, Richards JE, Othman MI, Schwinger E, Vollrath
D, Jacobson SG, Gal A. Retinal dystrophy due to paternal isodisomy for chromosome 1 or chromosome 2, with 
homoallelism for mutations in RPE65 or MERTK, respectively. Am J Hum Genet. 2002; 70(1):224-229.
Thompson DA, Gal A. Vitamin A metabolism in the retinal pigment epithelium: genes, mutations, and diseases. Prog 
Retin Eye Res. 2003; 2(5):683-703.
Tipton RE, Hussels IE. Leber’s congenital amaurosis and mental retardation. Birth Defects Orig Artic Ser. 1971; 
7(3):198.
Toth CA, Narayan DG, Boppart SA, Hee MR, Fujimoto JG, Birngruber R, Cain CP, DiCarlo CD, Roach WP. A 
comparison of retinal morphology viewed by optical coherence tomography and by light microscopy. Arch 
Ophthalmol. 1997;115(11):1425-1428. Erratum in: Arch Ophthalmol 1998
Travis GH, Christerson L, Danielson PE, Klisak I, Sparkes RS, Hahn LB, Dryja TP, Sutcliffe JG. The human retinal de-
generation slow (RDS) gene: chromosome assignment and structure of the mRNA. Genomics. 1991;10(3):733-
739.
Travis GH, Groshan KR, Lloyd M, Bok D. Complete rescue of photoreceptor dysplasia and degeneration in trans-
genic retinal degeneration slow (rds) mice. Neuron. 1992; 9(1):113-119.
Travis GH. Mechanisms of cell death in the inherited retinal degenerations. Am J Hum Genet. 1998; 62(3):503-
508.
Travis GH. DISCO! Dissociation of cone opsins: the fast and noisy life of cones explained.
Neuron. 2005; 46(6):840-842.
Trieschmann M, Spital G, Lommatzsch A, van Kuijk E, Fitzke F, Bird AC, Pauleikhoff D. Macular pigment: quantitative 
analysis on autofl uorescence images. Graefes Arch Clin Exp Ophthalmol. 2003; 241(12):1006-1012.
Trimble JL, Ernest JT, Newell FW. Electro-oculography in infants. Invest Ophthalmol Vis Sci. 1977; 16(7):668-670.
Tripathi BJ, Tripathi RC, Livingston AM, Borisuth NS. The role of growth factors in the embryogenesis and differentia-
tion of the eye. Am J Anat. 1991; 192(4):442-471.
Tsang SH, Chen J, Kjeldbye H, Li WS, Simon MI, Gouras P, Goff SP. Retarding photoreceptor degeneration in 
Pdegtm1/Pdegtml mice by an apoptosis suppressor gene. Invest Ophthalmol Vis Sci. 1997; 38(5):943-950.
Tso MO, Zhang C, Abler AS, Chang CJ, Wong F, Chang GQ, Lam TT. Apoptosis leads to photoreceptor degenera-
tion in inherited retinal dystrophy of RCS rats.
Invest Ophthalmol Vis Sci. 1994; 35(6):2693-2699.
Tucker CL, Ramamurthy V, Pina AL, Loyer M, Dharmaraj S, Li Y, Maumenee IH,Hurley JB, Koenekoop RK. Functional 
analyses of mutant recessive GUCY2D alleles identifi ed in Leber congenital amaurosis patients: protein domain 
comparisons and dominant negative effects.
Mol Vis. 2004; 10:297-303.
Tzekov RT, Liu Y, Sohocki MM, Zack DJ, Daiger SP, Heckenlively JR, Birch DG. Autosomal dominant retinal degen-
eration and bone loss in patients with a 12-bp deletion in the CRX gene.
Invest Ophthalmol Vis Sci. 2001; 42(6):1319-1327.
Tzekov RT, Sohocki MM, Daiger SP, Birch DG. Visual phenotype in patients with Arg41Gln and ala196+1bp muta-
tions in the CRX gene. Ophthalmic Genet. 2000; 21(2):89-99.
Ulshafer RJ, Allen CB. Scanning electron microscopy of the retina in an animal model of hereditary blindness. Scan 
Electron Microsc. 1984;(Pt 2):841-848.
Ulshafer RJ, Allen CB. Ultrastructural changes in the retinal pigment epithelium of congenitally blind chickens. Curr 
Eye Res. 1985; 4(10):1009-1021.
Unoki K, LaVail MM. Protection of the rat retina from ischemic injury by brain-derived neurotrophic factor, ciliary 
neurotrophic factor, and basic fi broblast growth factor. Invest Ophthalmol Vis Sci. 1994; 35(3):907-915.
Uteza,Y., Rouillot, J.S., Kobetz,A., Marchant, D., Pecqueur, S.,Arnaud, E., Prats, H., Honiger, J., Dufi er, J.L., Abit-
bol, M., Neuner-Jehle, M., 1999. Intravitreous transplantation of encapsulated fi broblasts secreting the human 
fi broblast growth factor 2 delays photoreceptor cell degeneration in Royal College of Surgeons rats. Proc Natl 
Acad Sci U S A 96, 3126–3131.
Sharola BW.indd   120 29-May-07   10:45:48 AM
Leber congenital amaurosis 121
Vaizey MJ, Sanders MD, Wybar KC, Wilson J. Neurological abnormalities in congenital amaurosis of Leber. Review 
of 30 cases. Arch Dis Child. 1977; 52(5):399-402.
Valente, E. M.; Salpietro, D. C.; Brancati, F.; Bertini, E.; Galluccio, T.; Tortorella, G.; Briuglia, S.; Dallapiccola, B. 
Description, nomenclature, and mapping of a novel cerebello-renal syndrome with the molar tooth malformation.
Am. J.Hum. Genet. 2003; 73:663-670.
Valente EM, Silhavy JL, Brancati F, Barrano G, Krishnaswami SR, Castori M, Lancaster MA, Boltshauser E, Boccone 
L, Al-Gazali L, Fazzi E, Signorini S, Louie CM, Bellacchio E; International Joubert Syndrome Related Disorders 
Study Group; Bertini E, Dallapiccola B, Gleeson JG. Mutations in CEP290, which encodes a centrosomal protein, 
cause pleiotropic forms of Joubert syndrome. Nat Genet. 2006 Jun; 38(6):623-625.
Valle D, Kaiser-Kupfer MI, Del Valle LA. Gyrate atrophy of the choroid and retina: defi ciency of ornithine aminotrans-
ferase in transformed lymphocytes.
Proc Natl Acad Sci U S A. 1977; 74(11):5159-5161.
Valverde D, Vazquez-Gundin F, del Rio E, Calaf M, Fernandez JL, Baiget M. Analysis of the IRBP gene as a cause 
of RP in 45 ARRP Spanish families. Autosomal recessive retinitis pigmentosa. Interstitial retinol binding protein. 
Spanish Multicentric and Multidisciplinary Group for Research into Retinitis Pigmentosa. Ophthalmic Genet. 
1998; 19(4):197-202.
Van Buren, J.M. (1963) The retinal ganglion cell layer. Charles C. Thomas, Springfi eld, Illinois
van der Spuy J, Chapple JP, Clark BJ, Luthert PJ, Sethi CS, Cheetham ME. The Leber congenital amaurosis 
gene product AIPL1 is localized exclusively in rod photoreceptors of the adult human retina. Hum Mol Genet. 
2002;11(7):823-831.
van der Spuy J, Munro PM, Luthert PJ, Preising MN, Bek T, Heegaard S, Cheetham ME. Predominant rod photore-
ceptor degeneration in Leber congenital amaurosis. Mol Vis. 2005 22;11:542-553.
van de Pavert SA, Kantardzhieva A, Malysheva A, Meuleman J, Versteeg I, Levelt C, Klooster J, Geiger S, Seeliger 
MW, Rashbass P, Le Bivic A, Wijnholds J. Crumbs homologue 1 is required for maintenance of photoreceptor 
cell polarization and adhesion during light exposure. J Cell Sci. 2004; 117(Pt 18):4169-4177.
Van Hooser JP, Aleman TS, He YG, Cideciyan AV, Kuksa V, Pittler SJ, Stone EM, Jacobson SG, Palczewski K. Rapid 
restoration of visual pigment and function with oral retinoid in a mouse model of childhood blindness. Proc Natl 
Acad Sci U S A. 2000; 97(15):8623-8628.
Van Hooser JP, Liang Y, Maeda T, Kuksa V, Jang GF, He YG, Rieke F, Fong HK, Detwiler PB, Palczewski K. Recovery 
of visual functions in a mouse model of Leber congenital amaurosis. J Biol Chem. 2002; 277(21):19173-19182
Varon R, Vissinga C, Platzer M, Cerosaletti KM, Chrzanowska KH, Saar K, Beckmann G, Seemanova E, Cooper PR, 
Nowak NJ, Stumm M, Weemaes CM, Gatti RA, Wilson RK, Digweed M, Rosenthal A, Sperling K, Concannon 
P, Reis A. Nibrin, a novel DNA double-strand break repair protein, is mutated in Nijmegen breakage syndrome. 
Cell. 1998; 1;93(3):467-476.
Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, Sutton GG, Smith HO, Yandell
M, et al The sequence of the human genome. Science. 2001; 291(5507):1304-1351. Erratum in: Science 2001; 
292(5523):1838.
Velculescu VE, Zhang L, Vogelstein B, Kinzler KW. Serial analysis of gene expression.
Science. 1995; 270(5235):484-487.
Veske A, Nilsson SE, Narfstrom K, Gal A. Retinal dystrophy of Swedish briard/briard-beagle dogs is due to a 4-bp 
deletion in RPE65.Genomics. 1999; 57(1):57-61.
Vollrath D, Feng W, Duncan JL, Yasumura D, D’Cruz PM, Chappelow A, Matthes
MT, Kay MA, LaVail MM. Correction of the retinal dystrophy phenotype of the RCS rat by viral gene transfer of Mertk. 
Proc Natl Acad Sci U S A. 2001; 98(22):12584-12589.
Von Ruckmann A, Fitzke FW, Bird AC. Distribution of fundus autofl uorescence with a scanning laser ophthalmo-
scope. Br J Ophthalmol. 1995; 79(5):407-412.
Von Ruckmann A, Fitzke FW, Bird AC. Distribution of pigment epithelium autofl uorescence in retinal disease state 
recorded in vivo and its change over time. Graefes Arch Clin Exp Ophthalmol. 1999; 237(1):1-9.
Von Ruckmann A, Fitzke FW, Bird AC. In vivo fundus autofl uorescence in macular dystrophies. Arch Ophthalmol. 
1997; 115(5):609-615.
Wada Y, Tada A, Itabashi T, Kawamura M, Sato H, Tamai M. Screening for mutations in the IMPDH1 gene in 
Japanese patients with autosomal dominant retinitis pigmentosa. Am J Ophthalmol. 2005; 140(1):163-165.
Waardenburg PJ (1961) Congenital and early infantile retinal dysfunction (high-graded) amblyopia and amaurosis 
Leber. In: Waardenburg PJ, Franceschetti A, Klein D (eds) Genetics and ophthalmology. 1st ed. Blackwell 
Scientifi c, Oxford, pp 1567–1581.
Sharola BW.indd   121 29-May-07   10:45:49 AM
122
Wagner RS, Caputo AR, Nelson LB, Zanoni D. High hyperopia in Leber’s congenital amaurosis. Arch Ophthalmol. 
1985; 103(10):1507-1509.
Wallace AJ. SSCP/heteroduplex analysis. Methods Mol Biol. 2002; 187:151-163.
Wallace AJ. Mutation scanning for the clinical laboratory: automated fl uorescent sequencing. Methods Mol Med. 
2004; 92:81-114.
Wanders RJ, Tager JM. Lipid metabolism in peroxisomes in relation to human disease. Mol Aspects Med. 1998; 
19(2):69-154.
Wang WP, Ni KY, Zhou GH. Multiplex single nucleotide polymorphism genotyping by adapter ligation-mediated 
allele-specifi c amplifi cation. Anal Biochem. 2006; 355(2):240-248.
Weber JL, May PE. Abundant class of human DNA polymorphisms which can be typed using the polymerase chain 
reaction. Am J Hum Genet. 1989; 44(3):388-396.
Weiland JD, Liu W, Humayun MS. Retinal Prothesis. Annu Rev Biomed Eng. 2005;7:361-401.
Weiss AH, Biersdorf WR. Visual sensory disorders in congenital nystagmus. Ophthalmology. 1989; 96(4):517-523.
Weisz JM, Humayun MS, De Juan E Jr, Del Cerro M, Sunness JS, Dagnelie G, Soylu M, Rizzo L, Nussenblatt 
RB. Allogenic fetal retinal pigment epithelial cell transplant in a patient with geographic atrophy. Retina 1999; 
19(6):540-545.
Wells J, Wroblewski J, Keen J, Inglehearn C, Jubb C, Eckstein A, Jay M, Arden G, Bhattacharya S, Fitzke F, et al. 
Mutations in the human retinal degeneration slow (RDS) gene can cause either retinitis pigmentosa or macular 
dystrophy. Nat Genet. 1993; 3(3):213-218.
Whiteley SJ, Litchfi eld TM, Coffey PJ, Lund RD. Improvement of the pupillary light refl ex of Royal College of Surgeons 
rats following RPE cell grafts. Exp Neurol. 1996; 140(1):100-104.
Wingender E, Chen X, Fricke E, Geffers R, Hehl R, Liebich I, Krull M, Matys V, Michael H, Ohnhauser R, Pruss M, 
Schacherer F, Thiele S, Urbach S. The TRANSFAC system on gene expression regulation. Nucleic Acids Res. 
2001; 29(1):281-283.
Winston A, Rando RR. Regulation of isomerohydrolase activity in the visual cycle.
Biochemistry. 1998; 37(7):2044-2050.
Wodarz A, Grawe F, Knust E. CRUMBS is involved in the control of apical protein targeting during Drosophila 
epithelial development. Mech Dev. 1993; 44(2-3):175-187.
Wong P. Apoptosis, retinitis pigmentosa, and degeneration. Biochem Cell Biol. 1994; 72(11-12):489-498.
Woodruff ML, Wang Z, Chung HY, Redmond TM, Fain GL, Lem J. Spontaneous activity of opsin apoprotein is a 
cause of Leber congenital amaurosis. Nat Genet. 2003; 35(2):158-164.
Wrigstad A, Narfstrom K, Nilsson SE. Slowly progressive changes of the retina and retinal pigment epithelium in 
Briard dogs with hereditary retinal dystrophy. A morphological study. Doc Ophthalmol. 1994; 87(4):337-354.
Wrigstad A, Nilsson SE, Narfstrom K. Ultrastructural changes of the retina and the retinal pigment epithelium in Briard 
dogs with hereditary congenital night blindness and partial day blindness. Exp Eye Res. 1992; 55(6):805-818.
Xue L, Gollapalli DR, Maiti P, Jahng WJ, Rando RR. A palmitoylation switch mechanism in the regulation of the visual 
cycle. Cell. 2004; 117(6):761-771.
Yagi T, Hayashida Y. [Implantation of the artifi cial retina] Nippon Rinsho. 1999; 57(5):1208-1215.
Yamazaki H, Ohguro H, Maeda T, Maruyama I, Takano Y, Metoki T, Nakazawa M, Sawada H, Dezawa M. Preserva-
tion of retinal morphology and functions in royal college surgeons rat by nilvadipine, a Ca(2+) antagonist. Invest 
Ophthalmol Vis Sci. 2002; 43(4):919-926.
Yanai D, Lakhanpal RR, Weiland JD, Mahadevappa M, Van Boemel G, Fujii GY, Greenberg R, Caffey S, de Juan E Jr, 
Humayun MS. The value of preoperative tests in the selection of blind patients for a permanent microelectronic 
implant. Trans Am Ophthalmol Soc. 2003; 101:223-8; discussion 228-230.
Yang RB, Garbers DL. Two eye guanylyl cyclases are expressed in the same photoreceptor cells and form homom-
ers in preference to heteromers. J Biol Chem. 1997; 272(21):13738-13742.
Yang RB, Robinson SW, Xiong WH, Yau KW, Birch DG, Garbers DL. Disruption of a retinal guanylyl cyclase gene 
leads to cone-specifi c dystrophy and paradoxical rod behavior. J Neurosci. 1999; 19(14):5889-5897.
Yau KW. Phototransduction mechanism in retinal rods and cones. The Friedenwald Lecture. Invest Ophthalmol Vis 
Sci. 1994; 35(1):9-32.
Young RW. Cell differentiation in the retina of the mouse. Anat Rec. 1985; 212(2):199-205.
Young RW. Passage of newly formed protein through the connecting cilium of retina rods in the frog. J Ultrastruct 
Res. 1968; 23(5):462-473.
Young RW, Droz B. The renewal of protein in retinal rods and cones. J Cell Biol. 1968; 39(1):169-184.
Sharola BW.indd   122 29-May-07   10:45:49 AM
Leber congenital amaurosis 123
Yzer S, van den Born LI, Schuil J, Kroes HY, van Genderen MM, Boonstra FN, van den Helm B, Brunner HG, 
Koenekoop RK, Cremers FP. A Tyr368His RPE65 founder mutation is associated with variable expression and 
progression of early onset retinal dystrophy in 10 families of a genetically isolated population. J Med Genet. 
2003; 40(9):709-713.
Yzer S, Leroy BP, De Baere E, de Ravel TJ, Zonneveld MN, Voesenek K, Kellner U, Ciriano JP, de Faber JT, Rohrsch-
neider K, Roepman R, den Hollander AI, Cruysberg JR, Meire F, Casteels I, van Moll-Ramirez NG, Allikmets R, 
van den Born LI, Cremers FP. Microarray-based mutation detection and phenotypic characterization of patients 
with Leber congenital amaurosis. Invest Ophthalmol Vis Sci. 2006; 47(3):1167-1176.
Zernant J, Kulm M, Dharmaraj S, den Hollander AI, Perrault I, Preising MN, Lorenz B, Kaplan J, Cremers FP, 
Maumenee I, Koenekoop RK, Allikmets R. Genotyping microarray (disease chip) for Leber congenital amaurosis: 
detection of modifi er alleles. Invest Ophthalmol Vis Sci. 2005; 46(9):3052-3059.
Zhao, M., Momma, S., Delfani, K., Carlen, M., Cassidy, R.M., Johansson, C.B., Brismar, H., Shupliakiov, O., Frisen, 
J., Janson, A.M. Evidence for neurogenesis in the adult mammalian substantia nigra.Proc Natl Acad Sci U S A, 
2003; 100, 7925–7930.
Zhao Y, Hong DH, Pawlyk B, Yue G, Adamian M, Grynberg M, Godzik A, Li T. The retinitis pigmentosa GTPase 
regulator (RPGR)- interacting protein: subserving RPGR function and participating in disk morphogenesis. Proc 
Natl Acad Sci U S A. 2003; 100(7):3965-3970.
Zhu DP, Antonarakis SE, Schmeckpeper BJ, Diergaarde PJ, Greb AE, Maumenee IH.
Microdeletion in the X-chromosome and prenatal diagnosis in a family with Norrie disease.
Am J Med Genet. 1989; 33(4):485-488.
Zrenner E, Gekeler F, Gabel VP, Graf HG, Graf M, Guenther E, Haemmerle H, Hoeffl inger B, Kobuch K, Kohler K, 
Nisch W, Sachs H, Schlosshauer B, Schubert M, Schwahn H, Stelzle M, Stett A, Troeger B, Weiss S. Subretinal 
microphotodiode array as replacement for degenerated photoreceptors? Ophthalmologe. 2001; 98(4):357-
363.
Zrenner E. The subretinal implant: can microphotodiode arrays replace degenerated retinal photoreceptors to 
restore vision. Ophthalmologica. 2002; 216 Suppl 1:8-20; discussion 52-53.
Web Sources and Bioinformatics URLs
Web address Site Uses
http://www.cephb.fr/cephdb/ Centre d’Etude du Polymor-
phisme Humain (CEPH)
Database of human polymorphisms
http://www.ciliaproteome.org/ Ciliary Proteome Database Database of ciliary proteome
www.epd.isb-sib.ch Eukaryotic promoter database 
(EPD)
Annotated eukaryotic initiation sites and 
promoter sequences (Perier et al 2000)
www.expasy.ch/prosite ProSite Protein domains and 
patterns
Biologically signifi cant patterns and 
profi les (Hofman K 1999)
http://www.ensembl.org Ensembl genome browser Genome browser with information about 
markers and genes
http://gai.nci.nih.gov/CHLC Cooperative Human Linkage 
Center
Database of polymorphic markers and 
genetic maps
http://www.genethon.fr/php/index.php Genethon Database of polymorphic markers and 
genetic maps.
http://genome.ucsc.edu University of Southern 
California Genome Browser
Includes chromosomal location, genes, 
ESTs,reference sequences with extensive 
links to other sites
www.genome.wi.mit.edu Whitehead Genome Institute 
(Massachussetts Institute of 
Technology)
Primer design (Primer 3 software)
Sharola BW.indd   123 29-May-07   10:45:49 AM
http://www.ncbi.nlm.nih.gov/Genbank/ National Center for 
Biotechnology Information 
(NCBI) and the interna-
tional nucleotide sequence 
database collaboration
Database of genetic sequences.
http://research.marshfi eldclinic.org/
genetics/
Center for Medical Genetics, 
Marshfi eld, Wisconsin, USA
Database of genomic markers
http://www.nhgri.nih.gov National Human Genome 
Research Institute (NHGRI)
Detailed chromosome-specifi c physical 
maps and links to other sites
http://www.ncbi.nlm.nih.gov/ National Center for 
Biotechnology Information 
(NCBI)
DNA sequence repository for cloned 
genes, genomic sequence and ESTs
http://www.ncbi.nlm.nih.gov/genome/
sts/epcr.cgi
National Center for 
Biotechnology Information 
(NCBI) genomic information
e-PCR
http://www.ncbi.nlm.nih.gov/omim/ Online Mendelian Inheritance 
in Man, OMIM (McKusick-
Nathans Institute for Genetic 
Medicine, Johns Hopkins 
University, Baltimore, MD 
and National Center for 
Biotechnology Information, 
National Library of Medicine 
Bethesda, MD, USA
Database of human genetic disorders 
inclusive of clinical information, genetic 
data and molecular characterization of 
known disease genes.
http://www.ncbi.nlm.nih.gov/Pubmed National Center for 
Biotechnology Information, 
National Library of Medicine 
Bethesda, MD, USA
Medical publications and abstracts
www.ncbi.nlm.nih.gov/SNP Single Nucleotide Polymor-
phism database of National 
Center for Biotechnology 
Information
SNP datababe
http://www.pdg.cnb.uam.es/UniPub/
iHOP/
Information hyperlinked over 
proteins (iHOP)
Gene network for navigating literature
http://www.retina-international.com/
sci-news/gcmut.htm
Mutation Database of Retina 
International (Curated by 
Markus Preising)
Mutation Database of specifi c retinal 
genes and protein alterations
http://www.sanger.ac.uk http://www.sanger.ac.uk 
Sanger Center for sequencing
Large scale sequencing center for 
chromosome 6 as well as other 
chromosomes
http://www.sph.uth.tmc.edu/RetNet RetNet (Curated by Stephen 
Daiger)
Database of retinal disease loci and 
genes
www.transfac.gdb.de/transfac Transcription factor database 
of the genome database
Database of transcription sites 
Wingender et al 2000
http://www.wi.mit.edu/home.html Whitehead Genome Institute 
(Massachussetts Institute of 
Technology)
Physical contig maps of all human 
chromosomes
http://webhost.ua.ac.be/hhh/ Hereditary hearing loss 
database
Overview of the genetics of hearing loss 
Sharola BW.indd   124 29-May-07   10:45:49 AM
3A novel locus for Leber congenital 
amaurosis maps to chromosome 6q
Am J Hum Genet. 2000, 66(1):319-26
Sharola BW.indd   125 29-May-07   10:45:49 AM
Sharola BW.indd   126 29-May-07   10:45:49 AM
A novel locus for Leber congenital amaurosis maps to chromosome 6q 127
Rich AM, BrockWA, Pena A (1988) Spectrum of genitourinary
malformations in patients with imperforate anus. Pediatr
Surg Int 3:110–113
Ross AJ, Ruiz-Perez V, Wang Y, Hagan D-M, Scherer S, Lynch
SA, Lindsay S, et al (1998) A homeobox gene, HLXB9, is
the major locus for dominantly inherited sacral agenesis.Nat
Genet 20:358–361
Seri M, Martucciello G, Paleari L, Bolino A, Priolo M, Salemi
G, Caroli F, et al (1999) Exclusion of the Sonic Hedgehog
gene as responsible for Currarino syndrome and anorectal
malformations with sacral hypodevelopment. Hum Genet
104:108–110
∗ Present affiliation: Department of Experimental Oncology, Institute of On-
cology, Milan.
Address for correspondence and reprints: Dr. Steve Scherer, Department of
Genetics, Room 9107, The Hospital for Sick Children, 555 University Avenue,
Toronto, Ontario M5G 1X8, Canada. E-mail: steve@genet.sickkids.on.ca
� 2000 by The American Society of Human Genetics. All rights reserved.
0002-9297/2000/6601-0032$02.00
Am. J. Hum. Genet. 66:319–326, 2000
A Novel Locus for Leber Congenital Amaurosis Maps
to Chromosome 6q
To the Editor:
Leber congenital amaurosis (LCA) (MIM 204000/
204100) is a clinically and genetically heterogeneous ret-
inal disorder that occurs in infancy and is accompanied
by profound visual loss, nystagmus, poor pupillary re-
flexes, and either a normal retina or varying degrees of
atrophy and pigmentary changes (Leber 1869, 1871;
Franc¸ois 1968). The electroretinogram (ERG) is extin-
guished or severely reduced (Franceschetti 1954). LCA
is largely a recessive disease, although autosomal dom-
inant pedigrees have been identified (Sorsby et al. 1960;
Heckenlively 1988). To date, three genes for LCA have
been identified and sequenced: retinal guanylate cyclase
(GUCY2D) on chromosome 17p13; retinal pigment ep-
ithelium protein (RPE65) on chromosome 1p31; and
cone-rod homeobox (CRX) on chromosome 19q13.3.
One additional locus has been identified on chromosome
14q24 (Stockton et al. 1998). We show evidence for
linkage to chromosome 6q11-16 in a multigenerational
kindred of Old Order River Brethren. The disease gene
maps to a 23-cM interval flanked by DNA polymorphic
markers D6S1551 and D6S1694, with a maximum two-
point LOD score of 3.38 (recombination fraction [v]
zero) at D6S391. Two candidate genes on chromosome
6 were screened for mutations: gamma aminobutyric
acid rho1 and rho2 (GABRR1 and GABRR2) at 6q14-
21 (Cutting et al. 1992), and interphotoreceptor matrix
proteoglycan (IMPG1) at 6q13-15 (Gehrig et al. 1998).
The incidence of LCA is 3 in 100,000 persons and
accounts for �5% of all inherited retinal dystrophies
(Perrault et al. 1996). Clinical and genetic heterogeneity
have been demonstrated (Wardenburg 1961; Camuzat
et al. 1996). The phenotype has been associated with
familial juvenile nephronophthisis and cone-shaped
epiphyses (Saldino-Mainzer syndrome) and with kidney
disease (Senior-Loken syndrome), osteoporosis, meta-
bolic diseases, and neurological abnormalities (Loken et
al. 1961; Senior et al. 1961; Dekaban 1969; Mainzer et
al. 1970; Ellis et al. 1984).
The first locus for LCA was mapped to 17p13 with
the use of homozygosity mapping in consanguineous
families of North African descent (Camuzat et al. 1996).
Mutations in the retina-specific guanylate cyclase gene
(RETGC 1), on chromosome 17p13, involved in pho-
totransduction, were subsequently identified (Perrault et
al. 1996). Mutations in RPE65 on chromosome 1p31,
specific to the retinal pigment epithelium involved in
retinoid metabolism, were reported in patients with
LCA, thus establishing a second gene (LCA2) for this
heterogeneous disease (Marlhens et al. 1997). The pho-
toreceptor-specific homeobox gene CRX, on chromo-
some 19q13.3, has been implicated as the third gene,
since mutations were demonstrated (Freund et al. 1998).
A novel locus on chromosome 14q24 (LCA3) was iden-
tified in consanguineous Saudi Arabian families (Stock-
ton et al. 1998).
We studied a consanguineous family belonging to the
Old Order River Brethren, a religious isolate originating
in eastern Pennsylvania. The Old Order River Brethren
descended from the Swiss, who emigrated to America in
the 1750s in pursuit of religious freedom (Breckvill
1972). The kindred includes three affected individuals
in two related sibships (fig. 1) who were initially eval-
uated at the Johns Hopkins Center for Hereditary Eye
Diseases (JHCHED) and who are being followed an-
nually. The patients presented with visual acuities in the
order of 20/100–20/400, nystagmus, high hypermetro-
pia, poor pupillary reflexes, and normal fundi. Progres-
sive hypermetropia and increasing peripheral retinal
mottling, of varying degree, were noted. The ERG was
abolished. Review of other systems was unremarkable.
We report a novel locus for LCA (LCA5) in this pedigree,
on chromosome 6q11-16, by linkage analysis and ho-
mozygosity mapping.
Venous blood samples were obtained from 27 family
members of the Old Order River Brethren community
and a cheek brush sample was obtained from an infant
(individual 29). Consents were obtained in accordance
with regulations of the Johns Hopkins Medical Insti-
tutions’ Joint Committee on Clinical Investigation.DNA
was isolated from whole blood by means of the QIAamp
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A Novel Locus for Leber Congenital Amaurosis Maps
to Chromosome 6q
To the Editor:
Leber congenital amaurosis (LCA) (MIM 204000/
204100) is a clinically and genetically heterogeneous ret-
inal disorder that occurs in infancy and is accompanied
by profound visual loss, nystagmus, poor pupillary re-
flexes, and either a normal retina or varying degrees of
atrophy and pigmentary changes (Leber 1869, 1871;
Franc¸ois 1968). The electroretinogram (ERG) is extin-
guished or severely reduced (Franceschetti 1954). LCA
is largely a recessive disease, although autosomal dom-
inant pedigrees have been identified (Sorsby et al. 1960;
Heckenlively 1988). To date, three genes for LCA have
been identified and sequenced: retinal guanylate cyclase
(GUCY2D) on chromosome 17p13; retinal pigment ep-
ithelium protein (RPE65) on chromosome 1p31; and
cone-rod homeobox (CRX) on chromosome 19q13.3.
One additional locus has been identified on chromosome
14q24 (Stockton et al. 1998). We show evidence for
linkage to chromosome 6q11-16 in a multigenerational
kindred of Old Order River Brethren. The disease gene
maps to a 23-cM interval flanked by DNA polymorphic
markers D6S1551 and D6S1694, with a maximum two-
point LOD score of 3.38 (recombination fraction [v]
zero) at D6S391. Two candidate genes on chromosome
6 were screened for mutations: gamma aminobutyric
acid rho1 and rho2 (GABRR1 and GABRR2) at 6q14-
21 (Cutting et al. 1992), and interphotoreceptor matrix
proteoglycan (IMPG1) at 6q13-15 (Gehrig et al. 1998).
The incidence of LCA is 3 in 100,000 persons and
accounts for �5% of all inherited retinal dystrophies
(Perrault et al. 1996). Clinical and genetic heterogeneity
have been demonstrated (Wardenburg 1961; Camuzat
et al. 1996). The phenotype has been associated with
familial juvenile nephronophthisis and cone-shaped
epiphyses (Saldino-Mainzer syndrome) and with kidney
disease (Senior-Loken syndrome), osteoporosis, meta-
bolic diseases, and neurological abnormalities (Loken et
al. 1961; Senior et al. 1961; Dekaban 1969; Mainzer et
al. 1970; Ellis et al. 1984).
The first locus for LCA was mapped to 17p13 with
the use of homozygosity mapping in consanguineous
families of North African descent (Camuzat et al. 1996).
Mutations in the retina-specific guanylate cyclase gene
(RETGC 1), on chromosome 17p13, involved in pho-
totransduction, were subsequently identified (Perrault et
al. 1996). Mutations in RPE65 on chromosome 1p31,
specific to the retinal pigment epithelium involved in
retinoid metabolism, were reported in patients with
LCA, thus establishing a second gene (LCA2) for this
heterogeneous disease (Marlhens et al. 1997). The pho-
toreceptor-specific homeobox gene CRX, on chromo-
some 19q13.3, has been implicated as the third gene,
since mutations were demonstrated (Freund et al. 1998).
A novel locus on chromosome 14q24 (LCA3) was iden-
tified in consanguineous Saudi Arabian families (Stock-
ton et al. 1998).
We studied a consanguineous family belonging to the
Old Order River Brethren, a religious isolate originating
in eastern Pennsylvania. The Old Order River Brethren
descended from the Swiss, who emigrated to America in
the 1750s in pursuit of religious freedom (Breckvill
1972). The kindred includes three affected individuals
in two related sibships (fig. 1) who were initially eval-
uated at the Johns Hopkins Center for Hereditary Eye
Diseases (JHCHED) and who are being followed an-
nually. The patients presented with visual acuities in the
order of 20/100–20/400, nystagmus, high hypermetro-
pia, poor pupillary reflexes, and normal fundi. Progres-
sive hypermetropia and increasing peripheral retinal
mottling, of varying degree, were noted. The ERG was
abolished. Review of other systems was unremarkable.
We report a novel locus for LCA (LCA5) in this pedigree,
on chromosome 6q11-16, by linkage analysis and ho-
mozygosity mapping.
Venous blood samples were obtained from 27 family
members of the Old Order River Brethren community
and a cheek brush sample was obtained from an infant
(individual 29). Consents were obtained in accordance
with regulations of the Johns Hopkins Medical Insti-
tutions’ Joint Committee on Clinical Investigation.DNA
was isolated from whole blood by means of the QIAamp
Blood Kit (Qiagen), according to the manufacturer’s in-
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structions. The alkali method was used to obtain DNA
from the single cheek sample.
Initially, the affected members and their first-degree
relatives were screened to exclude linkage to the regions
of the previously described genes involved in LCA on
chromosomes 1, 17, and 19. The screen was then ex-
tended, by use of the whole-genome 8A multiplex ver-
sion of markers spaced at 20 cM (Research Genetics).
A region of homozygosity was identified on chromosome
6q. Further analysis, with additional markers in all po-
tentially significant family members, was undertaken.
Marker information was obtained from the Genome
Database.
PCR-based genotyping, with fluorescent labeled
markers, was performed by means of the Applied Bios-
ystems 373 automated DNA sequencer. PCR reactions
were performed in a 9600 Perkin Elmer thermocycler,
and the PCR products were checked for amplification
with a 3% agarose gel (Saiki et al. 1988).
The amplified PCR product was genotyped by means
of the automated DNA sequencer. GENESCAN ANAL-
YSIS 2.0.0 and GENOTYPER version 1.1 software were
used, to size the PCR products and to analyze the data.
Allele sizes were scored by two independent observers.
Two-point linkage analysis was performed by use of
the MLINK option of the FASTLINK program, version
5.1 (Lathrop et al. 1984; Cottingham et al. 1993.) In
this pedigree, LCA was analyzed as an autosomal re-
cessive trait with complete penetrance, with an assumed
allele frequency of .0032. A total of 40 microsatellite
markers (Research Genetics) on chromosome 6 were an-
alyzed, to determine the minimum region containing the
new gene (Lander and Botstein 1987). Marker allele fre-
quencies were estimated by means of the Genetic Anal-
ysis System, version 2.0 (Young), and GCONVERT
(Duffy). The final LOD scores were computed by means
of the allele frequencies generated by the GCONVERT
program. Recombination frequencies for males and fe-
males were assumed to be equal. All inbreeding loops
in the family were disconnected for computational rea-
sons (Ott 1991) (fig. 1).
The GENEHUNTER program was used to perform
multipoint linkage analysis against a fixed map of 17
informative markers, with an assumed equilibrium be-
tween marker and test loci (Kruglyak et al. 1996). These
markers were selected from the original 40microsatellite
markers because they were highly polymorphic and their
relative orders and map distances were well estimated
in public databases. The comprehensive genetic map of
the Center for Medical Genetics,MarshfieldMedical Re-
search Foundation, provided the sex-averaged genetic
distances for the markers noted in figure 1. The same
map provided the order for 37 markers. The remaining
three markers were placed by means of the Genome
Location Database. Subsequently, the genetic framework
map from the Center for Medical Genetics, Marshfield
Medical Research Foundation, reduced the 37 markers
to 23, indicating that some markers occurred at identical
positions. Thus, in the analyses in which multiple mark-
ers had identical positions, the markers with reduced
information content were dropped in favor of those with
better information content.
Multipoint LOD scores were computed with the same
model described above for two-point analysis. Multi-
point nonparametric linkage (NPL) scores were also
computed with the use of only the affected individuals.
Because of the inherent limitation on pedigree size in the
GENEHUNTER program, the large pedigree was
trimmed and broken into two separate units, accounting
for some potential loss of power in the analysis. The
data were examined for regions of allelic homozygosity
in the affected individuals (Dib et al. 1996). Haplotype
analysis was used to further define the interval contain-
ing the disease locus (Lathrop et al. 1985).
The following retina-specific genes on chromosome 6
were evaluated for the presence of disease-causing mu-
tations: the GABRR1 and GABRR2 genes on chro-
mosome 6q14.1-21 (Cutting et al. 1991, 1992) and the
IMPG1 gene on chromosome 6q13-15 (Gehrig et al.
1998) (fig. 2).
GABRR1 and GABRR2 are assumed to have arisen
by gene duplication and share a 50% homology with
each other. GABA is a neuroinhibitory transmitter me-
diating fast synaptic inhibition by activating chloride
channels. GABRR1 is expressed largely in the retina;
GABRR2 is expressed primarily in the brain. GABRR1
expression in the developing retina suggests its possible
role as a candidate gene. In exons 1 and 4, polymorphic
changes were identified. This did not change in the
amino acid. These polymorphic changes were also iden-
tified in the normal population. No sequence changes
were noted in GABRR2.
IMPG1, a novel gene encoding a major proteoglycan
of the interphotoreceptor matrix, is expressed in the ret-
ina by both rods and cones and maps to 6q13-15; it was
considered a further candidate gene for LCA (Gehrig et
al. 1998). No significant changes were noted after the
17 coding exons of this gene were sequenced.
Linkage of LCA in the Old Order River Brethren was
found at chromosome 6q11-16, supported by statisti-
cally significant two-point LOD scores with maximum
LOD score (Zmax) 3.38 ( ) at D6S391 (table 1). Hap-v = 0
lotype analysis of recombination events localizes the dis-
ease locus to a region of 23 cM, flanked by D6S1551
and D6S1694, thus identifying a new locus for LCA.
Critical recombinant events were observed at marker
D6S1551 in individual 29, who is unaffected, and at
marker D6S1694 in individual 24, who is affected, de-
fining the centromeric and telomeric boundaries, re-
spectively. A common haplotype covers the region in all
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Figure 2 Results of multipoint LOD score analysis using the GENEHUNTER program. The centromere is located toward the left of the
graph. Maximum LOD scores were obtained between markers D6S391 and D6S450.
the affected individuals (fig. 1). Homozygosity of other
highly informative markers across the candidate region
was noted.
The maximum multipoint LOD score was 3.10 be-
tween D6S391 and D6S450, a 9.5-cM interval (fig. 2).
The multipoint NPL score was significant, with P !
for a 23-cM region. Sequencing of candidate genes.004
GABRR1 and GABRR2 and IMPG1 revealed poly-
morphic changes only.
LCA in the Old Order River Brethren, a highly inbred
community, maps to a 23-cM interval on chromosome
6q11-16, as defined by linkage analysis and homozy-
gosity mapping. Since this population is genetically iso-
lated, and since LCA is quite rare, we presume that a
single common ancestor was a carrier for this recessive
trait (Lander and Botstein 1987). The large size of the
region of homozygosity in the family and the history of
migration indicate the recency of the mutation in the
population (fig. 1).
LCA in this pedigree was not associated with multi-
system abnormalities. Renal function remains normal.
Neurological and hepatic function were within normal
limits. The patients are of normal stature and intelli-
gence. Neither photophobia nor photoattraction was re-
ported in infancy, although pressing on the globes (the
digito-ocular phenomenon of Franceschetti-Bamatter)
played a prominent part in childhood behavior (Fran-
ceschetti 1954). Visual dysfunction, nystagmus, and the
digito-ocular phenomenon were noticed in early infancy.
A high hyperopic refractive correction was noted in all
the patients (Wagner et al. 1985). Ophthalmoscopic ex-
amination in infancy revealed normal fundi, but in child-
hood, attenuated retinal vasculature with a varying de-
gree of pigmentary changes was noticed. Electroret-
inography showed a markedly reduced response in the
affected individuals. Vision has been stable in all affected
members of the family who have been followed clinically
at JHCHED.
Genetic studies have identified a large region on chro-
mosome 6q responsible for several retinal dystrophies
(Small et al. 1992, 1993, 1997; Stone et al. 1994; Kelsell
et al. 1995, 1998; Sauer et al. 1997; Griesinger et al.
1998; Rabb et al. 1998; Ruiz et al. 1998). LCA5 lies in
the overlapping region of autosomal recessive RP at
6cen-q16 (Ruiz et al. 1998), progressive bifocal cho-
rioretinal dystrophy (PBCRA) at 6q12-21 (Kelsell et al.
1995), North Carolina macular dystrophy at 6q14-16.2
(Small et al. 1993), Stargardt-like dominant macular de-
generation (STGD3) at 6q13 (Stone et al. 1994; Grie-
singer et al. 1998), and dominant cone-rod dystrophy
(CORD7) at 6q13-15 (Kelsell et al. 1998) (fig. 3). The
occurrence of multiple loci so closely spaced in the ge-
nome could indicate the presence of a number of retinal
genes in continuum, since the phenotype of all these
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Figure 3 Chromosome 6 ideogram, showing the location of can-
didate genes screened and retinal disease loci in the region.
Table 1
Two-Point LOD Scores for Linkage between LCA and Chromosome 6 Markers
LOD SCORE AT v =
ORDER .00 .01 .50 .10 .20 .30 .40 vmax Zmax
D6S257 1.33 .17 .67 .92 .93 .71 .39 .145 .97
D6S1628 1.24 1.00 1.49 1.52 1.29 .93 .49 .084 1.53
D6S1658 1.23 .63 .15 .04 .19 .18 .11 .239 .20
D6S430 1.17 1.41 1.85 1.82 1.46 1.00 .51 .066 1.86
D6S1551 1.32 .27 .82 .94 .88 .67 .37 .117 .95
D6S1619 1.20 1.17 1.03 .87 .59 .36 .17 .001 1.20
D6S1596 1.23 1.20 1.10 .96 .71 .47 .23 .001 1.23
D6S391 3.38 3.30 3.00 2.62 1.87 1.16 .55 .001 3.38
D6S1707 3.15 3.07 2.76 2.37 1.63 .98 .47 .001 3.15
D6S251 3.22 3.14 2.83 2.45 1.71 1.06 .50 .001 3.22
D6S445 2.97 2.89 2.59 2.23 1.56 .98 .48 .001 2.97
D6S1627 2.33 2.28 2.07 1.82 1.33 .87 .43 .001 2.33
D6S1644 2.20 2.15 1.93 1.66 1.17 .74 .35 .001 2.20
D6S1631 2.70 2.63 2.38 2.07 1.47 .93 .45 .001 2.70
D6S450 2.28 2.23 2.01 1.74 1.24 .79 .38 .001 2.28
D6S1056 1.47 1.42 1.22 1.02 .70 .46 .23 .001 1.47
D6S300 1.24 1.33 1.43 1.36 1.07 .71 .35 .050 1.43
D6S1716 .08 .10 .13 .14 .13 .11 .08 .090 .14
D6S1694 .40 .31 .14 .07 .07 .07 .04 .848 .19
D6S1717 .73 .74 .77 .77 .65 .43 .20 .827 .39
D6S261 1.18 .60 .10 .10 .23 .21 .13 .231 .23
retinal dystrophies, their ophthalmologic appearance,
age at onset, and the extent and pattern of visual loss
are varied. On the other hand, like the ABCR gene mu-
tations that cause autosomal recessive retinitis pigmen-
tosa (Martinez-Mir et al. 1997, 1998), juvenile and late-
onset fundus flavimaculatus (Allikmets et al. 1997a),
cone-rod dystrophy (Cremers et al. 1998), age-related
macular disease, and recessive Stargardt disease (Kaplan
et al. 1993; Gerber et al. 1995, 1998; Allikmets et al.
1997b), leading to distinct phenotypes (Lewis et al.
1999), it is possible that a single large gene in the prox-
imal centromeric portion of the long arm of chromosome
6 could cause a myriad of retinal dystrophies, LCA being
the most severe.
Perhaps LCA5 is allelic with STGD3, RP25, CORD7,
MCDR, and PBCRA. It is conceivable that mutations
in different sites cause different structural alterations in
the predicted protein, predisposing to varying pheno-
types (Rozet et al. 1998).
The three other genes causing LCA are known to cause
other phenotypically varied retinal dystrophies as well,
raising the possibility of a similar situation in the LCA5
gene. GUCY2D mutations (LCA1) have been identified
in autosomal dominant cone-rod dystrophy (Kelsell et
al. 1998), although RPE65 (LCA2) mutations cause au-
tosomal recessive retinitis pigmentosa as well as LCA
(Morimura et al. 1998). Mutations in the cone-rod hom-
eobox gene are now known to cause autosomal domi-
nant cone-rod dystrophy, LCA, and late-onset dominant
retinitis pigmentosa (Sohocki et al. 1998). It is currently
possible to identify mutations of the known LCA genes
in less than one-third of the patients with LCA (Dhar-
maraj et al. 1999). The isolation of another locus for
this retinal disorder, LCA5, on chromosome 6q, will
account for an additional proportion of patients with
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an identifiable gene mutation. Recruitment of additional
families with LCA to further narrow the critical region
is under way, and candidate gene analysis continues.
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Abstract Leber congenital amaurosis (LCA, MIM 204001) is a clin-
ically and genetically heterogeneous retinal disorder characterized by
severe visual loss from birth, nystagmus, poor pupillary reflexes, reti-
nal pigmentary or atrophic changes, and a markedly diminished elec-
troretinogram (ERG). Purpose: To examine 100 consecutive patients
with LCA in order to assess the relative burden of the three known
genes involved in LCA, namely retinal guanylyl cyclase (GUCY2D),
retinal pigment epithelium protein (RPE65), and the cone-rod homeobox
(CRX), and to define their clinical correlates. Methods: Mutational
analysis and detailed clinical examinations were performed in patients
diagnosed with LCA at the Johns Hopkins Center for Hereditary Eye
Diseases and the Montreal Children’s Hospital. Results: Mutations were
identified in 11% of our patients: GUCY2D mutations accounted for
6%, while RPE65 and CRX gene mutations accounted for 3% and 2%,
respectively. The clinical presentation was variable; however, the visu-
al evolution in patients with mutations in GUCY2D and CRX remained
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stable, while individuals with mutations in the RPE65 gene showed
progressive visual loss. Conclusions: This study suggests that molecu-
lar diagnosis of Leber congenital amaurosis could provide important
information concerning prognosis and course of treatment.
Key words Leber congenital amaurosis; heterogeneity; mutations;
phenotype-genotype correlation
Introduction Leber congenital amaurosis is a heterogeneous in-
herited retinal disorder presenting in infancy with severe visual loss,
nystagmus, sluggish pupillary responses, variable ophthalmoscopic ap-
pearance, and an extinguished ERG.1,2 The retina may appear normal,
or varying degrees of pigmentary disturbance or atrophy may be evi-
dent.3,4 Additional ocular features may include high degrees of myopia
or hypermetropia, cataracts, and keratoconus.5,6 The diagnosis of LCA
is based on clinical evaluation and the absence or severe attenuation of
scotopic and photopic electroretinographic responses.2 Clinical and
genetic heterogeneity have been demonstrated.7-9
LCA has been associated with polycystic kidney disease (Senior-
Loken syndrome) and cone-shaped epiphyses (Saldino-Mainzer disease).
Osteopetrosis and neurodevelopmental abnormalities have also been
reported.10-15
Four causative genes and two additional loci have been identified to
date in patients with LCA.16-22 The presence of a fifth gene has been
speculated.23
Mutations were identified in the retinal guanylyl cyclase gene
(GUCY2D) LCA1 (OMIM #204000) or RETGC-1 involved in the pho-
totransduction cascade.16 Marlhens et al.17 reported mutations in the
RPE65 gene, the protein of which is essential in vitamin A metabolism
LCA2 (OMIM#204100). CRX, a cone rod homeobox gene encoding a
transcription factor was identified as the third gene causing LCA.18,19
LCA4, (OMIM#604393) AIPL1, (OMIM *604392) an aryl hydrocar-
bon protein-like gene expressed in photoreceptors and the pineal gland
has been implicated as the fourth gene.20 Mutations have been reported
in guanylate cyclase-activating protein GCAP3 involved in phototrans-
duction on chromosome 3q13.23 Additional loci have been mapped to
chromosome 14q24, LCA3 (OMIM *604232) and chromosome 6q11-
q16 LCA5, but no genes to date have been identified in these regions.21,22
Our study was undertaken to determine the relative burden of the
three initially identified genes in 100 consecutive probands diagnosed
with LCA and to correlate genotype with phenotype.
Patients and methods
patients Our 100 probands were diagnosed either at the Johns Hop-
kins Center for Hereditary Eye Diseases or at the Montreal Children’s
Hospital and are of worldwide distribution. Informed consent was ob-
tained in accordance with the Johns Hopkins Medical Institutions or
McGill University ethical protocols and venous blood was collected in
EDTA tubes. A complete history was elicited on all of the patients and
detailed physical and ocular examinations were performed. The diag-
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nostic criteria included severe visual loss since infancy, nystagmus,
poor pupillary responses, and abolished ERGs. The ERGs were per-
formed in accordance with the International Society for Clinical Elec-
trophysiology of Vision (ISCEV) criteria in most of the patients. Ref-
sum’s disease, peroxisomal disorders, abetalipoproteinemia, and Batten’s
disease were excluded.
methods DNA was extracted from peripheral blood leukocytes us-
ing the standard phenol-chloroform method.25 All patients were tested
for mutations in GUCY2D, RPE65, and CRX. One hundred normal
control chromosomes were analyzed for each of the genes.
GUCY2D PCR-SSCP analysis was undertaken to identify mutations.
SSCP variants were sequenced directly and mutations confirmed by
restriction digestion and compared to 100 normal controls.26 A total of
100 ng of genomic DNA was used in a 25 ªl reaction mixture contain-
ing 1.25 M of dCTP, dGTP, and dTTP, 6.25 M dATP, 0.60 U Taq
polymerase, and 35S dATP (12.5 mCi/ml NEN) as tracer. Sequences
and conditions for the primers of the 20 exons were obtained from
previously published data.16 Restriction enzyme analysis was undertak-
en using PCR products that were digested overnight with appropriate
enzymes, and were analyzed by gel electrophoresis. SSCP analysis was
performed.27 Two sets of conditions were used and fragments were
analyzed on a 6% acrylamide gel using 5% or 10% glycerol. SSCP
fragments with an aberrant migration pattern were sequenced directly
from the PCR product using 35S dATP (Sequence PCR Product Se-
quencing Kit, usb) and the amplifying primers.
RPE65 PCR-SSCP analysis was performed for the 14 exons of the
RPE65 gene. SSCP variants were sequenced manually and confirmed
using restriction enzyme digestion. A total of 80 ng genomic DNA was
used in a 25 ªl PCR reaction mixture along with 2.5 ªl 10X PCR buffer
(Perkin Elmer, NJ, USA), 0.5 ªl of 10 ªM forward and reverse primers,
2.5 ªM dNTPs, 1 ªl of 12.5 Ci 35S-dATP and 35SdCTP, and 0.5 ªl Taq
polymerase. Primer sequences were obtained from previously published
data.17 The products were checked for amplification using a 3% agarose
gel. SSCP was performed. Samples with aberrant migration patterns
were sequenced directly from amplified PCR products. The PCR
products were separated on a 1.6% low melting-point agarose gel; the
appropriate bands excised, treated with β-agarase, and subsequently
purified using phenol-chloroform. Direct sequencing of the purified
PCR product using the ThermoSequenase Radiolabeled Terminator
Cycle Sequencing Kit with 33P labeled dideoxy nucleotides (usb) ac-
cording to the manufacturer’s instructions was performed.
CRX Following PCR amplification, all three exons were either se-
quenced manually or automatically. A total of 200 ng DNA was used
in a standard 50 ªl PCR reaction mixture containing 5 ªl of 10X PCR
buffer (Perkin Elmer), 2.5 ªM dNTP, 0.25 ªl Taq polymerase, and 2
ªl each of forward and reverse primers. Annealing temperatures and
primer sequences were obtained from published data.19 Following PCR
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amplification, fragments were analyzed on an 8% PAGE gel with ethid-
ium bromide staining. Direct manual sequencing using the ThermoSe-
quenase Radiolabeled Terminator Cycle Sequencing Kit with 33P la-
beled dideoxy nucleotides (usb) were performed according to the
manufacturer’s instructions. Samples from 12 probands were sequenced
using the automated Perkin-Elmer ABI Systems Sequencer (Version
100).
Results
mutations
GUCY2D The observed mutations are as outlined in Table 1. Muta-
tions were identified in the GUCY2D gene in six patients. Only two of
the six mutations were homozygous. Patients harboring these mutations
presented with severe visual loss, but have remained stable. The ho-
mozygous 1 bp deletion in exon 1 at position +56 in the 5'UTR region
detected in an Afghani proband, the product of a consanguineous union,
segregated in the family. The same mutation was found in a heterozy-
gous state in an Egyptian proband.
The second homozygous mutation (patient #6) was also detected in
an Egyptian proband, the product of a consanguineous mating, and
involved the catalytic domain in exon 17, causing a 10 bp deletion
followed by a 4 bp insertion (Fig. 1). The mutant protein hinders retinal
guanylyl cyclase (RetGC) activity causing severe visual loss. This
nucleotide rearrangement results in the loss of conserved amino acids
His1019, Val1020, Asn1021, and Leu1022, with the insertion of valine
and threonine. No frameshift was created.
One compound heterozygote (patient #3) of non-consanguineous
Egyptian origin had mutations in exons 2 and 3 that code for the ex-
tracellular domains. Leu 325 is highly conserved and the change to
proline is likely to be significant since the secondary amino group
alters the folding of the extracellular tail of the enzyme in a hydropho-
bic environment.
Three heterozygous mutations in GUCY2D were identified. Despite
complete sequencing of the entire coding region, it has not been pos-
sible to identify the second mutation. Two of these mutations, P858S
and L954P, in the catalytic domain are missense mutations and occur
in highly conserved portions of the gene (Fig. 2). A proline to serine
Patient Exon Type Base Amino acid Domain
no. change change
1 1 Hom DelG (+56) 5'-UTR 5'-UTR
2 1 Het DelG 5'-UTR 5'-UTR
3 2 Het G387A Cys105Tyr Extracellular
3 Het T1047C Leu325Pro Extracellular
4 13 Het C2645T Pro858Ser Catalytic
5 15 Het T2934C Leu954Pro Catalytic
6 17 Hom 4 bp ins/10 bp del Catalytic
 table 1. GUCY2D mutations.
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Fig. 1. GUCY2D mutation from
patient #6. DNA sequence of part of
exon 17 showing insertion of 4 bp and
a deletion of 10 bp, resulting in the
loss of His1019, Val1020, Asn1021,
and Leu1022 and with the insertion of
valine and threonine.
Fig. 2. Pedigree and nucleotide
sequence from patient #5.
Heterozygous mutation L954P
detected in exon 15 of GUCY2D in the
proband and father.
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change alters the polarity considerably, while the substitution of pro-
line for leucine adds a secondary amino group causing an alteration in
binding. The heterozygous mutation in the 5’UTR segregates in the
family. Fifty percent of all probands had at least one identifiable poly-
morphism (Table 2).
RPE65 Three mutations were identified in the RPE65 gene. Two were
homozygous, while one was heterozygous (Table 3). The V19 2 bp
deletion in exon 2 was identified in a Syrian proband, the product of
a consanguineous union. This caused a frameshift leading to premature
truncation of the protein (Fig. 3).
E102STOP was identified in a Greek family of consanguineous mat-
ing. A homozygous nonsense mutation in exon 4 was detected in both
affected siblings, while the parents were heterozygous carriers.
A heterozygous mutation was detected in intron1-4. A G→A transi-
tion involving a splice site was observed in the product of a non-
consanguineous mating.
CRX The CRX mutations accounted for 2% of mutations in our study.28
Both were heterozygous frameshift mutations (Table 4). The L2371bp
deletion in exon 3 creates an alternate reading frame and eliminates the
original stop codon leading to elongation of the protein. The P9ins1bp
in exon 1 in a proband of multiple origin was also identified in one of
the parents who was clinically normal. The null allele causes a total
disruption of the predicted protein further downstream causing a lack
of the homeodomain, the WSP motif, and the OTX tail.
Sequence variants in two genes We report a special case wherein
sequence variants in more than one gene were identified. Sequence
variants in the kinase homology domain of GUCY2D were found in a
patient. This GUCY2D variation did not cosegregate both of the affected
probands in the family, but was detected only in the worse-affected
sibling in the pedigree. The Pro701Ser alteration in GUCY2D was not
identified in 100 controls. LCA5 on chromosome 6 has been implicated
as the second locus in both siblings.
Exon Base pair Amino acid Restriction Patient Domain
change change enzyme origin
4 G1192G Val373Val Egyptian Extracellular
4 C1309T Asp412Asp MboI created Egyptian
5 A(-28)G Intronic change DdeI destroyed Multiple Transmembrane
10 G2182A Ala703Ala BsrBI destroyed Multiple Kinase-like
12 T2418A Leu782His Multiple Kinase-like
13 G(+37)T Intronic change PvuII destroyed Multiple Catalytic
17 G(+32)T Intronic change MnlI destroyed Multiple Catalytic
19 C3355T Leu1094Leu BfaI created Catalytic
20 C3528T 3’UTR MspI created Multiple 3’UTR
8 A1790G Ile573Val Greek Kinase-like
10 C2174T Pro701Ser ScrFI destroyed Multiple Kinase-like
 table 2. GUCY2D sequence
variants.
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Patient no. Exon Mutation Type
7 4 E102X Nonsense
Homoz.
8 2 V19del12bp Frameshift
Homoz.
9 Int-4 G→A Splice
Heteroz.
 table 3. RPE65 mutations.
Patient no. Exon Mutation Type
10 1 P9ins1bp Heteroz.
11 3 L237del1bp Heteroz., de novo
Fig. 3. Homozygous RPE65 mutation
V19del2bp from patient #8 and
control. Partial nucleotide sequence of
exon 2 showing deletion of
nucleotides 57 and 58, as indicated by
the dot in the sequence of the control.
 table 4. CRX mutations.
Discussion
analysis of mutations Leber congenital amaurosis is the earliest
and most severe form of retinal dystrophy. This study presents a spec-
trum of mutations and their clinical correlates. All 11 reported muta-
tions are novel and several new polymorphisms were identified.
Perrault et al.16 identified mutations in GUCY2D in eight out of 15
families with LCA, while Camuzat et al.8 reported five mutations in 18
families. In our study of 100 probands, we identified six new mutations
in GUCY2D.
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Perrault et al.29 reported mutations in RPE65 in eight out of 15 fam-
ilies with LCA. Morimura et al.30 detected mutations in ~16% of cases
with the disorder. In comparison, we report mutations in the RPE65
gene in 3% of our probands.
Freund et al.18 identified two de-novo mutations in the CRX gene out
of 74 patients with LCA. Our study accounts for 2% of patients with
identifiable CRX mutations.
 Overall, Perrault et al.31 were able to account for mutations in 27%
of their patients with LCA, while Lewis et al.32 reported eight muta-
tions in 45 multiplex families.
We were able to demonstrate that GUCY2D mutations are distributed
worldwide and occur in diverse ethnic groups. RetGC1 is an important
component of the phototransduction cascade and was purified from rod
photoreceptors.33 GUCY2D maps to chromosome 17p13.1, and the pre-
dicted protein sequence has structural domains that are well conserved
and closely related to other membrane cyclases.34 The mutations iden-
tified predict changes in the highly conserved region: two missense
mutations, two each in exons that code for the extracellular and cata-
lytic domains, and one frameshift mutation located in the 5'UTR re-
gion. A high degree of mutational heterogeneity was observed. The ΔG
mutation observed in consanguineous Egyptian and Afghani pedigrees
could indicate identity by descent or represent a hot spot for recurring
mutations. Haplotype analysis, which we were unable to perform due
to lack of sufficient DNA samples from family members, is required to
provide more information. However, the frameshift induced would re-
sult in the predicted protein lacking the extracellular, transmembrane,
kinase-like, putative dimerization and catalytic domains causing a se-
vere loss of visual function related to constant low cGMP levels in the
photoreceptors.
Expression studies are underway to understand the role of these
mutations on wild-type RetGC activity, which is influenced by GCAP
in a calcium-sensitive manner.
The retinal pigment epithelium has been implicated in retinal devel-
opment.35 This has been validated since mutations in RPE65 are known
to cause LCA or early-onset recessive retinitis pigmentosa presenting
in early infancy.17,24,30 RPE65 is highly conserved throughout mamma-
lian evolution and is localized to human 1p31.36
The novel mutation in exon 2, V192bp, causes a frameshift following
the deletion of 2 bps. It is likely that the resulting allele expresses no
functional protein or one with significantly reduced function.
The nonsense mutation identified in the Greek family in exon 4,
E102 STOP, leads to a presumed null allele with no residual function
of the RPE-65 protein so essential for retinoid metabolism.
The G→A transition observed in intron 1 (-4) is likely to affect cor-
rect splicing of mRNA leading to grossly abnormal protein production.
The cone-rod homeobox gene, a transcription factor for several retinal
genes, is necessary for the development and maintenance of photore-
ceptor function.19,37 It plays a vital function in embryonic development
and cellular signaling. Mutant alleles of the CRX gene have been as-
sociated with Leber congenital amaurosis, autosomal dominant retinitis
pigmentosa, and dominant cone-rod dystrophy (CORD).18,38,39 Mutations
Sharola BW.indd   144 29-May-07   10:45:55 AM
Mutational analysis and clinical correlation in Leber congenital amaurosis 145
in the CRX gene have been detected in patients with dominant or spo-
radic LCA.39,18 CRX has also been implicated in both CORD and LCA
in the same family.40 A normal phenotype has been observed in the
proband’s father who along with the proband exhibits the same mutant
null allele.28 The P9ins1bp in exon 1 was identified in one parent and
the proband. The mutant protein in heterozygote state seems insuffi-
cient to cause disease. On the one hand, this could indicate the pres-
ence of a somatic mosaic in the father. On the other, it could be indic-
ative of a digenic model of two interacting mutant gene products in a
double heterozygote state. The possibility of adequate levels of func-
tional wild type protein in the proband’s father in comparison to the
proband could be speculated. The presence of a null mutation P9Ins1bp
in the face of a normal phenotype could be indicative of a leaky mu-
tation whereby enough active product is generated; however, the activ-
ity may be quantitatively or qualitatively different from the wild type.
The predicted protein lacks all of the conserved motifs with the pres-
ervation of only the initial nine amino acids followed by a frameshift.
The L237del1bp in exon 3 occurs de novo in a proband of mixed
ancestry, creating an alternate reading frame with the elimination of the
original stop codon. The predicted protein lacks the conserved OTX
tail and a portion of the carboxy terminus. The mutation was not iden-
tified in the parents or controls. The inactivation of one allele could
result in no transcription, leading to a mutant phenotype.41 Conversely,
this mutation could have a dominant negative effect whereby mutant
protein interferes with the action of the wild type protein. Both muta-
tions in the CRX gene were heterozygous in nature and cause frame-
shifts, resulting in gross truncation of the protein. The C→T transition
polymorphism in intron 1(+12 position) was observed in 10% of the
population.
genotype-phenotype correlation and biochemical features
Three genes whose protein products have markedly disparate retinal
functions have been implicated in the same disease, LCA. Clinical and
genetic variations are evident in this heterogeneous disorder and it is
now our challenge to compare the phenotype of patients with the three
different kinds of mutations and correlate it with the genotype.
In a recent comparison of disease outcomes in patients with GUCY2D
and RPE65 mutations, Perrault et al.29 found that patients harboring
mutations in GUCY2D complained of severe photophobia and present-
ed with profound visual loss, severe hyperopia, and a stable visual
course. In contrast, they noticed that patients with identifiable RPE65
mutations presented with a history of night blindness, moderate or no
hyperopia, visual acuities ranging from 20/100 to 20/200, and transient
visual improvement.29 These results are not, however, in complete ac-
cordance with the conclusions of our study, which includes all of the
known LCA genes to date and a larger cohort. The chief difference is
in the natural history since patients with identifiable RPE65 mutations
in our study did not noticeably develop better visual function over
time, unlike those from the recently reported study by Perrault et al.30
Nevertheless, patients with mutations in GUCY2D appear to have a
stable stationary visual course. GUCY2D mutations decrease production
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table 5. Clinical features and mutations.
of cGMP in photoreceptor cells leading to constant closure of cGMP-
gated cation channels and maintain a constant light-adapted state.
The patients in our study harboring GUCY2D mutations did not ex-
hibit marked photophobia and one patient had significant night blind-
ness. Patients presented with a visual acuity ranging from 20/200 to
light perception, mild to moderate hyperopia, pendular nystagmus, and
sluggish pupillary responses. Ophthalmoscopic changes were minimal
in five patients (Fig. 4). Attenuated blood vessels and mottling of the
retina associated with a bull’s-eye-like maculopathy was observed in
one patient with demonstrable homozygous mutations in the 5'UTR
region. The ERG recorded in infancy was extinguished in all patients.
The clinical course of the disease has remained stable in all of our
patients who we have followed over a significant period (Table 5).
Histopathological examination revealed degenerate photoreceptor cells
in previous studies.42 It is conceivable that a constant light state without
adequate photorecovery could hinder normal photoreceptor cell sur-
vival.
The presence of a null allele in GC-1 in the rd chicken, a model for
LCA, demonstrates degeneration of the rods and cones, abolishing
phototransduction.43 Perhaps the stability of visual evolution in our
patients is explicable on the basis of a fixed loss of photoreceptor
function in early infancy.
Alterations in the RPE65 gene sequence were observed in three pa-
tients who presented with a history of night blindness and visual acuity
in the range of 20/100-3/200. Poor pupillary reactions, nystagmus, and
gradual progressive visual loss over a period of 15-20 years were no-
ticed. Retinal appearance varied from normalcy at the initial examina-
tion in infancy to varying degrees of pigmentary changes and mottling
(Fig. 5). High hyperopia was noticed in one pedigree, while myopia
was seen in the others. Attenuation of blood vessels and slight pallor
of the optic discs were also observed. The ERG was uniformly extin-
guished under both photopic and scotopic conditions. The V19del2bp
mutation co-segregated in the family and the patient who initially pre-
sented with a history of night blindness and a visual acuity of 20/100
has progressively worsened. She has had five successive annual exam-
inations and the retinal appearance shows increased pigment migration
peripherally with an area of widening peripapillary atrophy (Fig. 6).
Loss of function mutations in RPE65, V19del2bp, and E102 STOP as
reported in our study further reiterate the importance of retinoid metab-
olism at the level of the pigment epithelium for adequate photoreceptor
function.44 Redmond et al.45 demonstrated recently the overaccumulation
of all-tans retinyl esters in the retinal pigment epithelium of RPE65-
deficient mice, thereby leading to gradually progressive structural dis-
organization and inadequate rod outer disc function. It is conceivable
that the lack of functional rhodopsin production coupled with the altered
vitamin A metabolism could account for night blindness and worsening
visual function in our patients (Table 5). The progressive deterioration
of outer segment integrity is consistent with the increase in pigment
mottling as noted in the ophthalmoscopic appearance (Fig. 5). However,
in comparison to previously published data with regard to visual func-
tion, our findings are not entirely in agreement since Perrault et al.
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Fig. 5. Fundus photograph of patient
#7 with RPE65 mutation showing
pallor of the optic disc with attenuated
retinal blood vessels, pigmentary
stippling of the retina, early pigment
migration, and hypopigmented areas
in the macula and surrounding
regions.
Fig. 6. Fundus photograph of patient
#8 with the V19del1bp mutation in
RPE65. Note mild optic disc pallor,
early attenuation of retinal
vasculature, hypopigmention in the
peripapillary, and macular areas with
increased visibility of the choridal
vascular pattern.
Fig. 4. Fundus photograph of patient
#5 with the L954P mutation in
GUCY2D. Optic disc and macula
appear within normal limits. Retinal
vasculature is attenuated.
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described better appreciation of form and improved visual function in
patients with RPE65 mutations.29
The P9ins1bp alteration in exon 1 of the CRX gene was demonstrated
in a proband who presented initially in infancy with poor fixation,
pendular nystagmus, sluggish pupillary responses, sensorineural deaf-
ness, and an extinguished ERG. Ophthalmoscopic examination revealed
diffuse retinal mottling and a coloboma-like lesion in the macula (Fig.
7). Serial examinations over the next 20 years confirmed stable oph-
thalmoscopic appearance and visual acuity of 20/300 OU. However,
difficulty with night vision continues (Table 5).
The de-novo L237del1bp mutation in the CRX gene was observed in
an infant who presented with the history of photophobia, poor fixation,
pendular nystagmus, sluggish pupillary reflexes, moderate hyperopia,
and attenuated retinal blood vessels. The ERG was abolished. The
mutation was not present in the normally sighted parents. The clinical
course has not been clearly defined over a prolonged period since the
proband is presently only three years of age.
CRX, a transcription factor, belongs to the otd/OTX family of ho-
meobox genes and appears to be a regulator of photoreceptor specific
gene expression.37 The presence of null alleles is consistent with the
most severe forms of retinal dystrophy due perhaps to very reduced
transcription activity as defined in one of our studies.28 CRX is ex-
pressed in the developing retina and binds to several photoreceptor-
specific genes. Hence, mutations within the CRX gene could explain
the presence of varying phenotypes.39 More recently, a marked decrease
in the number of nuclei and reduced thickness of the outer nuclear layer
associated with the absence of rod and cone activity were demonstrated
in CRX knockout mice.46 The reduction in photoreceptor-specific mole-
cules in the already compromised outer segments could explain the loss
of rod and cone function in the probands.
special cases There is compelling evidence to explain the role of
modifying factors in LCA in the special case described. It is possible
Fig. 7. Fundus photograph of patient
#10 with the P9ins1bp mutation in
CRX. Note optic disc pallor, early
attenuation of retinal vasculature,
diffuse retinal mottling, and the
presence of a macular coloboma-like
appearance.
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that the mutations in the kinase homology domain (KHD) of GUCY2D
alters the phenotype of the disease thereby increasing the severity of
LCA, as observed when these mutations are coupled with mutations in
other genes involved in LCA.
The Swiss proband harboring the KHD mutation in exon 10, C2174T,
presented in infancy with poor fixation, pendular nystagmus, sluggish
pupillary response, and an abolished ERG. Periodic fundus examina-
tions revealed increasing peripheral mottling and high hypermetropia.
Visual acuity was counting fingers (CF) at 2 feet. The other affected
sibling in whom the mutation was not detected presented in infancy
with nystagmus, poor fixation, decreased pupillary responses, and an
abolished ERG. Retinal appearance was within normal limits; however,
an increasing degree of hypermetropia was noted and vision of CF-2 ft
OU was recorded. LCA-5 on chromosome 6q was implicated as the
second gene involved. The GUCY2D sequence variation could account
for the increased severity in phenotype documented in this family. The
severity of the disease in both these siblings was not of the same
magnitude, lending support to the hypothesis of modifying factors al-
tering the phenotype.
technical aspects of mutations and future directions
Several novel homozygous and heterozygous mutations were identi-
fied. It was not possible to detect the second mutation in seven patients
in whom heterozygous mutations were identified, despite sequencing of
all coding regions. It is possible that the second mutation lies outside
the analyzed region. Conceivably, mutations may have escaped detec-
tion for technical reasons or there could be mutations in other genes
leading to the same phenotype. Junctional mutations may have been
possibly missed, hidden under the primer or perhaps due to inadequate
lengths of junctional amplification. The detection of mutations by SSCP
assay has the disadvantage of a 70-98% detection rate coupled with
problems in predicting the detectability and banding pattern on the
gel.47 However, the simplicity of SSCP analysis made it our scanning
mutation detection method of choice for GUCY2D and RPE65 genes as
a first step. To increase our mutation detection rate, we will need to
make use of chemical cleavage mismatches which offers a higher de-
tection rate.48 Heteroduplex analysis is underway. Work continues to
detect small rearrangements by making use of Southern blots.
As our initial method included only exonic screening, our approach
now includes analysis of the non-coding regions. RT-PCR amplifica-
tion is proposed to detect intronic variants and define splice-site point
mutations. Promoter region analyses continue in our effort to identify
mutations in the other allele.
The severity of the phenotype could not be explained based on the
location of the mutation. The phenotype is not gene-specific; however,
the course of the disease may be gene-specific as observed in our study
(Table 5). Patients harboring GUCY2D or CRX mutations seem to have
a stable clinical course in comparison to patients with mutations in
RPE65 whose visual functions deteriorate. It is possible that factors
other than a single gene mutation play a role in the clinical heteroge-
neity of the disorder since less than one-third of the patients with at
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least one known gene mutation have been accounted for in our study.
The role of gene interactions cannot be overlooked. The three recently
identified genes causing LCA are involved in different aspects of retinal
structure and function. In order to determine the appropriate treatment
for LCA whether it be RPE transplants, gene therapy, or pharmacolog-
ical intervention, it is important to understand and correlate the molec-
ular genetics, pathophysiology, and biochemical mechanisms involved.
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The Phenotype of Leber Congenital Amaurosis
in Patients With AIPL1 Mutations
Sharola Dharmaraj, MD, FRCS; Bart P. Leroy, MD; Melanie M. Sohocki, PhD; Robert K. Koenekoop, MD, PhD;
Isabelle Perrault, PhD; Khalid Anwar, MD; Shagufta Khaliq, PhD; R. Summathi Devi, MD; David G. Birch, PhD;
Elaine De Pool, MD; Natalio Izquierdo, MD; Lionel Van Maldergem, MD; Mohammad Ismail, MD;
Annette M. Payne, PhD; Graham E. Holder, PhD; Shomi S. Bhattacharya, PhD; Alan C. Bird, MD, FRCOphth;
Josseline Kaplan, MD, PhD; Irene H. Maumenee, MD
Objectives: To describe the phenotype of Leber con-
genital amaurosis (LCA) in 26 probands with muta-
tions in aryl hydrocarbon receptor interacting protein-
like 1 protein (AIPL1) and compare it with phenotypes
of other LCA-related genes. To describe the electroreti-
nogram (ERG) in heterozygote carriers.
Methods: Patients with AIPL1-related LCA were iden-
tified in a cohort of 303 patients with LCA by polymer-
ase chain reaction single-strand confirmational polymor-
phism mutation screening and/or direct sequencing.
Phenotypic characterization included clinical and ERG
evaluation. Seven heterozygous carrier parents also un-
derwent ERG testing.
Results: Seventeen homozygotes and 9 compound het-
erozygotes were identified. The W278X mutation was
most frequent (48%of alleles). Visual acuities ranged from
light perception to 20/400. Variable retinal appear-
ances, ranging from near normal to varying degrees of
chorioretinal atrophy and intraretinal pigment migra-
tion, were noted. Atrophic and/or pigmentary macular
changes were present in 16 (80%) of 20 probands. Kera-
toconus and cataracts were identified in 5 (26%) of 19
patients, all of whom were homozygotes. The ERG of a
parent heterozygote carrier revealed significantly re-
duced rod function, while ERGs for 6 other carrier par-
ents were normal.
Conclusions: The phenotype of LCA in patients with
AIPL1 mutations is relatively severe, with a maculopa-
thy in most patients and keratoconus and cataract in a
large subset. Rod ERG abnormalities may be present in
heterozygous carriers of AIPL1 mutations.
Clinical Relevance:Understanding and recognizing the
phenotype of LCA may help in defining the course and
severity of the disease. Identifying the gene defect is the
first step in preparation for therapy since molecular di-
agnosis in LCA will mandate the choice of treatment.
Arch Ophthalmol. 2004;122:1029-1037
L EBER CONGENITAL AMAURO-sis (LCA) was first de-scribedbyTheodoreLeber in18691 as a congenital formofretinitis pigmentosa. It rep-
resents a clinically and genetically heter-
ogeneous disorder with severe visual
impairment from birth.2,3 Fundus exami-
nation results are not frequently initially
normal, but chorioretinal atrophy, nar-
rowing of the retinal vasculature, intra-
retinal pigment migration, white fundus
flecks, and macular aplasia have been de-
scribed.4-8 The retinal basis of the visual
loss is shown by absent or severely dimin-
ished rod and cone responses on electro-
retinography (ERG).9Nystagmus, enoph-
thalmos, sluggish pupillary responses,
keratoconus, cataracts, andhyperopiahave
also been described.10-12
Leber congenital amaurosis is usu-
ally inherited as an autosomal recessive
trait, although dominant inheritance has
been reported.13-16 Currently,mutations in
6 different retinal genes have been shown
to cause LCA. The genes include (1) reti-
nal guanylate cyclase (GUCY2D),17 (2) reti-
nal pigment epithelium–specific 65kD
protein (RPE65),18 (3) cone-rod ho-
meobox (CRX),19-22 (4) crumbs gene ho-
molog of CRB1,23,24 (5) retinitis pigmen-
tosa GTPase regulator–interacting protein
(RPGRIP-1),25,26 and (6) AIPL1, encoding
the aryl hydrocarbon receptor interact-
ing protein-like 1 protein.27,28
The AIPL1 gene consists of 6 exons
and encodes a protein of 384 amino acids.
This sequence includes 3 tetratricopep-
tide repeat motifs thought to be associ-
ated with protein-protein interaction, and
its similarity with aryl hydrocarbon inter-
actingprotein is suggestive of aprotein fold-
ing function.27,28 The exact functions of the
AIPL1 gene are not fully understood.How-
ever, recent data suggest that the protein
may be involved in photoreceptor differ-
Author affiliations are listed at
the end of the article.
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entiation during development and subsequent survival of
photoreceptors.29 Indeed, through interaction with the
NUB1 protein, it might be involved in regulation of the
cell-cycle progression during photoreceptor matura-
tion.29 Mutations in AIPL1 account for 7% of LCA.28
Clinical outcomes differed for patientswith LCA and
GUCY2D mutations when compared with those with
RPE65 defects30-33 in terms of the natural history of this
disorder. In addition, some heterozygous carriers of
GUCY2Dmutations, who have offspring with LCA, have
been shown tohave significant cone abnormalities onERG
results, with essentially normal rod ERG findings.34 Most
heterozygotes with RPE65 mutations have normal ERG
findings.32
The purpose of this large study is to describe the phe-
notype of LCA in patientswithAIPL1mutations and com-
pare it with the known phenotypes of patients with mu-
tations in other LCA genes. The phenotype of 26 patients
with LCA of different ethnic origins with mutations in
AIPL1 is described. The genotype of most patients has
previously been published.15,28 The ERG and clinical find-
ings in a female heterozygous carrier are also reported.
METHODS
Informed consent was obtained from all patients involved in
this study or from their legal guardians in accordance with the
Declaration of Helsinki. The review and ethics boards of the
institutions approved this study.
OPHTHALMIC EVALUATIONS
The clinical diagnosis of LCAwas made on the basis of the fol-
lowing diagnostic criteria: severe visual impairment from birth
or during early infancy accompanied by nystagmus, absent or
very sluggish pupillary responses, and absent or markedly re-
duced rod and cone ERGs. All ERGs were performed accord-
ing to the International Society for Clinical Electrophysiology
of Vision standards.35 The examinations were undertaken in 5
centers and included slitlamp biomicroscopy, retinoscopy, and
indirect ophthalmoscopy following pupillary dilation (Table1).
Clinical pictures were taken, and keratometry was performed.
GENETIC EVALUATIONS
DNAwas extracted from peripheral blood leukocytes or cheek
swabs. A cohort of 303 patients with LCAwas screened formu-
tations in AIPL1. Patients were from a wide range of racial and
ethnic backgrounds. The 6 exons of AIPL1 were screened us-
ing single-strand conformation polymorphism analysis (SSCP)
followed by direct sequencing when an aberrant migration pat-
tern was noted on the SSCP gels. In 39 probands, direct se-
quencing was used to screen for mutations in AIPL1, while in
the others, SSCP was initially undertaken using primers and
conditions previously described.27 The genotype of most of the
patients with AIPL1-related LCA in this study has been pub-
lished previously (Figure 1).27,28
RESULTS
Mutations in AIPL1 were detected in 26 probands with
LCA (Figure 1). Seventeen probands were homozy-
gotes, while 9 were compound heterozygotes. Twenty-
four of the 52 mutated AIPL1 alleles carried the W278X
mutation. All sequence changes identified in our pa-
tients were absent in 205 control samples.
NIGHT BLINDNESS, PHOTOATTRACTION,
AND PHOTOAVERSION
Night blindness was reported in 13 probands and pho-
toaversion in 4. Photoattraction (staring at lights) was
noted in 2 probands (Table 1).
VISUAL ACUITIES AND
CYCLOPLEGIC REFRACTIONS
Visual acuities were found to vary between probands and
ranged from20/400 to light perception. Nine patients had
light perception. Seven patients had handmotion vision
(Table 1). Cycloplegic refractions performed in 10 pa-
tients showed hyperopia in 8 (+3.00 diopters [D] to +7.00
D) and myopia in 2 (–0.50 D to –2.75 D).
RETINAL AND MACULAR APPEARANCE
Twenty-four probands with an AIPL1-related LCA geno-
type had some formof pigmentary retinopathy that ranged
from mild midperipheral salt and pepper-like retinopa-
thy to diffuse and severe chorioretinopathy (Figures 2,
3, 4, 5, 6 and 7). The youngest patient with pigmen-
tary changes was 4 months old. Two patients, a 2-year-
old and a 3-year-old, had essentially normal retinas with
indistinct foveal reflexes. A maculopathy of variable ap-
pearance was noted in a significant number of patients
(Figures 2, 3, 4, 5, and 7). Information about the macu-
lar appearance was available in 20 of the 26 probands.
Maculopathy was noted in 16 (80%) of 20 probands. In
4 probands, all young children (ranging from ages 2-6
years), an abnormal indistinct foveal reflex was noted,
which likely represents an early stage of maculopathy.
This strongly suggests that a significant number of pa-
tients with LCA and AIPL1 mutations develop a macu-
lopathy. Themaculopathy ranged in appearance frommild
foveal atrophy with variable degrees of macular stip-
pling to aplasia. The youngest patient with macular at-
rophy was 8 years old (Table 1).
KERATOCONUS AND CATARACTS
Information about the presence of keratoconuswas avail-
able in 19 probands (Table 1). Keratoconus was diag-
nosed in 6 probands (32%), and cataracts were noted in
association with the keratoconus in 5 of these 6 pa-
tients. Distinct hydrops with scarring and breaks in the
Descemetmembranewere noted in proband 17. The cata-
racts ranged from cortical changes to posterior subcap-
sular cataracts.Of interest, keratoconus and cataractswere
only seen in patients who were homozygous for AIPL1
mutations. Keratoconuswas not observed in patientswith
compound heterozygous mutations. The youngest pa-
tient with keratoconus and cataract was aged 10 years.
OPTIC DISC APPEARANCE
Varying degrees of optic nerve pallor were noted in all
patients after the age of 6 years. The optic nerve head ap-
peared normal in children younger than 6 years, except
in an infant (Table 1).
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ERG FINDINGS
The ERG findings obtained in the 3 sets of clinically nor-
mal parents of probands 7, 10, and 26who carry theAIPL1
mutation in a heterozygous state did not show any abnor-
malities. However, the ERG of 1 carrier parent of pro-
band 2 with the W88X mutation showed significant rod
abnormalities (Figure 8). She did not have any ocular
complaints, andher clinical examination findingswerenor-
mal. This 47-year-oldmother had vision of 20/20OU. Al-
though her retinal examination results were unremark-
able, full-field flash ERG showed rod b-wave amplitudes
to be reduced to approximately one third of normal, with
no change in implicit time. This is well below the lower
limit of normal. The 30-Hz flicker and single flash cone
AIPL1
V96I Y134F A197P A336 del 2bp
R302L
C239RT114I
W88X
M79T
5′
V33 ins 8bp
C42X
IVS2-2A>G
Q163X
L257 del 9bp
G262S
W278X
1 2 3 4 5 6 3′
P376S
Figure 1. Structure of the AILPL1 gene with the relative locations of the
mutations in the 26 probands.
Table 1. Clinical and Genetic Characteristics of 26 Probands With AIPL1 Mutations
Proband Origin
AIPL1 Mutations
Age at
Examination History
Visual
Acuity Maculopathy
Optic
Nerve
Pallor Keratoconus Cataract
Pigmentary
Retinopathy
Refraction,
dioptersAllele 1 Allele 2
1 India M79T M79T 24 y Absence of
NB and PA
LP Mild Moderate Absence Absence Severe NA
2 Bangladesh W88X W88X 30 y NA LP Severe Moderate Moderate Mild Severe NA
3 Belgium V96I V96I 4 m NA No FF Mild Mild Absence Absence Absence NA
4 France Y134F Y134F NA Absence of
NB
Presence of
PA
NA NA NA NA NA Severe +5.00
5 Palestine Q163X Q163X 10 y Presence of
NB
LP Mild Moderate Mild Moderate Severe NA
6 Morocco A197P A197P NA Absence of
NB
Presence of
PA
5/200 NA NA NA NA Severe +7.00
7 United
States
C239R C239R 16 y Presence of
NB
HM Mild Moderate Absence Absence Severe −0.50
8 Saudi
Arabia
W278X W278X 8 y Presence of
NB
FF Moderate Mild Absence Absence Severe NA
9 United
States
W278X W278X 57 y Presence of
NB and
DOP
LP Moderate Moderate Mild Severe Severe NA
10 United
States
W278X W278X NA Presence of
NB
HM Moderate Mild Absence Absence Severe NA
11 Pakistan W278X W278X 16 y Presence of
NB
LP Severe Moderate Moderate Absence Severe NA
12 Pakistan W278X W278X 25 y NA LP Severe Moderate Moderate Moderate Moderate NA
13 United
States
W278X W278X 3 y Presence of
NB
HM IFR Absence Absence Absence Absence +7.00
14 Portugal W278X W278X NA Presence of
NB and PA
LP NA NA NA NA Severe +7.00
15 Belgium W278X W278X NA NA NA NA NA NA NA Severe NA
16 Belgium W278X W278X NA NA LP Mild Mild NA NA Severe NA
17 India R302L R302L 16 y Absence of
NB and PA
HM Moderate Moderate Severe Severe Moderate +6.00
18 United
States
C42X G262S 17 y Presence of
PAT
HM Mild Mild Absence Absence Severe NA
19 United
States
V33 ins 8bp W278X 6 y Presence of
PAT
HM IFR Absence Absence Absence Mild +6.00
20 United
States
T114I P376S 8 y Presence of
NB
20/400 Severe Mild Absence Absence Moderate −2.75
21 France T114I P376S NA Absence of
NB
Presence of
PA
NA NA NA NA NA Severe NA
22 United
States
Leu257 del
9bp
W278X 2 y Presence of
NB and
DOP
No FF IFR Absence Absence Absence Absence +6.50
23 United
States
G262S W278X 19 y Presence of
NB
HM Mild Mild Absence Absence Moderate NA
24 Ireland W278X IVS2-2AG 3 y Presence of
NB
FF IFR Absence Absence Absence Mild +3.00
25 France W278X IVS2-2AG NA NA LP NA NA NA NA Severe NA
26 United
States
W278X A336 del 2bp 27 y Presence of
NB
20/1200 Mild Mild Absence Absence Severe NA
Abbreviations: DOP, digito-ocular phenomenon; FF, fixation and following; HM, hand motions; IFR, indistinct foveal reflex; LP, light perception; NA, not available;
NB, night blindness; PA, photoaversion; PAT, photoattraction.
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Figure 2. W287X/W278X mutation, proband 12 at 25 years of age. Posterior
pole, right eye, showing atrophic macular area optic nerve pallor and
pigmentary changes.
Figure 3. W287X/W278X mutation, proband 8 at 8 years of age. Left eye,
early macular changes showing retinal pigmentary epithelium disruption.
Figure 4. W88X/W88X mutation, proband 2 at 30 years of age. Posterior
pole, left eye, showing atrophic macular and retinal pigment epithelium
disruption and optic nerve pallor.
Figure 5. W88X/W88X mutation, proband 2 at 30 years of age. Superior
midperiphery, left eye, showing intraretinal pigment accumulation, optic
nerve pallor, and atrophic macula with pigmentary changes.
Figure 6. T114I/P376S mutation, proband 20 at 8 years of age. Peripheral
retinal mottling.
Figure 7. T114I/P376S mutation, proband 20 at 8 years of age. Right eye,
showing macular coloboma-like atrophy and mild optic nerve pallor.
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responses werewithin normal limits (Figure 8). The ERG
responses were reproducible on repetition.
COMPARING THE LCA PHENOTYPES
TheLCAphenotypeswithmutations intheotherLCAgenes
(GUCY2D, RPE65, CRX, CRB1, and RPGRIP1) were com-
pared with the LCA phenotypes of the current study and
tabulated in Tables 2,3,4,5, and6. The AIPL1-related
LCAphenotype is severe innature,withpronouncedmacu-
lar involvement in individuals older than6yearswithvary-
ingdegreesofopticnervepallor.Additional findingsofkera-
toconus and cataract could be present.
BothGUCY2D-related and AIPL1-related LCA phe-
notypes have markedly decreased visual acuities, visual
fields, and ERGs.30,31,33 However, maculopathy, remark-
able peripheral pigmentary changes, cataract, and sig-
nificant optic disc pallor were not detected in patients
with mutations in GUCY2D.30,31,33 Keratoconus was re-
ported by El-Shanti et al36 in a Jordanian pedigree. Com-
pared with the reported GUCY2D phenotype,30,31,33 the
AIPL1 phenotype appears to be similar in severity of vi-
sual loss. Phenotypical differences exist in the pattern of
pigmentary changes, cataract, and keratoconus, which
are more frequent in AIPL1-related LCA (Table 2).
The RPE65 phenotype reported in earlier studies30-
32,37,38 shows that the visual acuities, visual fields, and ERG
measurements were better than in the AIPL1 phenotype.
PatientswithRPE65-relatedLCAmaydevelopamildmacu-
lopathy, and the documented peripheral retinal changes
are characterized as grainy and/or salt andpepper-like. The
maculopathy of patients with AIPL1-related LCA appears
to bemore pronounced in all probands older than 6 years,
while the peripheral retinal changes range frommottling
to bone spicule-like formation. Cataract and keratocu-
nus were present in one third of the patients with AIPL1-
relatedLCA.Lorenz et al32 conclude that patientswithLCA
and RPE65 mutations are distinguishable on clinical
grounds, based on their measurable visual acuities, their
transient visual improvement in childhood followedbyde-
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Figure 8. Top row, Electroretinogram (ERG), right eye, of the 47-year-old, heterozygous carrier parent of proband 2 carrying the W88X AIPL1 mutation. It shows
a significantly reduced amplitude of rod-specific scotopic to one third of normal values and of maximal combined rod and cone response; cone-specific 30-Hz
flicker and single flash cone ERGs are within normal limits. Second row, ERG of proband 2 at 27 years of age (carrying the W88X/W88X mutation) showing no
measurable responses. Third row, ERG of proband 2’s 30-year-old affected sister (carrying the W88X/W88X mutation) showing no measurable responses. Fourth
row, Typical normal findings in a 45-year-old control.
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terioration in later life,measurable cone ERGs (which also
diminish in later life), measurable visual fields, and sig-
nificant night blindness. The data from our study suggest
that patientswithLCAandmutations inAIPL1donot have
a similar course (Table 3).
From the several reported cases of patients with
LCA and CRX mutations, visual acuities of 20/300
to light perception, with 1 case of 20/80, were
described.15,16,19-22,31,33,39-43 Marked atrophy in the macula
was recorded in 71%ofCRX-related LCA,while inAIPL1-
related LCA,maculopathywas pronounced in 80% of the
patients after 6 years of age. Marked pigmentary reti-
nopathy was noticed in 84% of patients with AIPL1-
related LCA unlike inCRX-related LCA, where it was ob-
served in 33% (Table 4).
Compared with that of patients with CRB1 muta-
tions, the phenotype of our patients with AIPL1 muta-
tions appears to be less variable and more severe. Small
white dots and zonal retinal/choroidal hypoplasia were
seen in the patients with CRB1-related LCA23 but not in
patients with AIPL1-related LCA (Table 5). The pres-
ence of cataract, keratoconus, and optic disc pallor were
not reported in the CRB1-related LCA phenotype. The
constant features reported in the CRB1-related pheno-
typeweremoderate to high hyperopia, the relatively early
appearance ofwhite spots, andnummular pigment clumps
in the retina.23
The RPGRIP1-related LCA phenotype has been re-
ported in 3 patients.25 Visual acuity was light percep-
tion. Hyperopia and absence of intraretinal pigment mi-
Table 2. Comparisons of Leber Congenital Amaurosis Phenotypes:
Patients With GUCY2D Mutations vs Patients With AIPL1 Mutations
Source
Sample
Size Gene
Acuity,
Range
Refraction,
diopters Visual Field Electroretinogram Maculopathy
Pigmentary
Retinopathy Keratoconus Cataract
Optic
Nerve
Pallor
Perrault
et al30
20 GUCY2D Counting
fingers
to light
perception
Severe
hyperopia
Nondetectable Nondetectable Absent Normal at
birth, salt
and
pepper-like
changes
later
1 patient Absent
Dharmaraj
et al31
6 GUCY2D 20/150 to
light
perception
6 patients
(+1.00 to
+5.50)
Nondetectable Nondetectable Absent Essentially
normal
retina in
some; mild
pigmentary
changes in
others
Absent Absent
Lotery
et al33
2 GUCY2D 20/1333 to
no light
perception
2 patients
(+1.50 to
+4.00)
Absent Absent Absent
Current
study
26 AIPL1 20/400 to
light
perception
8 patients
(+3.00 to
+7.00);
2 patients
(−0.50 to
−2.00)
Nondetectable Nondetectable Pronounced
in 80%
Marked bone
spicule-like
pigmentary
changes in
84%
Present in
6 of 18
patients
Present in
5 of 18
patients
Present
after 6
years
of age
Table 3. Comparisons of Leber Congenital Amaurosis Phenotypes: Patients With RPE65 Mutations vs Patients With AIPL1 Mutations
Source
Sample
Size Gene
Acuity,
Range
Refraction,
diopters Visual Field Electroretinogram Maculopathy
Pigmentary
Retinopathy Keratoconus Cataract
Optic
Nerve
Pallor
Lorenz
et al32
4 RPE65 20/70 to
20/200
4 patients with
hyperopia
Preserved
peripheral
Rod,
nondetectable;
cone,
recordable
progressed to
nondetectable
Mild Granular Absent Absent
Thompson
et al37
20 RPE65 20/60 to hand
motions;
most
patients
20/100
7 patients with
hyperopia;
3 patients
with
myopia; 13
patients not
reported
Residual Residual to
nondetectable
Lotery
et al33
12 RPE65 20/50 to light
perception;
most
patients
20/200
9 patients
(+0.50 to
+3.50);
3 patients
(−0.50 to
−1.50)
Current
study
26 AIPL1 20/400 to
light
perception;
most
patients
hand
motions
8 patients
(+3.00 to
+7.00);
2 patients
(−0.50 to
−2.00)
Nondetectable Nondetectable Pronounced
in 80%
Marked bone
spicule-like
pigmentary
changes in
84%
Present in
6 of 18
patients
Present in
5 of 18
patients
Present
after 6
years
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gration were noted in 2 patients. However, bone spicule-
like pigmentary deposits in themidperipheral zone were
noted in a third patient. No evidence of maculopathy as
seen in the patients with AIPL1-related LCA was ob-
served (Table 6).
COMMENT
The retinal phenotype of AIPL1-related LCA is that of a
severe, congenital retinal dystrophywith a notablemacu-
lopathy. The retinal appearances in our patients ranged
from near normal (in a 3-year-old and a 6-year-old) to se-
verely atrophic (and in all patients older than 6 years)with
marked maculopathy and pigmentary retinopathy. Vary-
ing degrees of intraretinal pigment migration culminat-
ing in bone spicule-like pigment and gross pigment clumps
in the retinas were observed. Overall, a high prevalence
of macular lesions was observed in our patients com-
pared with patients with LCA caused by mutations in the
other 5 genes implicated in this disease. Atrophic macu-
lar lesions were particularly frequent and were observed
in 16 (80%) of 20 patients; 11 harbored a premature stop-
codon mutation, either in a homozygous or a heterozy-
gous state. Macular involvement as seen on ophthalmos-
copy likely beginswith an indistinct dull or irregular foveal
reflex and progresses to a diffuse ill-defined area of reti-
nal pigment stippling and atrophy, leading to a marked
atrophic maculopathy. Owing to the differences in age at
the time of first examination, it was not possible to deter-
mine the accurate age of onset of the maculopathy.
Table 4. Comparisons of Leber Congenital Amaurosis Phenotypes: Patients With CRX Mutations vs Patients With AIPL1 Mutations
Source
Sample
Size Gene
Acuity,
Range
Refraction,
diopters Visual Field Electroretinogram Maculopathy
Pigmentary
Retinopathy Keratoconus Cataract
Optic
Nerve
Pallor
Jacobson et al,21
Lotery et al,33
Nakamura et al,42
Rivolta et al,41
Silva et al,22
Sohocki et al,15
Swaroop et al,43
Zhang et al40
143 CRX 20/300 to
light
perception;
20/80 in 1
patient
−7.00 to +6.00 Restriction
(30 degrees)
nonrecordable
Decreased to
nondetectable;
95% decrease in
cone amplitude
Present in 8
of 14
patients
Present in
1 patient
Absent Present in
6 of 14
patients
Current study 26 AIPL1 20/400 to
light
perception
8 patients
(+3.00 to
+7.00);
2 patients
(−0.50 to
−2.00)
Nondetectable Nondetectable Pronounced
in 80%
Marked bone
spicule-like
pigmentary
changes in
84%
Present in
6 of 18
patients
Present in
5 of 18
patients
Present
after 6
years of
age
Table 5. Comparisons of Leber Congenital Amaurosis Phenotypes: Patients With CRB1 Mutations vs Patients With AIPL1 Mutations*
Source
Sample
Size Gene
Acuity,
Range
Refraction,
diopters Visual Field Electroretinogram Maculopathy
Pigmentary
Retinopathy Keratoconus Cataract
Optic
Nerve
Pallor
Lotery
et al23
19 CRB1 20/40 to light
perception
12 patients
(+0.80 to
+5.50)
Decreased to
nondetectable
Present in
some
Present in
some
Present Absent
Current
study
26 AIPL1 20/400 to
light
perception
8 patients
(+3.00 to
+7.00);
2 patients
(−0.50 to
−2.00)
Nonrecordable Nondetectable Pronounced
in 80%
Marked bone
spicule-like
pigmentary
changes in
84%
Present in
6 of 18
patients
Present in
5 of 18
patients
Present
after
6 years
of age
Abbreviation: RPE, retinal pigment epithelium.
*Nummular pigmentation in the retina and retinal zonal atrophy with hypoplasia of the choriocapillaris and RPE were present in some patients in the Lotery et al
study but absent in the current study. Small retinal dots were present in many of the patients in the Lotery et al study but absent in the current study.
Table 6. Comparisons of Leber Congenital Amaurosis Phenotypes:
Patients With RPGRIP1 Mutations vs Patients With AIPL1 Mutations
Source
Sample
Size Gene
Acuity,
Range
Refraction,
diopters Visual Field Electroretinogram Maculopathy
Pigmentary
Retinopathy Keratoconus Cataract
Optic
Nerve
Pallor
Dryja
et al25
3 RPGRIP1 Light
perception
+2.60 to +6.90 Nonrecordable Nondetectable Absent in 1 of
1 patients
Reported in
1 proband
(bone-spicule
like)
Absent Absent Present
Current
study
26 AIPL1 20/400 to
light
perception
8 patients
(+3.00 to
+7.00);
2 patients
(−0.50 to
−2.00)
Nondetectable Nondetectable Pronounced
in 80%
Marked bone
spicule-like
pigmentary
changes in
84%
Present in
6 of 18
patients
Present in
5 of 18
patients
Present
after 6
years
of age
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The heterozygous carrier parent of the W88X
mutation was found to have a significant and reproduc-
ible rod ERG abnormality with essentially normal cone
ERG results. These ERG findings are significantly dif-
ferent from the heterozygous carriers of GUCY2D muta-
tions, who have significant cone ERG abnormalities but
relatively normal rod ERG findings.34 The rod ERG
abnormalities in the AIPL1 carrier correlate with recent
reports showing AIPL1 expression exclusively in rod
photoreceptors in the differentiated retina.44 However,
more ERGs in carriers of AIPL1 mutations need to be
studied to better understand the role of AIPL1 in rela-
tion to rod function.
The presence of keratoconus in patients with LCA
has beenwell documented.45-48 The high incidence of kera-
toconus in patients with a homozygous sequence change
of AIPL1 in our cohort may well be significant. Kerato-
conus was observed in 6 probands, all with homozy-
gous mutations. There is no definitive consensus about
the origin of keratoconus in patients with LCA. The in-
cidence of keratoconus has been reported to be as high
as 54.5 cases per 100.0 in the general population, and it
has been noted in 29% of children with LCA and 2% of
all children with blindness.10,49 Keratoconus in patients
with LCA occurred in 2% of 0- to 14-year-olds and in
30% of 15- to 45-year-olds, further illustrating the later
onset of the pathologic corneal features in comparison
with the retinal dysplasia.50 The absence of keratoconus
prior to 9 years of age also has been well documented46
and is the case in our cohort too.
Cataract has been associated with many different
types of retinal dystrophy. Its association with retinitis
pigmentosa has been well documented.51,52 Cataract has
been noted at or beyond the second decade of life in pa-
tients with LCA.46 In this study, cataracts were observed
in 5 probands (27%). Progressive retinal degenerative
changes in associationwith keratoconus and cataract have
been reported during the course of the disorder.46,47 The
incidence of both keratoconus and cataract increasedwith
increasing age in our cohort.
The LCA phenotypes are highly variable15,23,31,32 and
change with age,46 and the phenotypes associated with
the currently known LCA genes overlap.31-33 Compari-
sons between the reported LCA phenotypes of different
studies23,25,30-33 are hampered by a lack of uniform assess-
ment strategies, age matching, and uniform follow-up.
Despite these obvious difficulties, it is important to study
these LCA phenotypes in an effort to understand the evo-
lution of disease based on genotype.
In summary, patients with AIPL1-related LCA ap-
pear to have a particularly severe phenotype, character-
ized by marked visual impairment, nondetectable fields
and ERGs, optic disc pallor,maculopathy, peripheral reti-
nal bone spicule-like pigmentation, and a significant
prevalence of keratoconus and cataract.
Mutations in AIPL1 disrupt the normal function of
photoreceptors. AIPL1 is not only expressed in mature
rod photoreceptors44 but also during development in both
rods and cones.29 The dysfunctional role ofAIPL1 in pho-
toreceptor cell cycle progression leads to photoreceptor
cell death during development by disrupting the nor-
mal regulation of the cell cycle.29 More detailed under-
standing of the pathogenesis of each molecular subtype
of LCA will provide further insight into treatment.
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Abstract Leber congenital amaurosis (LCA) is a clinically and
genetically heterogeneous severe retinal dystrophy presenting in
infancy. To explain the phenotypical variability observed in two
affected siblings of a consanguineous pedigree diagnosed with LCA
and establish a genotype-phenotype correlation, we screened
GUCY2D, RPE65, CRX, AIPL1, and RPGRIP1 for mutations. The
more severely affected sibling carried a heterozygous missense muta-
tion in the GUCY2D gene (Ile539Val), which did not segregate with
the disease phenotype. Subsequently, a homozygous nonsense mutation
(Glu102STOP) in the RPE65 gene was identified in both affected sib-
lings, thus identifying the causative gene. This data provides evidence
for the presence of genetic modulation in LCA. It appears that the 
heterozygous GUCY2D mutation further disrupts the already com-
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promised photoreceptor function resulting in more severe retinal dys-
function in the older sibling. We suggest that the unusual phenotypic
variability in these two siblings with LCA is caused by the modifying
effect of a heterozygous GUCY2D mutation observed against the
disease background of a homozygous RPE65 mutation.
Key words Leber congenital amaurosis; genetic modifier;
GUCY2D; RPE65
Introduction Growing evidence points towards the simultaneous
involvement of several genes in the determination of disease.1,2 Mono-
genic traits are not simple, and genetic modifiers influence disease.3,4
Digenic segregation has been demonstrated in retinitis pigmentosa.
The affected phenotype is caused by mutations in two independent
photoreceptor-specific genes ROM1 and peripherin/RDS with struc-
turally related proteins that interact to form a heteromeric complex at
the rims of photoreceptor disc membranes.1,5
Leber congenital amaurosis (LCA) is a severe inherited retinal dys-
trophy involving both rods and cones and is characterized by the onset
of blindness during the first months of life.6 Patients typically have nys-
tagmus and a variable appearance of the retina ranging from normal
to a retinitis pigmentosa-like picture. A non-recordable electroretino-
gram (ERG) confirms the diagnosis.
While there is substantial variation in disease severity among fami-
lies, intrafamilial similarity is commonly observed. Most cases are auto-
somal recessive, although a few autosomal dominant pedigrees have
been reported.7–10 Several independent genes and three loci for LCA
have been identified to date. The genes include GUCY2D (LCA1) on
chromosome 17p13.1;11 RPE65 (LCA2) on 1p31,12,13 CRX on 19q13,14
AIPL1 on 17p13.1,15 CRB1 on 1p,16 and RPGRIP1 on 14q11.17 These
genes code for proteins that fall into several functional categories
ranging from transcription factors to structural tissue components. The
three loci at which the gene are yet to be identified map to include
LCA3 on 14q24,18 LCA5 on 6q11-16,19 and LCA9 on 1p36.20 Early-
onset retinal dystrophy has been reported with mutations in LRAT,
located on chromosome 4q31.21 Mutations in TULP1 on 6p21.3 are
known to cause autosomal recessive RP.22–24
The RPE65 protein plays a crucial role in the isomerisation of all-
transretinal to 11cis-retinal in the retinal pigment epithelium.25 Retinal
degeneration is mediated by continous opsin signalling, as pigment
lacking 11cis-retinal activates transduction.26
Retinal guanylate cyclase (RetGC-1), the protein encoded by
GUCY2D is important for the replenishment of cyclic Guanosine
Monophosphate (cGMP) in the photoreceptor outer segments, follow-
ing light-activated depletion.27 The greatly reduced levels of cGMP
prevent photorecovery and lead to retinal degeneration.11,28
The observation of significant intra-familial phenotypic variation
between two siblings in a consanguineous pedigree led us to study the
possibility of gene interaction and/or the modulatory effects of their
gene products.
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Fig. 1. Pedigree showing segregation
of GUCY2D and RPE65 mutations
in a consanguineous Greek pedigree.
Report The study was conducted following informed consent in
accordance with the institutional ethics review board and the Declara-
tion of Helsinki. We studied a three-generation consanguineous family
of Greek ancestry (Figure 1) in which two siblings were diagnosed with
LCA.29 The parents were first-degree cousins and their complete oph-
thalmologic evaluation failed to identify any abnormalities. The ERGs
were performed in accordance with the ISCEV criteria, and they
included full-field ERGs using a corneal contact electrode and obtain-
ing responses in dark and light adapted conditions to single high- and
low-intensity flashes and flicker stimuli.
The proband (IV-1) presented shortly after birth with searching eye
movements and inability to fixate or track moving objects. Pupillary
examination elicited a relatively sluggish response in both eyes.
Anterior segments were normal as were the fundi on ophthalmoscopic
examination. An electro-retinogram (ERG) demonstrated total
absence of electrical activity of the retina (unrecordable cone and rod
ERGs), thus confirming the diagnosis of LCA.
At the age of seven, esotropia of 30 prism diopters and hyperopia of
+6.00D were noted.Visual acuity of 0.06 OD and 0.07 OS was recorded.
On fundoscopy, the optic discs appeared to be within normal limits but
salt- and pepper-like pigmentary changes were observed in the retinas.
On follow-up examinations, a slow worsening of her condition was
recorded over a period of 20 years. Fundus examination showed retinal
mottling affecting the mid and far peripheral regions, relative preser-
vation of the macular area, slow progressive narrowing of retinal
vessels, and pallor of optic discs. Several attempts to record visual fields
proved to be unsuccessful. She had grossly limited visual fields on con-
frontation testing and was unable to navigate independently. Night-
blindness further compounded her navigatory ability. At twenty-three
RPE65
GUCY2D
E102X / E102X
+ / I539V
RPE65
GUCY2D
RPE65
GUCY2D
1 2 3 4
1 2
E102X / E102X
+ / +
E102X / +
      + / +
E102X / +
 + / I539V
21
II
III
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1 2
I
E102X / +
    + / +
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Fig. 2. Fundus appearance of the
proband (IV-1) at 27 years of age
showing pallor of the optic disc,
attenuation of retinal vasculature,
peripheral retinal mottling, and areas
of atrophy in the macula.
Fig. 3. Optical coherence
tomography (OCT) of the proband’s
(IV-1) retina in the macular area
showed mild thinning of the foveal
retina (150mm).
years of age, the patient’s best corrected vision was 0.015 in both eyes.
Persistent nystagmus and sluggish pupillary reflexes continued to be
noted. The fundus examination revealed pale optic discs, dull macular
reflexes, significant arteriolar attenuation, and considerable peripheral
pigmentary changes.
At 27 years of age her visual acuity was light perception (OD) and
counting fingers close to face (OS). On fundoscopy (Figure 2), pallor
of the optic discs, attenuation of retinal vasculature, peripheral retinal
mottling, and areas of atrophy in the macula were observed. Exami-
nation of the posterior pole using optical coherence tomography
(Figure 3) showed mild thinning of the foveal retina (150mm) in the
both eyes. (Normal = ~160mm). The thickness of the parafoveal retina
ranged from 225 to 300mm in the right eye while in the left eye it ranged
from 280 to 290mm. Thickening of the choroid was reported in both
eyes. She is now unable to read normal sized print, which she could do
until the age of 20. A slow, progressive decline of vision was observed
since the age of 20. She continues to experience the same level of night
blindness and uses braille.
Her younger sibling (IV-2) also presented with nystagmus and
decrease of visual function in the first months of life. The initial clini-
cal evaluation was compatible with the diagnosis of LCA. An ERG
obtained during the first year of life revealed no detectable rod and
cone responses, confirming the diagnosis of LCA. However, her condi-
tion remained stable. In her late teens, the best corrected visual acuity
was 20/200 (0.1) in both eyes, with less pronounced nystagmus. She
complained of nightblindness. Ophthalmoscopic examination showed
mild arteriolar attenuation in otherwise normal fundi. No extensive
macular or peripheral pigmentary changes as observed in her sister
were present. At the age of 18, her vision remained stable and, unlike
her older sibling, she was able to navigate independently. Hyperopia of
+2.50 D OD and +0.75 D OS was recorded.
At 20 years of age, her visual acuity remains at 0.05 in both eyes and
she has milder nystagmus. However, on fundoscopy (Figure 4) retinal
mottling, attenuated vasculature, and atrophic changes with clumping
2
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Fig. 4. Fundus appearance of IV-2
showing retinal mottling, attenuated
vasculature, and atrophic changes
with clumping of pigment in the
macula.
Fig. 5. Optical coherence
tomography (OCT) of the macular
area of IV-2. The thickness of the
retina at the fovea measured 120mm.
(Normal = ~160mm)
of pigment in the macula were noted. Optical coherence tomography
(Figure 5) of both macular areas showed the thickness of the retina at
the fovea to be 120mm in the right eye and 230mm in the left eye. The
thickness in the parafoveal area ranges from 235 to 290mm in the right
eye and from 280 to 290mm in the left eye. The thinning of the foveal
area in the right eye could be attributed to the atrophy of the retinal
pigment epithelium. She reads normal-sized newsprint held a few
inches close to face without magnification but with mild difficulty and
continues to experience night-blindness.
Genetic analysis Mutation analysis of GUCY2D, RPE65, CRX,
AIPL1, and RPGRIP1 were undertaken in the the two affected 
siblings (IV-1 and IV-2).
We sequenced the coding region and intron-exon junctions of
GUCY2D, after PCR amplification using previously published sets of
primers.11 In the more severely affected sibling (IV-1), we found het-
erozygosity for a missense mutation in exon 7 (Figure 6) at nucleotide
1615 (A > G). This change converts an extremely conserved isoleucine
in the kinase-homology domain to a valine (Ile539Val), and was not
detected in 58 normal control subjects of the same ethnicity. We did 
not find a second mutation in the GUCY2D gene of the proband 
(IV-1), nor did we find any sequence alterations in GUCY2D in the
other affected sibling (IV-2). The parents were tested and the 
same heterozygous mutation was also found in the mother (III-2).
However, this sequence change could not be the disease-causing 
mutation since it was not found in the younger sister (IV-2). Using 
Ras I that generates fragments of 103 and 20bp sizes, the parents,
III-1, and III-2, along with the affected siblings IV-1 and IV-2, were
analysed. The restriction analysis (Figure 7) confirmed the presence 
of the mutant allele in the proband (IV-1) and the mother (III-2) 
only.
Screening the exons of RPE65 for mutations was performed using
single stranded conformation analysis followed by manual sequencing
of genomic PCR amplimers, as per previously published sets of
4
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Fig. 6. Sequence surrounding
nucleotide 1615 of GUCY2D in
proband IV-1 (upper) and a normal
control (lower). Arrow indicates the
mutant base, which is heterozygous
in the proband IV-1.
Fig. 7. Restriction analysis of the
GUCY2D sequence variation. The
forward oligonucleotide for exon 7
as per published data (Perrault et al.,
1996) and the new (antisense) oligo
5¢ CCG TCTTGG TTG CTG GGC
GTA 3¢ were used for amplification.
Amplimers were digested with RasI
and analyzed on a 1% agarose gel.
The affected older sibling IV-1 and
the unaffected mother III-2 carry the
mutated alele and a normal allele,
while the younger affected sibling
IV-2 and the unaffected father III-1
carry the normal alleles.
primers.30 Sequencing revealed (Figure 8) homozygosity for a nonsense
mutation at nucleotide 304 (G > T) in both affected siblings (IV-1 and
IV-2) leading to the conversion of a glutamic acid into a premature stop
at codon 102 (E102X). This causes truncation of 80% of the C-termi-
nal domain. Since the mutant sequence did not contain any restriction
sites, new primers were designed to generate a novel EcoRI site in
amplimers of wild-type DNA, which is absent in amplimers of mutant
DNA. Using this approach, heterozygosity for this mutation was con-
firmed in the parents III-1 and III-2 (Figure 9).This homozygous muta-
tion is very likely the primary cause of LCA in both siblings as it
segregates with the disease phenotype.
AIPL1, RPGRIP1, and CRX were also screened in the probands in
an effort to identify other modulating factors. However, no sequence
variants were detected.
The mother, who was a double heterozygote for the RPE65 and
GUCY2D mutations, was further subjected to a complete eye exami-
nation and ERG, in accordance with the ISCEV criteria, and was found
to be phenotypically normal.
Discussion Both retinal guanylate cyclase and the RPE65 protein
are involved in different aspects of photoreceptor function. The former
is necessary for the recovery of the dark state after photoexcitation,
while RPE65 is important in retinoid metabolism. GUCY2D in the
photoreceptor outer segments plays a pivotal role in phototransduc-
tion. It is stimulated by guanylate cyclase activating protein (GCAP)
at low calcium concentration to resynthesise cGMP depleted by light.31
Mutations in GUCY2D prevent the restoration of the basal level of
cGMP in photoreceptor cells, along with the permanent closure of the
cGMP gated cation channels.11 Evidence suggests that the heterozy-
gous GUCY2D mutation in this family acts as a modifier in the back-
ground of the RPE65 mutation and leads to a more severe phenotype
in the proband (IV-1).
6
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Fig. 8. Sequence surrounding
nucleotide 304 of RPE65 in the
proband IV-1 and the affected sister
IV-2 showing the homozygous
change G Æ T (top). Heterozygous
change observed in both
consanguineous parents III-1&2
(middle), and a normal control
(below). Arrow indicates the mutant
base, which is homozygous in both
IV-1 and IV-2.
Fig. 9. Restriction analysis of the
RPE65 mutation. A new set of
primers (5¢acatgggctctacggattgctcct3¢,
5¢cttgcagggatctggaaagcacaggtgccgaa3¢)
were used. The amplimers were
digested with EcoRI and analyzed
on a 1% agarose gel. Both affected
siblings IV-1 and IV-2 carry two
mutated alleles, while their parents
(III-1 and III-2) carry both a normal
and a mutated allele.
The sequence change in GUCY2D alters the highly conserved
protein kinase-homology domain of retinyl guanylate cyclase that
binds ATP and specifies the affinity and cooperativity of interaction
with (GCAP2) guanylyl cyclase activating protein 2.32 The isoleucine
of GUCY2D at position 539 is conserved in several species, including
Bos taurus, Canis familiaris, Rattus norvegicus, and Mus musculus.
Furthermore, this amino acid is also conserved in other members of 
the membrane guanylyl cyclase family including the natriuretic peptide
receptors NPR-A and NPR-B, the intestinal receptor for E. coli heat
stable enterotoxin Sta Receptor, and the sea urchin sperm guanylyl
cyclase.33 This sequence change in GUCY2D occurs in exon 7, which is
part of the kinase homology domain of the gene.A heterozygous muta-
tion Arg540Cys in a Dutch patient with LCA has also been detected
in exon seven.34 Heterozygous mutations in GUCY2D lead to autoso-
mal dominant cone-rod dystrophy.35,36
Most importantly, the change in GUCY2D not being present in the
second affected sibling (IV-2) precludes to better visual function. In the
absence of further detriment in the background of a null mutation, both
the severity and the progress of the disease do not follow the same
course as seen in the older sibling (IV-1) who harbors sequence alter-
ations in two genes. Functional studies are currently underway to eval-
uate the potential impact of this mutation in an in vitro model. It is
likely that the heterozygous GUCY2D mutation appears to further
disrupt the already severely compromised photoreceptor metabolism.
8
9
Sharola BW.indd   173 29-May-07   10:46:16 AM
174
The retinal pigment epithelium, besides being involved in photore-
ceptor renewal, maintainence, and survival, is also important for
retinoid metabolism and photo recovery. Recycling of 11cis-retinal
occurs in the retinal pigment epithelium. During phototransduction,11-
cis-retinal is converted to all-trans-retinal. However, the regeneration
of 11-cis-retinal from all-trans-retinal is possible only in the pigment
epithelium where retinal isomerase is present.37 RPE65 participates 
in the visual cycle, and mutations in RPE65 disrupt the synthesis of 
11-cis-retinal, resulting in the absence of both 11-cis-retinal and
rhodopsin with accumualation of retinyl esters.25 Rpe65 specifically
binds to all-trans-retinyl esters in the membrane of the endoplasmic
reticulum and presents these esters as substrate to the enzyme iso-
merase for synthesis of the 11-cis-retinol. The conversion of 11-cis-
retinol to 11-cis-retinal is achieved through the action of 11-cis-retinal
dehydogenase.38
The cone degeneration observed in these patients may also be due
to the presence of a similair pathway in cones.39,40 The homozygous
mutation E102X, in exon 4 of RPE65 detected in both the affected indi-
viduals of this family, leads to a gene product with little or no residual
function. Mutations in RPE65 could explain the dysfunctional status
due mainly to the absence of the visual chromophore in the retina to
complete the visual cycle as RPE65 is essential for the regeneration of
rhodopsin.
A missense mutation in the same position (Glu102 Lys) risen as a
new mutation in combination with another inherited missense muta-
tion (Arg 91 Trp) has been associated with LCA.30 The residual func-
tion of the mutant alleles is inadequate to sustain the visual cycle in the
retinal pigment epithelium. This causes a marked decrease in rod sen-
sitivity.41 Unlike rods, cones appear to be able to take up and oxidise
11-cis retinol to regenerate the active photopigment through Muller
cells.42 Cone survival may also depend on rod-derived factors, and cell-
cell interactions are known to play a vital role coordinating photore-
ceptor development and survival.43 Each cone is surrounded by a
glycocalyx that creates a structural microdomain linking each cone to
a retinal pigment epithelial cell.This close interdependence and the fact
that retGC-1 is more highly expressed in cones44 could also explain why
cone survival is further compromised by the GUCY2D mutation in an
environment of altered retinal pigment epithelial function.
Variable expression of the LCA phenotype in a large genetic isolate
has been observed in patients with RPE65 mutations.45 However, since
all the additional LCA genes were not analysed in that study, it may
be more difficult to postulate that the phenotype was solely dictated
by the disease-causing RPE65 mutation.45 ERG changes, notable for
decreased cone photopic waves, has been observed in heterozygous
carriers of GUCY2D-related LCA,46 but this was not observed in the
carriers of this study. ERG changes, notably cone flicker timing delay,
combined with fundoscopic changes similair to fundus albipuctatens,
have been detected in carriers of RPE65-related LCA,47 however,
neither was detectable in this study. Sequence variants in more than
one LCA gene have been observed, and the pathogenic significance is
being analysed.48
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Genotyping Microarray (Disease Chip) for Leber
Congenital Amaurosis: Detection of Modifier Alleles
Jana Zernant,1,2 Maigi Ku¨lm,2,3 Sharola Dharmaraj,4 Anneke I. den Hollander,5
Isabelle Perrault,6 Markus N. Preising,7 Birgit Lorenz,7 Josseline Kaplan,6
Frans P. M. Cremers,5 Irene Maumenee,8 Robert K. Koenekoop,9 and Rando Allikmets1,10
PURPOSE. Leber congenital amaurosis (LCA) is an early-onset
inherited disorder of childhood blindness characterized by
visual impairment noted soon after birth. Variants in at least six
genes (AIPL1, CRB1, CRX, GUCY2D, RPE65, and RPGRIP1)
have been associated with a diagnosis consistent with LCA or
early-onset retinitis pigmentosa (RP). Genetically heteroge-
neous inheritance complicates the analyses of LCA cases, es-
pecially in patients without a family history of the disorder, and
conventional methods are of limited value.
METHODS. To overcome these limitations, arrayed primer ex-
tension (APEX) technology was used to design a genotyping
microarray for early-onset, severe retinal degenerations that
includes all of the 300 disease-associated variants currently
described in eight genes (in addition to the six just listed, the
early-onset RP genes LRAT and MERTK were added). The
resultant LCA array allows simultaneous detection of all known
disease-associated alleles in any patient with early-onset RP.
The array was validated by screening 93 confirmed patients
with LCA who had known mutations. Subsequently, 205 novel
LCA cases were screened on the array, followed by segregation
analyses in families, if applicable.
RESULTS. The microarray was 99% effective in determining
the existing genetic variation and yielded at least one disease-
associated allele in approximately one third of the novel pa-
tients. More than two (expected) variants were discovered in a
substantial fraction (22/300) of the patients, suggesting a mod-
ifier effect from more than one gene. In support of the latter
hypothesis, the third allele segregated with a more severe
disease phenotype in at least five families.
CONCLUSIONS. The LCA genotyping microarray is a robust and
cost-effective screening tool, representing the prototype of a
disease chip for genotyping patients with a genetically heter-
ogeneous condition. Simultaneous screening for all known
LCA-associated variants in large LCA cohorts allows systematic
detection and analysis of genetic variation, facilitating prospec-
tive diagnosis and ultimately predicting disease progression.
(Invest Ophthalmol Vis Sci. 2005;46:3052–3059) DOI:
10.1167/iovs.05-0111
L eber congenital amaurosis (LCA) defines a clinically andgenetically heterogeneous group of congenitally blind pa-
tients. It is diagnosed as an early-onset, bilateral retinal dystro-
phy associated with a severely diminished or absent electro-
retinogram (ERG) before the age of 1 year.1 Shortly after birth,
patients usually present with poor fixation, nystagmus, photo-
phobia, and amaurotic pupils. Later, in most patients, a large
variety of retinal changes appear, including salt-and-pepper
pigmentation, attenuated vessels, and atrophy of the retinal
pigment epithelium (RPE). LCA is mostly inherited as an auto-
somal recessive, genetically heterogeneous (multigenic) disor-
der. Mutations in at least eight genes have been associated with
the retinal pathology consistent with the diagnosis of LCA
and/or early-onset RP. Since the identification of guanylate
cyclase 2D (GUCY2D)2 in 1996 as the first LCA gene, muta-
tions in five more genes—AIPL1, CRB1, CRX, RPE65, and
RPGRIP1—have been shown to cause LCA.3,4 Variant alleles in
some other genes, such as LRAT, MERTK, PROML1, and
TULP1 have been described in patients with early-onset RP.
Altogether, our current knowledge explains 50% of the ge-
netic causality of LCA.5
Clinical and genetic heterogeneity has substantially compli-
cated the assessment of the genetic determinants in LCA cases,
especially the sporadic ones. Disease-associated alleles in the
six major genes have shown substantial heterogeneity. Cur-
rently,300 disease-associated variants have been identified in
all known LCA-associated genes; however, only a few of these
alleles have been detected in more than 1 or 2 families. After
tedious screening with single-strand conformational polymor-
phism (SSCP) analysis, denaturing high-performance liquid
chromatography (DHPLC), and direct sequencing, the most
comprehensive studies have been able to determine from
28%6,7 to 45%5 of all disease-causing alleles. Important
factors that influence mutation analysis are the effort and the
cost of screening all LCA-associated genes. Currently, mutation
analysis involves screening at least 80 amplicons (exons) that
encompass the entire open reading frames of the eight genes.
Therefore, all available mutation detection techniques remain
labor intensive, time consuming, and expensive.
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To overcome these challenges and to generate a high vol-
ume, cost-effective, and efficient screening tool, we developed
the LCA genotyping microarray. The LCA array contains all
currently known (300) disease-associated genetic variants
and several common polymorphisms from eight genes in-
volved in early-onset severe retinal dystrophies (Supplemen-
tary Table S1, http://www.iovs.org/cgi/content/full/46/9/
3052/DC1). In this report, we describe the efficiency of the
chip for the genetic analysis of LCA and discuss several appli-
cations made possible by the array.
METHODS
Study Subjects
LCA patient cohorts (298 unrelated individuals) were derived from two
locations in North America: Wilmer Eye Institute (Johns Hopkins Uni-
versity, Baltimore, MD) and Montreal Children’s Hospital (Montreal,
Quebec, Canada); and from two centers in Europe: University Medical
Centre (Nijmegen, The Netherlands); and Hoˆpital Des Enfants Malades
(Paris, France). The Nijmegen Center cohort included patients from
Germany, the Netherlands, and Belgium. Of the 298 patients, 93 had
been screened for mutations in six LCA genes at the four centers. The
remaining 205 patients, recruited at the U.S., Canadian, and Dutch
centers, had not been screened. Collections of matched control sam-
ples (200 unrelated individuals) were ascertained at the same locations.
Research procedures were in accordance with institutional guidelines
and the Declaration of Helsinki. Informed consent was obtained at
each Center from all patients after the nature of procedures to be
performed was fully explained.
A more detailed description of clinical procedures has been pub-
lished.5,8 Briefly, the inclusion criteria for patients with LCA were the
following: (1) onset of symptoms—that is, severe impairment of visual
function in early infancy; (2) nondetectable or severely diminished
ERG before the age of 1 year; and (3) an absence of systemic disease
features. Collected detailed clinical data included the age of onset,
history of the patient and family (compatible with autosomal recessive
inheritance), visual acuity (if measurable), electroretinography, and
fundus photography. Detailed interviews with parents (and patients, if
applicable) were conducted, and pedigrees were established.
Molecular Methods
Sixty amplicons from eight genes were PCR amplified, as described
previously.9 Primer sequences are available on request. In the amplifi-
cation mixture, 20% of the dTTP was substituted by dUTP.10 The
amplification products were concentrated and purified (GENErALL
PCR kit; General Biosystems, Inc., Seoul, Korea). The fragmentation of
amplification products was achieved by adding thermolabile uracil
N-glycosylase (Epicenter Technologies, Madison, WI) and the follow-
ing heat treatment.10
One-sixth of every amplification product was used in the primer
extension reaction on the LCA array. Each arrayed primer extension
(APEX) reaction consisted of a fragmented and denatured PCR prod-
uct, 4 units of DNA Polymerase (ThermoSequenase; GE Healthcare,
Piscataway, NJ), 1 reaction buffer, and 1.4 M final concentration of
each fluorescently labeled ddNTP: Texas red-ddATP, fluorescein-
ddGTP (GE Healthcare), Cy3-ddCTP, and Cy5-ddUTP (NEN; Boston,
MA). The reaction mixture was applied to a microarray slide for 15
minutes at 58°C. The reaction was stopped by washing the slide at
95°C in double-distilled water (Milli-Q; Millipore, Bedford, MA).11 The
slides were imaged (Genorama QuattroImager; Asper Biotech, Ltd.,
Tartu, Estonia) and the sequence variants were identified with a com-
puter program (Genorama Genotyping Software; Asper Biotech,
Ltd.).9,12
Array-identified variants were confirmed by direct sequencing with
dye termination chemistry (Taq Dyedeoxy Terminator Cycle Sequenc-
ing kit; Applied Biosystems, Inc. [ABI], Foster, City, CA), according to
the manufacturer’s instructions. Sequencing reactions were resolved
on an automated sequencer (model 377; ABI).
Electronic Databases
Databases used in the study included Online Mendelian Inheritance in
Man (OMIM), http://www.ncbi.nlm.nih.gov/omim (National Center
for Biotechnology Information, National Institutes of health, Bethesda,
MD); RetNet Retinal Information Network, http://www.sph.uth.tm-
c.edu/Retnet/home.htm (University of Texas Houston Health Science
Center, Houston, TX); The Genome Database (GDB), http://gdbww-
w.gdb.org/gdb/ (RTI International, Research Triangle Park, NC); and
the Retina International Scientific Newsletter Mutation Database:
http://www.retina-international.org/sci-news/mutation.htm (main-
tained by Markus Preising, Molecular Genetics Laboratory, University
of Regensburg, Regensburg, Germany).
RESULTS
Design of the LCA Microarray
Microarrays were designed and manufactured with APEX tech-
nology.13,14 A detailed description of the methodology is avail-
able elsewhere (www.asperbio.com; Asper Biotech, Ltd.).10,12
Briefly, 5-modified, sequence-specific oligonucleotides are ar-
rayed on a glass slide. In general, these oligonucleotides are
designed with their 3 end immediately adjacent to the variable
site. PCR-prepared and -fragmented target nucleic acids are
annealed to oligonucleotides on the slide, followed by se-
quence-specific extension of the 3 ends of primers with dye-
labeled nucleotide analogues (ddNTPs) by DNA polymerase.
The APEX reaction is, in essence, a sequencing reaction on a
solid support.
One advantage of APEX, compared with other common
microarray-based techniques, such as hybridization with allele-
specific oligonucleotide probes, is that all variable nucleotides
are identified with optimal discrimination at the same reaction
conditions, rendering this approach far more specific for mul-
tiplex mutation detection.15 This method successfully detects
single-nucleotide polymorphisms (SNPs), deletions, and inser-
tions in heterozygous and homozygous patient samples.11,12
APEX also permits at least one order of magnitude higher
power of discrimination between genotypes, when compared
with hybridization-based techniques.15 Template-dependent
extension reactions with four uniquely dye-labeled ddNTPs
yield covalent bonds between an oligonucleotide and a dye
terminator. This allows stringent washing of slides after APEX,
yielding minimal background signal. The time required for
complete APEX analysis, including sample preparation, is less
than 4 hours. Once designed, these microarrays can be modi-
fied (upgraded) easily with new variants.
By systematic analysis of all published, reported, and com-
municated data, we compiled the most comprehensive data-
base of LCA-associated variants (Supplementary Table S1). The
number of sequence changes currently considered disease-
associated exceeds 300. By design, we included on this chip all
variants from the coding region and adjacent intronic se-
quences of the eight LCA/early-onset RP genes: AIPL1, CRB1,
CRX, GUCY2D, RPE65, RPGRIP1, MERTK, and LRAT. Intronic
sequences were included only in cases with predicted or doc-
umented involvement in splicing. Several common polymor-
phisms were also included, mainly from the coding regions
(K192E and E1033Q in RPGRIP1, A52S and L782H in
GUCY2D, D90H in AIPL1), to facilitate haplotype assignments.
The resultant LCA microarray contains 307 variants (Supple-
mentary Table S1, Table 1). Each sequence change was de-
signed to be queried in duplicate from each sense and anti-
sense strand by the software (Genorama Genotyping Software;
Asper Biotech, Ltd.).
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Validation of the LCA Array
Validation of the array served a dual purpose: to estimate the
efficiency of the array in detecting variants on the chip by
screening samples with known variants and to gauge its effi-
ciency in detecting disease-associated alleles in LCA cohorts,
compared with other methods, such as SSCP and direct se-
quencing. The overall efficiency of the array was enhanced by
designing primers with mismatched or modified bases for sev-
eral variants where sequence presented additional challenges
(e.g., hairpin loops, and repeats). Currently, all 307 variants are
detected by the latest version of the chip; 294 positions are
detected from both strands, whereas 13 (4.2%) variants are
detected reliably from one strand. Since the same oligonucle-
otides detect both mutant and wild-type (wt) sequence, these
data were obtained with positive controls for 102 variants and
with wt (control) DNA for the rest.
The array, which originally contained 267 variants, was
validated in a cohort of 93 confirmed LCA samples collected at
the four centers. The initial screening by SSCP or DHPLC had
resulted in the detection of 99 variants that were deemed
disease-associated by confirmed clinical assessment and segre-
gation analysis.17,21,22 These comprised 145 alleles (78%) and 5
“modifier” variants (the third sequence change in a different
gene from the causal) in 99 positions. Four variants, which had
been described by SSCP/DHPLC gave a wt signal on the array;
these results were confirmed by direct sequencing. Most likely,
these represent false-positive results due to an experimental
error.
The microarray screening detected 20 additional alleles
missed by other methods and found new changes in 15 of the
93 samples, bringing the total to 154 alleles and 16 “modifier”
variants in 105 positions. The six variants missed (or not
described) in studies employing SSCP/DHPLC methods in-
cluded the V96I change in AIPL1, the R769Q and R1331H
variants in CRB1, the A132T change in RPE65 , the D1114G
change in RPGRIP1, and the del V1020_L1022 variant in
GUCY2D. Altogether, the LCA array identified 83% of all
known disease-associated alleles in this preselected cohort. All
variants detected by the array were confirmed by direct se-
quencing, and no conflicting sense/antisense calls or false
positives were identified; i.e., all variants included on the array
are detected with 100% accuracy.
Screening Test Populations on the
LCA Microarray
To evaluate the LCA array further, we screened 205 previously
unanalyzed patients with LCA of diverse ethnicity derived from
three of the four participating centers. At each center, the best
effort was made to avoid phenocopies and cases with ques-
tionable diagnoses. In each North American cohort, the eth-
nicity of subjects was mostly consistent with “European Amer-
ican”; however, approximately one-third of the samples
originated from Asian ethnic groups (e.g., Indian, Pakistani,
Iranian). The European cohort mainly contained patient sam-
ples from Germany, The Netherlands, and Belgium. The chip
screening results for these cohorts are summarized in Table 2.
The screening efficiency of the LCA array was remarkably
similar in all three cohorts, yielding from 20.3% (the Cana-
dian sample) to 23.8% (the U.S. sample) of all possible disease-
associated LCA alleles (Table 2). The LCA array detected at least
one disease-associated allele in approximately one third of
patients. The remarkably similar mutation detection rate in all
cohorts suggests a similar frequency of known disease-associ-
ated LCA alleles across all populations. However, the frequency
of individual alleles showed substantial differences between
the screened patient populations. For example, mutations
were frequent in the AIPL1 gene in the Dutch cohort (20%),
but very rare in the cohort from Baltimore. At the same time,
CRB1 alleles accounted for the LCA phenotype in 8.5% of cases
from Baltimore, but they were not detected at all in the Nijme-
gen cohort included in this study. However, in an independent
cohort from the same center, CRB1 mutations were a frequent
cause of LCA (Cremers F, unpublished data, July 2005). Dis-
ease-associated alleles from GUCY2D and RPGRIP1 were rela-
tively evenly distributed across all cohorts. Almost no muta-
tions were found in the CRX and RPE65 genes in the entire
TABLE 1. Genetic Variation in LCA Genes
LCA Gene Exons Amplicons
Known
Mutations
Mutation
Frequency
in LCA
(%)
LCA
Array
(%)
AIPL1 6 6 25 5.816* 7.8
3.45
CRB1 12 13 68 9.0–13.517,18 5.4
10.05
CRX 3 3 29 2.019 1.5
2.820
0.65
GUCY2D 20 14 67 6.06,21 11.7
20.322
21.25
RPE65 14 10 81 6.86 2.4
8.223
11.424 15.625
6.15
RPGRIP1 24 18 32 5.326 4.9
5.627
4.55
Total 79 64 302 33.7
* Mutation frequencies are shown with the reference sources.
TABLE 2. Screening Efficiency of the LCA Array in Three Patient Cohorts
Gene
Nijmegen, The Netherlands
41 Patients (82 Alleles)
Montreal, Canada
59 Patients (118 Alleles)
Baltimore, MD
105 Patients (210 Alleles)
Patients Alleles % Patients Alleles % Patients Alleles %
AIPL1 8 10 19.5 4 6 6.8 4 6 2.9
CRB1 0 0 0 2 2 3.4 9 14 8.6
CRX 0 0 0 1 1 1.7 2 2 1.9
GUCY2D 4 4 9.8 8 11 13.6 12 17 11.4
RPE65 0 0 0 1 1 1.7 4 5 3.8
RPGRIP1 2 3 4.9 2 3 3.4 6 6 5.7
Total 14
(34%)
17
(20.7%)
34 18
(30.5%)
24
(20.3%)
30 37
(35%)
50
(23.8%)
35
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screened patient population, although the RPE65 gene is rep-
resented on the array by the largest number (81) of alleles
(Supplementary Table S1; Table 1). This observation suggests
that allelic variation in the RPE65 and CRX genes is more likely
associated with the diagnosis of early-onset severe retinal dys-
trophies rather than with LCA, if characterized by strict crite-
ria.5
Three variants were found in all three patient cohorts. The
most frequent allele in the Dutch cohort, W278X in AIPL1
(29% of all alleles found), was detected once in Canadian
samples and twice in samples from Baltimore (both 4%).
C948Y in CRB1 and P701S in GUCY2D had similar frequencies
in all the three sample cohorts, 6% to 8% and 11% to 12%,
respectively, whereas P701S was also the most frequent allele
in Canadian samples. The CRB1 variant 611_617 delAAATAGG
was the most frequent allele in samples from Baltimore (14% of
alleles), but was completely absent in other cohorts. The seg-
regation of this mutation with the disease in families of Puerto-
Rican origin clearly suggests a founder effect. The Canadian
cohort showed the highest heterogeneity —17 different vari-
ants accounting for 24 disease-associated alleles. In the Dutch
samples, we found 17 alleles (8 different variants), whereas 50
alleles (23 individual variants) were detected in the Baltimore
cohort. In summary, comprehensive microarray analysis cur-
rently allowed the identification of the causal gene in approx-
imately one third of all LCA samples.
The pathogenicity of alleles on the chip was inferred from
all available published data and further analyses of specific
alleles in this study. All alleles, except for a small selection of
clearly defined common polymorphisms, had been defined as
“disease-associated” by a combination of criteria applied to all
genetic studies, including: (1) the cosegregation of an allele
with the disease phenotype in a family; (2) the absence of the
allele in a substantial number (200 chromosomes) of subjects
defined as “general population”; and (3) the determined or
deducted effect of a variant on the protein function. However,
even including all these, several alleles cannot be called highly
penetrant and/or 100% disease associated. These fall into two
major categories: The first group includes those variants de-
tected only once in a patient with LCA, which should be called
“rare variants” by most strict criteria, unless definite informa-
tion on a functional consequence of a sequence change is
available. Analyses by mutagenesis to assess the effect of vari-
ous alleles on the protein function have been performed for
GUCY2D,28–31 AIPL1,32,33 and CRX,34,35 but these studies
have examined a limited number of alleles in tests that are
often not directly coupled to the (proposed) protein function.
The second group includes a few variants, with higher than
expected frequencies in the general population for a highly
penetrant allele. Some variants from this category include the
D1114G variant in RPGRIP1 and the P701S missense change in
GUCY2D. For example, the allele frequency of the P701S
variant in the general population of white origin is 2%. If this
variant were disease-associated with complete penetrance, the
disease prevalence for GUCY2D-associated LCA alone would
be 1 in 2500, at least 20 times more than observed. We
detected this variant in 5% of patients with LCA, including
three homozygous probands derived from extended families of
Iranian origin. Segregation analyses confirmed that the P701S
variant cosegregated with the disease in all three extended
pedigrees, one of which (LCA-108) is shown in Figure 1.
Moreover, patient IV-3 from this pedigree was heterozygous
for P701S. Direct sequencing of the GUCY2D gene in this
patient revealed another, previously unknown, missense allele
H945R on the other chromosome, further supporting the con-
clusion that GUCY2D is the disease gene in this family. Another
explanation for the P701S allele’s being disease associated in
Iranians is the founder effect—that is, the possibility of another
variant’s being in cis with P701S in Iranians, but not in other
populations. However, we did not find any other variants in
GUCY2D on the same chromosome with P701S. In conclusion,
our current data—complete segregation of this variant with
the disease in three extended pedigrees, lack of nonsymptom-
atic homozygotes, and compound heterozygosity in one pa-
tient—support P701S as being associated with LCA, at least in
some populations.
Multiple Alleles in Patients with LCA, Suggesting
Modifiers of the LCA Phenotype
Screening on the LCA chip revealed multiple cases in which
possibly disease-associated alleles were detected in more than
one gene in one patient. These included 12 cases in which
heterozygous alleles from two genes were found, and 10 cases
in which homozygous or compound heterozygous variants
from one gene were detected, together with a heterozygous
allele from a different LCA gene—a total of 22 of 300 (7.3%).
The odds of detecting a third allele by chance can be
calculated as follows. The incidence of LCA is estimated to be
between 1 in 50,000 and 1 in 100,000 persons (i.e., approxi-
mately 1/75,000). Assuming that six LCA genes account for
approximately 50% of the cases, we could expect a total of 12
LCA genes, resulting in 1 in 900,000 individuals harboring a
specific genetic form of LCA. This means that 1 in 225,000
marriages is at risk, and that 1 in 474 individuals carry a specific
LCA-associated genetic defect. Therefore, it is expected that 12
of 474, or 1 in 40, individuals are carriers of a disease-causing
LCA mutation by chance. Consequently, in this study we ex-
pected to find 300/40/2, or 3 patients, with LCA who carry a
disease-causing mutation by chance alone. The same result is
obtained by using the Hardy-Weinberg equilibrium and basic
binomial statistics. However, we detected a modifier allele in
22 cases, a statistically significant difference (P  0.0001;
Fisher exact test). An inclusion of a more prevalent allele in the
analysis, such as the GUCY2D P701S variant described earlier,
would increase (double) the number of expected modifier
alleles. The data shown in the previous section strongly suggest
at least a modifier, if not a causal, status for P701S, which
justifies the inclusion of this allele in the statistical analyses.
Moreover, it would not change the conclusion that the fre-
quency of detection of the modifier alleles by the array is
significantly different from that expected by chance alone.
Unfortunately, nearly all of these cases were sporadic or
simplex, and no other siblings were available for segregation
analysis and/or phenotype comparison. Five families with
more than two LCA-associated alleles and multiple affected
individuals were available for detailed clinical and genetic anal-
ysis (Fig. 2).
FIGURE 1. Pedigree of a family segregating LCA with the GUCY2D
P701S variant.
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In a family of Palestinian origin, LCA-001 (Fig. 2A), the
homozygous Q163X allele of the AIPL1 gene segregated with
the disease. An additional T273L missense allele from CRX was
detected in patient II-2. LCA was diagnosed in the affected
proband (II-2) in early infancy with a severely diminished ERG.
The presence of keratoconus and cataracts was noted by the
end of the first decade of life. There was a history of night
blindness, and the visual acuity was light perception (LP) in
both eyes. Retinal examination showed pale optic discs, arte-
riolar attenuation, and marked intraretinal pigment migration.
Atrophic changes were seen in the macula, and the foveal
reflex was ill defined. Individual II-4, who did not harbor the
CRX T273L allele, presented with a similar phenotype, al-
though he was clearly less severely affected than II-2 at a
comparable age.
In a consanguineous Greek family, LCA-201, the disease
phenotype was caused by a homozygous E102X RPE65 muta-
tion (Fig. 2B). The older sibling (III-1) had inherited an addi-
tional GUCY2D I573V variant from her mother. Because the
mother is asymptomatic, we can exclude multiallelic inheri-
tance; however, the older sister with three alleles clearly had a
more severe visual dysfunction than did her younger sibling
(III-2) at a comparable age. Specifically, at age 23, the older
sibling (III-1) had best corrected visual acuity of 20/1300
(0.015) in both eyes, very limited visual fields by confrontation,
night blindness, sluggish pupils, and roving nystagmus. The
fundus examination revealed pale optic discs, dull macular
reflexes with diffuse yellowish stippling, significant arteriolar
attenuation, and considerable peripheral pigmentary changes.
At a similar age, the younger sibling (patient III-2) had a visual
acuity of 20/400 (0.05) in both eyes, with less-pronounced
nystagmus. Ophthalmoscopic examination revealed mild arte-
riolar attenuation with areas of pigment clumping and atrophy
in the macula, in addition to generalized mottling of the retina.
However, unlike her older sibling, she was able to read normal-
sized newsprint with the aid of a magnifying device and to
navigate independently.36
In a consanguineous family from India, LCA-283, a homozy-
gous R302L variant of the AIPL1 gene cosegregated with the
disease (Fig. 2C). Of the three affected members, one (IV-1)
harbored an additional CRB1 R1331H allele. This patient’s
phenotype was advanced compared with her sister’s (IV-2).
Specifically, her retinal features included chorioretinal atrophy,
extensive pigmentary mottling, narrowing of retinal arterioles,
and stippling of the macula, with (extensive) areas of atrophy.
In addition, she had severe keratoconus and cortical cataracts.
Her younger sister, examined at a comparable age, had only a
few peripheral bone-spicule–like pigmentary deposits and tiny
areas of pigmentary atrophy and stippling in the macular re-
gion, moderate keratoconus, and clear lenses. Their cousin
(IV-5), who also did not have the third allele, was younger at
the time of clinical examination, excluding a direct phenotypic
comparison.
In an extended pedigree belonging to the Old Order River
Brethren, a religious isolate of Swiss descent residing in eastern
Pennsylvania (LCA-180; Fig. 2D), the disease-causing gene had
been linked to a new locus on 6q14.37 Of the two affected
siblings, one had inherited an additional GUCY2D P701S al-
lele.21 When compared at the same age, the sibling with three
alleles presented with a more severe ocular phenotype and
experienced greater difficulty with decreased visual function.
Retinal examination revealed higher hyperopia and more ex-
tensive peripheral pigmentary mottling.
Finally, in a Puerto-Rican family (LCA-064, Fig. 2E), the LCA
phenotype was caused by a homozygous S448X nonsense
mutation in GUCY2D in a single affected child. Although the
patient had no affected siblings, the phenotype was not con-
sistent with the usual one in GUCY2D-associated cases.5,38 It
appears to have been modified by an additional CRX allele,
A158T, which resulted in the development of a prominent
macular coloboma in both eyes. Most recently,38 we reviewed
the clinical phenotype of 28 patients with LCA from three
independent studies, who had GUCY2D mutations and found
that none of them had documented maculopathy, whereas we
found that most of the patients with LCA with CRX mutations
have maculopathy or macular coloboma.
In summary, these cases, although limited to five families,
offer the first clues to how alleles from other than the primary
disease-causing LCA gene can modify the disease presentation.
The fact that heterozygous alleles from LCA genes can have a
FIGURE 2. LCA pedigrees harboring
mutant alleles from more than one
LCA gene.
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modifying effect on the disease expression is further supported
by observations that heterozygous carriers of LCA-associated
genes, such as parents of patients with LCA with CRB1,
GUCY2D, AIPL1, and RPGRIP1 mutations, who can have mild,
but clearly detectable by ERG, defects of visual processes38,39
(Koenekoop RK, unpublished data, July 2005).
DISCUSSION
We designed and validated a comprehensive mutation-detec-
tion system for Leber congenital amaurosis, the “disease chip”
which contains all known disease-associated genetic variations
in eight genes. The DNA from 300 patients, who had phe-
notypes consistent with LCA, was screened with the array.
Validation included determining the efficiency of detecting
known mutations and the overall efficiency of screening new
cohorts with LCA or early-onset autosomal recessive (ar)RP.
The chip was 100% effective in detecting known variants; 293
positions were reliably detected from both strands and 13
(4.2%) positions from one strand (Supplementary Table S1).
During routine screening, an average 1% of positions on the
chip remained unreliably detected in any given experiment.
This resulted from weak or undetectable signals in some posi-
tions, either due to a weaker PCR product, inefficient hybrid-
ization-extension on a particular oligonucleotide, or from a
combination of both, in some experiments. Therefore, in an
average experiment, the LCA chip’s efficiency can be esti-
mated to be 99%.
The chip alone determined possible disease-associated al-
leles in approximately one third of patients with LCA from
novel, previously unscreened cohorts. These results suggest
that the LCA array is an efficient screening tool for known
variants and that its efficiency for screening patient popula-
tions with LCA is comparable to other methods, but substan-
tially (10 times) faster, much cheaper, and less labor inten-
sive. The LCA array supplies several major applications,
including (1) quick and affordable (pre-) screening of all pa-
tients with a clinical diagnosis of LCA, allowing the pinpointing
of the disease-causing gene in 30% of patients with LCA; (2)
confirmation of the clinical diagnosis and selection of applica-
ble patients for emerging clinical trials (e.g., for those with
RPE65 mutations); and (3) simultaneous screening for all
known LCA-associated variants in large LCA cohorts, for sys-
tematic detection and analysis of genetic variation, including
modifier alleles, therefore facilitating prospective diagnosis and
predicting disease progression.
Efficiency of the LCA Array
Because by design the LCA array detects only known variants,
the expected efficiency of the chip can be calculated based on
several assumptions: (1) the number of patients with LCA
screened for new mutations from each ethnic group (i.e.,
whether the array is representative of any given population);
(2) the average fraction of alleles that are expected to be found
by direct sequencing; and (3) the estimated number of yet
unknown alleles for any ethnic group. For example, recent
studies screening sizable cohorts of patients with LCA have
detected LCA-associated alleles in the six major genes from
28%7 to 44% to 45%5 of all screened patients with LCA.
Assuming that, in the six genes, an average of 40% of the
mutations remain to be discovered across all populations of
European descent and that no more than 45% of all possible
alleles can be detected even by direct sequencing of patients
with LCA,5 the LCA array is currently expected to detect27%
(100  0.6  0.45) of disease-associated alleles in populations
of European origin. The number could be higher in some
populations in which more cases have been screened (Dutch
and French) and lower in the others, in which studies with
limited numbers have been conducted (English and Spanish).
These calculations also assume that all major alleles have been
found in European populations, such as the W278X allele in
AIPL1 and the C948Y allele in CRB1.
The experimental data correlated with theoretical calcula-
tions. The array detected 22% of all possible LCA-associated
alleles in 33% of patients across all cohorts (Table 2). As
expected, in most of the patients, the array detected both
disease-associated alleles, which is the result of the enrichment
of individual alleles in specific ethnic groups due to founder
effects. More robust and closer-to-predicted results are ex-
pected in smaller, carefully characterized cohorts derived from
a single clinical source. In addition, after the completion of the
screening described in this study, we updated the array with
the most recently discovered new gene, RDH1240,41 and 68
new mutations, bringing the total number of alleles on the LCA
array to 370. Therefore, it is reasonable to suggest that the
latest version of the LCA array is even more efficient than the
one described herein.
Comparison to Other Studies and/or Methods
Two classes of mutation-detection methods have been applied
to screening the six genes in LCA cohorts: those involving
separation of PCR products based on conformation changes
(e.g., SSCP, DHPLC) and those directly sequencing the open
reading frames of all six genes. Although direct comparison of
the LCA array’s efficiency in detecting genetic variation in
patients with LCA to these methods is tempting, one should
consider the basic difference between mutation detection
(SSCP, direct sequencing) and genotyping (LCA array) meth-
ods. The former are supposed to detect all variation in analyzed
sequences—the latter, only known variants. However, even
with these restrictions, the efficiency of the LCA array stands
out.
The array routinely detected LCA-associated alleles in ap-
proximately one third (34%) of patients, which is better than
SSCP-based studies,7 and approximately 10% lower than in
studies in which direct sequencing of well-characterized co-
horts was used and in which the average detection rate was
44%. Available data suggest that direct sequencing of patients
with sporadic cases of LCA would currently detect 10%
alleles in addition to those found with the LCA array. However,
the cost and effort involved (160 sequencing reactions per
sample) is at least one order of magnitude higher than with the
chip. Therefore, although direct sequencing of large cohorts of
patients with LCA remains expensive, one could consider se-
lective sequencing of the specific gene in the fraction of all
patients in whom the LCA array currently identifies only one
allele.
When comparing chip screening results with those ob-
tained from various studies in which different screening meth-
ods (mostly SSCP) were used, several interesting observations
emerge (Table 1). First, the fraction of the disease load was
consistent in only three of six genes (AIPL1, CRX, and RP-
GRIP1). Of these, CRX seems to be associated with the lowest
percentage (2%) of LCA cases. The estimated role of the
other three genes, CRB1, GUCY2D, and RPE65, varied widely
from 2.5% to 20% (Table 1). Some variation of a causal gene
load estimated from the analysis in separate cohorts is ex-
pected. The objective reasons include, for example, substantial
differences in the ethnicity of patients with LCA (e.g., the high
incidence, 20%, of GUCY2D alleles in populations of Medi-
terranean origin5) and in screening methods. The LCA array
identifies known alleles, whereas the other methods (e.g.,
SSCP) also detect new variants. However, subjective reasons,
which tend to influence the results even more, include differ-
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ences in clinical diagnostic criteria and in interpreting results
(i.e., determining whether a variant is disease associated, as
discussed earlier). For example, mutations in RPE65 have been
associated with the disease in 2.4% to 15.6% of cases (Table 1).
It has been suggested24 that this reflects differences in defining
the disease phenotype (early-onset RP versus LCA) rather than
the actual variation in the disease phenotype. Another likely
explanation has to do with the screening of relatively small
cohorts in which even a small number of detected alleles
would have a significant impact on the disease load. It is clear,
however, that if a cohort has been ascertained by strict criteria
for LCA and is of sufficient size, the fraction of RPE65-associ-
ated alleles will remain relatively small. Furthermore, these
observations strongly suggest that the molecular screening of
patients with similar diagnoses (e.g., the entire spectrum of
arRP) has to be performed for all RP-associated genes, to
achieve a conclusive diagnosis in each case.
Modifying Effects of Third Alleles
In 22 of 300 patients with LCA, we found variants in more than
one gene. In 10 of these, we found a homozygous defect in one
and a heterozygous defect in a second gene. In five of these
latter cases, we were able to obtain enough clinical informa-
tion and compare the severity and type of phenotypes between
age-matched affected siblings, one with the homozygous de-
fect alone, another with the same homozygous defect plus a
heterozygous defect in another gene. We assume that the
homozygous defect is causal, and we provide evidence that the
heterozygous defect modifies the LCA phenotype by an addi-
tive effect. In four cases, the phenotype was clearly more
severe in the affected individual with the three alleles. In one
case, the phenotype was strikingly different in the affected
patient with three alleles from the reported phenotypes asso-
ciated with this gene (GUCY2D).
SUMMARY
In conclusion, although the assessment of disease-associated
variation in LCA still represents a difficult task for ophthalmol-
ogists and geneticists, the LCA array offers a prototype diag-
nostic tool to advance our knowledge substantially, specifically
in LCA-associated disease and in ophthalmic genetics in gen-
eral. It also represents the first instance in which modifier
alleles can be detected in a single screening reaction, therefore
improving molecular diagnosis and providing more accurate
visual prognosis and suggestions of treatment options. The LCA
disease chip is available to the entire scientific community for
effective, high-throughput, accurate, and affordable screening
of all populations of interest.
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The description of Leber congenital amaurosis (LCA) by Theodor Leber (Leber 1869), although 
valid more than a hundred years later, has numerous caveats. The clinical heterogeneity of 
this disorder has signifi cantly expanded; the high genetic heterogeneity was not anticipated. 
Patients with LCA show a total loss of retinal function as evidenced by the markedly attenuated 
or absent ERG. LCA may be associated with renal, neuronal and skeletal abnormalities, as 
noted in Senior-Løken, Joubert and Saldino-Mainzer syndromes respectively. LCA has been 
shown to be caused by mutations in thirteen genes, each with a different function in the retina 
(Chapter 2).
8.1 A novel locus for LCA: LCA 5
Molecular genetics plays an important role in understanding inherited ocular disease (Musarella 
et al 1992, Petrash et al 1992). The positional candidate gene cloning approach has become 
the predominant method of gene identifi cation (Collins et al 1995). A mostly completed human 
genome sequence is now available and efforts to identify the gene at the LCA5 locus will be 
continued (IHGSC 2004). Using serial analysis of gene tags (SAGE) and expressed sequence 
tags (EST) databases, much information can be gained and more candidate genes will be 
identifi ed. The inosine monophosphate dehydrogenase type 1 (IMPDH1) gene was identifi ed as 
the causative disease gene in ADRP at 7q31.1, using solely murine retinal SAGE data (Bowne 
et al 2002, Blackshaw et al 2001). This gene has recently also been implicated in LCA (Bowne 
et al 2006).
Based on their chromosomal location and expression, GCAP, IMPG1, ELOVL4, LGS, 
POU3F2, GABA, FASH3BL, GAMMA, RIM1 and FKL1370 were screened for mutations without 
success in affected members of the Old Order River Brethren kindred (Chapter 3). Thus far 
1557 genes have been detected on chromosome 6 at the conclusion of the human genome 
project sequencing (Mungall et al 2003). Ninety six percent of the protein coding genes have 
been identifi ed and the chromosome also harbors the largest transfer RNA cluster co-localizing 
with the region of highest transcriptional activity (Mungall et al 2003). This, along with the addi-
tional genetic and molecular information obtained from the ever increasing electronic databases 
on human and other organisms enabled identifi cation of the responsible gene and establish the 
molecular defect.
Very recently the LCA5 gene also known as C6ORF152 has been identifi ed and the encoded 
protein lebercilin localizes to the connecting cilium in rods and cones.
The original critical interval described was about 33 Mb, and contained more than 100 genes 
(Dharmaraj et al 2000). (Chapter 3). A 9 Mb interval containing about 25 genes was identifi ed 
in a non-consanguineous patient using homozygosity mapping (den Hollander et al 2007). Can-
didate genes within this interval were identifi ed in the Ciliary Proteome Database (http://www.
ciliaproteome.org/) and C6ORF152 was screened as it showed weak similarity to CEP290. 
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The shared homozygous haplotype in the 3 Pakistani families was 780-kb and contained only 
3 genes, C6ORF152 being one of them. A large deletion overlapping the promoter and non-
protein coding exon 1 was identifi ed in the affected members of the Old Order River Brethren 
family. Other mutations too have been detected in several affected individuals (den Hollander 
et al 2007).
8.2 Genotype-Phenotype considerations
8.2.1 General observations
Although progress in the understanding of the molecular mechanisms underlying LCA have 
steadily grown, genotype-phenotype correlations are not straightforward. Mutations in the eleven 
known LCA-associated genes, only in rare cases are associated with a distinct phenotype, but 
generally show overlapping phenotypes (Lotery et al 2000, Dharmaraj et al 2000, Hanein et al 
2004, Yzer et al. 2006) (Chapters 4 & 5). CRB1 mutations for instance have been detected in 
RP with PPRPE and also in ARRP without PPRPE, besides causing LCA (den Hollander et al 
2004). As the number of patients in whom both genotypic and phenotypic data being available 
is too small it is often diffi cult to generate statistically signifi cant information.
8.2.2 Locus or gene-based phenotypical characteristics
All LCA genes show a high degree of allelic heterogeneity, which contributes to the huge phe-
notypic variability. (Suthers et al 1992, Riccardi et al 1993). Differences in the phenotypes in two 
kindreds mapping to LCA5 wherein the maculopathy was more pronounced in the Pakistani 
pedigree in comparison to the Old Order River Brethren typify phenotypic variability within a 
locus (Dharmaraj et al 2000, Mohamed et al 2003). This makes both prognosis and the natural 
course of the disease diffi cult to ascertain and genetic counseling more guarded. The pheno-
typic variability seen in patients from these diverse populations mapping to LCA5, further proves 
the diversity of this disease.
RDH12-associated LCA presents as progressive rod-cone degeneration perhaps due to the 
longer survival of cones in these retinas as is also observed in RPE65-associated LCA. Interest-
ingly, both these genes are involved in retinoid metabolism. With the increasing involvement of 
rods in LCA and the longer survival of cones, photopic function may be preserved longer, as 
noted in RDH12, AIPL1 and RPE65–associated LCA. Early rod dysfunction is also noted in the 
carriers of AIPL1-associated LCA (Dharmaraj et al 2004).
RPE65 and TULP1-associated LCA present as severe early onset retinal dystrophies. 
Absence of autofl uorescence is observed in the RPE65-associated phenotype (Lorenz et al 
2004). Photoreceptor function that can be rescued as delineated by the presence of normal 
autofl uorescence in some patients with LCA in the second decade of life has been reported 
(Scholl et al 2004). Increasingly poor vision at night is a common complaint in patients with 
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mutations in genes affecting the retinoid metabolism as noted in RPE65 mutations (Dharmaraj 
et al 2000, Lorenz et al 2000).
Patients with mutations in AIPL1 and RPE65 have a prominent pigmentary maculopathy 
(Dharmaraj et al 2004). AIPL1-associated LCA shows early macular involvement in a signifi cant 
proportion of patients. Macular coloboma–like lesions have been observed in patients with 
mutations in CRX, perhaps due to maldevelopment (Sohocki et al 1998, Silva et al 2000, Rivolta 
et al 2001, Tzekov et al 2001).
Patients with CRB1 mutations causing LCA, in several instances show a Coats-like phenotype 
(den Hollander et al 2004) and a thickening of the retinal layers by OCT, unlike that seen in other 
LCA patients (Jacobson et al 2003). Retinal thinning is easier to understand as it occurs due to 
thinning of the RPE and the photoreceptor layer. Both the presence of a Coats like-phenotype 
and RP with PPRPE due to CRB1 mutations hitherto lack a suffi cient explanation. GUCY2D-
associated LCA is a severe but stable phenotype with frequent complaints of photophobia, due 
perhaps to the impaired production of cGMP with the persistent closure of the cGMP-gated 
cation channels (Perrault et al 1996). CRX-associated LCA is the only subtypes of LCA with a 
dominant mode of transmission wherein affected parents have affected offspring (Sohocki et al 
1998, Rivolta et al 2001, Koenekoop et al 2002). De novo mutations have been identifi ed in CRX 
and IMDH1-associated LCA (Sohocki et al 1998, Rivolta et al 200, Bowne et al 2006).
RD3 mutations causing truncation of the protein involved in transcription lead to LCA (Fried-
man et al 2006). The phenotype observed shows pigmentary migration with atrophic maculopa-
thy not unlike those observed in patients with RPE65, or AIPL1 mutations.
CEP290 mutations cause LCA, Senior-Løken and Joubert syndromes (den Hollander et al 
2006, Perrault et al 2007). Mutations in this gene account for the largest number of Caucasian 
patients with LCA (den Hollander et al 2006, Perrault et al 2007) Neuropsychomotor delay, early 
cerebellar anomalies and renal anomalies have been noted in patients with CEP290 mutations 
(den Hollander et al 2006, Perrault et al 2007).
8.2.3 Recurrence of LCA sequence variants
Mutations in rare recessive diseases such as LCA may have a founder basis. Therefore, the 
presence of founder mutations was explored. A common Finnish founder mutation in GUCY2D 
causing LCA (2943delG) has been detected even in an outbred population. F565S appears to 
be a common mutation in GUCY2D occurring in families of North African descent (Hanein et al 
2004). Another common founder mutation detected in RPE65 (Y368H) accounts for disease in 
an isolated Dutch population (Yzer et al 2003).
To date, few recurrent mutations have been found the LCA genes, with the W278X mutation 
in AIPL1 being the most common in our study (Chapter 5, Dharmaraj et al 2004). It has been 
detected homozygously in consanguineous families as well as in combination with other muta-
tions in patients born of non-consanguineous union, and shows a high incidence in populations 
of South-East Asian descent (Damji et al 2001, Dharmaraj et al 2004). The presence of this 
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mutation in most instances leads to a very severe LCA phenotype (Dharmaraj et al 2004). The 
P23H rhodopsin mutation causing ADRP also is a founder mutation, accounting for ~40% 
of rhodopsin mutations in the USA (Dryja et al 1990, Berson et al 1991). Though most LCA 
variants are rare, most are recurrent and hence, it is worthwhile to use a microarray “disease” 
chip as a fi rst pass screening tool in every new case of LCA. The use of the LCA disease chip 
in any given patient with the clinical diagnosis of LCA has a 30-60% likelihood of detecting one 
or two mutations (Chapter 7, Zernant et al 2005, Yzer et al 2006, unpublished data Allikmets 
et al 2007).
8.2.4 Frequency of LCA variants
The frequency of mutations in each subtype of LCA is dependent on the populations screened. 
Twenty one percent of patients with LCA had mutations in CEP290 (den Hollander et al 2006). 
However the origin of these patients were Western European and Canadian (den Hollander et 
al 2006). In an Indonesian LCA cohort, RPE65 mutations were predominant (9.5%), followed by 
AIPL1 mutations (4.8%), while no mutations in GUCY2D were detected (Sitorus et al 2003). On 
the other hand, in a largely North African population, GUCY2D mutations were more common 
(Hanein et al 2004). A predominance of CRB1 mutations (~13%) was observed in the Nether-
lands and Germany, while CRB1 mutations accounted for 11% and 10% of patients from the 
United States of America and North Africa/France respectively (den Hollander et al 2001, Lotery 
et al 2001, Hanein et al 2004). A predominance of GUCY2D mutations has been detected in 
patients from Mediterranean countries (Hanein et al 2004). More patients of Asian descent 
have mutations in AIPL1 and RPE65 while more patients of Caucasian orgin have mutations in 
CEP290 (Dharmaraj et al 2004, Joseph et al 2002, Perrault et al 2007).
The LCA patients analysed in this thesis were collected world-wide and a predominance 
based on ancestral origins were not noted, although 19% of all AIPL1 mutations were noted in 
patients from the Indian sub-continent, and 27% of mutations were detected in patients from 
South-West Asia (Chapters 4 & 5, Dharmaraj et al 2000, Dharmaraj et al 2004). Mutations in 
LCA5 were detected in patients of world-wide orgin (den Hollander et al 2007).
8.3 Modifi er effects
Modifi er genes studied so far play a small role in disease. In LCA the role of modifi ers has been 
noted in disease progression (Chapter 6).
The genotyping microarray which is a “disease” chip has become useful in the detection of 
modifi er alleles in LCA. As multigenic inheritance complicates the genetic analyses of LCA this 
arrayed primer extension technology has allowed the testing of > 300 disease-associated vari-
ants in a single experiment. As it has shown 99% effectivity in determining an existent genetic 
variation, 33% in identifying another variation and 7% in identifying more than two variants, it is 
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a useful diagnostic aid for screening all patients diagnosed with LCA. Since the severity of the 
disease has been shown to increase in the presence of several modifi ers, it may be a predictor 
of disease progression (Chapter 7).
8.4 Future direction
Mutation detection is possible using different methods and each method has its own advantages 
and disadvantages (Table 1). When mutation detection in small genes is undertaken sequence 
analysis is used while capillary heteroduplex analysis can be performed when large genes are 
analysed. Currently semi-automated techniques provide accurate and rapid results. When the 
price of nucleotide sequencing will reduce another 2 to 4-fold, mutation scanning technology 
will become obsolete.
As evidenced by Hanein et al (2004), 70% of the detected mutations in LCA were previously 
reported, while 30% of the mutations identifi ed were novel. The use of the LCA disease chip in 
any given patient with the clinical diagnosis of LCA has ~30% likelihood of detecting a mutation 
(Allikmets 2004). The LCA microarray chip may be used as a genetic screening tool in ocular 
genetics, thus translating research from the bench to the bedside.
Finding novel genes expressed in the RPE and the photoreceptors using the Affymetrix 
gene chip technology will provide valuable information regarding candidate genes and this will 
be of great value in gene identifi cation (Yu et al 2004). As the number of genes causing retinal 
degeneration increase it is possible to identify disease causing mutations in ~ 60% of patients 
with AD RP (Daiger 2004).
Providing replacement for the mutant factors, inhibiting apoptotic pathways or stimulating 
anti-apoptotic pathways, down-regulating mutant gene expression, providing gene replace-
ment and specifi cally targeting gene correction, will help pave the way for treating this hitherto 
untreatable disease.
LCA being a disease leading to profound visual loss in infancy, it is promising to note that 
AAV-mediated correction of the defi cit in rpe65 -/- mice in utero leads to restoration of visual 
function (Dejneka et al 2004). Gene replacement therapy, even with relatively modest structural 
improvement leads to improved central visual function (Schlichtenbrede et al 2004). Although 
both dogs and mice have benefi ted from RPE65 gene therapy it is still important to target 
therapy only in regions of intact photoreceptors identifi ed by the normal thickness of the retina 
(Jacobson et al 2005). Since the fi nal outcome of all the pathogenic mechanisms leads to a 
loss of photoreceptor function, pharmacotherapy aimed at pre-apoptotic pathways preserves 
vision by decreasing retinal degeneration (Milam et al 1998). The temporal profi ling of gene 
expression in developing normal retinas and in murine retinas of retinal degeneration would aid 
in the identifi cation of pre-apoptotic signaling molecules which could be targeted with drugs 
(Yu et al 2004).
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In an effort to slow down, prevent or reverse cell death in the retinal photoreceptors it has 
become more important to understand cellular mechanisms from genes to disease. Both 
RPE65 and RDH12 mutations leading to loss of photoreceptor function could be amenable to 
therapy targeting the metabolism of retinoids. Pharmacological intervention using 9-cis retinal, 
a functional analog of 11-cis retinal, results in improved and sustained retinal function (Van 
Hooser et al 2002). Mutation-independent approaches to treat the degenerative retinopathy 
of LCA need to be employed to circumvent the diffi culties encountered with heterogeneity and 
targeting the causes of retinal degeneration may be one option. The mechanisms by which 
retinal degeneration occurs in LCA may be numerous; nevertheless it results in loss of both rod 
and cone function. The primary loss of rods as seen in rhodopsin mutants results not only in 
cone cell loss, but also the loss of second order neurons like ganglion cells. Cells expressing 
mutant protein perhaps trigger a number of other cellular pathways resulting in wide spread 
retinal degeneration. If apoptosis is the only fi nal common denominator of all dysfunctional 
retinal cellular pathways then modulating apoptosis would result in cell rescue. Bcl over expres-
sion and the inhibition of pre-apoptotic proteins and caspase have led to the rescue of retinal 
function (McGuire et al 2004).
Most of the treatment strategies for LCA have been initiated on the premise that the second 
order neurons are intact and are capable of transmitting impulses to the brain. It is important to 
understand the time of onset of degeneration in each subtype of LCA and the window during 
which second order neuron function is within normal limits. The plasticity of the visual pathway 
and the occipital cortex are also a key factor to the timing of targeted therapy. It is encouraging 
to note adequate myelination of the optic radiation and a degree of retained cortical function 
in patients with LCA, despite ganglion cell loss (Noble & Carr 1978, Steinlin et al 1992, Kujala 
et al 2000, Burton et al 2004, Sadato et al 2004). The plasticity of the neural retina following 
remodeling secondary to retinal degeneration allows for more therapeutic options (Jones et al 
2003). The use of retinal prosthesis will however bypass the dysfunctional cell types in the retina 
but currently only few trials are underway. However, the results in terms of potential benefi ts for 
patients will prove invaluable.
8.5 Conclusion
LCA, despite being a relatively rare disease, has been well studied over the last years. Under-
standing the genetics has also improved lately with mutations in thirteen genes now identifi ed 
for this disease. Analysis of the phenotype and establishing a relationship with the genotype 
remains a challenge. With the advent of laboratory automation, the human genome project took 
on an accelerated role and the information obtained from these high throughput centers ushered 
in bioinformatics that aided gene discovery. Although the human genome has been sequenced 
to a large extent facilitating greater access to novel gene identifi cation, further research and 
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analysis are required to fully understand the information embedded in this vast repository of 
sequence. Studying the biochemical and molecular basis of LCA are imperative to its greater 
understanding. As the disease is both clinically and genetically heterogeneous, treatment too 
may have to follow different paths. Animal models of LCA have increased our comprehension of 
the disease and may provide an avenue for clinical trials, although they may not truly represent 
human disease. Molecular diagnosis in LCA will permit an accurate diagnosis with clearer visual 
prognosis (Chapter 7).
Gene therapy, cell transplantation, pharmacogenomic based therapy and retinal prosthesis 
are all future considerations in the treatment of this disease. Pioneering treatment for LCA 
involves issues of consent, ethical approval, safety, and the effi cacy of new clinical trials. Greater 
collaboration within the scientifi c community, the pharmaceutical industry and the regulatory 
bodies will propel the therapeutic options for this rare infantile retinal dystrophy far ahead. 
Providing support to patients and their families is furthered by the numerous support groups. If 
in the last decade we have learned more about the molecular genetics of LCA than in the whole 
of the last century, how much more will we discover in the coming decade!
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9.1 Summary
Leber congenital amaurosis (LCA), a clinically and genetically heterogeneous retinal disease 
has been studied intensively in the past decade. LCA causes photoreceptor degeneration 
or aplasia in a number of ways and is at the severe end of the retinal dystrophy spectrum. 
Greater understanding of the pathogenesis might pave the way for more focussed and pertinent 
treatment strategies to alleviate this disorder. Finding answers to this severe form of retinal 
dystrophy will perhaps solve the conundrum of the pathogenesis of more common causes of 
retinal dystrophies like age-related macular disease and other hereditary retinal diseases.
Complete clinical characterization of each subtype of LCA based on the molecular genetics 
will suggest the type of therapy necessary. Understanding the natural history of the disease from 
a molecular perspective will also provide greater knowledge for counseling and is absolutely 
necessary to evaluate treatment effects.
In this thesis, the genetics of Leber congenital amaurosis was investigated in an effort to 
understand this rare retinal dystrophy and the study of consanguineous kindreds with LCA 
collected worldwide was undertaken. Initially the affected members of an Old Order River Breth-
ren kindred were screened in the then known genes that cause LCA, namely CRX, GUCY2D, 
RPE65. Genotyping using genome-wide markers was performed in an effort to fi nd novel loci 
and genes involved in LCA. Employing genome-wide linkage analysis, a new locus for LCA was 
identifi ed at the proximal end of chromosome 6q (Chapter 3).
As information about the genes involved in LCA became available, these genes were 
sequenced in the patients with LCA and their phenotypes analysed. Comparison of the pheno-
types resulting from each genotypic subset of LCA was undertaken in an effort to identify the 
possible specifi c clinical appearance and understand the natural history (Chapter 4).
The phenotype of AIPL1-associated LCA was analysed in a large cohort and this was further 
compared with other LCA phenotypes (Chapter 5).
The identifi cation of phenotypic variability with the genotype and the role of modifying infl u-
ences were also studied. It also became important to understand the genetics of LCA in the 
light of fi nding more than two sequence variants in the LCA genes in some patients. A further 
study to explain the role of modifi er genes was undertaken (Chapter 6).
A novel microarray method used to screen for mutations in patients with LCA was employed 
which enabled the correlation of phenotypic variance with genetic modifi ers and multi-allelism 
(Chapter 7).
In the study of the genetic and molecular basis of Leber congenital amaurosis, further het-
erogeneity of the disorder both clinically and genetically was established in the fi nding of another 
locus and several phenotypic characteristics. In the future it is hoped that we will be able to treat 
LCA. However this may be dependent on the genotype rather than the phenotype.
As each gene implicated in the pathogenesis of LCA infl uences retinal function in diverse 
ways ultimately leading to severe visual impairment, it becomes important to study the disease 
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from the embryonic stage and understand its evolution. All the genes implicated in LCA ulti-
mately lead to photoreceptor dysfunction. Targeting the fi nal common pathway of cell death 
could perhaps rescue the photoreceptors.
In all the divergent genotypes of LCA, therapy aimed at restoring the functional activity of 
the target cells, slowing the process of degeneration and arresting the disease process will be 
benefi cial in this hitherto intractable heritable ocular disease. Early steps towards clinical trials 
with extensive protocols and stringent safety guidelines will soon be underway.
9.2 Samenvatting
Amaurosis congenita van Leber (LCA), een klinisch en genetisch heterogeen ziektebeeld, werd 
in het afgelopen decennium intensief bestudeerd. Patiënten met LCA vertonen een degeneratie 
of dysfunctie van fotoreceptoren. LCA is de meest ernstige retina ziekte van het grote spectrum 
van retina dystrofi ën. Een betere klinische karakterisatie van ieder subtype van LCA gebaseerd 
op de moleculaire oorzaken zal counselling verbeteren. Een beter begrip van de pathogenese 
van deze ziekte vormt de basis voor nieuw te ontwikkelen behandelmethodes. Het ophelderen 
van deze ernstige vorm van retina dystrofi e zal mogelijk ook nieuwe inzichten verschaffen in de 
pathogenese van meer frequent voorkomende oogziekten zoals ouderdoms maculadegenera-
tie.
In dit proefschrift werden de genetische oorzaken van LCA bestudeerd door de analyse 
van wereldwijd verzamelde consanguine families met LCA. Aanvankelijk werden de aangedane 
personen van een Old Order River Brethren familie geanalyseerd op mutaties in de destijds 
bekende LCA genen, nl. CRX, GUCY2D, en RPE65. De lokalisatie van de moleculaire oorzaak 
in deze familie werd bestudeerd d.m.v. een genoom koppelingsstudie, en een nieuw locus voor 
LCA LCA5) werd gevonden op chromosoom 6q (Chapter 3).
Met het bekend worden van meer genen voor LCA werden deze middels sequentie analyse 
geanalyseerd in het DNA van de verzamelde patiënten en werden hun fenotypes nauwkeurig 
bestudeerd. Een genotype-fenotype correlatie werd gemaakt om genspecifi eke klinische beel-
den te onderscheiden en om het klinisch beloop beter te kunnen inschatten (Chapter 4).
Het fenotype van AIPL1-geassocieerde LCA werd geanalyseerd in een grote groep patiënten 
en werd vergeleken met andere LCA fenotypes (Chapter 5).
De identifi catie van fenotypische verschillen t.g.v. verschillende moleculaire oorzaken en de 
rol van modifi cerende factoren werden bestudeerd. Bij sommige patiënten werden meer dan 
twee varianten in een LCA gen gevonden (Chapter 6).
Een nieuwe LCA mutatie microarray chip werd gebruikt om mutaties op te sporen in patiën-
ten met LCA, waardoor er een correlatie gemaakt kon worden tussen fenotypische variatie, de 
aanwezigheid van modifi cerende genetische factoren, en het voorkomen van meer dan twee 
mutaties in een patiënt (Chapter 7).
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Omdat ieder gen betrokken bij de pathogenese van LCA de retina functie op diverse manie-
ren kan beïnvloeden, is het belangrijk de ziekte in diermodellen te bestuderen vanaf het embry-
onale stadium. Alle genen betrokken bij LCA leiden uiteindelijk tot fotoreceptor dysfunctie. Het 
beïnvloeden van de laatste fase van fotoreceptor celdood zal mogelijk aanleiding geven tot een 
vertraging van het ziekteproces. Binnen de diverse genotypisch verschillende vormen van LCA, 
zal een therapie gericht op het herstel van de functie van de betreffende cellen of het vertragen 
van het degeneratieproces, zeer belangrijk zijn in deze tot dusver onbehandelbare ziekte.
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